stock_JNJ r_up	prices:1 appeared:1 over:1 product:1 myeloma:1 '':1 date:1 unit:2 solutions:1 multiple:1 expects:1 market:3 story:1 long:1 $:1 not:1 top:1 portion:1 comments:1 p.m.:1 also:3 version:2 draft:1 issues:1 use:1 known:1 treatment:1 ``:1 rise:1 's:8 filings:1 than:1 big:1 earlier:1 corrected:1 competes:1 but:1 anticipated:1 lens:1 pressure:1 said:2 diagnostics:2 regulatory:1 immediately:1 grow:1 billion:1 term:1 faster:1 third:1 350:1 anticipates:1 follows:1 medical:1 official:1 rate:1 devices:2 --:1 range:1 contact:1 a.m.:1 error:1 overall:1 guidance:1 published:3
stock_JNJ r_down	heart:1 major:1 over:1 product:1 prices:1 rate:1 long:1 surgery:1 internal:1 unit:3 said:3 $:1 working:1 remains:1 top:2 been:1 than:1 also:1 interested:1 market:2 has:1 heart-device:1 development:1 do:1 program:1 's:5 big:1 rise:1 overall:1 competes:1 but:2 expects:1 pressure:1 not:1 anticipates:1 immediately:1 grow:1 billion:1 term:1 faster:1 350:1 require:1 official:2 devices:2 n't:4 portion:1 diagnostics:2 making:1 replacement:1 medical:1 valves:1
stock_JNJ r_down	major:1 facility:1 over:1 move:1 expects:1 60:1 through:1 year:1 provoke:1 yet:1 giant:1 documents:1 next:1 looking:1 take:1 which:1 eying:1 has:1 might:1 into:1 chairman:1 requested:1 ``:1 's:1 government:2 company:2 problems:2 firmer:1 said:1 acquisitions:1 investigating:1 during:1 manufacturing:2 panel:1 fiscal:1 '':1 runs:1 made:1 request:1 n't:1 turn:1 products:1 stand:1 release:1 recalls:1 maker:1
stock_JNJ r_up	comment:1 major:1 facility:1 over:1 move:1 expects:1 60:1 through:1 year:1 provoke:1 yet:1 giant:1 documents:1 next:1 looking:1 take:1 which:1 eying:1 has:1 might:1 into:1 chairman:1 requested:1 ``:1 's:1 government:2 company:2 problems:2 firmer:1 said:1 acquisitions:1 investigating:1 during:1 manufacturing:2 panel:1 fiscal:1 '':1 runs:1 made:1 request:1 n't:1 turn:1 products:1 stand:1 release:1 recalls:1 maker:1
stock_JNJ r_up	heart:1 because:1 woes:1 illustrates:1 superior:1 suggest:1 clinical:1 rhythm:1 so:1 plant:1 's:1 far:1 early:1 manufacturing:1 data:1 consequences:1 irregular:1 industry:1 drug:2 trial:1 stopped:1 experimental:1
stock_JNJ r_down	because:1 woes:1 busts:1 issued:1 global:1 find:1 infections:1 years:1 price:1 production:1 attempts:1 1.7:1 pulling:1 something:2 have:1 linked:1 market:1 out:1 manufacturing:1 eye:1 $:1 learn:1 rose:1 hope:1 long:1 autism:1 makers:1 finally:1 version:1 unit:1 produced:1 under:1 scant:1 new:2 get:1 collaboration:1 damaging:1 giants:1 then:1 health-care:1 's:5 string:1 views:1 broad:1 company:1 after:2 treatments:1 results:1 launching:1 genetics:1 midst:1 eye-care:1 effort:1 relying:1 those:1 billion:1 both:1 disease:1 developing:1 medicines:1 older:1 companies:1 solution:1 drug:2 plants:1 way:1 costs:1 analysts:1 transparency:1 positive:1 failures:1 execs:1
stock_JNJ r_down	health-care:1 antipsychotic:1 government:1 --:1 marketing:1 company:1 alleging:1 legal:1 surrounding:1 state:1 fraud:1 handed:1 dismissing:1 committed:1 judge:1 lawsuit:1 its:1 victory:1
stock_JNJ r_up	mighty:1 wide:1 include:1 look:1 hip:1 omitted:1 time:1 shares:1 pullback:1 second:1 orthopedic:1 recalled:1 recent:1 recall:2 medicine:1 products:1 implant:1 has:1 maker:1 more:2
stock_JNJ r_up	losses:1 follows:1 recalled:1 companies:2 moving:2 results:2 50:1 time:1 ended:2 6.5:1 oil:2 through:2 its:2 second:1 4.5:1 '':1 strong:2 develop:2 working:2 products:1 weaker:1 expanded:1 environment:2 version:1 7:1 omitted:1 medicine:1 9.5:1 p.m:1 has:2 500:4 stock:2 ``:1 extended:1 's:2 gains:2 wide:1 industrials:1 company:1 earlier:1 corrected:1 nationally:2 first:1 number:1 helping:2 sustainability:2 were:1 fell:6 200-day:2 cleaning:2 address:2 schools:2 televised:2 100:2 stocks:2 data:2 break:2 include:1 sentiment:2 manufacturing:2 spill:2 recall:3 average:2 futures:8 bellwether:2 up:2 times:1 more:2 points:6 31:1 stabilizing:2 improving:2 strategies:2 toward:2 spotlight:2 published:1
stock_JNJ r_down	nerve:2 major:1 caused:2 over:2 some:2 month:1 past:1 schools:1 performed:1 have:1 injuries:2 develop:1 working:1 over-the-counter:1 shares:1 makers:1 environment:1 other:1 helps:2 new:2 has:2 strategies:1 's:1 worse:1 company:1 but:2 sustainability:1 recalls:1 device:2 cases:2 than:1 recent:1 faulty:2 like:1 linger:1 concerns:1 medical:2 companies:1 drug:1 patients:2 common:2 popular:1 heartbeat:2 medicines:1 nearby:2
stock_JNJ r_down	consider:2 providers:3 health-care:2 sales:1 high:1 against:1 unit:1 court:1 alleged:1 discounts:1 samples:1 issue:1 gave:1 's:3 offering:2 company:1 healthcare:1 free:1 representative:1 filed:1 subsidiary:1 lawsuit:3 former:1 anemia:2 --:1 challenge:2 alleging:2 cash:1 drug:3 prescribing:2 kickbacks:2
stock_JNJ r_up	1.4:1 rating:1 optimism:1 625:2 two-day:1 industrials:1 over:4 move:1 dollar:1 each:1 regulatory:1 rate:1 including:1 dropped:1 checked:1 forefront:1 total:2 bank:1 its:1 unit:1 developer:1 24:1 hold:1 develop:3 $:10 pressured:1 against:1 pay:6 decision:1 45:3 4:1 declined:1 downgraded:1 potential:1 health:2 details:1 interest:1 diabetes:3 meeting:1 setting:1 500:1 more:2 development:1 's:4 gains:1 million:6 early:2 banks:1 slipped:1 milestones:1 let:1 drops:1 milestone:1 front:2 based:1 100:1 stocks:1 than:2 yuan:1 additional:1 begins:1 transaction:1 off:1 created:1 upfront:1 could:4 futures:3 up:3 drug:5 n't:1 credit:1 2:1 points:4 payments:1 time:1 worries:2 stock:1 maker:1 fell:2 3.3:1
stock_JNJ r_up	limited:1 although:1 energy:3 helped:1 report:1 's:1 activity:1 down:1 strength:1 federal:1 data:1 housing:1 administration:1 fight:2 higher:1 finish:1 hit:2 gains:1 after:1 strikes:1 regional:1 drilling:3 sharply:1 judge:1 deepwater:1 stocks:3 continued:1 projects:1 disappointing:1 lower:1 manufacturing:1 pulled:1 moratorium:1 were:1 slightly:1 sink:1
stock_JNJ r_up	finalized:1 being:1 month:1 including:1 still:1 children:1 before:2 cut:2 overhaul:1 headline:1 production:2 lawmakers:1 has:1 oversight:1 legislators:1 provisions:1 they:2 trade:1 follows:1 suppliers:2 medicines:1 financial:2 significantly:1 plant:2 expect:2 year:2 financials:1 out:1 even:1 said:4 p.m.:1 version:1 capital:1 supplies:1 ability:1 wo:1 agreement:1 many:1 industry:1 products:1 published:1 makes:1 first:1 own:1 slipped:1 down:1 reopen:1 suspended:1 wrap:1 unit:1 derivatives:1 would:2 legislation:1 been:1 their:1 regulation:1 expected:4 final:1 more:2 ``:2 funds:1 corrected:1 than:2 weighed:1 made:1 target:2 bill:2 up:1 n't:2 debated:1 limit:1 biotech:2 investors:1 stripped:1 alongside:1 pieces:1 '':2 have:1 negotiations:1 end:2 rather:1 which:1 '10:2 tighten:1 's:1 price:2 reach:1 most:1 stocks:1 ago:1 client:1 does:1 banks:1 its:1
stock_JNJ r_down	pharma:1 insurer:1 being:1 big:1 could:1 30:1 problems:1 pop:1 addressed:1 production:1 victory:1 doubts:1 stocks:1 medical:1
stock_JNJ r_down	actively:2 whose:2 lower:2 's:8 session:2 2.7:1 companies:2 slid:2 shares:2 2.9:1 fell:2 trading:2 declined:2 3.1:1 2.3:1 2.2:1 stocks:2 traded:2 500:2 2.4:1
stock_JNJ r_down	promises:2 required:2 give:2 some:2 slid:1 clout:2 actively:1 trading:1 shares:1 3.1:1 threshold:2 2.7:1 declined:1 if:2 whose:1 shareholders:4 boardrooms:2 adopted:2 few:2 version:2 3.9:1 500:1 's:1 favored:2 big:2 but:2 fell:1 stocks:1 provision:2 lower:1 --:2 bill:2 companies:1 session:1 after-hours:1 meet:2 traded:1
stock_JNJ r_up	comment:1 deal:3 drug:4 controversial:1 throughout:1 if:1 sell:2 investors:1 thinking:1 storms:2 treatment:1 eagerly:1 than:1 field:1 details:1 which:1 assuming:1 expected:1 new:1 you:2 price:1 stock:1 await:1 's:3 commercial:1 company:1 earlier:1 upon:1 caps:2 most:1 reason:1 weight-loss:3 approved:2 insights:1 protect:2 rare:1 signed:2 success:1 largely:1 --:1 value:1 grows:1 large:2 rests:1 came:1 time:1 economy:1 maker:2 experimental:2 double-dip:1
stock_JNJ r_up	widened:1 including:1 reports:1 its:3 unit:1 again:1 over-the-counter:1 due:1 linked:1 chemical:1 disclosed:2 's:1 trace:1 marketing:2 becoming:2 doctors:2 improve:2 publicly:2 surrounding:2 recall:1 medicines:1 drug:2 try:2 practices:2 payments:2 transparency:2 time:2 first:2 maker:2 latest:2
stock_JNJ r_down	sector:2 peace:2 show:1 global:1 focus:1 28:1 kicks:1 session:1 thanks:1 its:1 weekly:1 giant:1 rose:2 had:1 expectations:2 winning:2 helps:2 0.5:1 sent:1 undercut:1 move:2 gains:3 weakness:1 rise:2 results:2 early:1 nearly:2 they:1 austerity:2 retreat:1 aluminum:1 drop:1 1.2:1 try:1 payments:1 each:1 small:2 bets:1 set:1 slower:1 surrounding:1 growth:1 year:2 edged:3 eked:1 out:1 avoid:2 shares:1 between:2 reporting:2 ability:1 extend:2 marketing:1 weak:1 met:1 strong:1 improve:1 1.4:1 last:1 transparency:1 hesitant:1 exaggerated:1 taking:1 losses:2 messages:1 quiet:2 reports:2 action:2 maker:1 first:1 among:1 major:2 hopeful:1 currency:2 weaker:2 inventories:2 market:2 protectionism:2 impacts:1 top:1 threatening:1 due:1 tiny:1 next:1 their:2 expected:1 500:1 disclosed:1 upcoming:1 slumping:1 season:3 becoming:1 volume:1 biggest:1 part:1 gain:1 doctors:1 hopes:1 second-quarter:6 grew:2 ahead:4 publicly:1 performers:1 wholesale:2 up:5 pace:1 benchmarks:2 following:2 making:1 streak:2 biotech:1 climbed:2 investors:6 0.3:2 0.2:1 turned:1 1.9:1 pushed:1 drug:1 have:1 moves:1 4.7:1 make:1 sessions:1 1:1 also:1 practices:1 5:1 earnings:4 which:1 higher:2 week:5 begin:1 's:7 may:1 after:1 mixed:1 stocks:5 data:1 euro:1 lower:2 off:1 starting:1 breather:1 points:2 time:1 push:2 fresh:1 latest:1 corporate:1 lows:1
stock_JNJ r_down	breadth:1 founder:1 reductions:1 4.9:1 agreed:1 actions:1 trade:2 session:3 shares:3 settlement:1 its:5 boosts:1 whose:3 giant:1 $:14 adverse:1 rose:1 late:1 has:3 2010:1 earnings:1 bid:1 rise:1 five:1 updates:1 half:1 lost:1 companies:3 deal:6 3.5:1 trading:1 2.1:1 declined:1 said:4 comments:1 3:1 import:1 adding:1 weak:1 million:5 seventh:1 dwindling:1 appears:4 payout:1 larger:1 heating:4 leapt:1 products:5 slightly:1 first:1 comment:1 slipped:2 point:2 offerings:1 1.7:1 rising:1 throughout:1 market:5 bolster:4 passes:1 expected:2 500:3 more:1 acquire:1 sales:1 prices:1 analyst:2 buying:4 wide:1 18:1 up:5 value:1 actively:3 0.8:1 climbed:2 health-care:1 share:1 1.9:1 stroke-treatment:1 weighed:1 seen:2 marking:4 5.6:2 generally:1 lately:1 1:1 also:1 materials:1 5:1 details:1 higher:1 's:5 plans:4 helped:1 fell:2 eight:1 device:1 stocks:5 data:1 480:5 billion:1 lower:2 traded:3 medical:1 hikes:1 competitors:1 points:7 lineup:4 latest:4
stock_JNJ r_up	all:1 proposed:3 executive:2 shares:1 questions:4 its:7 fifth:1 partners:2 founder:1 rose:1 second-quarter:1 better:1 has:4 details:1 giants:1 tests:1 expirations:1 than:1 big:1 bid:1 effects:4 background:1 spur:2 loss:3 notable:1 --:3 medicines:2 companies:2 pursue:2 benefit:1 either:1 stock:2 side:4 mergers:1 gaining:2 smaller:1 weight:3 some:1 back:1 related:1 cash:2 second:1 multiple:1 flagship:1 shown:1 said:6 ways:1 comments:1 research:1 looking:1 enough:2 assuming:1 import:1 boost:1 sixth:1 continuing:1 weight-loss:3 key:2 post:1 come:1 declining:2 reaction:1 improved:1 industry:1 drug:11 wringing:1 long-term:3 experimental:3 first:1 raised:3 slipped:1 revenue:1 rising:1 least:1 market:1 been:1 their:2 clinical:1 low:1 expected:1 more:1 ``:3 pipelines:1 mostly:1 drugs:1 company:2 but:6 taken:1 demand:1 injection:1 pain:2 analyst:1 buying:1 11:1 weighed:1 indefinitely:1 gotten:1 up:1 n't:1 making:1 10th:1 lookout:2 proved:1 share:1 sales:1 biggest:2 '':3 have:2 seen:1 blockbuster:1 moves:1 productivity:2 5.6:2 patent:1 trials:1 agency:4 also:2 grapple:1 earnings:1 which:1 effectiveness:1 weak:1 economy:1 development:4 's:6 may:1 quote:1 price:1 after:1 update:1 leapt:1 significant:3 stocks:4 data:1 acquisitions:1 effective:1 amid:1 rather:1 chief:2 materials:1 model:1
stock_JNJ r_up	also:1 's:5 presence:1 drugs:1 reduce:1 but:1 may:1 does:1 --:1 protein:1 called:1 mean:1
stock_JNJ r_down	comment:1 advisory:2 another:1 certain:1 '':1 drug:1 have:1 such:1 overweight:1 issues:1 millions:1 federal:1 support:1 question:1 also:1 potential:1 safety:1 voted:1 health:1 if:1 assessment:1 obese:1 ``:1 used:1 's:1 sixth:1 overall:1 rejected:1 pressure:1 weight-loss:1 favorable:1 approval:1 concerns:1 panel:3 high:1 --:1 could:1 against:1 whether:1 patients:2 diabetes:1 believed:1 problem:1 asked:1 experimental:1 blood:1
stock_JNJ r_down	millions:1 advisory:1 another:1 certain:1 into:3 ``:1 '':1 experts:1 against:1 have:1 year:3 voted:1 overweight:1 if:1 asked:1 said:3 potential:1 federal:1 support:1 question:1 patients:2 comments:1 next:3 also:1 other:1 safety:1 details:1 closed:3 health:1 troubled:1 might:3 until:1 told:3 obese:1 plant:6 used:1 's:1 plans:3 overall:1 problems:3 rejected:1 pressure:1 regulators:3 weight-loss:1 favorable:1 approval:1 concerns:2 panel:3 high:1 --:1 assessment:1 could:1 well:3 such:1 drug:1 correct:3 whether:1 remain:3 diabetes:1 believed:1 problem:1 medical:1 experimental:1 blood:1
stock_JNJ r_up	investors:2 over:1 reports:3 sense:1 need:1 packed:1 housing:1 damage:1 earnings:2 quarterly:1 reputational:1 week:2 modestly:1 plant:1 broadly:1 get:1 company:1 earlier:1 weak:1 geared:1 drug:1 flurry:1 stocks:1 data:1 advanced:1 recent:1 closure:1 subdued:1 up:1 optimism:1 contain:1 mixed:1 recalls:1 corporate:1
stock_JNJ r_down	sector:1 saying:1 money:1 over:3 focus:4 quarters:1 not:1 manager:1 session:1 including:1 broader:1 7.5:1 its:5 ground:1 impact:1 whose:1 giant:1 cut:2 $:1 also:1 surprises:2 guidance:1 point:1 expectations:1 late:1 advisories:2 premarket:1 quarterly:3 posted:1 2010:1 sent:1 increased:1 very:1 over-the-counter:1 rise:1 watch:2 finish:2 results:1 early:2 report:1 now:1 string:1 gloom:2 gets:2 --:1 follows:1 drop:1 companies:3 lose:1 recalls:2 higher:6 weighs:2 because:1 declines:1 energy:2 some:1 plant:2 slowdown:1 past:1 see:1 elements:1 trading:3 sifted:2 close:1 index:2 extend:2 lead:2 shares:2 forecast:5 future:1 above:1 medicine:1 new:2 led:1 business:1 deflation:1 sparked:1 weak:2 bullish:1 met:1 weaker-than-expected:1 found:2 active:1 rises:1 roundup:1 reflect:1 quarter:1 starts:1 losses:4 reports:9 later:2 figures:1 afternoon:1 leading:1 mixed:2 slightly:1 lowers:3 outlook:1 revenue:2 into:1 powerful:2 down:1 likes:1 market:2 disappointment:1 pin:2 positive:1 housing:3 negative:1 their:2 strong:2 expected:1 territory:1 through:2 sending:1 but:9 part:1 metals:2 hopes:2 second-quarter:1 he:1 helped:1 third:2 batch:1 devices:1 believes:1 growth:1 ally:2 revenues:1 souring:1 camp:2 investors:3 health-care:1 sales:2 slowing:1 disappointing:2 full-year:1 dropped:1 have:2 rally:1 gains:3 flood:1 concerns:2 tumbling:1 earnings:9 several:1 stock:4 week:2 product:1 oil:1 's:2 problems:2 falls:2 77:1 modest:2 coming:1 stocks:5 recent:1 short:1 sentiment:3 manufacturing:2 medical:1 futures:4 reflecting:1 rallies:2 barrel:1 corporate:2 latest:2
stock_JNJ r_down	saying:3 agreed:1 years:3 planning:1 shake:3 its:1 issues:1 $:3 consumer-goods:1 late:1 board:3 condom:1 has:1 2011:1 over:1 sent:1 details:1 early:1 despite:1 world:1 disappointed:1 term:1 stimulus:1 signal:1 did:1 recalls:1 set:1 deal:1 further:1 shares:1 activist:3 residual:1 regulators:1 regulatory:1 strong:1 stage:1 could:1 losses:1 reports:2 maker:1 campaign:3 destroyed:3 guess:1 management:3 would:1 decent:1 there:1 returns:1 much:1 biggest:1 launching:3 firm:1 ``:3 company:5 acquire:1 but:3 hurt:1 whether:1 up:3 value:3 2010:2 n't:2 near:1 values:1 venture:1 were:1 revenues:1 months:1 600:2 investors:1 cited:1 sales:1 slowing:1 '':3 have:3 rally:1 scrutiny:1 tumbled:1 damage:1 concerns:1 tumbling:1 earnings:2 plant:1 's:9 shareholder:6 stocks:1 recent:4 billion:2 third:1 biotechnology:3
stock_JNJ r_down	operations:1 sector:1 epilepsy:2 results:2 years:1 session:2 tablets:1 signs:1 proceeding:1 still:2 its:6 issues:2 previous:1 planning:1 whose:3 1.14:1 cut:1 $:11 hunting:1 over-the-counter:3 rose:5 anemia:1 expectations:2 analyst:2 better:1 failed:1 causing:1 4:1 weakening:1 quarterly:2 has:3 2010:2 details:3 hip:1 global:1 string:3 than:1 government:2 grand:2 expectation:1 expects:1 orthopedic:1 background:1 new:2 report:1 now:3 procedures:1 discuss:1 bank:1 target:1 loss:2 term:1 amid:1 excluding:1 lost:2 --:1 medicines:4 companies:3 stimulus:1 settle:2 yields:1 recalls:3 higher:3 inspection:1 signal:1 replacement:1 set:2 financial:1 people:1 bellwether:1 heartburn:1 receipt:1 some:1 related:1 trends:1 growth:2 trading:3 kinds:1 makers:1 declined:2 2.4:1 investor:1 said:3 adds:1 missed:1 consumers:1 profit:3 disruptions:1 review:1 both:1 shares:3 forecast:3 behind:2 investigation:2 various:2 market:1 surging:1 net:2 reporting:1 kicked:1 jury:2 marketing:2 million:2 weak:1 giant:1 conglomerate:1 reported:3 regulators:2 economy:1 regulatory:1 strong:1 reaction:1 7.5:6 items:1 seeking:1 months:2 according:1 drug:5 range:1 fell:3 products:4 mixed:1 weaker-than-expected:1 makes:1 maker:2 comment:1 revenue:1 into:3 number:1 negative:1 down:1 device:2 maintained:1 65:1 losses:1 wider:2 throughout:1 unit:1 conference:1 pharmaceutical:2 been:1 waits:1 positive:1 due:2 per-share:1 their:1 pared:1 call:1 dealing:1 9.5:3 meeting:1 500:2 disclosed:1 disappointed:1 flat:1 head:1 relations:1 posting:1 offer:1 drugs:1 season:1 company:8 but:5 hurt:1 released:1 construction:1 court:1 gain:1 prices:2 surprising:1 lowered:1 despite:1 second-quarter:5 those:1 11:1 made:1 15:2 look:1 permits:1 18:1 edged:1 up:2 devices:1 n't:1 near:1 actively:2 ongoing:1 were:2 acquisition:2 numbers:1 0.8:2 slid:1 barely:1 investors:1 1.3:1 cents:1 certain:2 cited:2 received:1 share:5 sales:8 full-year:2 curb:1 reports:3 have:1 further:1 take:1 reputation:1 tumbled:2 information:1 damaged:1 bottles:1 bonds:1 medical-devices:1 aside:2 highlighted:1 points:6 build:1 which:1 income:1 implant:1 out:1 rides:1 stock:3 plant:3 's:19 slightly:3 though:1 may:1 earnings:7 price:1 after:4 problems:1 forecasts:1 offsetting:1 complaints:1 knee:1 stocks:3 pressuring:1 recent:4 acquisitions:1 lower:2 short:1 off:2 longer:1 third:2 traded:2 medical:2 futures:1 premarket:1 uncovered:1 federal:2 costs:1 subpoena:2 health-care:2 fresh:1 overseas:1 blue-chip:1 medical-device:1
stock_JNJ r_up	sector:1 epilepsy:1 results:1 aside:1 session:4 comments:1 7.5:3 still:1 its:3 24:1 whose:4 prescription-drug:1 $:3 over-the-counter:1 rose:3 expectations:1 second-quarter:4 disclosed:1 has:1 details:1 hip:1 updated:1 increased:2 government:1 orthopedic:2 hitters:1 updates:1 background:1 loss:2 lost:3 medicines:1 companies:4 settle:1 surging:1 after-hours:2 recalls:2 higher:2 replacement:1 heavy:1 set:1 some:2 related:1 challenges:1 actively:4 trading:4 pricing:1 year:1 2.3:1 edged:1 makers:1 declined:1 out:1 missed:1 3rd:1 profit:1 disruptions:1 shares:4 forecast:1 behind:1 investigation:1 deficit:1 new:1 net:3 earlier:1 jury:1 marketing:1 million:3 weak:1 conglomerate:1 reported:1 gained:1 both:1 pressure:2 dollars:1 barely:1 reports:1 products:1 threat:1 graph:1 slightly:1 maker:2 comment:1 into:1 1.6:3 2nd:1 maintained:1 wider:1 unit:1 waits:1 top:1 due:2 per-share:1 9.5:3 markets:1 500:4 more:1 received:1 registered:1 but:3 lowered:1 prices:2 than:1 posted:1 12:1 devices:1 growth:2 ongoing:1 heart:1 slid:2 climbed:1 1.1:1 1.2:1 1.3:1 health-care:1 sales:5 full-year:2 drug:2 triple:1 take:1 5.1:1 seeking:1 struggles:1 1:1 also:1 earnings:3 which:2 grand:1 implant:1 rides:1 company:5 stock:2 product:1 's:5 information:1 price:2 after:2 forecasts:1 76:1 fell:4 knee:1 stocks:4 lower:3 off:1 traded:3 persistent:1 face:1 federal:1 points:6 subpoena:2 overseas:1 medical-device:1
stock_JNJ r_up	1.4:1 biotech:3 1.1:1 deal:1 claim:1 health-care:1 positioned:1 actively:3 trading:3 looks:1 news:2 watchdog:1 any:1 whose:3 27:1 end:1 8.4:1 became:2 system:1 shares:3 better:1 shifts:1 only:2 points:9 interest:2 's:2 interested:2 500:3 higher:3 11:1 we:1 edged:1 increased:3 get:1 may:2 big:2 company:3 after:2 stem-cell:1 12:1 not:2 changing:1 101:1 payment:1 gained:2 stocks:3 grew:3 58:1 16:1 whether:1 die:1 companies:3 up:1 drug:2 public:2 session:3 after-hours:1 traded:3 maker:2
stock_JNJ r_up	comment:1 biotech:2 raised:1 challenging:1 deal:2 bigger-than-expected:2 year:1 tax:1 sales:5 full-year:1 growth:1 including:2 doubled:1 shake:1 seen:1 surgery:1 forecast:3 its:3 market:1 increase:2 end:3 guidance:1 detail:1 second-quarter:1 better:2 behind:1 earnings:2 new-home:2 outlook:1 conditions:1 rosy:2 more:1 's:5 get:2 any:2 boosted:3 company:3 next:1 connected:2 positioned:2 continued:1 than:1 lower:1 off:1 whether:2 climbed:2 companies:2 maintained:1 devices:1 competitors:1 surging:1 housing:2 following:2 maker:1 looks:2
stock_JNJ r_down	challenging:1 deal:1 win:1 sales:1 likely:1 devices:1 shake:1 seen:1 surgery:1 market:1 make:1 20:1 $:1 continued:1 support:1 behind:1 should:2 enough:1 board:1 surging:1 conditions:1 earnings:1 eventually:1 buy:1 's:2 than:1 bid:1 effort:1 second-quarter:1 formal:1 billion:1 pipeline:1 valued:1 off:1 could:1 doubled:1 maker:1 competitors:1 so:1 more:1 scrap:1
stock_JNJ r_up	among:1 secure:1 deal:3 increasingly:1 win:2 hard:1 alternatives:1 likely:2 including:3 medicines:3 further:1 makers:3 cut:3 20:2 $:2 generic:1 pay:3 support:2 shares:1 find:1 enough:2 parents:1 board:2 between:1 new:1 drops:1 company:1 eventually:1 after:1 's:7 offer:1 bid:1 de:2 pharmacy-benefit:1 agreement:1 stripped:1 takeover:1 they:3 prices:3 effort:2 formal:2 billion:2 manager:1 valued:2 target:1 countries:3 pinch:3 could:2 say:1 directors:1 feeling:3 make:2
stock_JNJ r_up	comment:1 adjusted:1 revenue:1 certain:2 tax:1 sales:2 helped:1 second:1 through:1 pricing:1 throughout:1 information:1 additional:1 merger-related:2 profit:4 expectations:2 second-quarter:2 other:1 details:2 lower-than-expected:1 doubling:1 include:1 15th:1 stock:1 's:6 than:2 decline:2 beat:2 earnings:2 price:1 but:1 includes:1 pressure:1 restructuring:4 takeover:2 updates:1 background:1 offset:2 analyst:1 reaction:1 booked:2 short:1 excluding:2 third:1 reported:4 drop:2 rate:1 drug:4 52:12 merger:2 near:1 costs:6 including:1 more:2 maker:4 fell:1 result:2
stock_JNJ r_up	biotech:4 significantly:1 had:1 into:4 share:5 we:1 private:2 need:1 privately:1 67:1 talks:6 69:3 lately:1 its:3 giant:1 $:5 merger:2 there:1 detailing:3 low-risk:2 than:1 lot:1 between:1 entered:4 has:3 friendly:4 more:1 firm:4 staying:1 good:1 high-dividend:2 reportedly:1 offer:1 company:1 marking:1 takeover:6 hear:1 letter:4 70:1 prices:1 news:1 stocks:2 proposal:2 pharma:1 sending:4 --:2 up:1 drug:3 've:1 offering:1 maker:3 acquisition:1
stock_JNJ r_up	comment:3 biotech:1 already:1 sees:1 deal:8 revenue:3 agreed:4 advisors:1 share:2 sales:3 awaited:1 catalysts:1 n't:1 selling:3 wow:1 69:1 its:4 move:1 pharmaceutical:2 giant:2 said:10 adds:4 $:2 stretch:1 exactly:1 detail:1 long:1 strategy:3 few:3 add:3 other:3 treatment:3 stable:4 several:1 conditions:7 price:2 earnings:3 firm:1 product:3 million:4 's:19 offer:1 company:4 acquire:4 shareholders:1 treatments:3 coming:1 fits:3 immediately:3 18.4:1 analyst:2 after:3 billion:1 reaction:1 reward:1 --:4 boost:3 medicines:4 cash:4 drug:5 options:3 flagship:3 did:1 risks:1 2012:3 maker:4
stock_JNJ r_up	blood-thinner:1 already:1 bleeding:1 share:1 price:1 69:1 its:1 feared:1 pharmaceutical:2 said:1 $:1 trial:1 stretch:1 marketed:1 warfarin:1 preventing:1 potentially:1 treatment:1 which:1 pivotal:1 fatal:1 cause:1 clots:1 more:1 's:5 offer:1 company:2 standard:1 long-term:1 blood:1 effective:1 --:1 n't:1 did:1 risks:1 rivaroxaban:1
stock_JNJ r_up	comment:2 operations:2 because:2 retired:1 clinical:1 joints:2 reported:1 reporters:2 sales:7 due:1 outcomes:1 improving:1 concerns:1 financial:1 margins:2 hospitals:2 surgery:2 addition:1 deals:2 said:3 analyst:1 profit:3 rose:2 wound:2 detail:2 hepatitis:1 its:8 better:3 asking:2 patient:1 board:1 under:1 performance:1 net:3 insurers:2 2010:2 higher:2 flat:3 executive:1 's:3 company:1 rise:1 abruptly:1 expects:2 pressure:1 slow:1 putting:2 two:1 offset:3 device:3 last:1 forecasts:1 weekend:1 second-quarter:3 standard:2 care:2 compared:1 beating:1 off:2 improved:1 16:9 --:3 medical:3 drug:1 alone:1 patients:2 frugal:2 remain:2 products:2 experimental:1 treatment:2 trials:1 told:2 maker:3 hips:3 replacement:3
stock_JNJ r_up	raised:1 sales:1 quarters:1 spinal:2 7.1:1 have:2 surgery:1 flagging:1 insurance:1 market:1 --:1 $:1 long:1 makers:1 source:1 various:1 ramping:1 biggest:1 new:1 several:1 hurdles:1 's:1 views:1 started:1 big:1 reporting:1 but:1 pressure:1 they:1 such:1 procedures:2 appear:1 billion:1 insurers:2 these:1 amid:1 industry:1 companies:2 up:1 devices:1 spine:1 efforts:1 comes:1
stock_JNJ r_up	associated:1 facility:1 certain:1 into:1 some:1 number:1 order:1 warning:1 traveling:3 filters:1 vessel:1 its:1 said:1 found:1 fatal:1 parts:1 details:1 main:1 treat:1 body:2 used:3 returning:1 may:1 clots:3 after:1 problems:2 warn:1 blood:4 letter:1 half:1 manufacturing:1 clot:2 lower:1 legs:1 --:2 warned:1 could:1 devices:4 keep:3 receive:1 patients:1 can:2 small:1 study:1 distribution:1 inspection:1 other:1
stock_JNJ r_down	help:2 known:1 including:1 filters:1 during:1 its:1 patches:2 other:3 treatment:2 has:2 which:2 returning:1 number:1 effects:2 half:1 using:1 learned:1 success:1 --:3 warned:1 companies:1 small:1 found:2 stock:1 inspection:2 side:2 often:2 findings:1 some:2 second:1 result:2 pills:2 popping:2 said:2 avoid:2 looking:1 outside:2 market:1 routine:1 falling:1 issue:1 body:2 deflation:1 reported:1 key:1 regulatory:1 manufacturing:1 received:1 essentially:1 receive:1 could:3 according:1 drug:1 keep:2 connection:1 studies:1 blood:3 facility:1 into:2 period:1 dominating:1 vessel:1 unit:1 three:1 maintenance:1 main:1 reaction:1 company:1 warn:1 doctors:2 prices:1 hold:1 10:1 made:1 dangerous:2 up:1 devices:4 patients:1 can:1 distribution:1 creeping:1 traveling:2 prospect:1 associated:2 investors:1 certain:1 site:1 say:2 warning:2 reports:1 painkillers:2 event:1 adverse:1 parts:1 widely:2 instead:2 widespread:1 clots:2 economy:1 used:4 may:2 price:1 after:1 problems:3 72:1 letter:2 stocks:1 curing:1 lower:1 2005:1 late-stage:1 oral:2 filing:1
stock_JNJ r_up	comment:1 1.1:1 investors:1 civil:2 series:3 demands:2 health-care:2 identify:2 general:3 '':6 regulatory:2 authorities:2 have:3 reached:1 its:3 n't:3 giant:2 said:5 record-low:1 $:1 no:1 government:1 spokesman:1 eager:1 state:5 rates:1 ever:1 price:1 stock:1 lowest:1 ``:6 buy:1 multiple:3 bonds:2 could:1 sold:1 updates:1 10-year:1 immediately:1 debt:2 states:2 billion:1 received:2 30-year:1 attorneys:3 did:2 medicines:3 over-the-counter:3 securities:1 connection:2 yields:1 time:1 recalls:5 corporate:2 filing:2
stock_JNJ r_down	rating:1 all:1 session:1 its:2 weekly:1 high-grade:1 $:6 should:1 municipal:1 government:2 safe:2 preparing:1 they:2 10-year:3 30-year:4 --:2 issue:1 companies:1 yield:1 securities:1 bond:2 set:3 people:2 warns:1 sign:2 really:2 since:1 safety:2 new:1 ever:3 10-:1 continuing:2 agencies:1 regulators:1 weight-loss:1 struggle:1 strong:1 receive:1 drug:2 trial:1 think:2 first:1 raised:1 fleeing:2 rated:1 record-low:2 addition:1 leading:1 three:1 rates:5 interest:3 expected:2 today:1 lowest:3 offering:2 purposes:1 two-part:1 record:1 bet:2 1.5:1 1.1:3 investors:3 spectrum:1 general:1 high:1 investment-grade:2 proceeds:1 sell:1 ratings:2 end:1 credit:1 bonds:10 other:1 which:1 used:1 's:1 plans:1 price:4 debt:3 stocks:1 billion:4 later:1 sale:1 time:2 corporate:6 nearly:1
stock_JNJ r_up	global:1 mainly:1 quarters:1 brain:1 skin:1 $:3 under:1 has:1 updated:1 his:3 risk:1 advances:1 cutting:1 legendary:1 consecutive:1 hedge:3 condition:1 underscores:1 securities:3 red:1 quarter:3 says:3 people:1 back:1 elderly:1 second:3 cost:1 surgery:1 even:1 said:1 comments:1 routine:1 new:2 conditions:1 therapies:1 after:1 difficulty:1 news:1 beginning:1 care:1 chapter:1 reaction:1 kids:1 could:1 drug:1 studies:1 experimental:1 cancer:2 chronic:1 diabetics:1 story:1 diseases:1 mark:1 2:1 type:1 final:1 brand:1 took:3 strikes:1 fund:3 sharply:3 line:1 analyst:1 posted:1 11:1 showed:1 up:1 value:3 patients:1 stages:1 associated:1 dropped:3 ink:1 increased:4 5.1:3 end:3 stake:6 42:9 stock:1 development:1 's:11 price:1 earlier:1 treatments:1 halted:1 4th:1 coming:1 billion:3 effective:1 amid:1 medical:1 disease:2 filing:3
stock_JNJ r_up	engagement:1 suitors:1 people:1 series:1 hiring:1 likely:1 strengthening:1 quality:1 unit:1 out:1 over-the-counter:1 rather:1 workers:1 there:1 300:1 other:1 medicine:1 drawn:1 more:1 product:1 's:2 may:1 pursuit:1 key:1 wedding:1 than:1 off:1 --:1 shotgun:1 area:1 drug:2 connection:1 lays:1 recalls:1 maker:1
stock_JNJ r_down	access:1 fibromyalgia:1 may:1 ease:1 health-care:1 two:1 anxious:1 symptoms:1 tidbits:1 news:1 bit:1 tai:1 more:1
stock_JNJ r_up	consider:2 investors:1 dividend-paying:2 surprisingly:1 relative:1 economic:1 weak:1 names:1 have:2 busy:1 offer:1 been:1 safety:3 low:1 new:2 you:1 bored:1 frustrated:1 more:1 poor:2 roster:2 dividends:1 after:3 stop:1 depths:1 increases:1 flown:1 lows:2 debt:1 fall:3 pair:1 strategists:1 stocks:2 data:2 paying:1 both:1 appeal:1 healthy:1 well:1 reports:1 leave:1 record:1 yields:5 can:1 plumbing:1 stock:1 bond:1
stock_JNJ r_up	among:2 because:2 investors:1 almost:2 certain:2 into:2 estimates:2 repurchases:2 balances:2 through:1 result:2 some:1 return:2 mergers:1 linked:2 unit:2 if:2 one:1 looking:1 unusual:1 $:2 would:2 no:1 spending:2 current:2 spread:1 much:2 combined:2 7:2 money:3 new:1 dividends:1 has:1 issue:2 company:1 500:2 boom:1 week:1 billion:2 pain:2 share:2 100,000:2 activity:1 disposable:2 confirmed:1 flurry:1 boxes:2 recalled:2 normalized:2 complaints:2 manufacturing:2 2008:2 11:2 last:1 assets:2 buybacks:1 's:2 markets:2 many:1 companies:5 cash:2 daily:2 calling:1 merger:1 contact:2 poured:2 were:2 voluntarily:2 2009:2 other:1 lenses:2
stock_JNJ r_down	help:2 shaky:1 results:1 session:2 businesses:1 shares:2 left:1 its:3 whose:2 giant:2 claim:2 based:1 purchases:1 good:2 environment:1 charge:1 4:2 has:1 details:2 tests:1 global:1 increased:1 get:2 weakness:2 100,000:1 routine:1 boxes:1 effects:1 they:2 immediately:1 like:1 lost:2 --:3 notes:1 drop:2 companies:2 slide:2 night:2 worries:2 study:1 voluntarily:1 looks:2 because:2 some:1 illegally:1 used:1 up:1 past:1 second:1 actively:2 trading:2 year:3 coverage:1 first-quarter:1 surgery:1 87:3 declined:3 spokeswoman:1 said:6 federal:3 jumped:3 comments:1 forecast:2 participants:1 health:2 toll:1 defibrillators:3 nuclear:1 issue:1 public:3 recently:4 scientific:2 existing-home:2 marketing:4 disposable:1 pressure:2 regulators:3 imaging:1 billionaire:1 approval:3 manufacturing:1 care:1 received:1 could:1 days:1 trial:1 products:6 lenses:1 comment:2 outlook:1 heart-rhythm:1 revenue:2 due:1 spinal:1 appropriate:1 reached:1 array:2 throughout:1 unit:6 standing:1 1.2:2 few:1 leading:2 system:1 their:1 returns:1 clinical:1 biggest:1 markets:2 500:2 triggered:1 relax:2 company:2 but:3 surprisingly:2 lowered:2 recalled:1 prices:1 pain:1 analyst:1 sleep:3 wide:2 made:3 slowed:1 devices:1 n't:2 record:2 while:1 values:1 were:2 taking:1 1.5:1 liabilities:1 investors:2 1.3:2 certain:1 health-care:1 sales:4 evidence:2 warning:3 linked:1 sell:1 radiation:1 1:1 contact:1 earnings:3 big:1 you:2 pension:1 economy:2 product:2 added:2 's:6 price:1 earlier:1 fell:6 letter:5 complaints:1 stocks:2 legal:1 fiscal:1 lower:2 surprising:1 amid:2 required:3 daily:1 without:3 talk:1 broad:2 clearance:1 starting:1 medical-device:3 latest:1
stock_JNJ r_down	1.5:1 quietly:1 1.7:1 1.3:1 supported:1 actively:1 trading:1 dropped:1 reducing:1 declined:1 out:1 whose:1 shares:1 program:1 has:2 500:1 after-hours:1 fell:1 sharply:1 stocks:1 lower:1 lost:1 companies:2 coalition:1 large:1 session:1 emissions:1 were:1 cap-and-trade:1
stock_JNJ r_down	operations:1 being:1 implants:2 month:1 higher:1 still:2 yet:1 issues:1 impact:2 adding:2 giant:1 much:1 hip:3 string:1 get:1 showing:1 background:2 not:2 --:1 recalls:1 revision:1 surgeries:4 replacement:3 prevent:1 because:3 financial:2 people:3 blood-thinning:1 back:1 second:1 said:2 voluntary:1 review:1 below:1 comments:1 its:1 spokesman:2 does:2 market:1 new:4 announced:1 pushing:1 reported:1 implanted:3 panel:1 rhythms:1 irregular:1 drug:3 experimental:1 first:1 previously:1 another:1 throughout:1 quality:3 unit:4 eye:1 additional:1 recalling:3 placing:1 due:1 next:1 needed:4 2:2 type:1 some:1 company:7 removed:2 than:1 recall:4 require:2 rate:5 devices:2 patients:3 evaluating:2 problem:2 called:1 heart:1 10000:1 have:2 cited:1 high:3 world-wide:1 parts:3 potentially:1 details:1 which:3 orthopedic-device:3 five-year:1 worldwide:2 repeat:3 's:4 strokes:1 problems:1 fell:1 data:2 amid:1 came:1
stock_JNJ r_up	because:2 10000:1 campaign:1 people:2 high:2 rate:2 world-wide:2 unit:2 touts:1 recalling:2 review:1 administration:1 below:1 needed:2 parts:2 health:1 new:1 insurers:1 orthopedic-device:2 hip:2 repeat:2 's:2 get:1 pushing:1 fell:1 breast-cancer:1 implanted:2 2:2 drug:1 n't:1 accelerated:1 donations:1 does:1 efforts:1 surgeries:2 replacement:2
stock_JNJ r_down	among:1 he:1 end:1 string:1 career:1 fix:1 there:1 problems:1 company:1 most:1 near:1 important:1 have:1 recalls:1 must:1 legacies:1 leaves:1 prompted:1
stock_JNJ r_down	yen:1 global:1 dollar:1 month:1 drug-stock:2 session:1 years:3 its:3 25:1 20:1 $:1 candidate:1 continued:1 fuel:1 2016:3 eventually:1 get:1 early:1 exporters:1 bringing:1 day:1 level:1 medicines:1 companies:1 race:1 after-hours:1 release:1 exceed:1 dead:1 jump:1 economic:1 trading:1 year:1 2.3:1 declined:2 provided:1 soured:1 lead:2 since:1 lean:2 shares:2 falling:1 whose:1 worries:1 news:1 100:1 received:1 ahead:1 could:1 losses:2 drug:1 34:1 traded:1 experimental:1 thinner:1 revenue:1 replace:1 another:1 market:1 confidence:1 housing:1 selloff:1 two:1 500:2 lowest:1 drugs:1 gain:1 sharply:1 3.6:1 has:1 16:1 actively:1 ongoing:1 1.4:1 seven:1 against:1 dropped:3 sharp:1 rally:2 4.4:1 develop:1 recovery:4 no:1 warfarin:1 till:3 you:1 status:1 's:1 141:1 fell:3 blood:1 end:1 stocks:1 data:1 billion:1 lower:1 sentiment:1 futures:3 overnight:1 points:6 2009:2 consumer:1
stock_JNJ r_up	gold:2 warfarin:3 global:2 looks:1 its:3 replacements:1 20:2 $:5 earned:1 workers:3 laid:1 silver:2 fuel:2 worth:1 eventually:2 judge:1 discuss:3 earn:2 staples:2 medicines:2 50:1 race:2 exceed:2 deal:1 some:1 economic:1 year:2 insurance:1 provided:2 said:3 since:1 research:1 cell:1 rotten:1 firms:1 stem:1 picking:1 raise:3 asks:1 could:2 according:1 tempting:1 experimental:2 lay:2 thinner:2 revenue:2 replace:2 reached:1 crisis:1 market:2 pharmaceutical:3 proceed:1 would:3 there:1 two:2 least:1 500:1 more:3 wants:3 offer:3 drugs:2 company:7 released:1 line:1 than:1 hike:1 up:1 apples:2 study:3 have:3 if:3 develop:2 dialysis:1 pay:1 42:1 potential:1 used:1 's:2 most:1 blood:2 nothing:1 2008:1 billion:2 off:3 average:1 sale:3 allow:1 biotechnology:3 barrel:1 executives:1 consumer:2
stock_JNJ r_up	never:1 's:4 words:1 investors:1 stockpicker:3 investing:1 individual:1 work:2 been:1 most:1 have:1 right:1 those:1 statement:1 you:2 now:1 true:1 than:1 market:3 more:1
stock_JNJ r_down	biotech:1 emerging:1 since:1 help:1 among:1 over:1 partnership:1 50:1 down:2 select:1 economic:1 gauge:1 looks:1 another:1 its:1 market:2 if:1 giant:1 group:1 $:4 earned:1 pay:1 workers:1 offer:1 42:1 least:1 crisis:1 pharmaceuticals:1 laid:1 5:1 negotiates:1 firms:1 markets:1 500:1 damages:1 wants:1 do:2 's:2 seeking:1 company:2 arthritis:1 needs:1 bear:1 most:1 succeed:1 bull:1 than:1 buying:1 raise:1 both:1 off:1 released:1 --:1 up:2 average:1 well:3 according:2 drug:1 consensus:1 did:1 analysts:1 advisers:1 study:1 more:1 rheumatoid:1 dissolve:1 executives:1
stock_JNJ r_up	because:1 investors:1 strengthen:1 agreed:2 partnership:3 cheap:1 negotiates:1 years:1 top:2 vs:1 9.75:1 its:3 principal:1 move:1 dump:1 would:3 writes:1 deflation:3 hepatitis:1 research:1 other:1 acting:1 concerns:1 735:2 questioned:1 stable:1 has:1 over:1 damages:3 firm:1 million:2 diseases:1 bonds:1 drugs:3 share:1 company:2 acquire:2 disclosed:2 gain:2 they:1 stocks:5 effort:2 arthritis:1 $:3 pipeline:1 widely-held:1 seeking:3 could:1 drug:1 keep:1 bad:1 assumptions:1 dissolve:3 biotechnology:2 rheumatoid:1 notion:1
stock_JNJ r_up	heavy:1 investors:2 sales:1 high:1 all-time:1 growth:1 have:1 2.5:2 run-up:2 bullish:3 broad:1 shares:1 insider:1 earnings:1 test:2 flat:1 run:1 may:2 despite:1 advance:1 many:1 climbed:1 up:1 pacing:1 remain:1 maker:1 software:1
stock_JNJ r_up	firm:3 biotech:3 unusual:3 own:3 advance:1 broad:1 climbed:1 allegations:3 regulators:3 pacing:1 one:3 twist:3 reported:3 directors:3 potential:3 2.5:2 boardroom:3 insider-trading:3 has:3 its:3 spat:3
stock_JNJ r_up	says:1 double:1 us:1 record:1 're:2 dip:1 he:1
stock_JNJ r_up	still:2 biotech:1 outlook:3 sees:1 broader:2 less:3 reductions:2 relieve:1 turbulent:2 sales:2 spinal:3 slowed:2 growth:3 shares:1 questions:1 year:2 recently:1 surgery:1 next:2 drug:1 its:2 market:4 seemed:1 announcement:1 cut:2 end:2 $:2 generic:1 rose:1 top:2 comments:2 forecast:2 type:1 continue:1 5:2 details:1 prices:1 has:2 company:3 2010:2 stock:1 used:1 's:6 way:1 than:1 share:1 price:1 after:1 much:1 pressure:1 fusion:1 rapid:1 predictable:2 updates:2 despite:1 throughout:1 assets:1 analyst:1 buying:1 manages:1 billion:1 faster:1 amid:1 industry:1 opportunities:1 backed:1 up:1 devices:3 suggests:1 patients:1 maintain:1 can:1 deterioration:1 were:1 growing:1 become:2 guidance:2 triggering:2
stock_JNJ r_up	sell:1 unusual:1 raising:1 without:1 --:1 move:1 all:1 approved:1 while:1 itself:1 treatment:1 cash:1 making:1 newly:1 its:1 launching:1 13:2
stock_JNJ r_up	says:1 prompted:2 retire:2 sales:2 hearing:1 second:1 raises:1 committee:2 year:2 children:2 unit:2 millions:2 information:1 hold:1 additional:1 over-the-counter:1 next:2 citing:1 causing:2 chairman:1 conduct:1 more:1 head:2 's:6 string:2 questions:1 after:2 problems:2 hundreds:2 recalls:1 manufacturing:2 lost:2 recall:2 dollars:2 30:3 massive:2 investigating:1 consumer:2 medicines:1
stock_JNJ r_up	sector:3 comment:3 all:2 holds:2 proposed:2 less:1 over:2 move:3 results:2 rest:3 month:1 questions:1 own:2 through:3 per:4 committee:2 talks:6 doesn’t:1 its:4 issues:1 hearing:1 increase:1 giant:6 retirement:1 group:1 $:8 over-the-counter:1 rose:4 had:1 haven:1 late:1 citing:1 equity:1 8:1 has:2 2011:1 remaining:1 momentum:1 economic:1 retire:1 gains:5 get:1 very:1 bid:1 rise:2 financing:1 early:3 inflation:1 new:3 front:1 2nd:1 continued:2 advanced:5 above:2 beginning:1 showed:1 --:6 medicines:1 companies:5 morning:3 continue:1 affiliate:2 retailers:1 after-hours:1 worries:1 recalls:1 higher:7 mergers:1 upward:1 still:1 bankruptcies:1 set:1 detail:2 propel:1 burst:1 told:2 back:1 related:2 up:3 second:1 actively:3 trading:6 2.3:4 prowl:1 out:1 investor:1 said:5 adds:1 unabated:2 since:1 shares:6 research:1 vaccines:2 include:1 3:1 does:2 unit:1 closed:1 conduct:1 consecutive:1 price:1 announced:3 movement:1 core:2 we:1 after:1 business:2 whose:3 cheered:2 investigating:1 news:1 debt:1 come:2 vaccine:2 pharma:2 session:3 last:1 ahead:1 movers:3 could:1 climbed:1 days:1 drug:4 range:1 ounce:2 products:1 afternoon:2 positive:1 mixed:1 better-than-expected:2 traded:1 maker:1 late-stage:1 1.5:1 among:1 already:2 point:1 appeared:1 manage:1 private:2 two:2 raises:1 103:1 open:1 market:1 pharmaceutical:1 foothold:1 van:2 deal:1 would:2 8.8:1 outstanding:4 negative:1 underlying:1 pared:1 development:1 too:4 strong:1 biggest:1 markets:3 500:4 low:2 firm:1 acquisitions:1 ``:3 buy:6 interest:1 safe:1 offer:6 relevant:1 share:4 company:12 acquire:4 but:2 finished:2 depth:1 wake:1 catalyst:1 gold:2 hold:1 surged:1 than:1 posted:2 weighed:1 13:1 12:1 announcing:1 solid:2 18:1 der:2 cash:2 n't:3 gathers:1 congressional:1 were:2 following:1 making:1 chairman:2 more:1 spotlight:2 biotech:5 slid:1 30:1 investors:2 flat:1 health-care:1 moved:3 head:2 '':3 reports:1 have:1 rally:1 need:1 seen:1 technology:2 negotiations:3 if:2 information:1 end:2 pay:1 make:2 meanwhile:2 fears:2 consumer:3 investment:1 concerns:1 earnings:2 fourth:1 stock:7 week:1 added:1 's:9 track:1 highs:3 earlier:1 director:3 modest:1 levels:2 shareholder:2 opening:3 climbing:2 stocks:9 data:2 recent:2 billion:7 purchase:1 lower:3 highlights:1 effective:1 slightly:1 futures:8 traditional:1 portion:1 points:9 healthcare:1 biotechnology:2 solidly:1 pulled:1
stock_JNJ r_up	billion:1 increase:1 already:1 $:3 pay:1 bid:1 vaccines:1 cash:1 its:1 n't:1 talks:1 portion:1 does:1 vaccine:1 own:1 2.3:3 foothold:1 maker:1 advanced:1
stock_JNJ r_down	prevent:1 weight:1 heart:1 being:1 into:2 move:1 blood-thinning:1 replace:1 likely:1 sought:2 hit:1 two-year:1 its:1 market:2 subject:2 closer:1 packages:2 knowledge:2 defective:2 no:1 avoid:2 warfarin:1 majority:1 recommended:1 investigation:2 details:2 new:3 type:1 company:3 congressional:2 disclosed:1 buy:2 's:4 get:1 strokes:1 moved:1 showing:1 wave:1 weight-loss:1 effects:1 sustained:1 strong:1 data:1 panel:1 loss:1 rhythms:1 irregular:1 blood:1 --:1 recall:2 up:2 drug:3 whether:2 patients:2 without:2 place:1 thinners:1 efforts:2 approve:1 side:1 experimental:1 first:2
stock_JNJ r_up	sticking:2 all:1 help:2 agreed:1 liked:1 hopes:2 shares:1 its:9 giant:1 accepted:1 overhaul:1 $:1 majority:3 backers:1 going:1 disclosed:3 premarket:1 has:2 fourth:1 seeking:2 five:1 effects:2 new:3 using:3 now:1 loss:3 --:4 companies:4 activity:1 obesity:2 side:2 bond:1 weight:3 fish:1 some:1 back:2 closer:1 decision:1 comments:1 spokesman:2 outside:2 safety:2 eliminate:2 capital:2 formula:1 learned:1 told:2 we:1 million:3 conglomerate:1 takeover:1 regulatory:2 approval:4 post:1 strong:3 beginning:1 change:1 panel:3 faced:1 could:5 drug:5 ten:1 analysts:2 long-term:2 maker:1 comment:1 major:1 danger:2 had:2 into:1 one:2 tendered:2 weight-loss:1 dividend:1 two-year:3 millions:2 pharmaceutical:2 shareholders:1 debt:1 deal:1 recalling:1 three:2 their:1 rates:1 markets:1 containers:1 lowest:1 offering:1 offer:2 share:1 company:3 reduce:1 doctors:2 baby:1 sustained:3 analyst:1 raising:1 10:2 include:2 showed:3 indefinitely:2 patients:5 're:1 venture:1 problem:1 completing:1 acquisition:1 history:1 nurses:2 health-care:1 moved:1 experts:2 against:2 have:1 lifetime:2 hospitals:1 greater:2 again:1 no:4 detail:1 also:1 recommended:2 concerns:2 which:1 product:8 used:2 's:6 after:1 yesterday:1 shareholder:1 coverage:1 device:2 stocks:1 data:3 billion:1 well:1 directors:1 allow:2 healthcare:2 corporate:1
stock_JNJ r_down	some:1 its:1 $:1 recalling:1 their:1 rates:1 capital:1 formula:1 learned:1 markets:1 containers:1 lowest:1 product:1 offering:1 company:1 million:1 five:1 baby:1 debt:1 raising:1 billion:1 could:1 bond:1 corporate:1 history:1
stock_JNJ r_up	saying:1 over:1 including:1 its:1 fifth:1 previous:1 giant:2 under:2 good:1 premium:1 increased:1 therapy:1 they:3 not:1 anemia:6 represents:1 name:1 chronic:1 --:5 follows:1 did:1 contain:5 noted:1 because:4 alfa:1 deal:1 reduce:1 related:1 perspective:1 11th:1 regulator:1 medications:1 appear:1 lots:6 review:1 version:1 sold:3 beginning:1 vaccine:1 reaction:1 interaction:1 industry:1 barely:4 drug:1 a.m.:1 published:1 maker:2 comment:1 visible:4 done:1 market:1 pharmaceutical:1 opposes:1 additional:1 recalling:5 been:1 pharmaceuticals:1 vials:3 much:1 treat:1 chemotherapy:1 markets:1 life:2 buy:1 offer:2 drugs:5 shelf:2 brand:1 corrected:1 but:2 failure:1 recalled:2 analyst:1 recall:1 n't:1 thin:5 were:1 result:1 biotech:1 certain:5 ``:8 '':9 say:1 have:1 sells:1 information:3 stake:1 which:3 products:1 company:4 week:1 product:1 used:1 's:5 may:5 said:2 shareholder:2 plan:1 extremely:5 why:1 renal:1 third:1 glass:8 flakes:7 starting:1
stock_JNJ r_down	says:1 deal:1 less:1 win:1 ``:1 '':1 done:1 go:1 still:2 investment:1 even:1 he:3 said:1 raise:2 banking:1 spending:1 make:1 long:1 its:1 returns:2 score:1 way:1 has:2 more:1 wants:1 head:1 's:1 complete:1 dependent:1 after:1 but:2 takeover:1 bank:1 must:2 cautious:1 thing:1 remain:1 client:1 advertising:1
stock_JNJ r_up	mouth-rinse:2 has:1 above:2 healthy:2 warned:2 stop:2 gum:2 reduce:2 gums:2 products:2 they:2 marketing:2 claims:2 line:2 promote:2 plaque:2
stock_JNJ r_down	limited:2 year-to-date:1 executive:1 month:6 forecast:1 its:6 before:1 20:1 21:2 over-the-counter:4 has:2 advantage:2 bonds:3 far:3 handling:4 probably:1 now:2 --:3 busiest:3 list:1 borrow:2 continue:1 popular:4 medicines:6 bond:1 due:2 existing:1 series:1 likely:1 3.5:1 year:4 said:1 pace:1 testify:1 research:1 cell:1 companies:3 marketing:1 new:7 previous:1 bought:1 resume:2 dividends:1 sold:1 stem:1 highly:2 others:1 snapped:2 article:1 100:3 debt:1 $:7 last:1 funded:1 shipping:2 products:4 advertising:1 published:1 changes:1 one:2 alone:1 total:1 quality:4 market:2 rated:2 monthly:1 revive:1 been:2 next:2 their:1 much:1 rates:2 low:2 interest:2 trails:1 more:3 firm:2 ``:1 quantities:2 company:5 scrutiny:4 than:3 11:1 high:1 made:1 recall:6 up:2 record:1 can:2 making:3 sales:1 '':1 strain:1 itself:1 investment-grade:3 have:8 immune:1 take:2 largest:1 struggling:1 offered:1 week:3 product:2 's:25 plans:2 though:1 after:1 problems:4 most:2 tries:1 involving:4 issuance:3 strategists:1 grow:1 billion:7 off:2 children:2 so:3 2009:3 corporate:1 drawing:4
stock_JNJ r_down	limited:3 junk-bond:2 $:3 years:1 four:1 identify:2 7.7:6 committee:2 its:7 10.4:2 over-the-counter:2 rose:4 fix:2 distributed:1 failed:2 add:1 disclosed:1 has:3 congressional:4 details:1 evening:1 advantage:1 bonds:1 far:1 records:2 nearly:2 month:4 chips:2 day:2 developments:1 --:5 medicines:3 companies:1 did:2 benefit:1 release:2 beneath:2 quarter:4 sank:1 bond:4 product:3 up:1 year:1 best:1 blue:2 said:4 missed:2 lead:2 federal:2 review:2 since:2 investigate:2 comments:1 children:4 written:3 market:5 medicine:2 new:1 told:2 available:2 underwriters:3 resume:3 sold:1 million:4 highly:1 broken:2 regulators:2 rated:1 spare:2 busiest:1 key:2 snapped:1 100:1 beginning:1 panel:2 ahead:1 months:1 according:1 drug:2 shipped:1 products:2 context:1 testimony:3 frequent:1 issuers:1 among:2 already:1 troubles:2 into:2 period:2 marked:2 one:5 snub:2 unit:2 industrials:2 top:1 due:4 been:6 next:7 rates:1 low:1 interest:1 'll:1 final:2 more:2 funds:4 company:3 tally:1 but:4 sales:2 than:1 present:2 he:4 third:2 recall:4 cash:2 pour:2 n't:2 9th:1 making:1 investment-grade:1 seven:1 investors:3 measure:2 0.4:2 surface:2 continued:2 shipping:4 have:5 totaled:1 bottles:5 flood:2 take:1 which:5 quantities:3 stock:2 week:8 begin:1 executives:1 's:22 plans:5 may:2 problems:2 update:1 most:2 fell:2 issuance:2 71:1 end:1 stocks:1 data:1 billion:3 2009:2 off:4 liquid:1 later:1 sale:2 points:2 so:1 first:1 corporate:1
stock_JNJ r_down	protect:2 's:2 investors:2 profit:2 many:2 jump:2 rates:2 boom:2 interest:2 bond:2 surprise:2 has:2 vulnerable:2 left:2
stock_JNJ r_down	respond:1 smaller:1 managers:1 certain:1 likely:1 during:1 portfolio:1 trick:1 different:1 goal:1 bullish:1 investing:1 suggest:1 while:1 hedge-fund:1 their:1 only:1 much:2 call:1 finding:1 got:1 falling:1 2010:1 ...:2 enable:1 optimists:1 very:1 funds:1 revenge:1 prices:2 2:2 stocks:3 types:1 like:2 scenario:1 mount:1 work:1 companies:1 drug:2 looked:1 patients:1 either:1 studies:1 late-stage:1
stock_JNJ r_up	control:1 limited:1 force:3 625:3 challenged:3 process:1 people:1 500,000:1 '':1 clear:1 warning:1 medicines:1 voiced:1 quality:1 thinks:1 concern:1 bottles:1 $:4 patent:3 pay:3 away:1 facility:1 proposed:1 should:1 procedures:1 their:1 production:1 potentially:1 damages:3 widely:1 medicine:1 instead:1 expired:1 numerous:1 announced:1 details:1 200:1 ``:1 used:1 's:2 which:1 infringement:3 million:3 problems:1 free:1 cabinet:1 recalled:1 disruptive:1 letter:1 contamination:1 lawsuit:3 vs.:2 billion:1 received:1 --:1 industry:2 could:3 up:3 drug:1 pursue:1 computer:3 verdict:3 medical-device:1 found:1 giving:1 changes:2 maker:4 prevention:1
stock_JNJ r_up	all:1 closely:2 move:2 focus:2 rest:1 years:2 report:3 own:3 including:2 shares:6 shake:1 still:2 its:17 previous:3 giant:6 $:3 rose:3 expectations:1 than:2 concerns:6 systems:2 equity:1 has:9 earnings:2 around:2 emergency:1 distance:2 big:2 bid:6 possible:2 therapy:1 background:1 despite:6 timing:2 progressive:1 level:2 --:9 companies:3 morning:1 facing:2 session:2 businesses:2 financial-market:2 higher:2 related:1 bankruptcies:1 because:1 deal:1 193:2 some:8 competition:2 up:4 26:1 tender:1 okay:1 employment:3 2.4:2 large:2 fails:1 said:10 jumped:1 review:2 since:2 per:5 1.75:1 does:3 market:1 new:1 psoriatic:1 conditions:2 arthritis:1 business:2 wo:1 agreement:6 key:1 active:1 news:1 100:2 speculation:1 vaccine:3 care:1 11000:2 improved:2 ahead:2 many:2 climbed:1 drug:1 turn:2 jumping:1 mergers:1 makes:2 think:6 comment:3 major:5 already:3 rallied:2 striking:2 within:2 reassure:1 private:1 reached:6 throughout:1 unit:2 pharmaceutical:10 shareholders:6 industrials:2 van:4 two:2 been:3 strategy:2 live:1 options:2 low:7 recommend:1 biggest:1 markets:2 500:2 combined:2 firm:1 acquisitions:1 ``:2 buy:4 offer:12 drugs:2 company:7 part:2 too:7 sharply:2 highest:2 analyst:1 those:1 women:1 organizations:1 financing:1 cash:3 believes:1 n't:6 gathers:1 were:2 more:2 biotech:4 adults:1 unable:1 outstanding:5 inadequate:1 share:8 '':2 reviewing:2 watched:2 close:2 rally:1 seem:1 gains:2 5.50:1 48:1 generic:2 holds:5 treatment:2 stock-market:1 other:2 details:1 drinks:1 nt:2 adjusting:2 stock:3 week:1 's:1 slightly:1 may:1 price:1 after:7 halted:1 regular:2 shareholder:2 coming:2 data:2 response:1 billion:5 lower:2 studies:1 futures:9 sale:2 maker:3 declining:1 portion:3 points:8 came:4 gain:2
stock_JNJ r_up	stake:1 proposed:1 less:1 executive:1 alternatives:2 soon:2 6.7:1 against:2 session:3 including:2 legal:1 its:6 before:1 whose:3 giant:2 $:5 rose:4 than:1 does:1 board:4 has:3 insight:2 around:3 evaluate:2 bid:8 possible:2 fall:1 association:2 --:3 54:1 companies:5 after-hours:1 some:3 defense:2 trading:4 declined:1 out:2 said:9 decision:1 shares:4 3:1 future:1 closed:1 reaching:2 agreement:3 extraordinary:1 vaccine:1 hostile:2 drug:2 published:1 mixed:1 slightly:1 maker:1 comment:1 organize:2 point:2 into:2 reached:3 should:3 pharmaceutical:2 shareholders:8 management:1 van:1 support:1 negative:1 too:4 expected:1 meeting:3 500:3 low:4 firm:2 flat:3 buy:6 offer:6 company:9 but:1 slides:2 part:2 despite:3 hold:1 potential:1 10:1 19:1 n't:1 while:1 actively:3 ruling:2 were:2 following:1 more:2 18.5:2 called:1 biotech:3 slid:1 give:2 share:1 1.9:1 dropped:1 holds:1 1:1 other:2 5:1 which:1 higher:1 's:9 upon:1 reflect:1 fell:2 shareholder:1 letter:1 stocks:6 concerns:3 billion:8 lower:1 think:3 points:7 withdraw:1 biotechnology:5
stock_JNJ r_up	firm:2 gathering:1 advisers:1 executive:1 alternatives:2 soon:1 defense:1 including:2 company:3 year:1 should:1 its:4 out:2 said:2 van:1 $:2 managing:1 data:1 support:1 offer:2 management:1 comments:1 quickly:1 current:1 start:1 potential:1 upon:1 board:3 details:1 implant:1 has:2 thousands:1 across:1 more:1 hip:1 buy:1 's:4 reaching:2 track:1 evaluate:2 bid:3 problems:1 hundreds:1 director:1 part:1 shareholder:2 knee:1 effort:1 association:1 billion:3 made:1 hostile:2 --:1 18.5:2 sweeten:1 companies:2 against:1 called:1 authorized:1 withdraw:1 each:1 biotechnology:3 surgeries:1 other:2 replacement:1
stock_JNJ r_up	among:1 large-cap:3 cancer:1 some:1 extended:1 including:1 have:2 beyond:1 find:1 market:1 3.9:1 failed:1 been:1 whom:1 spread:1 buys:2 has:1 until:1 good:1 recently:1 bargains:1 months:1 survival:1 men:1 treatments:1 but:1 report:1 stocks:3 prostate:1 surprising:1 average:1 brand-name:1 companies:2 drug:1 bad:1 can:1 other:1
stock_JNJ r_down	show:1 being:1 developed:1 results:1 quarters:1 cuts:1 issues:1 cut:1 revenue:1 failed:1 only:1 spread:1 treatment:1 has:1 big:1 survival:2 killer:1 compound:1 3.9:2 advanced:1 companies:2 skewed:1 either:1 because:2 bigwigs:1 national:1 some:1 back:1 extended:2 expect:1 year:1 beyond:1 makers:1 declined:1 subject:1 consumers:1 reform:1 behind:1 health:1 after:1 recently:1 men:3 expiry:1 reported:1 boosting:1 news:1 post:1 pipeline:1 pressure:1 industry:1 months:2 drug:2 slightly:1 options:1 among:1 major:1 cancer:5 supply:1 lung:1 whom:1 third-quarter:1 been:2 credit-ratings:1 their:1 sagging:1 upcoming:1 offer:1 drugs:2 big-name:1 than:1 those:1 downbeat:1 well:1 health-care:1 sales:1 have:4 no:1 patent:1 also:2 other:2 earnings:1 several:1 added:1 's:3 price:1 earlier:1 problems:1 treatments:1 most:1 prostate:3 recent:2 acquisitions:1 lower:1 programs:1 charges:1 average:1 bottom:1 lines:1 costs:1
stock_JNJ r_up	named:1 says:1 officer:1 cancer:1 departing:1 into:1 global:1 private:1 financial:1 businesses:1 newly:1 combining:1 high-profile:1 largest:1 throughout:1 hospitals:1 its:1 unit:2 replacements:2 business:2 lead:1 less:1 moves:1 two:1 quickly:2 parts:1 program:1 details:1 suit:1 new:2 implant:2 microchip:1 gave:1 hip:2 ago:1 head:1 formed:1 's:4 said:1 nationwide:2 than:1 company:2 practice:1 problems:2 joint:1 management:1 five:1 registry:3 doctors:1 not:1 knee:2 president:1 data:2 former:1 recent:1 2:4 renal:2 launch:1 follows:1 months:1 up:1 cat:1 collect:2 chief:1 gears:1 recall:1 become:2 more:2 order:2 executives:1
stock_JNJ r_up	advisory:2 over:2 expects:2 chronic:2 appropriate:1 another:2 battle:2 blockbuster:2 its:2 kidney:2 cardiovascular:2 use:2 said:2 decision:2 high-stakes:1 increase:1 strokes:1 concerns:2 2011:6 's:2 drugs:3 marketing:2 advice:2 problems:2 ask:2 now:2 panel:2 rights:2 whether:1 disease:2 drug:2 face:2 --:1 patients:2 maker:1 risks:1 similar:2 other:1
stock_JNJ r_up	'better:1 plastics:2 100,000:1 previously:1 series:1 health-care:1 number:3 certain:1 say:1 including:1 have:1 year:1 dividend:1 quality:1 makers:2 unit:1 use:1 said:4 bottles:3 culprit:1 recalling:2 there:2 problems:1 same:1 consumer-goods:1 chemical:4 companies:2 materials:2 details:1 caused:1 biggest:2 company:1 more:2 plant:2 continues:1 's:5 trace:1 bonds:1 caplets:2 odor:3 after:2 continuing:1 gander:1 goods:1 recalled:1 complaints:2 20:3 manufacturing:1 beginning:1 than:3 packaging:1 stocks:1 made:2 last:1 pickers:1 world:2 recall:1 hunt:1 list:1 yield:1 agree:2 thought:1 other:1 future:2 products:2 small:2 recalls:1 stock:1 consumer:1 called:1
stock_JNJ r_down	caused:1 dollar:2 results:6 postponing:1 surgical:1 broader:2 whose:2 citing:3 under:1 quarterly:1 third:1 division:1 updated:2 risk:1 far:1 continues:1 focus:4 updates:1 anemia:1 issue:2 companies:3 small:1 round:1 prevent:1 smaller:1 estimates:1 past:3 rate:2 cost:1 makers:2 decelerating:1 index:2 adds:1 appear:1 shares:1 current:1 version:1 led:1 reported:1 108:1 active:1 100:1 strong:1 38:1 study:1 double-digit:1 reports:5 chemical:1 products:8 analysts:2 published:1 changes:1 maker:2 followed:1 replace:1 market:3 recalling:1 third-quarter:9 markets:1 more:2 flat:1 ``:1 share:5 company:10 corrected:1 hurt:1 recall:2 can:1 example:1 heart:2 weaker:2 tax:3 currency:1 dropped:2 1.2:1 bolstered:2 string:1 maturities:1 democracy:2 warfarin:1 1:2 rose:5 fourth:1 economy:5 product:3 strokes:1 after:5 tied:1 modest:1 4th:1 such:2 law:1 rhythms:1 sectors:1 amid:1 futures:2 chief:2 order:1 office:1 move:1 outlook:5 trade:1 cold:1 its:12 stock-index:1 before:1 delay:1 21:1 lackluster:1 premarket:2 might:1 2010:4 earnings:18 hurting:1 good:1 finance:1 effects:1 they:2 not:1 now:1 bank:1 easily:1 name:1 five-year:1 bond:1 heavy:1 week:1 financial:1 prompted:2 slowdown:1 year:4 margins:1 profit:2 7:1 sluggish:4 announced:1 earlier:1 risen:2 put:1 beginning:2 could:2 first:1 omitted:1 number:1 one:2 suspended:1 leading:1 2:7 rates:1 stock:5 mostly:1 part:1 deceleration:1 than:2 12:1 15:1 target:4 depressed:2 hike:1 patients:3 future:1 were:5 feeling:1 1.7:1 investors:3 1.9:1 13th:1 investment-grade:1 have:2 close:2 orthopedics:2 saw:1 also:4 causing:1 take:1 which:4 performance:1 unsecured:1 pain:1 trace:1 price:3 falls:1 barrage:1 rollout:1 approved:2 soared:1 medical:3 points:6 weigh:1 came:1 sector:2 saying:1 session:1 giant:5 writes:1 controls:1 gains:2 caplets:1 overall:2 nearly:1 report:6 during:1 procedures:2 areas:1 tumult:1 medicines:5 taxes:1 morning:1 blew:1 blood-thinning:1 see:1 2.2:8 surgery:1 declined:1 knees:1 said:11 voluntary:1 away:1 forecast:3 3:1 various:1 across:1 recently:1 weak:2 debt:1 reaction:1 improved:1 irregular:1 uncertainty:1 drug:7 a.m.:1 surprises:2 among:1 underperforming:2 2nd:1 throughout:2 decline:4 raise:2 due:8 been:2 interest:2 expected:1 500:1 nickel:3 offered:1 priced:1 recalled:1 last:2 those:1 enrollment:1 n't:1 while:3 ongoing:1 3rd-quarter:1 cents:1 health-care:8 surprisingly:1 expenses:1 helped:1 spooked:1 technology:1 tumbled:1 another:1 complaints:1 widely:1 higher:3 development:1 used:2 temporary:1 forecasts:1 issuance:1 catheter:1 recent:6 lower:8 off:1 largely:1 charges:1 makes:2 thought:1 materials:1 decliners:2 corporate:3 latest:2 quarters:1 announcement:1 $:15 over-the-counter:4 stent:1 had:2 advisories:2 has:1 provisions:2 orthopedic:1 five:1 disappointed:1 furniture:1 four-part:1 follows:2 securities:1 officer:1 night:1 popular:1 recalls:9 downward:2 soft:1 replacement:2 because:1 people:1 some:1 trends:3 growth:2 election:1 competitor:1 lead:3 broad:1 comments:2 conservative:1 unit:3 beating:1 patient:1 business:1 slight:1 odor:2 pressure:3 offset:4 snapped:1 manufacturing:1 roundup:1 quarter:2 costs:4 range:1 seeing:1 raised:4 corporate-bond:1 device:1 pharmaceutical:1 spending:3 lot:1 biggest:2 lowest:1 billion:3 buy:1 offering:1 but:4 lowered:5 analyst:1 he:1 whether:1 up:2 record:1 similar:1 called:1 certain:2 sales:13 '':1 full-year:2 4.4:2 47:3 flood:1 other:1 5:3 details:4 's:22 problems:3 fell:4 stocks:1 fiscal:1 remote:1 hips:2 serious:1 medical-device:1
stock_JNJ r_up	limited:1 move:1 results:1 baby:1 same:1 its:2 contaminated:1 delay:1 $:2 stent:3 expectations:1 analyst:1 program:1 rollout:1 treatment:1 has:3 earnings:5 good:1 far:1 big:1 overall:1 updates:1 background:2 new:1 report:2 corporate-bond:1 bank:1 several:1 lost:1 excluding:1 --:1 tumult:1 drop:3 securities:1 cholesterol:1 worries:1 recalls:1 prevent:1 chunk:1 blood-thinning:1 slowdown:1 past:1 growth:1 exceeded:1 patient:1 hamper:1 decelerating:1 said:1 adds:1 3rd:1 4:1 hepatitis:1 18:1 increase:2 may:1 safety:3 7:1 formula:1 ground:1 boost:1 therapies:1 led:2 withdrawal:3 reported:3 offset:2 snapped:1 news:1 beginning:1 recall:6 rhythms:1 irregular:1 launch:1 study:2 months:1 drug:6 called:1 spending:1 range:1 products:1 analysts:1 graph:1 efforts:1 reclaim:1 comment:1 already:1 revenue:2 third-quarter:3 down:3 device:1 unfolded:1 rising:2 suspended:1 throughout:2 market:1 investors:1 basis:1 holdings:1 due:4 development:1 markets:1 more:2 mostly:1 drugs:2 company:1 focusing:1 than:2 high:1 12:2 rival:1 enrollment:1 up:1 devices:3 patients:2 baby-formula:3 promising:1 following:1 10th:1 similar:1 could:2 heart:2 associated:3 figure:1 health-care:1 measure:1 sales:4 weighed:3 currency:1 investment-grade:1 spooked:1 sells:1 comments:1 issue:2 against:1 began:1 acts:1 s:1 40:9 chemical:1 flood:1 concerns:3 details:2 which:1 layoffs:3 smell:1 stock:2 week:1 used:1 's:7 hopes:1 though:1 strokes:1 price:1 earlier:1 effect:1 diet:3 fueled:2 fell:1 issuance:1 complaints:1 catheter:1 approved:1 billion:2 short:1 lead:1 scenario:1 stents:1 costs:6 push:1 nearly:2
stock_JNJ r_up	sector:2 1.7:1 sales:1 past:1 trading:1 2.6:1 2.4:1 index:1 stocks:1 recovery:1 rose:1 third-quarter:1 earnings:1 closed:2 new:1 has:1 boost:2 higher:2 after:1 boosted:1 material:1 results:1 focusing:1 strong:2 posted:1 helped:1 launch:1 --:1 18:1 months:1 companies:1 up:2 $:2 range:1 products:1 airline:2 push:1
stock_JNJ r_down	launch:1 18:1 months:1 sales:1 past:1 focusing:1 range:1 products:1 push:1 new:1 has:1 boost:1
stock_JNJ r_up	all:1 investors:1 bell:1 into:1 move:1 results:1 month:1 itself:2 shares:1 have:1 approval:1 been:1 throughout:1 its:4 spread:1 sell:2 cancer:1 unusual:1 said:1 additional:1 eagerly:1 had:2 treatment:1 comments:1 yet:1 preventing:1 their:1 potential:1 details:1 quarterly:1 new:1 has:1 's:2 stock:1 do:1 premium:1 same:1 big:1 company:2 after:3 use:1 but:1 anticipated:1 drug:3 takeover:1 nearly:1 key:1 half:1 last:1 trying:1 data:1 approved:1 raising:1 built:1 regarding:1 made:1 attempt:1 success:1 lost:1 launch:1 --:2 cash:1 value:1 n't:1 reports:1 without:1 analysts:1 time:1 more:1 denosumab:1 bone:1 numbers:1
stock_JNJ r_down	comment:1 background:1 revenue:1 into:1 decline:1 expectations:4 challenges:1 individual:2 agents:1 shares:1 exceeded:2 recent:2 its:4 osteoporosis:4 pharmaceutical:1 denosumab:2 giving:1 rose:2 outstanding:1 thanks:2 third-quarter:3 per-share:1 increase:1 also:2 earnings:1 income:2 details:2 net:2 through:1 hope:1 more:1 product:1 full:2 's:4 though:1 dropped:2 company:3 results:2 first:2 sales:6 drug:6 increases:1 operating:2 catalyst:2 key:4 new:1 known:2 during:2 strong:2 disappointed:2 analyst:2 posted:1 11:6 lower:1 quarter:2 launch:2 --:2 fewer:1 profit:1 below:2 costs:3 products:2 small:1 serious:1 works:1 maker:2 came:2 executives:1
stock_JNJ r_down	saying:2 help:1 agreed:2 ninth:1 including:2 settlement:2 its:8 before:1 giant:1 $:3 rose:1 guidance:2 had:1 charge:1 alter:2 meant:2 sued:1 boxes:2 were:3 not:2 continued:2 loss:3 --:4 quarter:3 deal:1 related:1 growth:2 meters:1 distributor:2 even:2 said:1 hide:2 federal:2 jumped:2 forecast:1 net:3 cost-cutting:2 million:3 operating:2 monitor:1 prosecutors:2 launch:3 drug:6 products:5 maker:3 comment:2 adjusted:1 revenue:2 due:2 61:1 diabetics:1 defendants:2 third-quarter:3 interest:1 selling:1 statement:1 allegedly:1 but:1 hurt:1 analyst:1 those:2 case:1 versions:1 n't:2 depreciation:1 tax:1 strips:3 full-year:3 swung:3 counterfeit:1 confirmed:3 detail:1 same:1 earnings:1 test:2 product:2 used:1 multiple:2 though:2 levels:1 president:1 diabetes:2 third:1 medical:2 sclerosis:2 sale:2 profit:2 starting:1 order:2
stock_JNJ r_down	help:1 just:1 less:1 increasingly:1 agreed:2 move:1 results:2 competitive:1 businesses:1 hepatitis:1 headlines:1 its:7 24:1 announcement:1 cut:1 $:8 rose:1 guidance:2 presence:1 expectations:1 finally:1 other:1 marks:1 weeks:1 has:2 2010:3 earnings:4 hurting:1 around:1 food:3 advances:1 continues:1 cover:1 early:1 cutting:1 every:1 effects:2 they:1 salmonella:1 procedures:1 day:1 treating:1 owning:1 success:1 --:1 across:1 try:2 small:1 recalls:3 speculation:1 economy:1 replacement:2 shunned:1 financial:1 deal:2 trend:1 globe:1 some:2 sign:1 2.9:1 growth:1 result:1 year:2 beyond:1 n't:1 potential:1 eggs:1 profit:1 jumped:1 comments:3 research:2 looking:1 unit:1 closed:1 dividends:1 new:2 increasing:1 boost:1 highs:1 notice:1 pushing:1 recently:3 business:1 hefty:1 lessens:1 million:1 blockbusters:1 reported:1 step:1 franchise:1 stay:2 come:1 900:1 getting:1 industry:1 30:3 restructuring:1 against:1 carries:1 place:1 felt:2 barriers:1 efforts:1 maker:4 outlook:1 cancer:2 revenue:2 into:1 replace:1 down:1 long:1 verge:1 throughout:2 shrinking:1 market:3 pharmaceutical:1 raise:2 would:1 third-quarter:4 been:2 next:1 hitting:1 orthopedics:1 recent:1 today:1 buy:2 triggered:1 drugs:1 company:8 but:5 sales:4 volume:1 lowered:1 all-cash:1 slowdown:2 effort:1 analyst:1 buying:1 posted:2 valued:1 recall:1 access:1 plunged:1 up:1 devices:1 neurovascular:2 flagship:1 while:1 cancers:1 risks:1 were:1 following:2 market-wide:2 could:1 acquisition:1 projections:1 1.5:2 investors:2 prompting:1 almost:1 certain:1 exceeded:1 share:1 updated:1 continued:1 say:1 tag:1 drug:4 have:1 take:1 linked:1 sell:1 aging:1 strength:1 weakened:1 six:1 shares:1 1:1 also:1 parts:1 details:2 which:1 big:2 outbreak:1 insurers:1 stock:1 product:1 analysts:1 's:8 knees:2 price:3 after:2 treatments:1 forecasts:1 blood:2 expand:1 exposure:1 billion:4 third:1 stronger:2 part:1 time:1 fresh:1 overseas:1 starting:1 hips:2
stock_JNJ r_up	operations:2 six:1 set:1 they:1 just:1 less:1 sales:1 agreed:2 probe:1 outlook:1 month:1 held:1 tablets:1 hepatitis:4 cuts:1 settlement:1 its:19 earlier:1 looking:1 giant:2 upgrade:1 $:7 had:1 expectations:1 than:1 late:2 charge:1 other:4 quarterly:1 government:1 has:7 might:2 2010:3 gave:2 updated:1 views:2 cholera:1 bid:2 possible:2 results:1 boost:1 background:1 downturn:1 buyer:1 replace:1 procedures:1 aggressively:1 insurers:1 excluding:1 --:4 follows:1 pharma:1 throughout:1 've:1 recalls:1 obesity:2 week:1 because:4 financial:2 verge:1 weight:1 reported:1 product:2 related:1 sign:1 challenges:1 widened:2 second:1 cost:1 third-quarter:3 year:1 pain:2 air:2 targets:2 said:6 profit:1 contributed:1 comments:1 debate:1 vaccines:2 health:1 supplied:1 increasing:1 numerous:1 announced:1 third-party:1 business:1 pharmaceutical:1 wo:2 odor:2 million:2 unusual:1 blockbusters:1 drug:13 incident:1 weight-loss:1 weaker-than-expected:1 contamination:4 regulatory:1 approval:1 problem:2 vaccine:4 manufacturer:1 weeks:1 extraordinary:2 items:1 industry:1 forecast:1 contract:1 keep:1 prior:1 planned:1 soda:1 requests:1 maker:5 first:1 raised:1 revenue:2 distributed:1 into:1 offset:1 owned:1 two:2 temporarily:2 been:2 suspended:2 total:1 research:1 uncertainties:1 shareholders:2 raise:2 dropped:1 positive:1 there:2 due:3 least:1 next:1 confident:1 reduction:1 treat:1 time:1 territory:1 meeting:2 more:1 back:1 ago:1 plunge:1 offer:2 drugs:1 company:6 but:1 hurt:1 biotech:1 lowered:1 hopes:2 90:4 former:2 customer:1 10:3 rejection:1 recall:3 getting:1 signed:1 neurovascular:1 n't:2 while:1 growth:2 can:1 were:3 following:1 meet:3 pressure:2 property:1 bet:1 pricing:1 1.5:1 associated:2 aging:1 deaths:1 certain:1 cited:1 exceeded:1 site:2 general:2 investment-grade:1 have:1 blockbuster:2 linked:2 again:2 marking:1 bottles:2 against:2 950:4 get:1 able:1 aside:1 makers:2 also:1 potential:1 details:4 which:4 big:1 new:1 layoffs:1 stock:2 shipments:2 plant:4 over:1 's:11 plans:1 advances:1 though:1 may:3 earnings:2 price:1 after:2 treatments:1 pushing:1 halted:2 fell:1 rejected:1 citing:1 complaints:1 anticipated:1 2011:5 billion:3 booked:1 short:1 off:1 sale:1 looked:1 reports:3 part:1 bottle:1 pay:1 biotechnology:2 reserve:1 resolution:1 medical-device:1 latest:1
stock_JNJ r_down	over:2 lawyer:1 gold:1 reaping:1 in-house:1 box:1 anticipate:1 dust:1 likely:2 oversupply:1 election:2 file:1 multimillion-dollar:1 stimulus:1 sufficient:1 its:1 market:2 out:1 needs:1 $:2 reassert:1 quality:1 interviews:1 there:1 political:1 pump:1 long:1 rounds:1 their:1 outside:1 2:1 writes:1 details:1 wrongdoing:1 employee:1 new:1 save:1 company:1 hope:1 economy:2 junk:2 then:1 complaint:1 oil:1 's:2 continue:1 government:1 wo:1 whistleblower:1 after:1 stop:1 primed:1 races:1 if:1 snake:1 they:1 rollout:1 suspected:1 stocks:3 wipe:1 he:1 payout:1 fraud:1 investors:1 --:1 many:1 medicines:1 settles:1 companies:1 disease:1 dominance:1 n't:1 more:2 overdrive:1 so:1 can:1 fundamental:1 leading:1 800:2 think:1 once:1
stock_JNJ r_up	all:1 just:1 in-house:1 hopes:1 session:2 comments:1 questions:2 its:1 bunch:1 impact:1 whose:2 difference:1 terms:2 21:1 rose:7 reaping:1 had:1 program:2 disclosed:1 premarket:1 employee:1 has:3 hope:1 then:1 complaint:1 get:1 far:1 big:1 whistleblower:1 not:1 he:3 one:1 advanced:1 strengths:1 like:2 --:1 follows:2 heist:2 companies:4 after-hours:1 stock:1 disorder:3 deal:5 3.7:1 actively:2 3.2:1 result:1 lawyer:1 year:3 close:1 little:1 regulator:1 said:5 profit:3 movie:2 legal:2 access:2 version:3 deficit:3 closed:1 new:1 approach:1 attention:3 recently:2 risen:1 million:1 agreement:2 takeover:1 news:2 $:8 payout:1 last:3 steal:1 climbed:2 drug:3 published:1 traded:1 maker:1 comment:1 supply:1 third-quarter:1 64:1 article:1 your:1 market:2 decline:1 8.3:1 necessarily:1 interviews:1 multimillion-dollar:1 due:1 next:2 start:2 wrongdoing:1 entered:1 panel:1 9.2:1 enforcement:1 ``:1 selling:2 way:1 share:1 company:1 races:1 gain:2 prices:1 suspected:1 analyst:2 posted:2 fraud:1 effective:1 18:1 up:5 n't:2 500:2 were:3 trading:2 dosage:1 associated:1 1.1:1 1.3:2 3.1:1 moved:1 sales:3 0.7:1 0.6:1 '':1 unit:1 reports:1 file:1 sharp:1 blockbuster:2 contest:2 generic:6 make:1 detail:1 shares:6 costs:3 details:2 which:2 layoffs:1 higher:2 week:1 's:12 71:1 coming:1 stocks:2 guys:2 billion:2 scenario:1 together:1 traditional:1 chief:1 points:5 so:1 clears:2 weigh:2 2009:1
stock_JNJ r_up	company’s:1 pharmaceutical:1 gains:1 deal:1 generic:1 marketing:1 drug:3 leads:2 version:1 stock:1 popular:1 news:1 stocks:2 higher:2
stock_JNJ r_up	operations:1 help:1 executive:1 cheap:1 results:2 bring:1 through:1 its:3 $:1 pump:1 might:2 bevy:1 emergency:1 expects:1 not:2 expectations:1 resolve:1 --:3 follows:1 medicines:1 businesses:1 dip:1 mean:1 financial:1 direct:1 election:2 year:1 even:2 said:4 profit:1 enough:2 version:1 between:1 new:1 issue:1 correct:1 million:2 commercial:1 expansion:1 debt:1 doldrums:2 benefits:1 license:1 issuers:1 comment:1 among:1 revenue:2 into:1 revive:1 down:1 would:1 there:1 system:1 least:1 next:1 pharmaceuticals:1 rates:1 interest:1 billion:1 ``:1 company:2 hurt:1 hopes:1 analyst:1 household-name:1 2011:6 meet:1 acquisition:1 600:1 sales:2 '':1 cure:2 partner:1 trip:1 sell:1 detail:1 which:1 economy:1 week:1 's:7 track:1 after:2 first-half:1 services:1 stocks:2 fiscal:3 third:1 costs:1 healthcare:1 joining:1
stock_JNJ r_down	aided:1 issued:1 executive:1 cheap:1 results:1 years:1 bring:1 portfolio:1 injuries:2 issues:1 high-grade:1 $:3 rose:1 pump:1 better:2 8:1 has:1 might:1 bevy:1 bonds:2 rise:2 12:1 updates:1 reporters:1 not:1 one:1 treating:2 --:3 busiest:1 companies:1 two:1 replacement:3 prevent:1 financial:1 some:1 second:1 election:1 year:1 even:1 knees:2 total:1 profit:2 since:1 its:4 enough:1 7:4 provider:1 net:2 told:1 opening:1 marketing:1 sold:1 reported:2 healing:1 debt:1 doldrums:1 last:1 30:1 days:1 products:4 comment:1 own:1 into:1 system:1 down:1 rising:2 names:1 throughout:1 market:1 would:1 their:1 third-quarter:2 least:2 sports:2 rivals:1 rates:1 interest:1 6:1 taken:1 flat:1 selling:1 company:3 wounds:2 expected:1 than:1 include:1 up:1 believes:1 were:2 following:1 months:1 600:1 19.2:1 joints:1 household:1 share:1 sales:6 according:1 cure:1 investment-grade:1 technology:1 sell:1 detail:1 which:1 economy:1 's:6 after:1 driven:1 push:1 said:2 but:1 device:1 stocks:1 data:1 billion:3 revive:1 medical:2 well:1 daily:1 traditional:1 banks:1 expands:1 hips:2 nearly:1
stock_JNJ r_down	comment:1 operations:2 temporarily:2 share-price:1 expects:3 month:2 down:3 full-year:5 swung:1 its:9 issues:2 contaminated:3 late:2 said:3 additional:1 suggest:1 third-quarter:3 hepatitis:2 writing:3 targets:2 inventory:3 net:3 store:1 shipments:2 plant:2 's:2 gains:1 company:1 after:5 site:2 halted:2 levels:2 line:3 now:3 analyst:1 vaccine:7 posted:2 loss:3 2009:3 last:2 abandoned:2 ahead:1 --:2 launches:1 drug:1 due:2 pediatric:1 revenues:3
stock_JNJ r_down	raised:1 followed:1 committee:1 office:1 text:1 infant:1 actions:1 general:1 facilities:1 tag:1 signed:1 another:1 regulate:1 its:1 unit:1 millions:1 pharmaceutical:1 documents:1 $:2 22:1 over-the-counter:1 products:2 seeking:1 detailing:1 been:1 children:1 genetic:1 new:1 firms:1 oversight:1 company:1 tests:1 after:1 's:5 venture:1 government:1 may:1 follow-up:1 price:1 million:2 difficulty:1 treasurer:1 district:1 letter:1 despite:1 ties:1 hearing:2 appears:1 additional:1 roundup:1 severs:1 her:1 manufacturing:1 have:1 recall:2 employees:1 request:2 35:1 morning:1 while:1 place:1 threat:1 island:1 messaging:1 consumer:2 having:1 comes:1
stock_JNJ r_down	advisory:1 office:1 global:1 $:1 talks:1 its:1 improperly:1 litigation:1 antipsychotic:1 deposits:1 civil:1 investigation:1 disclosed:1 has:1 affected:1 government:2 fat:1 matters:1 therapy:1 resolve:2 lost:1 these:1 sedation:1 disorder:1 mean:1 long-running:1 competition:1 second:1 year:1 discussions:1 further:1 declined:1 said:4 opened:1 review:2 marketed:1 spokesman:1 bipolar:1 does:1 new:1 appeal:1 terms:1 schizophrenia:1 schedule:1 protection:1 regulatory:1 approval:1 panel:2 ahead:1 according:1 drug:4 prior:1 studies:1 experimental:1 first:1 comment:1 previously:1 vote:1 reached:1 unit:1 paves:1 best-selling:1 system:3 been:1 clinical:1 treat:2 way:2 billion:1 ``:2 door:1 company:1 but:2 sales:1 effort:1 criminal:1 uncertain:1 whether:1 up:1 n't:2 ongoing:1 can:1 associated:1 commissioner:1 '':2 have:1 again:1 patent:1 trials:1 granted:1 agency:1 4.9:1 recommended:1 potential:1 which:1 before:1 independent:1 's:7 running:1 rejected:2 device:1 cleared:1 approved:3 recent:1 appoint:1 oral:1 disease:2 generic:1 2007:1 termination:1 2009:1 resolution:1 filing:1 once:1
stock_JNJ r_down	emerging:2 some:2 blood-thinning:2 cuts:1 close:2 market:2 20:2 $:2 rejects:1 union:1 lung-cancer:1 decade:2 proposal:1 play:2 may:2 big:2 become:2 end:2 believe:2 class:2 care:1 billion:2 surprising:1 medicines:2 drug:1 players:1 benefit:1 analysts:2 long-term:1 making:2 could:2
stock_JNJ r_up	limited:1 all:1 stake:1 have:1 1.2:1 appeared:1 best:1 sales:1 up:1 disappointing:1 held:1 stroke:1 dilute:1 including:1 names:1 eliminating:1 measure:1 led:1 reducing:1 rescue:1 help:1 preventing:1 throughout:1 $:1 their:2 investing:1 surprises:1 top:1 there:1 warfarin:1 patients:1 shares:1 environment:1 few:1 only:1 other:1 disclosed:1 strong:1 you:1 several:1 hope:1 stayed:1 49:1 30:1 handful:1 's:6 rose:2 business:1 drugs:1 sold:1 million:1 outperformed:1 took:1 0.4:1 early:1 following:1 gains:1 reading:1 although:1 1.1:1 world:1 stocks:2 data:1 increase:1 manufacturing:1 performer:1 retail:1 look:1 third:1 also:1 positions:1 study:1 climbed:1 companies:1 drive:1 52:1 while:2 points:1 red:1 components:1 were:2 rivaroxaban:1 trading:1 quarter:1 better-than-expected:1
stock_JNJ r_down	sector:1 help:1 results:1 month:1 alternative:1 atrial:1 should:1 environment:1 going:1 dominant:2 get:1 positions:1 drop:1 companies:1 52:1 trap:1 release:1 found:1 quarter:1 pharmaceuticals:1 dilute:1 bleeding:1 nearing:1 depends:1 growth:1 eliminating:1 year:1 factors:1 while:1 7:2 medicine:1 new:1 business:1 million:1 regulatory:1 approval:1 appears:1 $:2 prescription:1 many:1 according:1 drug:2 thinner:2 least:1 another:1 reducing:2 your:1 their:1 positive:1 long:1 rivals:1 fibrillation:1 way:1 more:1 drugs:1 reign:1 last:1 whether:1 patients:1 complications:1 rivaroxaban:2 called:2 medication:1 pass:1 end:1 doctor:1 perform:1 stake:1 warfarin:2 preventing:1 other:2 test:1 you:1 several:1 half-century:1 's:6 strokes:1 diversifying:1 blood:2 stocks:1 data:1 exposure:1 salary:1 third:1 well:1 drive:1 filing:1
stock_JNJ r_down	sector:2 stalked:1 being:1 course:1 stepping:1 children:1 writes:1 had:1 improvement:1 going:2 parents:1 has:1 ...:1 government:1 billionaire:1 bid:1 background:1 now:1 investor:1 --:1 speculation:2 financial:1 series:1 's:10 buffeted:1 declined:1 op-ed:1 said:2 adds:1 jumped:1 its:1 participants:2 safety:1 cost-cutting:1 measures:1 recently:1 business:1 step:1 takeover:1 prescription:2 shelves:1 industry:2 products:1 analysts:1 faces:1 maker:1 comes:1 first:1 comment:2 into:1 long:1 reducing:2 market:1 unusual:1 rivals:2 been:1 pharmaceuticals:2 statement:1 drugstore:1 until:1 ``:1 buy:1 way:2 form:1 drugs:2 company:3 took:2 part:1 he:1 announcing:1 recall:1 launched:1 biotech:1 share:1 dialogue:2 '':1 have:1 their:2 again:1 productivity:1 returning:1 note:1 other:3 largest:1 ordinary:1 panic:1 pain:1 price:1 after:2 diversifying:2 regular:2 rumors:1 fray:1 exposure:2 tricky:1 task:1 amid:1 accelerated:1 without:1
stock_JNJ r_up	cancer:1 people:1 process:1 caused:1 back:1 visible:1 reports:1 have:1 pain:1 children:1 faces:1 again:1 now:1 private-label:1 due:1 long:1 vials:1 safety:1 parents:1 has:1 drugstore:1 filled:1 more:1 buy:1 's:3 returning:1 drugs:1 void:1 after:1 recalled:1 manufacturing:1 than:1 tricky:1 task:1 created:1 recall:2 shelves:1 drug:2 switch:1 products:1 were:1 200,000:1 maker:1 first:1
stock_JNJ r_down	exploring:1 help:1 deal:1 assess:1 continues:1 long:1 options:1 break:1 also:1 other:1 buying:1 parties:1 new:1 deadlock:1 might:1 bullishly:1 structure:1
stock_JNJ r_down	help:2 over:2 allergy:1 results:1 tablets:1 broader:1 children:2 traders:1 add:1 other:2 4:3 has:1 oversight:1 do:1 continues:2 break:2 fall:3 assess:2 identifying:1 drop:1 serves:1 worries:1 investors’:1 deal:2 trading:1 112:1 slumped:1 concern:1 index:1 said:1 consumers:1 tensions:3 near:1 shares:1 safety:1 between:2 new:2 million:1 exchange:2 climbs:2 dental:1 brewing:1 packages:1 news:1 100:1 debt:4 island:1 drug:2 spotlight:1 options:2 down:1 parties:2 rounds:1 market:1 manufacturing:3 additional:1 political:1 two:1 long:2 process:1 rates:1 threaten:1 dozens:1 500:1 more:1 exploring:2 ``:1 fire:2 unsettled:1 but:1 gap:1 peninsula:1 recalled:2 western:1 sharply:1 those:1 developing:1 might:2 nations:1 n't:1 while:1 ongoing:1 were:1 situation:1 deadlock:2 scanners:1 launched:1 0.9:1 1.1:1 investors:1 rattle:1 '':1 reports:1 border:1 bottles:1 radiation:1 1:1 also:2 concerns:2 stock:2 tension:2 's:7 after:1 problems:4 fell:2 citing:1 device:1 climbing:1 stocks:2 data:1 structure:2 fiscal:1 slides:1 amid:1 medical:1 futures:6 accelerated:1 points:3 800,000:1
stock_JNJ r_up	operations:1 because:1 says:1 process:1 alongside:1 number:1 according:1 likely:1 reviewing:1 its:2 $:3 lead:1 over-the-counter:1 recalling:1 been:2 investment:1 program:1 exit:1 which:2 largest:1 has:2 more:2 firm:1 gives:1 's:3 boon:1 million:1 venture-capital:1 withdrawing:1 medicines:1 sale:2 labeling:1 incubator:1 2003:1 ongoing:1 popular:1 recalls:1 problem:1 800:1 medical-device:1
stock_JNJ r_down	biotech:1 six:1 cancer:1 30:1 guidelines:2 share:1 number:1 one:1 ended:1 been:1 value:1 need:1 makers:1 per:1 conventional:1 said:1 adds:1 proceed:1 over-the-counter:1 generic:2 develop:1 comments:1 investment:1 complex:1 draft:1 asset:1 way:1 which:2 firms:1 has:1 markets:1 2010:1 announced:1 more:2 's:1 copying:1 drugs:2 company:1 most:1 compared:1 lucrative:1 paving:1 labeling:1 net:1 such:1 because:1 than:1 antibodies:1 clarify:1 --:2 withdrawing:1 industry:2 months:1 drug:3 regulator:1 recalling:1 compete:1 published:1 popular:1 problem:1 difficult:1 medicines:3
stock_JNJ r_down	antibiotic:2 ordered:2 investors:1 deaths:2 over:2 ends:1 ending:1 down:1 medical:1 130:2 licensing:2 have:1 families:1 seem:1 payers:1 yet:1 after:2 out:1 arbitration:2 use:1 court:2 $:6 media:1 responsible:2 two:2 its:2 targets:2 their:1 potential:2 which:2 biotechnology:2 pay:2 many:2 boost:1 ruling:2 ...:1 we:2 million:2 's:4 breach:2 payouts:1 may:1 dividends:1 company:2 healthcare:4 giant:4 agreement:2 dispute:2 regulators:1 engage:1 know:1 found:2 between:2 friends:1 day:1 those:1 tricky:1 tracking:1 like:1 --:2 conditions:1 could:1 companies:2 drug:3 n't:1 patients:2 can:2 social:1 serious:1 retail:1 age:1 experimental:2
stock_JNJ r_down	named:4 mandatory:2 executive:2 years:2 down:2 65:2 president:2 old:2 plan:2 its:2 retirement:2 graph:1 veteran:2 since:2 due:2 comments:1 1:2 board:2 widely:2 under:2 expected:2 new:2 2011:2 company:4 stock:1 move:2 's:5 replacing:2 sixth:1 price:1 but:2 policy:2 step:2 updates:1 background:2 chairman:2 beginning:1 analyst:1 he:2 third:1 55:2 turns:2 industry:1 drug:1 facing:2 chief:2 continue:2 succession:2 turnover:1 starting:2 signaling:2
stock_JNJ r_up	operations:3 caused:2 over:1 expects:1 rest:1 halting:3 go:1 its:12 issues:3 before:1 giant:6 pharma:6 had:1 late:3 has:2 2011:1 agreed:6 do:1 updated:1 his:1 worse:3 early:1 boxes:1 they:1 despite:1 not:1 procedures:1 maintaining:2 spinal-device:1 countries:2 --:7 12th:1 companies:1 recall:2 recalls:2 higher:1 traces:2 respond:1 because:2 deal:1 series:2 some:1 hurdles:1 widened:2 schizophrenia:1 cost:1 pricing:1 year:1 recently:1 acid:2 targets:3 plans:5 said:7 stood:1 practices:1 vaccines:3 health:1 terms:5 residual:2 agreement:1 conglomerate:2 takeover:6 backed:1 approval:1 users:2 manufacturing:4 beginning:1 change:5 $:2 react:1 ahead:1 's:12 maker:1 lenses:2 comment:2 due:3 temporarily:3 reached:1 open:3 market:2 van:3 proceed:5 prove:3 top:1 two:4 assessment:1 final:1 eyes:2 option:5 offer:6 company:1 but:3 plant:7 lowered:1 recalled:1 gain:1 than:3 raising:1 he:1 10:1 15:1 abandoned:3 17:1 type:1 der:3 official:1 cash:6 regulator:3 biotech:3 certain:1 health-care:2 site:3 slowing:1 general:1 full-year:3 drug:1 have:3 aged:1 if:3 confirmed:1 recommended:1 other:2 details:2 meeting:1 insurers:1 stock:1 shipments:3 badly:1 product:2 pain:2 intended:1 price:1 after:3 problems:4 forecasts:1 lens:1 shareholder:1 authorities:1 adds:1 recent:1 billion:8 children:1 daily:1 thought:3 contact:3 left:3 order:1 latest:2
stock_JNJ r_up	agreed:1 have:1 's:2 miss:1 its:1 option:1 giant:1 said:1 pharma:1 any:1 maintaining:1 we:2 terms:1 plans:1 offer:1 running:1 takeover:1 change:1 $:1 billion:2 proceed:1 list:1 cash:1
stock_JNJ r_down	control:1 already:1 have:1 over:1 influence:2 sales:1 prices:1 benefited:1 purchasing:1 want:1 hospitals:2 makers:2 closer:1 driving:1 decisions:1 hospital:1 due:1 long:1 their:1 costs:2 which:1 implantable:1 care:1 markets:1 sliding:1 grip:1 physicians:1 product:1 slumping:1 tool:1 but:1 defibrillators:1 pricey:1 key:1 doctors:3 losing:1 like:1 acquiring:1 puts:1 battling:1 --:1 self-employed:1 devices:1 without:1 practices:1 incentive:1 hips:1 replacement:1
stock_JNJ r_down	control:2 seeing:1 named:1 annual:1 cancer:1 heart:2 certain:2 over:2 period:3 two:2 past:2 cardiologist:2 year:2 need:2 multiple:2 resigned:1 arm:2 industries:1 increase:3 barred:2 group:2 bracing:1 practice:2 hospital:2 had:2 patients:7 comments:1 slowdowns:1 spokesman:1 insider:1 potential:3 treatment:1 maintenance:1 details:1 he:2 meeting:1 company:2 stock:1 updated:1 extended:3 's:3 risk:3 allegedly:2 replacing:1 weakness:1 price:1 after:4 them:2 sales:2 did:2 released:2 fell:2 therapy:1 additional:1 according:2 during:1 hundreds:2 than:2 types:2 secondary:5 unexpectedly:1 days:2 last:2 showed:5 --:2 many:1 could:1 months:1 companies:1 myeloma:2 drug:2 n't:2 stents:2 range:1 hired:2 cancers:2 time:3 putting:2 higher:2 studies:4 taking:5 investigators:2 consultant:2
stock_JNJ r_up	seeing:2 cancer:1 period:1 industries:2 range:2 slowdowns:2 increase:1 bracing:2 treatment:1 extended:1 's:1 risk:1 weakness:2 potential:1 secondary:1 showed:1 many:2 could:2 months:2 companies:2 patients:1 time:1 taking:1
stock_JNJ r_up	all:1 agency:1 agreed:2 allergy:2 ended:1 own:1 its:3 industries:1 giant:2 $:1 tablet:2 had:1 hay:1 bracing:1 equity:1 weakness:1 bid:1 material:1 financing:1 they:1 --:3 companies:1 morning:1 surging:1 higher:1 mergers:1 bankruptcies:1 financial:1 related:1 n't:3 said:2 2.32:1 broad:1 shares:2 does:1 provides:2 across:1 notice:1 sixth:1 sold:1 agreement:1 regulators:2 takeover:2 offset:1 news:1 vaccine:1 gained:1 many:1 could:1 months:1 according:1 range:1 products:3 advertising:2 maker:1 comment:1 seeing:1 already:1 point:1 private:1 reached:1 market:1 decline:1 van:1 there:2 slowdowns:1 biggest:1 more:1 website:1 acquisitions:1 ``:1 formally:2 offer:3 company:3 than:1 posted:1 13:1 rival:2 cash:1 spokeswoman:1 gathers:1 abandon:2 launched:2 claim:4 outstanding:1 health-care:2 evidence:2 '':1 holds:1 sufficient:2 principle:1 fever:1 's:3 provided:1 after:2 stocks:1 billion:2 sale:1 portion:1 points:1 relief:3 biotechnology:2
stock_JNJ r_down	advisory:1 health-care:1 soaring:1 news:1 makers:2 giant:1 $:1 2.32:1 its:1 recommended:1 new:1 pill:1 formally:1 offer:1 company:1 diet:1 takeover:1 approval:1 panel:1 billion:1 products:1 biotechnology:1 spotlight:2 launched:1
stock_JNJ r_down	stake:1 suitors:1 heartburn:2 health-care:1 increased:1 likely:1 itself:1 decides:1 its:3 issues:1 before:1 sell:1 regulator:1 giant:1 said:1 end:1 million:2 variety:1 bonds:1 had:1 factory:1 your:1 access:1 wood:2 boom:1 lot:1 finding:2 means:1 appeal:1 offered:1 more:2 firm:2 product:2 global:1 's:2 risk:1 offering:1 offer:1 company:1 become:1 update:1 overvalued:1 growing:1 market:1 recalled:2 packages:2 contamination:1 buyer:1 little:1 than:2 bank:1 13:2 has:1 attempt:1 target:1 --:3 industry:1 after:2 metal:2 finances:1 investment:1 whether:1 products:1 diagnostics:1 quick:1 biotechnology:2 reward:1 declare:1 consumers:2
stock_JNJ r_down	heart:1 private-equity:1 into:1 domestic:1 down:1 itself:1 year:1 should:1 its:2 needs:1 said:1 next:1 earnings:1 units:1 firms:1 break:1 expected:1 five:1 why:1 ahead:1 launch:1 double:1 up:1 admit:1 pure-play:1 failures:1 investments:1 valves:1
stock_JNJ r_down	office:5 executive:5 years:1 committee:3 its:2 giant:2 retirement:1 $:3 graph:1 than:1 policy:1 has:3 gave:1 tentatively:1 pay:1 them:1 retire:2 diseases:2 updates:1 background:1 chairmen:3 judge:1 level:1 52:1 race:2 succession:2 execs:1 mandatory:1 violated:1 officials:1 pricing:1 year:2 makers:2 since:2 research:1 state:2 intraday:1 new:3 creating:2 marketing:1 million:1 members:2 beginning:2 both:1 climbed:1 drug:3 products:2 maker:1 executives:3 named:2 into:2 within:2 verge:1 easy-money:1 unit:4 pharmaceutical:2 heads:2 additional:1 their:1 5th:1 there:2 two:3 been:1 next:2 stuck:1 expected:2 markets:2 duties:1 more:3 ``:3 drugs:2 company:1 highest:1 appointed:1 kind:2 join:2 expanded:3 up:2 devices:2 're:2 making:2 10th:1 medical:2 ordered:1 health-care:2 head:2 '':3 spender:1 moves:1 no:1 personnel:1 elevated:2 chairman:7 finding:1 stock:1 development:1 though:1 price:1 after:2 fast-growing:2 law:1 effective:2 vice:3 age:1 2002:2 chief:2 practices:1 so:2 diagnostics:2 push:2 nearly:1
stock_JNJ r_down	spurred:1 excessive:1 agreed:1 month:2 its:2 $:4 over-the-counter:5 treatment:1 under:1 has:1 over:2 background:1 heightened:1 follows:1 medicines:3 lapses:1 recalls:4 inspection:1 says:1 deal:3 series:1 some:1 190:1 past:1 year:1 estimated:1 subject:2 said:1 spokesman:1 market:1 medicine:1 million:2 found:3 active:1 beginning:1 last:1 most:1 32:1 motion:1 products:2 fallen:1 inspectors:3 address:1 2nd:1 regulatory:1 quickly:1 quality:3 unit:1 illustrate:1 findings:1 top:1 due:1 been:1 next:1 more:3 ``:1 buy:1 brand:1 hurt:1 recalled:1 focusing:1 these:1 work:1 cash:1 country:1 closing:1 acquisition:1 detailed:1 sees:1 share:1 sales:1 fellow:1 '':1 have:3 damaged:1 end:1 ingredients:1 provide:1 details:1 which:3 company:3 plant:3 's:4 sickness:1 problems:2 76:1 brands:1 such:1 scrutiny:1 response:1 recent:1 reputation:1
stock_JNJ r_up	global:1 focus:1 committee:1 winds:1 chair:1 economist:1 whose:2 rose:2 has:1 2011:3 congressional:1 good:1 gains:1 half:1 now:1 money-making:2 impressive:1 lost:1 companies:2 recalls:1 investors’:1 right:1 actively:2 trading:3 year:2 2.2:1 investment:2 out:1 said:2 quality:1 shares:2 surprise:1 full:1 recently:1 25:1 little:1 pleasant:1 regulators:1 downgrade:1 100:1 debt:1 manufacturer:1 both:1 incoming:1 many:1 changed:1 contract:1 mixed:2 traded:2 asked:1 point:1 into:1 awaited:1 down:1 probing:1 miss:1 use:1 leading:1 2:2 don’t:1 markets:1 500:3 ``:1 but:1 recalled:1 last:1 buying:1 posted:1 11:1 13:1 look:2 while:1 were:4 providing:1 1.5:1 climbed:2 investors:1 1.3:1 '':1 want:1 no:1 make:1 ideas:2 incentive:1 also:1 performance:1 stock:2 week:1 product:1 repeat:1 's:11 problems:1 fell:3 strategists:1 stocks:3 data:1 off:1 futures:3 chief:1 points:8 volumes:1
stock_JNJ r_down	all:1 consider:1 departing:1 retire:2 years:1 helm:1 its:2 cardiovascular:1 increase:1 giant:1 27:1 also:1 than:1 late:1 suffered:1 has:1 2011:1 executive:1 updated:1 move:1 self-inflicted:1 traffic:1 background:1 during:2 trouble:1 successor:1 countries:1 --:1 follows:1 large:1 did:1 some:1 challenges:1 slowed:1 economic:1 result:1 year:2 tumultuous:1 said:3 review:1 current:2 adverse:1 downturn:1 before:1 business:1 marketing:2 pressure:1 weight-loss:1 search:1 industry:1 drug:2 approve:1 asked:1 comment:1 major:1 would:1 three:1 time:1 authorization:1 more:1 company:3 but:1 hurt:1 filed:1 analyst:1 rejection:1 integrating:1 whether:1 devices:1 n't:1 could:1 acquisition:1 share:1 evidence:1 hospitals:1 risk:1 end:2 provide:1 agency:2 member:1 application:1 potentially:1 chairman:1 performance:1 spinal-device:1 events:1 poor:1 's:3 plans:2 price:1 after:1 wounds:1 such:2 fiscal:2 maker:1 chief:1 tenure:1 medical-device:1
stock_JNJ r_down	deal:1 caps:1 held:1 reports:1 have:1 such:2 blockbuster:1 payers:1 its:2 issues:1 blue:1 index:1 marking:2 said:1 bottles:3 willingness:1 since:2 due:2 other:1 fourth:2 new:1 hardball:1 odor:1 's:2 plans:2 price:1 midcaps:1 includes:1 19,000:6 know:1 complaints:1 dividend:1 stocks:1 chips:1 analyst:1 recall:4 months:1 list:1 up:1 drug:2 small:1 fresh:1 senior:1 playing:1 talk:1
stock_JNJ r_down	drama:1 act:1 takeover:1 nearing:1 final:1
stock_JNJ r_up	senators:1 suspend:1 painkiller:3 probe:1 spinal:1 have:2 linked:2 out:2 pharmaceutical:1 confirmed:1 trials:2 unemployment:1 damage:2 been:2 may:2 clinical:2 new:2 type:1 more:1 giants:1 drugs:2 halted:2 joint:2 concerns:2 those:2 kind:1 surgeries:1 companies:1 studies:1
stock_JNJ r_up	``:1 oil:1 's:3 look:1 fair:1 spill:1 corporate:1 share:1 than:1 '':1 its:1 heat:1 companies:1 crises:1 some:1 handled:1 saw:1 2010:1 more:1
stock_JNJ r_down	do:1 we:3 swans:1 's:2 ugly:1 predict:1 writes:1 but:1 forecasts:1 n't:2 next:1 ducklings:1 five:1 know:1 year:1 need:1 ca:1 face:1 2011:1 birds:1 today:1
stock_JNJ r_up	1.4:1 1.5:1 1.7:1 1.1:1 session:2 health-care:1 states:1 actively:2 trading:2 year:1 whose:2 cancer:1 overhaul:1 $:2 rose:2 fix:1 six:1 question:1 shares:2 1:1 closed:1 test:1 new:3 troubled:1 2010:1 500:2 higher:2 's:2 partners:1 approvals:1 watch:1 stats:1 stocks:2 gained:2 like:1 climbed:2 companies:3 drug:1 points:1 comes:1 after-hours:1 traded:1 1.25:2
stock_JNJ r_up	among:1 her:1 dividends:1 veteran:1 companies:1 picks:1 favorites:1 growing:1 cash-rich:1
stock_JNJ r_down	control:1 large-cap:1 best:1 keep:1 health-care:1 up:1 disappointing:1 held:1 unit:1 including:1 have:1 partner:1 expedited:1 its:4 market:1 said:3 sum:1 able:1 hepatitis:1 should:1 options:1 potentially:1 treatment:1 dividends:1 new:2 several:1 company:3 brand:1 division:1 executive:1 's:6 big:1 sold:1 under:1 undisclosed:1 next:1 regulators:1 lucrative:1 closely:1 stocks:1 stage:1 bring:1 whether:1 companies:1 heating:1 drug:1 2010:1 reviews:1 chief:1 race:1 products:1 evaluating:1 comebacks:1 granted:1 experimental:1
stock_JNJ r_down	already:1 investors:1 sectors:3 pay:1 could:2 attention:1 political:1 three:1 priorities:1 shifting:1 key:1 turns:1 need:1 applies:1 especially:1 sway:2 twists:1 market:1 stock:1
stock_JNJ r_down	sector:2 saying:1 all:1 77:2 fears:1 over:10 expects:2 years:2 session:3 shares:8 after-tax:2 go:1 settlement:3 its:2 whose:3 giant:5 renewed:5 based:1 $:6 had:2 analyst:1 late:2 contract:2 equity:1 has:4 kick:1 damages:2 rejected:2 returned:1 close:1 than:2 bid:2 suffering:3 updates:1 world:1 bankruptcies:1 success:2 lost:3 --:3 approach:3 drop:1 companies:4 morning:1 did:1 after-hours:1 worries:7 output:3 finishing:1 higher:1 fore:1 enforce:2 mergers:1 week:7 set:1 financial:5 billion:1 valuing:1 declines:1 shareholders:1 reduce:3 related:3 2.9:1 officials:4 trading:6 year:2 multiple:1 80:2 declined:2 index:7 shown:2 said:2 lead:2 leak:5 review:1 patients:1 hepatitis:1 increase:1 bailout:7 closed:2 got:1 current:1 issue:2 across:5 red:1 shows:1 shut:4 led:1 approached:1 healthcare:2 sixth:1 million:2 weak:3 pumping:5 agreement:2 reported:1 takeover:1 key:5 ask:2 approval:2 100:6 debt:2 speculation:1 panel:2 gained:7 both:1 pipeline:6 last:8 ahead:1 losses:7 37:1 drug:1 expedited:1 0.8:1 prior:1 afternoon:1 mixed:1 share:3 traded:4 asked:2 comment:1 fourth-quarter:3 slipped:2 1.5:1 private:1 one:1 down:5 downside:3 shutdown:6 news:7 vote:1 open:1 market:1 per:2 take:4 pharmaceutical:1 gathers:1 repeal:1 soars:1 due:5 station:5 rates:1 biggest:2 proposal:1 markets:5 500:4 more:2 firm:4 acquisitions:1 mining:2 750:1 received:2 0.5:1 company:1 slump:1 but:1 sales:2 blue-chip:1 disruption:1 gain:2 filed:2 95:3 aluminum:1 posted:1 11:1 10:1 financing:1 12:1 word:2 pushed:1 these:2 straight:1 heavyweight:4 supplied:2 n't:1 record:2 while:1 actively:3 were:1 following:3 2:1 say:1 similar:1 souring:1 1.4:5 heart:2 weaker:3 1.1:1 investors:2 1.3:1 cents:2 0.3:1 contribute:2 1.8:2 0.4:3 need:1 stroke:1 cure:1 dropped:7 have:2 13.7:2 ready:1 sharp:1 keep:1 any:2 health-law:1 information:1 4.6:2 end:2 5.6:1 stents:4 sovereign:1 granted:1 42:1 detail:1 40:1 website:1 also:4 without:1 5:2 details:1 which:7 season:1 stock:4 gaining:2 added:1 's:6 forced:1 may:1 earnings:1 price:1 after:9 treatments:1 driven:6 75:1 fell:14 studies:1 device:2 oil:3 stocks:8 weekend:12 pressuring:5 recent:2 ago:2 lower:5 off:6 sentiment:4 amid:6 medical:2 futures:3 roughly:1 maker:2 reports:8 points:12 rallies:1 banks:1 decliners:1 having:3 talk:1
stock_JNJ r_up	heart:1 major:1 gainers:1 stent:1 investors:1 over:1 one:2 hopes:1 ready:2 offer:1 cure:1 trading:1 daily:1 article:1 go:2 sharp:1 should:1 its:1 declined:1 rundown:1 pharmaceutical:2 shown:2 stocks:1 based:1 mounting:1 review:1 there:1 water:1 hepatitis:1 launch:1 increase:1 also:1 hot:1 rates:1 market:1 which:1 late:1 biggest:3 health:1 has:5 economy:1 gaining:1 added:1 's:4 closed:1 received:1 put:1 body:1 treatments:1 dark:1 worries:1 said:1 designed:1 filed:2 regulatory:1 world:2 approval:3 euro-zone:1 multiple:1 declining:1 keep:1 both:1 lower:1 amid:1 2012:1 success:1 fully:1 --:3 similar:1 could:1 current:1 companies:3 drug:1 expedited:1 n't:1 device:1 published:1 banks:1 management:1 decliners:1 stock:1 studies:1 granted:1
stock_JNJ r_up	standing:1 high:1 would:1 's:3 $:4 business:1 all-time:1 company:1 health-care:1 companies:1 get:1 1,000:3 their:1 audiences:1 have:1 reached:1 strategies:1 happen:1 344:1 week:1
stock_JNJ r_up	operations:2 proposed:1 over:2 allegations:1 judge:1 go:1 cold:1 its:2 issues:2 giant:1 pharma:1 had:1 failed:1 has:1 2010:2 his:1 very:2 safe:1 shutting:1 sues:1 report:1 accepted:1 --:3 hunt:1 says:1 people:1 begin:1 year:2 index:1 said:2 expert:1 find:1 vaccines:2 version:1 safety:1 defibrillators:1 shut:1 terms:1 million:1 agreement:1 takeover:1 groups:1 alone:1 dividend:1 $:1 resumed:2 both:1 kids:1 last:2 drug:1 foreign:1 products:1 massive:1 usually:1 facility:1 down:2 put:1 market:2 use:1 due:2 long:1 treat:1 taken:1 ``:1 health-care:1 company:2 hopes:1 subsidiary:1 ear:1 high:1 target:1 up:1 can:2 selling:1 heart:1 adults:1 doses:1 '':1 itself:1 ponder:1 generic:1 equipment:1 recommended:1 winners:1 electrical:1 pal:1 stock:1 plant:3 's:4 after:2 problems:1 such:1 data:1 short:1 effective:1 tricks:1 infections:1 biotechnology:2
stock_JNJ r_down	sector:5 saying:2 managed:2 feedback:1 gold:4 being:1 developed:2 move:1 ``:3 results:1 trade:1 ended:2 through:2 skin:2 talks:1 cold:1 its:3 issues:2 giant:2 group:2 over-the-counter:2 merger:2 had:3 including:1 late:1 other:4 condition:2 under:2 policy:1 has:4 drug:4 sent:1 meant:1 modestly:1 string:2 press:1 evaluate:1 end:1 miners:3 records:2 wishes:1 nearly:2 not:2 affect:1 2.2:3 silver:4 bank:3 well:1 --:1 medicines:2 morning:2 pullback:1 continue:1 steps:1 recalls:6 speculation:2 sank:2 replacement:1 highs:1 because:1 says:1 medical-device:1 reported:1 2.8:1 trading:1 result:4 7th:1 close:3 declined:2 out:1 index:14 said:5 consumers:1 record:1 profit:1 decision:2 lead:1 miner:3 sites:1 shares:10 research:2 increase:2 cause:1 across:2 ends:1 after:1 weighing:1 million:5 water:1 pressure:2 regulators:2 takeover:3 issued:1 regulatory:2 news:1 100:6 manufacturing:4 central:3 clarify:1 broad-based:1 could:3 losses:2 step:1 reports:1 surge:1 products:1 gainer:2 action:1 discussions:1 traded:4 maker:2 experimental:2 fourth-quarter:1 followed:1 slipped:3 distributed:1 increased:1 down:8 date:1 64:1 quality:1 market:1 once:1 unusual:1 strong:1 additional:3 recalling:1 top:1 there:1 negative:1 tablets:1 next:1 poured:1 examination:2 treat:2 statement:2 chip:1 more:3 firm:6 media:1 mining:8 efficacy:1 engaged:1 company:6 diversified:2 benchmark:7 took:1 but:3 psoriasis:2 wake:2 gain:2 sharply:3 prices:4 rallying:1 hips:1 convinced:1 potential:1 '':3 pushed:1 these:1 recall:2 edged:1 roof:1 air:1 reviews:1 matter:1 while:6 contrary:1 indicating:1 historical:2 were:1 problem:1 9.3:1 called:1 unlikely:1 0.9:1 1.5:1 later:1 investors:1 do:1 certain:1 0.3:2 0.2:1 share:1 0.4:2 surface:1 0.6:1 weighed:6 n't:1 hypertension:1 reviewing:1 want:2 further:2 need:1 rally:1 technology:6 any:3 if:1 again:3 bottles:1 no:1 47:3 thorough:2 denying:1 note:1 also:2 points:2 2.5:1 which:3 largest:1 units:3 gains:2 stock:5 week:4 product:2 's:11 plans:2 knees:1 may:3 price:1 earlier:4 problems:1 falls:1 applications:2 drag:1 fell:5 authorities:1 requirements:3 stocks:1 unless:1 rallied:5 lower:8 pressured:4 big:1 studies:1 clear:1 required:1 metal:4 analysis:1 practices:1 so:1 talk:1 rallies:1 banks:3 recalled:4 reserve:3 filing:1 came:2 latest:4
stock_JNJ r_down	denies:1 received:1 's:3 matter:1 list:1 bid:1 time:1 companies:1 50:3 but:1 cash:1 talks:1 only:1 takeover:1 stockpiles:1 biggest:1 world:1 formal:1 believes:1 market:1 before:1
stock_JNJ r_up	all:1 give:1 health-care:1 year:1 ``:1 '':1 held:1 good:1 want:1 news:1 their:1 mutual:1 said:1 group:1 eligible:1 pay:1 citing:1 wo:1 bonuses:1 reputation:1 health:1 widely:1 approvals:1 performance:2 proposal:1 has:1 might:1 2010:1 law:1 tighten:1 noise:1 's:2 plans:1 rules:1 funds:1 company:1 attention:1 incentives:1 opposes:1 retirement:1 portfolios:1 affect:1 stocks:1 you:1 after:1 physician:1 hits:1 full:1 withdrawing:1 employees:1 n't:3 regular:1 so:1 workplace:1 many:1 mixed:1 obesity:1 medical-device:1
stock_JNJ r_up	upgraded:1 rating:1 major:1 smaller:2 increasingly:1 well:1 into:1 health-care:1 results:1 expirations:1 likely:1 investment-grade:1 have:1 pipelines:1 affected:1 makers:2 before:1 bolster:1 again:1 cut:1 but:1 leverage:1 consumers:1 also:1 patent:1 large:1 much:1 there:1 been:1 research:1 their:1 citing:1 continue:1 agreements:1 fourth:1 developers:1 markets:1 red:1 more:1 status:1 relationships:1 's:1 increased:1 drugs:1 screen:1 contract:1 looming:1 sales:1 joint:1 fast-growing:1 cutting:1 try:1 push:1 they:1 highest:1 carnage:1 organizations:1 quarter:1 improved:1 working:1 ahead:1 pursue:1 many:1 companies:1 see:1 drug:2 deals:1 ventures:1 costs:2 today:1 back:1 amid:1 long-term:1 notch:1 maker:1 licensing:1
stock_JNJ r_down	prices:1 fourth-quarter:1 shed:1 key:1 tougher:1 results:1 setback:1 ended:1 including:1 defects:1 reports:1 year:2 tumultuous:1 hospitals:1 market:1 gone:1 note:1 devices:1 suggest:1 top:1 bargaining:1 away:1 better:1 concerns:1 new:1 firms:1 markets:1 2010:1 handful:1 risk:1 slumping:1 may:1 after:1 but:1 weight-loss:1 birth:1 report:1 data:1 amid:1 last:1 getting:1 whether:1 light:1 companies:1 drug:2 sliding:1 n't:1 prior:1 have:1 dealt:1 following:1 asked:1 medical-device:1 projections:1
stock_JNJ r_down	whose:1 watch:1 companies:1 focus:1 shares:1 trade:1 active:1 see:1 session:1 expected:1
stock_JNJ r_down	12000:2 emerging:1 8.50:1 issued:4 over:1 executive:2 results:2 projected:1 buyer:3 session:4 through:2 high-profile:3 its:6 consumer-confidence:2 before:1 home-price:2 whose:1 buyers:1 $:8 22:1 flood:2 stent:1 had:1 expectations:3 late:2 charge:2 offers:2 4:1 policy:1 has:2 might:1 2010:2 overcome:1 hip:2 affected:1 analysts:5 weakness:1 rise:2 regulatory:1 early:1 fallout:1 fall:2 report:2 during:2 trouble:1 trade:1 continued:1 day:1 lost:1 ended:1 did:1 drop:1 companies:1 deals:1 --:1 continue:1 surging:1 recall:2 recalls:5 quarter:2 attracting:1 shed:1 set:2 cost:2 posts:2 blitz:1 hurdles:1 related:2 slowdown:2 see:1 actively:1 trading:2 year:2 home:1 margins:1 declined:2 out:1 index:4 said:2 lead:2 bag:1 profit:7 blue-chip:3 since:3 recorded:2 below:2 shares:3 forecast:4 current:1 aground:1 health:1 new:1 previous:2 numerous:1 announced:1 specialist:1 we:1 attention:1 run:1 business:1 grappling:1 300:1 timeline:1 million:3 weak:1 monetary:1 reported:2 sift:1 weaker-than-expected:1 alone:1 estimate:1 closing:1 after:3 900:2 ahead:3 pressure:1 industry:1 changed:1 drug:2 fell:10 products:1 disappointment:1 rose:2 mixed:2 operating:1 interested:1 slightly:2 maker:1 confidence:2 fourth-quarter:6 outlook:1 slipped:2 bell:1 named:1 near-term:1 down:1 device:2 post:1 market:1 decline:4 little:1 industrials:1 would:2 spending:1 prospects:1 housing:2 political:1 hammered:1 next:1 disappointed:1 statement:1 expected:2 markets:1 500:3 more:2 sort:1 giant:1 posting:2 offer:1 polled:1 39:1 company:6 delayed:1 but:2 quarterly:3 economic:1 wake:1 prices:3 highest:2 than:2 buying:1 11:1 10:3 12:15 2011:4 up:1 n't:2 while:1 growth:3 cautiously:1 amid:1 following:1 problem:1 could:1 dropped:2 0.9:2 heart:1 slid:2 losses:1 slip:3 investors:6 health-care:3 share:2 sales:6 disappointing:2 caution:1 reports:1 tab:1 close:2 100:2 rally:2 bidders:1 spell:1 balloon:1 savings:2 any:1 also:1 consumer:2 potential:2 role:1 earnings:11 fourth:1 income:1 9:2 a.m.:4 events:1 stock:4 product:2 finish:1 's:9 price:1 await:1 includes:1 most:1 'd:1 rolling:1 catheter:1 stocks:6 data:4 lower:3 short:2 deluge:1 released:4 traded:1 moved:1 futures:8 well:2 chief:1 points:9 weigh:2 2008:3 looking:1 corporate:1
stock_JNJ r_down	operations:1 saying:1 over:1 implants:6 years:2 6.4:3 including:2 still:1 its:2 cut:1 crisis-management:1 antipsychotic:1 surprises:2 should:1 advisories:2 treatment:1 details:1 take:1 do:1 auto:1 possible:3 breast:4 2:3 lymphoma:2 --:2 drop:1 companies:1 large:2 steps:1 1,900:1 force:1 people:1 likely:1 7th:1 estimated:1 wo:1 regulator:1 said:4 comments:1 cell:2 pressures:1 health:1 unit:1 between:2 filled:1 jobs:1 silicone:1 sold:1 million:2 commercial:1 reported:1 restructuring:1 manufacturing:1 beginning:1 care:1 roundup:1 rare:2 industry:1 drug:1 aged:1 massive:1 changes:1 maker:2 executives:1 fourth-quarter:1 cancer:2 60:1 market:1 pharmaceutical:1 would:1 next:1 much:1 type:2 ``:1 brand:1 aware:1 link:2 known:2 cases:1 those:1 women:2 10:1 15:1 17:1 recall:1 work:1 schizophrenia:1 n't:2 while:1 future:1 quarters:1 investigating:2 medication:1 predict:1 experts:1 reports:1 have:1 dent:1 needs:1 blockbuster:1 agency:1 damage:1 recommended:1 5:1 earnings:2 several:1 worldwide:1 's:5 react:1 lay:1 health-cost:1 response:1 off:1 minimize:1 well:1 face:1 costs:1 corporate:1 latest:2
stock_JNJ r_up	comment:1 fourth-quarter:2 associated:1 among:1 issued:1 health-care:1 period:2 one:1 60:1 year:1 inflated:2 year-earlier:2 said:3 overhaul:1 profit:1 rose:3 saw:1 revenue:1 28:3 expectations:1 per:1 forecast:1 better:1 citing:1 costs:1 5:1 details:1 assuming:1 women:2 2011:1 earnings:3 product:1 's:2 company:1 million:1 sales:2 volume:1 4th:1 gain:2 prices:1 cases:1 94:6 recall:1 case:1 helped:1 short:1 last:1 6th:1 plunged:2 drug:1 large:2 divestiture:2 while:2 fell:1 graph:1 higher:2 slightly:2 maker:2 experimental:1 effects:1
stock_JNJ r_down	heart:2 '':1 ask:1 's:1 its:2 if:1 given:1 said:2 court:1 $:4 federal:2 pay:2 detail:1 tiny:2 should:2 location:1 statement:1 appeal:1 ``:1 his:2 jury:3 million:2 judge:1 subsidiary:2 overturn:1 disappointed:1 482:4 patent:2 stents:2 verdict:2 ruling:1
stock_JNJ r_down	summer:1 one:1 go:2 confusing:1 again:1 $:2 away:1 seems:1 which:1 more:1 gets:1 opens:1 economy:1 picture:1 hormone:1 jury:1 rules:1 becomes:2 never:1 come:1 482:2 winter:1 up:1 against:1 thing:1 wanes:1
stock_JNJ r_up	fourth-quarter:1 sales:1 high:1 another:1 year:1 's:1 margins:1 yet:1 litigation:1 index:1 compared:1 profit:1 has:1 pal:1 higher:1 hit:1 screen:1 earlier:1 chart:1 reported:1 although:1 dividend:1 posted:1 loss:1 lower:1 sortable:1 charges:1 together:1 --:2 maker:1 medical-device:1
stock_JNJ r_down	saying:1 major:2 illness:2 designed:1 although:1 fourth-quarter:1 within:1 declines:1 health-care:1 near-term:1 results:1 quarters:1 challenges:1 device:1 through:1 legal:1 year:2 consumer-products:1 watched:1 plan:1 throughout:1 two-year:1 its:2 pharmaceutical:2 giant:1 swung:1 devices:1 working:1 profit:1 surprises:2 expectations:1 same:2 advisories:2 charge:1 cures:2 potentially:1 earnings:1 defibrillators:1 new:1 themselves:4 areas:1 markets:1 company:1 details:1 reshape:1 product:1 outlook:1 's:3 big:2 implantable:1 earlier:1 different:2 expected:1 sales:2 ranges:1 pressure:1 turbulent:1 busy:1 portfolio:1 signaling:1 closely:1 fends:1 world:2 future:1 posted:1 roundup:1 both:1 off:1 most:1 companies:3 restructuring:1 reports:1 facing:1 stents:1 while:2 prescribing:2 diagnosed:2 weighing:1 were:1 following:1 heart:1 corporate:1 maker:1 medical-device:1 latest:1
stock_JNJ r_up	heart:4 5:2 fourth-quarter:2 bleeding:1 companies:1 setback:2 one:1 brain:1 stroke:1 value:2 have:1 recently:2 throughout:1 its:3 market:1 out:1 writedown:1 said:2 trial:1 profit:3 people:1 had:1 patients:1 forecast:3 increase:1 pressures:1 citing:2 concerns:3 safety:2 details:1 clinical:1 swung:2 stopping:1 led:1 around:1 linked:2 could:1 company:1 treatments:1 like:1 abandon:1 boost:1 background:1 report:1 recent:1 loss:3 abandoned:2 2011:3 taking:1 bottom:1 lines:1 second:1 drug:8 write-down:1 prior:3 while:1 strokes:1 long-term:3 study:1 history:1 maker:3 experimental:3 late-stage:1
stock_JNJ r_up	all:1 into:1 narrower:1 sales:1 general:1 held:1 full-year:1 declares:1 narrowed:1 its:1 if:1 said:2 profit:1 rose:1 since:1 recorded:1 2001:3 which:1 net:1 before:1 meeting:1 firm:1 multiple:1 fourth:2 offer:1 effect:1 driven:1 extraordinary:1 cut:1 operating:2 come:1 approved:1 drugmaker:1 loss:1 posted:1 revenues:1 --:3 items:1 losses:1 sclerosis:1 drug:1 charges:1 costs:1 agenda:1 time:1 biotechnology:1 quarter:2 first:1
stock_JNJ r_up	aided:1 stake:1 suitor:1 proposed:1 executive:4 years:1 held:1 skin:1 helm:1 its:10 announcement:1 group:1 $:2 had:1 potential:1 board:1 has:3 reversal:1 resolved:2 retire:1 gains:1 beat:1 bid:3 rise:1 courtroom:1 they:1 during:1 entire:1 --:5 medicines:1 lookout:1 did:1 better-than-expected:1 alive:1 past:1 likely:1 tender:2 further:1 margins:1 makers:1 2.4:2 said:7 profit:1 since:1 shares:1 medicine:1 drawn:1 net:1 alleged:1 associate:1 upon:1 agencies:2 reported:2 manufacturing:2 vaccine:3 launch:1 margin:1 could:1 drug:4 products:1 replacement:1 maker:4 stakes:1 comment:1 fourth-quarter:2 adjusted:1 period:1 oversaw:1 one:1 device:2 rising:1 shareholders:1 strong:1 their:1 top:2 support:1 two:1 been:1 fight:1 few:1 too:1 interest:1 time:1 more:1 buy:2 offer:2 company:6 infection:1 low:1 hopes:1 former:3 10:2 keeping:1 main:1 resume:2 n't:1 future:1 replaced:1 can:2 promising:2 bidder:1 called:1 biotech:3 partnership:1 share:1 sales:2 selling:2 partner:1 attract:1 check:1 lengthy:1 holds:1 42:1 detail:1 intends:1 other:1 earnings:2 which:2 development:1 plant:2 's:8 after:3 problems:2 forecasts:1 reflect:1 most:1 shareholder:2 improving:1 knee:1 billion:4 medical:2 looked:1 chief:1 2007:1 withdraw:1 healthcare:1 biotechnology:2
stock_JNJ r_down	comment:1 wearing:2 detailed:1 force:1 heart:1 cuts:1 implants:3 sales:4 assess:1 rate:1 actively:1 have:3 further:1 close:2 labor:1 causing:2 market:1 size:1 surfaces:1 has:2 confirmed:1 said:1 working:1 stent:1 reducing:1 agency:1 metal-on-metal:1 its:3 website:1 high:1 concerns:2 safety:1 details:1 which:4 test:1 several:1 ideal:1 hip:2 ``:1 ball:1 's:6 both:1 share:1 unit:1 problems:2 workforce:1 consolidation:1 pressure:2 part:1 key:1 device:1 pain:1 analyst:1 declining:1 areas:1 faced:2 '':1 all-metal:3 effectiveness:1 off:2 look:2 covering:1 these:1 amid:3 taking:2 metal:3 devices:1 page:1 spokeswoman:1 relief:1 launched:1 move:1 medical:2 hips:1 replacement:2
stock_JNJ r_up	purchases:1 because:1 testing:1 sales:1 through:1 devices:1 its:1 out:1 hazards:1 system:1 does:1 stock:1 's:1 recalled:1 approval:1 cleared:1 require:1 reports:1 n't:1 patients:1 were:1 medical:1 latest:1
stock_JNJ r_down	less:1 soon:1 its:2 blow:1 antipsychotic:2 pharmacy:1 disclosed:1 discovering:2 has:1 2012:3 ...:1 good:1 hit:1 expirations:1 possible:1 wave:1 fall:1 not:1 world:1 70,000:6 injectable:2 reduced:1 respond:1 deal:1 sends:1 beyond:1 declined:1 said:2 lead:1 receiving:1 anti-anemia:1 schedule:1 yesterday:1 kicking:1 received:1 shelves:1 could:1 drug:3 approve:2 frequent:1 letters:1 letter:3 two:1 market:1 '':1 asks:1 holdings:1 best-selling:1 due:1 lot:1 more:1 website:1 ``:1 complete:1 efficacy:1 drugs:1 recalled:2 10:1 cracks:2 syringes:4 versions:1 spokeswoman:1 evaluating:1 sales:1 dosing:1 evening:1 ready:1 information:1 generic:1 agency:2 write:1 application:2 potentially:1 which:1 's:10 users:1 huge:1 after:2 update:2 coverage:1 such:1 response:1 recent:1 off:1 sometimes:1 infections:1 patent:1 latest:1
stock_JNJ r_down	control:1 biotech:1 smaller:1 depart:1 have:1 deal:2 then:1 acquired:1 infections:1 hard:2 challenges:1 ended:2 been:1 long:2 another:1 hit:1 makers:1 risk:2 pharmaceutical:1 said:2 $:1 lead:1 specialty-drug:1 avoid:1 though:1 had:1 purchasing:1 tend:1 finally:2 attractive:1 new:1 has:2 low:1 project:1 full:1 's:2 tried:1 found:1 track:1 got:1 company:1 but:3 following:1 part:2 biotechnology:1 frequently:1 courtship:2 now:2 those:1 billion:1 made:1 talent:1 assets:1 syringes:1 these:1 deals:1 --:1 work:2 companies:1 large:1 record:1 pitfalls:1 marriage:2 acquisition:3 70,000:2 mixed:1 making:2 2009:1 its:1 could:1 comes:2 users:1
stock_JNJ r_up	site:1 '':1 tendered:1 have:1 11th:1 open:1 its:1 shareholders:1 said:1 operation:1 remains:1 had:1 shares:1 their:1 enough:1 version:1 closed:1 pm:1 firm:1 ``:1 buy:1 offer:1 corrected:1 vaccine:1 billion:1 16:1 follows:1 cash:1 published:1 biotechnology:1 maker:1
stock_JNJ r_up	because:1 cancer:1 over:1 health-care:1 year:1 defect:2 dose:2 states:1 medical:1 drug:3 395:2 cuts:1 recently:1 its:1 unit:1 containing:2 overhaul:1 clarification:1 not:1 agency:1 due:3 least:2 vials:1 asking:1 new:1 has:1 might:1 ruling:1 product:3 's:2 700,000:1 confirmed:1 packaging:2 recalled:3 device:1 last:1 injection:2 potential:2 received:1 rejection:1 liquid:1 concerns:1 amid:1 could:2 devices:2 spokeswoman:1 reports:2 while:1 planned:1 quick:1 insufficient:2 pulled:1 guide:1 talk:1 result:2
stock_JNJ r_down	declared:1 said:1 offer:2 --:1 company:2 pharmaceuticals:1 tender:1 biotechnology:1 has:1 completed:1
stock_JNJ r_down	billion:1 appeals:1 court:1 $:3 patent-infringement:1 reversed:1 1.8:3 against:1 decision:1
stock_JNJ r_down	heart:2 because:1 supply:1 health-care:1 catheters:1 accused:1 policy:1 cows:1 its:1 unit:1 improperly:1 information:1 confirmed:1 asthma:1 trigger:1 avoid:1 sitting:1 tiny:1 live:1 potential:1 health:1 defrauding:1 employee:1 has:1 used:1 's:1 plans:1 government:1 big:1 reporting:1 stop:1 giant:1 most:1 pigs:1 traffic:1 lawsuit:1 former:1 supplying:1 disruption:1 considered:1 programs:1 attacks:1 devices:1 drug-pricing:1 facing:1 stents:1 near:1 install:1 changes:1
stock_JNJ r_down	sentence:1 issued:2 global:1 soon:1 beset:1 mental-health:1 through:1 its:4 staff:1 giant:1 believe:1 $:3 tablet:2 over-the-counter:1 stent:2 had:1 including:1 treatment:1 weeks:1 has:2 2010:6 do:2 customers:1 get:1 stop:1 focus:1 possibly:1 cutting:1 not:5 provision:1 level:1 --:1 12th:1 medicines:1 facing:1 steps:1 wholesale:1 lapses:1 recalls:3 chew:2 because:2 series:2 year:3 said:5 funding:1 expert:1 legal:1 label:1 crush:2 may:1 does:1 market:1 supplies:1 numerous:1 seeks:1 notice:1 business:1 million:1 threatened:1 agreement:1 reported:1 directions:1 approval:1 packages:1 supplying:1 last:1 taking:2 biologics:1 place:1 planned:1 repeats:1 changes:1 comment:1 own:1 divide:2 supply:2 into:1 two:1 regulatory:1 tiny:1 unit:3 long:1 would:1 recalling:1 top:1 due:2 been:1 rivals:1 trigger:1 declining:1 website:1 ``:2 health-care:1 catheters:2 company:2 took:1 disruption:2 newer:1 slashed:2 167:1 word:1 recall:2 devices:2 n't:3 while:2 install:1 dissolve:2 acquisition:1 heart:1 partnership:2 share:2 sales:4 '':2 reads:1 have:1 sell:1 information:1 confirmed:1 45:6 preventing:1 potential:1 details:1 which:5 performance:2 incorrect:1 product:3 used:1 's:8 bonus:2 price:1 problems:1 most:1 important:1 ago:1 third:1 face:1 stents:1 wording:1
stock_JNJ r_up	gaining:1 hunger:1 hard:1 sales:1 sense:1 technology:1 market:1 ground:1 planet:1 there:1 s:1 shares:1 safety:1 4:1 easy:1 utility:1 today:1 nervousness:1 auto:1 blue-chips:1 most:1 stocks:1 bode:1 man:1 straight:1 performing:1 well:2 heart:1 while:1 steps:1 time:1 averages:1 having:1
stock_JNJ r_down	sector:1 outlook:1 already:1 reversal:2 doing:1 we’re:1 down:2 celebrating:1 second:2 names:1 go:1 makers:1 market:2 really:1 working:1 headline:1 writes:1 since:1 2000:1 trend:1 much:1 worlds:1 9:1 today:1 good:1 's:2 leg:2 market’s:1 secular:1 bear:1 birthday:2 defensive:1 bull:1 stocks:1 both:1 lower:1 last:2 prepare:1 changed:1 flow:1 value:1 bag:1 s:1 momentum:1 underway:1 mixed:1 bet:1
stock_JNJ r_up	comment:1 does:1 because:2 just:1 list:1 over:1 defect:2 ninth:1 due:1 packaging:2 surgical:2 including:1 have:2 mean:1 's:1 stockholders:1 quality:1 your:1 if:3 information:1 manufacturing:1 adds:1 lead:2 over-the-counter:1 agency:1 patients:2 late:1 other:1 parts:1 various:1 which:2 money:1 affecting:1 you:2 has:2 sent:1 more:1 website:1 them:2 used:2 multiple:1 may:2 sixth:1 seventh:1 but:1 alert:1 batches:1 recalled:3 letter:1 regulatory:1 product:1 than:1 104:2 posted:1 past:1 read:1 18:1 could:2 months:1 infections:2 spokeswoman:1 amount:1 contact:1 products:1 today:1 lapses:1 recalls:1 problem:1 latest:1 out:1 medicines:1 lenses:1 first:1
stock_JNJ r_up	reductions:1 dealing:1 move:1 competition:1 '':1 growth:1 seen:1 confirmed:1 sluggish:2 pharma:1 driving:1 top:2 spokesman:1 which:1 conditions:2 heart-device:1 cost-cutting:1 ``:1 's:2 continues:1 workforce:1 restructuring:1 focused:1 fierce:1 areas:1 conducting:1 talent:1 markets:2 underscores:1 deals:1 ongoing:1 efforts:1
stock_JNJ r_up	advisory:1 emerging:3 strengthened:1 over:2 move:2 expects:2 setback:2 month:1 four:1 quotes:2 including:1 comments:2 forecast:1 fine:1 its:4 previous:1 whose:1 giant:2 group:1 $:1 rose:1 had:1 promoting:1 treatment:3 indications:1 under:2 8:2 has:2 2011:7 2010:3 indicating:1 2012:3 pay:1 global:2 risk:7 rebound:2 finish:2 were:1 birth:4 during:2 continued:2 represents:2 name:3 --:4 follows:2 stock:2 prevent:2 drug-sector:2 because:2 exposed:1 around:3 born:2 rate:1 growth:5 organic:4 year:3 migraines:2 said:9 profit:1 review:2 shares:1 p.m.:1 -2-:1 3:1 version:2 health:2 new:5 net:1 correct:1 15th:1 told:1 available:2 led:2 sold:2 million:1 strong:2 care:1 suggested:3 prospects:1 quarter:2 last:4 taking:2 guilty:1 drug:7 34:3 products:2 advertising:3 published:1 maker:2 comment:1 among:1 revenue:4 into:2 encouraging:1 defects:4 pregnancy:4 throughout:2 decline:1 additional:1 rivals:2 statement:3 which:2 upbeat:2 markets:3 final:2 4:1 firm:1 ``:4 initiated:1 brand:2 corrected:1 but:2 demand:1 prices:1 subsidiary:1 women:2 include:1 showed:2 versions:2 clients:1 up:3 below:1 budgets:1 owns:2 closing:1 revenues:2 spotlight:2 biotech:1 strengthening:2 strengthen:3 health-care:1 '':4 increased:2 information:1 recovery:1 generic:5 suggest:2 agency:2 also:2 5:4 babies:2 tumbles:1 9:1 a.m.:1 company:2 higher:5 used:4 's:3 warnings:5 price:1 after:6 uses:1 coverage:1 preliminary:1 off-label:1 data:5 recent:2 placement:1 accelerated:2 databases:2 fresh:1
stock_JNJ r_down	funding:1 like:1 increasingly:1 start-ups:1 becoming:1 early-stage:1 companies:1 dearth:1 facing:1 important:1 venture:1 which:1 capital:1 device:1 traded:1 medical:1
stock_JNJ r_up	symptoms:1 already:1 knees:1 started:1 outperform:1 showing:1 health-care:1 leaving:1 n't:2 're:1 unit:1 they:1 president:1 hips:1 stocks:1 makes:1 top:1 market:1 replacement:1
stock_JNJ r_down	biotech:1 says:1 give:1 dose:1 weather:2 have:1 unit:1 pharmaceutical:1 leak:1 alternate:1 adverse:1 potential:1 potentially:1 between:1 product:1 's:1 gains:1 warnings:2 cartridges:1 device:1 news:1 stocks:3 losses:1 reports:1 small:1 recalls:2
stock_JNJ r_down	consent:2 agreed:1 binding:1 actions:1 one:1 depends:1 improvements:1 signed:1 years:1 out:1 symptoms:1 decree:2 takes:1 puts:1 agency:1 three:1 signals:1 tight:1 take:1 under:1 has:1 really:1 correct:1 's:6 problems:1 giant:1 scrutiny:1 most:1 if:1 hands:1 regulatory:2 manufacturing:2 effort:1 vaccine:1 plants:1 actual:1 matters:1 drug:2 matter:1 s:1 can:1 serious:1 maker:1
stock_JNJ r_up	after:1 's:1 criticizes:1 pays:1 partnership:1 bypass:1 off:1 drinking:1 panel:1
stock_JNJ r_down	decline:1 product:1 his:1 's:3 bonus:1 series:1 overall:1 sales:1 value:1 reduced:1 reflect:1 compensation:1 dropped:1 7:3 recalls:1 performance:1 2009:1 2010:1
stock_JNJ r_up	appeals:1 some:1 there’s:1 private:1 prices:1 rate:1 cost:1 value:1 have:1 year:1 still:1 insurance:1 decade:1 n't:1 use:1 rapidly:1 spending:1 writes:1 reaching:1 had:1 been:1 shares:1 recommended:1 roiled:1 health:1 7:2 forward:1 restrain:1 panic:2 events:1 stock:1 do:1 good:1 's:7 plans:1 prescriptions:1 government:1 brand:1 but:1 step:1 therapy:1 report:1 climbing:1 stocks:3 name:1 last:1 look:2 publicly:1 medicines:1 funded:1 up:1 drug:1 regulator:1 push:1 injectable:1 gene:1
stock_JNJ r_up	roundup:1 wires:1 22:1 these:1 newspapers:1 sites:1 their:1 does:1 stories:1 not:2 news:2 has:1 2011:1 accuracy:1
stock_JNJ r_down	raised:1 into:1 some:1 planning:1 trading:1 questions:1 close:1 run:1 open:1 before:1 4.1:1 anymore:1 thinking:1 workers:1 shares:1 has:1 ca:1 ...:1 's:1 after:1 takeover:1 news:1 insights:1 like:1 up:1 reports:1 n't:1 succession:1 following:1 came:1
stock_JNJ r_down	sector:1 ...:1 one-year:1 right:1 's:2 look:1 we:2 big:1 bill:1 anniversary:1 past:1 'd:3 health:2 have:1 year:1 overhaul:1 has:1 treated:1 care:2
stock_JNJ r_up	saying:1 made:1 's:4 could:1 barrier:1 recalling:1 recall:1 company:1 wound:1 wounds:1 drain:1 packaging:1 surgical:2 used:1 products:2 compromised:1 units:1 pulls:1 its:1 unit:2 latest:1
stock_JNJ r_up	``:1 plans:1 trial:1 treatments:1 priorities:1 '':1 comparing:1 citing:1 clinical:1 various:1 injectable:1 scrapped:1 has:1 oral:1 its:1 antipsychotic:1
stock_JNJ r_down	has:1 2009:1 caplets:1 prompted:1 over-the-counter:1 issued:1 medicines:1 since:1 smelling:1 implicated:1 citing:1 complaints:1 another:2 series:1 lapses:1 recalls:2 similar:1 quality:1 round:1 those:1 recall:1
stock_JNJ r_up	prompted:1 revamping:1 focus:1 trade:1 see:1 session:1 have:1 quality:1 unit:1 whose:1 giving:1 fix:1 shares:1 expected:1 new:1 troubled:1 multiple:1 problems:1 leadership:1 active:1 effort:1 companies:1 recalls:1 makes:1
stock_JNJ r_down	among:1 major:1 work:1 managed:1 trucker:1 consulting:1 ended:1 motor:1 year:1 177:1 close:1 during:1 its:2 best:1 85:1 little:1 highest:1 $:2 trials:1 since:1 stocks:1 their:1 clinical:1 9:1 2011:2 2010:1 speaking:1 finish:1 gains:1 boosted:1 million:2 rail:1 paid:2 most:1 doctors:1 such:1 strong:1 items:1 changed:1 2008:1 other:1 averages:1 institutions:1
stock_JNJ r_up	major:1 brakes:1 price:1 companies:1 drug:1 increases:1 pressing:1 including:1 groups:1 put:1 religious:1
stock_JNJ r_up	sector:1 major:1 throwing:1 global:2 some:1 marked:1 session:1 trading:1 technology:1 recommending:1 indexes:1 looking:1 other:1 forth:1 isn’t:1 flat:1 volume:1 broken:1 finished:1 invest:1 strategies:1 safer:1 buying:1 calls:1 sectors:1 countries:1 light:1 34:2 calamity:3 amid:2 caution:1 havens:2 wind:1
stock_JNJ r_down	looked:1 's:2 help:2 deal:1 illnesses:1 hospitalized:1 technology:1 study:1 up:2 shares:3 back:1 helped:1 patients:1 edge:3 prevention:1 clot:1 markets:1 gains:1 higher:1
stock_JNJ r_down	firm:1 named:1 bleeding:1 certain:1 some:1 cost:1 investment:1 shown:1 preventing:1 2:2 rates:1 board:1 appeal:1 boost:1 nice:1 development:1 's:3 get:1 drugs:1 company:1 use:1 deflect:1 pressure:1 blood:1 attempt:1 former:2 join:1 effective:1 could:2 drug:2 patients:1 limit:1 rivaroxaban:1 biotechnology:1 higher:1
stock_JNJ r_down	agreed:1 probe:3 allegations:1 obtain:1 agrees:1 bribes:1 $:4 federal:1 pay:2 three:1 under:1 leader:1 company’s:1 illegally:1 business:1 marketing:1 million:4 paid:1 70:4 doctors:1 former:1 countries:1 into:1 settles:2 well:1 foreign:1 settle:2 kickbacks:1 chip:1
stock_JNJ r_up	help:1 them:1 '':1 businesses:1 industries:1 out:1 sell:1 management:1 hunting:1 writes:1 six:1 slapped:1 their:1 hot:1 analysts:1 ...:1 ``:1 coming:1 grow:1 faster:1 prospects:1 12:3 talent:1 staples:1 considered:1 profiles:1 can:1 fresh:1 consumer:1 executives:1
stock_JNJ r_up	lowers:1 indications:1 buying:1 just:1 over:1 global:1 sales:1 down:1 questions:1 consumer-products:1 its:1 market:1 giant:1 anticipation:1 $:1 puts:1 skidding:1 guidance:1 2.5:1 107:1 orthopedics:1 earnings:1 spike:1 recent:1 today:1 economy:1 undercut:1 recommends:1 stung:1 demand:1 prices:2 than:1 raising:1 posted:1 fiscal:1 has:1 uncertain:1 third:1 replacement-joint:1 --:1 amid:1 more:1 fresh:1 barrel:1 quarter:1 soft:1
stock_JNJ r_down	impact:1 sector:1 far:1 budget:1 one:1 n't:1 behind:1 defense:1 stocks:1 chatter:1 having:1 today:1
stock_JNJ r_up	because:1 over:1 some:2 years:1 trading:1 have:1 linked:1 unit:1 unusual:1 lead:2 recalling:1 two:1 been:1 its:1 note:1 few:1 potentially:1 which:1 advancers:1 has:1 north:2 odor:2 after:1 different:1 recalled:1 complaints:1 stocks:3 last:1 getting:1 drug:4 lots:1 products:1 afternoon:1 problem:1 treated:1
stock_JNJ r_up	sector:1 saying:1 deck:1 over:2 results:1 years:1 report:3 stored:1 talks:4 settlement:1 its:2 weekly:2 regions:1 suicide:1 20:4 $:5 surprises:2 workers:1 advisories:2 quarterly:2 agreed:1 dispute:1 around:1 watch:3 not:1 quarters:1 day:2 loss:1 companies:1 morning:1 round:1 prevent:1 shed:1 says:1 deal:4 second:1 economic:3 trading:3 fail:2 our:1 nuclear-plant:1 encouraged:1 profit:1 shares:1 enough:1 bln:2 scientists:1 lower-than-expected:1 advancers:1 ends:1 climbs:2 marketing:2 million:1 stem:1 lucrative:1 although:1 news:1 suggest:1 roundup:1 could:1 drug:3 afternoon:3 rose:1 retain:1 maker:2 among:1 rank:1 one:1 two-year:1 would:1 friends:1 takeovers:1 biggest:1 cycle:1 500:2 firm:2 buy:3 company:1 but:1 lift:3 gain:1 weighed:1 valued:1 rights:2 cells:1 up:1 future:1 were:2 investors:1 give:2 certain:2 health-care:1 disappointing:1 optimistic:1 have:1 larger-cap:1 technology:1 gains:5 pay:1 indexes:1 note:1 hot:1 earnings:1 fourth:1 gets:1 stock:2 week:2 after:1 courtesy:1 climbing:1 stocks:3 data:2 recent:1 billion:2 purchase:1 reports:2 part:1 rallies:2 corporate:1 latest:2
stock_JNJ r_down	sector:1 help:1 show:1 fears:2 dollar:1 trade:1 mild:1 session:1 including:1 cuts:3 talks:3 its:4 whose:1 giant:3 renewed:2 20:1 $:1 it’s:1 under:1 quarterly:1 has:1 his:3 expirations:1 combination:1 government:1 billionaire:1 continues:1 watch:7 early:1 fall:2 not:1 world:1 bit:1 now:1 --:2 drop:2 morning:1 banking:1 continue:1 reinvigorate:1 worries:3 downward:1 economically:1 deal:1 headwinds:1 some:2 euro-zone:2 see:1 close:3 biggest-ever:1 makers:1 out:1 lead:2 giving:1 since:1 shares:3 investigation:1 business:3 sink:2 defensive:1 active:1 quits:1 debt:3 first-quarter:1 rests:1 broad-based:1 could:1 courtesy:1 drug:1 keep:1 sensitive:1 figures:1 outlook:2 into:2 negative:1 names:1 secretive:1 owner:1 resilience:1 market:1 decline:2 strong:1 would:1 leading:1 flying:1 sovereign:1 their:1 way:1 expected:1 markets:1 more:1 firm:1 selling:1 gear:1 season:1 company:1 haunt:1 lift:1 sharply:1 buying:1 made:1 15:1 pace:1 cards:1 acquisition:2 sort:1 weaker:1 joints:1 health-care:2 sales:1 high:1 strain:1 beats:2 itself:1 against:1 our:1 rally:3 confirms:3 billion-dollar:1 patent:1 get:1 medical-devices:1 thinks:1 shifts:1 chest:1 potential:2 earnings:2 largest:2 outbreak:1 struggling:1 gets:1 stock:3 play:1 's:6 intensifies:1 price:1 after:5 flurry:1 device:1 stocks:7 friends:1 billion:1 lower:2 largely:1 starting:2 futures:2 reports:2 2006:1 relief:1 banks:1 deck:2 consumer:1 medical-device:2 surge:1
stock_JNJ r_up	sector:1 all:2 help:1 just:1 year-to-date:1 move:2 dollar:3 results:7 month:3 session:1 economy:1 touch:1 suffer:1 year-earlier:1 its:4 litigation:2 whose:2 giant:2 27:1 pharma:2 23:4 troubles:1 expectations:1 lifts:2 persist:1 quarterly:2 stable:1 dividends:1 has:2 2011:2 ...:1 increased:1 rise:3 overall:1 focus:2 boost:3 worst:1 negative:1 report:2 look:1 lost:1 --:1 follows:1 medicines:1 drop:2 companies:2 assuming:1 doubled:1 morning:2 surging:1 seeks:1 after-hours:2 release:1 recalls:2 raised:1 quarter:2 eases:2 mergers:1 better-than-expected:2 bankruptcies:1 due:1 doing:1 wrestling:1 back:1 related:1 up:1 challenges:1 see:1 added:1 trading:1 expected:1 year:1 's:12 11th:1 revises:1 out:1 enticing:1 bullish:1 profit:5 shares:5 forecast:5 current:1 52-week:1 version:1 provider:1 heavyweights:1 hurt:1 issue:1 announced:1 earlier:1 led:1 2.9:1 found:1 hefty:1 gathers:1 stronger-than-expected:1 here:1 quick:1 offset:1 news:2 strong:1 generate:1 gained:1 both:1 most:2 many:1 months:1 reports:5 surge:2 amount:1 a.m.:2 analysts:2 published:2 action:2 traded:2 revise:1 among:1 outlook:3 revenue:1 private:1 2nd:1 down:1 weak:1 losses:2 market:2 debt:1 few:1 positive:1 housing:3 managed-care:1 selloff:1 three:1 cash:1 their:3 growth:1 stock:2 6:1 taken:1 start:1 500:1 ``:1 received:1 some:1 company:1 equity:1 corrected:1 but:2 sentiment:1 biggest:1 fest:1 lift:2 link:1 gain:3 titans:1 '':1 financing:1 target:1 solid:1 trends:1 value:1 lead:1 n't:2 actively:2 starts:2 following:1 weaker:2 associated:1 investors:1 soars:2 flow:1 health-care:2 exceeded:1 sales:1 high:1 full-year:1 against:2 accounting:1 technology:1 worry:1 rout:1 brightened:1 other:3 1.3:1 earnings:8 products:1 offered:1 higher:4 product:1 currencies:1 first-quarter:4 intensifies:1 watch:2 after:7 update:1 helping:1 mixed:1 helped:2 fell:2 long-term:1 stocks:4 data:1 euro:1 acquisitions:1 lower:3 especially:1 largely:1 charges:1 futures:3 well:2 points:3 so:1 time:1 buoy:1
stock_JNJ r_up	saying:1 all:1 help:1 show:1 caused:1 dollar:2 results:2 quarters:1 against:1 session:1 comments:1 signs:1 its:7 osteoporosis:1 whose:1 replacements:1 $:4 stent:2 unemployment:1 28:1 expectations:1 should:1 advisories:2 treatment:1 stalled:1 equity:1 has:1 overcome:1 details:2 hip:1 updated:1 hit:2 added:1 rules:1 big:1 showing:1 updates:1 performance:1 report:1 defended:1 continued:3 falling:1 anemia:1 1.03:1 59:1 like:1 level:1 --:4 inventory:1 companies:2 fortunes:1 morning:1 12th:1 quarter:2 dip:3 mergers:1 replacement:2 bankruptcies:1 unexpected:1 woes:1 acquired:1 7.5:1 related:1 slowdown:1 3.6:3 growth:2 0.6:1 settled:3 year:1 's:13 makers:3 out:1 knees:1 medical-supplies:1 actively:1 lead:3 profit:1 since:1 compensation:1 shares:4 increase:1 behind:1 future:1 closed:1 crude:2 new:2 newly:1 expiration:1 turmoil:1 ability:1 business:3 heavily:1 after-hours:1 struggle:1 snapped:1 news:1 strong:1 beginning:1 bone:1 roundup:1 last:2 acquisition:1 soft:1 could:1 double-digit:1 drug:8 products:3 analysts:1 rose:2 changes:1 maker:1 first:2 comment:1 copper:1 major:1 cancer:1 sweet:1 private:1 one:1 down:1 franchise:2 65:1 another:1 throughout:1 offered:1 market:1 shareholders:1 industrials:1 bite:1 revive:1 1.52:1 rivals:1 orthopedics:2 stock:1 biggest:1 barrel:2 euro:1 gained:1 500:1 187:2 flat:1 0.2:1 company:5 slump:1 but:1 hurt:1 delivery:1 contract:2 economic:1 demand:1 highest:1 analyst:1 posted:2 disappointing:1 financing:1 showed:1 launches:1 up:5 project:1 patients:1 gathers:1 sent:1 trading:1 closing:1 more:1 launched:1 gone:1 weaker:1 surprises:2 cents:2 exceeded:1 sales:4 expenses:1 13th:2 full-year:1 dropped:1 rally:3 4.4:3 ponder:1 no:1 pay:1 struggles:1 1:1 also:1 high:1 points:4 5:1 take:1 tie:1 greenback:1 higher:3 product:1 oil:2 first-quarter:2 plans:1 cede:1 earnings:3 price:1 after:1 euro-zone:1 forecasts:1 driven:1 most:1 fell:1 device:1 knee:1 stocks:2 data:2 pulled:1 recent:2 acquisitions:1 reimbursement:1 assets:1 backed:1 charges:1 approve:1 futures:1 well:1 traditional:1 reports:1 ortho:2 traded:1 9.6:1 reiterated:1 2008:1 hospital:1 corporate:1 hips:1 latest:1
stock_JNJ r_down	bankruptcies:1 all:1 cancer:1 sales:1 expectations:1 year:1 product:1 related:1 expenses:1 3.6:3 struggle:1 launched:1 recommending:1 another:1 exceeded:1 first-quarter:1 should:1 its:3 market:1 osteoporosis:1 strong:1 additional:1 profit:1 review:1 two:2 hepatitis:1 next:1 rules:1 details:1 equity:1 biggest:1 new:1 recent:2 stock:1 week:1 hurt:1 updated:1 's:3 reimbursement:1 drugs:2 price:1 results:1 77:2 most:1 regulators:1 private:1 treatment:1 news:1 one:1 continued:1 analyst:1 panel:1 acquisitions:1 driven:1 financing:1 quarter:1 last:3 showed:1 disappointing:1 --:4 launches:1 anemia:1 well:1 drug:4 morning:1 traditional:1 whether:1 patients:1 gathers:1 products:1 bone:1 allow:1 higher:1 changes:1 maker:1 mergers:1 dropped:1
stock_JNJ r_up	slapped:1 '':2 tag:1 hepatitis:1 have:1 approval:1 should:1 market:2 shown:1 perform:1 review:2 agency:1 28:1 two:1 recommending:1 next:1 recommended:1 rates:1 widely:1 expected:1 effectiveness:1 week:1 ``:2 's:3 drugs:3 use:1 standard:1 regulators:1 therapy:1 liver:1 they:1 improving:1 article:1 strong:1 panel:1 --:1 outperform:1 up:1 disease:1 whether:1 patients:1 cure:1 analysts:1 allow:1 published:1
stock_JNJ r_up	comment:1 proposed:1 health-care:2 long-running:2 product:1 reviewed:1 13th:1 diabetes:2 fake:2 battle:2 its:2 staff:1 information:1 giant:2 said:1 adds:1 beginning:1 review:2 clinical:1 test:2 products:2 has:2 stock:1 updated:1 strips:2 's:4 discovered:2 company:1 continues:2 seventh:1 liver:1 data:1 analyst:1 panel:1 treating:1 reaction:1 effective:1 showed:1 versions:2 disease:1 drug:2 counterfeit:2 faces:1 global:2 similar:1
stock_JNJ r_up	all:1 chain:1 global:2 results:1 surgical:5 talks:2 issues:1 whose:2 concerned:1 40-year:1 opportunities:1 quarterly:1 updated:1 premium:2 rise:1 account:1 spate:1 focus:2 updates:2 exact:1 --:8 positions:1 companies:5 deals:1 team:1 nearing:1 cost:1 pass:1 index:1 giving:1 shares:5 practices:2 version:1 unsure:1 conglomerate:2 reported:3 operating:2 100:1 strong:1 earthquake:1 first-ever:1 ahead:3 32:1 37:1 suggests:1 complicated:1 maker:9 market:9 shareholders:1 would:4 two:1 more:1 sort:1 flat:2 ``:4 company:5 award:1 hold:1 keeping:1 reviews:1 remain:1 values:1 thin:1 growing:2 challenging:1 give:4 predict:1 share:3 topic:1 arise:1 occur:1 end:4 turn:1 traders:1 hot:1 earnings:4 stock:7 hurdles:1 plans:3 may:2 after:3 modest:3 4th:1 coming:3 such:1 capitalize:1 purchase:7 third:1 light:1 futures:6 chief:1 reshape:1 over:1 expects:3 years:2 including:1 looks:1 still:1 its:5 stock-index:1 before:3 22:2 continued:1 16.6:1 premarket:1 underpin:1 policy:1 might:1 2010:1 not:3 investor:1 day:2 represents:2 rocky:1 always:1 mean:2 product:1 related:1 trading:2 expect:1 year:1 our:1 out:2 network:1 profit:3 blue-chip:1 health:1 issue:2 correct:1 announced:1 await:1 lucrative:1 proxy:1 beginning:1 care:1 benefits:1 could:3 times:1 thing:1 first:1 already:1 slipped:2 one:1 given:1 management:1 top:1 orthopedics:5 final:2 acquire:2 than:1 15:2 14:2 aims:1 compensation:2 future:1 were:1 briefing:1 steep:1 1.6:1 sees:1 1.1:1 investors:4 unchanged:1 talking:1 substantial:1 have:4 linked:1 relatively:2 sell:1 able:1 equipment:1 concerns:1 which:5 performance:2 price:1 courtesy:1 plan:1 significant:4 device:2 why:1 antitrust:2 medical:3 stronger:1 points:6 consumer:1 advisory:1 agreed:1 defended:2 session:2 portfolio:2 fifth:1 impact:4 giant:6 it’s:1 should:1 do:2 his:2 hit:1 gains:1 means:1 watch:1 nearly:1 wedding:1 during:1 trade:2 release:1 actively:2 sea:1 close:1 clarifies:1 said:8 away:1 probably:1 across:1 ends:1 terms:2 opening:1 confusion:1 succeed:1 news:1 both:1 influential:1 trader:1 annual:2 takeover:3 a.m.:1 wringing:1 vault:1 traded:3 comment:1 adjusted:1 tough:1 bell:1 exploit:1 conference:1 1.2:1 treat:4 expected:2 meeting:2 500:2 4:1 firm:3 demand:1 prices:1 n't:3 career:1 while:2 taking:1 costly:1 health-care:3 disappointing:1 technology:1 disappear:1 pay:3 parts:1 inventory:1 largest:1 higher:1 lid:1 used:4 edged:1 bonus:1 moving:1 opportunity:1 off:2 savings:1 costs:2 corporate:1 left:1 less:1 increasingly:1 executive:1 injuries:4 grappling:1 cut:1 $:27 also:4 rose:1 supply:1 royal:1 board:1 has:6 bid:1 historic:1 background:2 press:2 world:1 reap:1 advanced:1 lost:1 follows:1 recalls:1 deal:16 growth:3 sight:1 scale:1 lead:5 decision:1 comments:2 does:1 fractures:4 bolster:2 business:3 monetary:1 discount:1 leadership:1 offset:1 peer:1 manufacturing:2 shine:2 cautious:1 mixed:1 bond:2 executives:1 into:1 negative:2 your:2 21.3:20 biggest:1 buy:6 offer:1 but:8 wireless:1 trying:1 muster:1 up:2 devices:7 cautiously:1 moved:1 sales:3 '':3 moves:1 puzzling:1 45:1 detail:1 other:1 test:1 's:26 problems:2 included:1 stocks:3 friends:1 structure:2 billion:16 salt:1 2006:1 volumes:1 medical-device:5
stock_JNJ r_down	operations:1 advisory:1 spurred:1 consider:1 agreed:1 executive:1 results:1 month:2 top:1 held:1 session:1 economy:2 shares:3 inaugural:1 7.8:1 year-earlier:1 its:10 whose:1 giant:3 $:4 favor:1 rose:1 concerned:1 had:1 including:1 voted:1 policy:4 various:1 has:2 increased:2 means:1 rise:2 increases:4 they:2 despite:1 not:3 dose:1 areas:1 insert:1 mandated:1 promising:1 61:1 --:12 54:2 57:2 proposals:1 deals:1 merge:1 after-hours:1 lapses:1 recalls:3 quarter:1 drug-sector:2 right:1 billion:1 due:1 series:2 grabs:2 draw:1 used:2 up:1 vote:3 actively:1 trading:1 all:1 year:2 11th:1 2.7:1 out:1 said:3 ways:2 since:1 overly:1 publish:1 companies:5 does:1 trauma:1 closed:1 consecutive:2 appeal:2 boost:2 told:1 recently:2 risen:2 25:1 million:3 component:2 votes:1 reported:1 opposition:1 dividend:8 strong:1 beginning:3 payout:2 21.3:1 piles:2 taking:1 annual:1 through:1 analysts:1 maker:1 businesses:1 first:2 comment:1 study:1 revenue:1 into:1 period:1 2nd:1 improving:2 investors:2 consumer-products:2 dilutive:1 shareholders:4 law:1 raise:2 would:1 8.6:1 5th:1 two:1 tightly:2 approved:2 meeting:1 500:1 treatment:1 company’s:1 acquisitions:1 soar:1 becoming:2 but:1 bulk:1 quarterly:3 executive-pay:1 solid:1 rival:1 cash:2 value:2 n't:1 growth:1 can:1 were:2 growing:1 spotlight:2 tap:2 figure:1 cents:4 health-care:3 share:2 sales:2 against:1 urged:1 need:2 seek:2 comments:2 marking:2 5.6:2 clutch:2 pay:1 4.8:1 earnings:1 which:2 interview:1 if:1 company:8 higher:1 week:1 product:3 added:1 's:6 critics:2 boosted:4 earlier:1 problems:1 forecasts:1 director:1 fell:1 shareholder:4 72:1 device:1 such:1 stocks:1 eighth:2 buybacks:2 purchase:1 short:1 light:1 popularity:2 chief:1 points:3 bottle:1 8th:1 latest:2
stock_JNJ r_up	operations:1 rating:1 212:1 advisory:1 agreed:1 doctors:1 limited:1 businesses:1 hepatitis:3 research:2 year-earlier:1 its:8 issues:1 earlier:1 giant:2 unanimously:1 $:12 graph:2 nearly:1 analyst:1 citing:1 potential:2 integrate:1 violations:2 has:1 2011:1 2010:4 details:2 versus:1 over:1 which:2 combination:2 continues:1 watch:1 updates:2 background:1 exchanges:1 report:1 highly:1 him:1 advanced:2 resolve:2 excluding:1 --:3 follows:1 list:2 50:1 've:1 settle:1 payments:1 endorsed:1 essential:1 better-than-expected:1 development:1 version:1 ten:1 competition:1 up:1 10th:1 likely:1 officials:2 year:1 discussions:2 's:20 insurance:1 declined:1 said:7 plays:1 profit:4 projected:1 comments:2 forecast:1 investigation:2 fifth:1 new:1 told:1 working:1 favored:1 sixth:1 million:4 acquisition-related:2 tripled:2 unit:1 downgrade:1 approval:1 along:1 beginning:4 generate:1 declining:1 pharma:1 reaction:1 pipeline:1 weeks:1 last:1 puts:1 items:1 drug:4 foreign:2 credit:1 range:1 a.m.:1 acquisition:1 published:1 slightly:1 maker:4 comes:1 late-stage:2 comment:1 disclosure:1 projection:1 cancer:2 previously:3 into:2 private:1 three:1 bribery:2 news:1 market:1 bolster:1 pharmaceutical:2 coveted:1 heads:1 leverage:1 21.3:1 spending:3 5th:1 two:1 been:3 approved:2 production:1 growth:1 treat:2 chemotherapy:2 panel:1 type:2 patients:4 more:1 ``:1 offer:1 drugs:3 company:4 surges:2 corrected:1 photos:1 lowered:1 representative:1 graphics:1 than:1 testosterone:1 11:3 professionals:1 made:1 damages:1 heavyweight:1 pill:1 placed:1 while:2 cost:1 risks:1 9th:1 following:1 panels:1 treated:2 called:1 additional:1 certain:4 health-care:2 sales:2 agent:1 '':1 full-year:1 have:1 protein:1 negotiations:1 end:1 generic:1 pay:3 agency:2 targets:1 1:2 also:1 recommended:1 other:1 role:1 earnings:2 fourth:1 figures:1 stock:2 week:2 rise:1 first-quarter:4 boosted:1 price:3 after:2 helped:1 important:1 70:1 services:1 law:2 prostate:2 payment:1 billion:2 lower:3 analysis:1 savings:1 costs:2 diversify:1 2009:2 filing:1 8th:1
stock_JNJ r_up	closed:1 among:1 all:1 deal:2 agreed:1 health-care:1 major:1 month:1 authorities:1 actively:2 3.2:1 expect:1 cancel:1 close:1 6.9:1 after-hours:1 market:1 if:1 knees:1 fee:1 $:4 21.3:1 products:1 session:2 top:1 rose:1 two:1 shares:2 while:1 other:1 orthopedics:1 trauma:1 disclosed:1 650:3 party:1 2.4:1 subject:1 markets:1 500:2 2012:1 acquire:2 's:3 which:1 whose:2 9.5:1 company:1 million:1 points:5 includes:1 conglomerate:1 slipped:1 fell:2 five:1 half:1 included:1 approval:1 stocks:2 billion:1 lower:1 transaction:1 last:1 would:1 lost:2 antitrust:1 spine:1 hips:1 companies:3 merger:1 trading:2 segments:1 place:1 either:1 were:1 mixed:1 termination:1 traded:1 maker:1 medical-device:1 first:1
stock_JNJ r_up	summer:1 all:1 over:1 half:1 dollar:1 competitive:1 trade:2 session:5 including:1 its:2 24:1 whose:5 giant:1 20:1 $:5 22:1 merger:1 rose:1 guidance:1 4:3 premarket:1 quarterly:1 8:1 2011:1 agreed:1 2012:2 evening:1 big:1 watch:1 possible:1 know:1 exchanges:1 report:1 exporters:1 products:1 --:2 companies:7 50:1 fewer:1 morning:1 ignore:1 spine:1 bad:1 either:1 after-hours:2 shed:2 bolstering:1 prompted:1 deal:2 medical-device:1 estimates:1 actively:5 trading:6 expect:1 year:1 first-quarter:2 2.7:1 subject:1 knees:1 said:1 missed:1 profit:2 since:1 near:1 shares:6 favor:1 trauma:1 closed:1 pharmaceutical:2 million:1 weak:2 conglomerate:1 reported:1 brokerage:1 abroad:1 gained:1 goods:1 last:1 would:1 technical:1 losses:1 reports:2 segments:1 place:1 analysts:1 mixed:3 traded:2 maker:1 first:1 among:1 major:1 slipped:2 revenue:1 two:1 down:2 authorities:1 news:1 cancel:2 market:2 pouring:1 fee:1 21.3:1 top:2 charts:1 their:1 orthopedics:1 650:1 expected:2 markets:1 500:3 more:2 lowest:1 eyes:1 releases:1 slumping:1 month:1 company:2 acquire:2 but:2 line:1 than:1 those:1 10:1 hips:1 edged:2 up:2 while:1 midday:1 were:2 making:1 0.8:1 trades:1 have:1 bigger-than-expected:1 correction:1 health-care:2 sales:3 slip:1 2.2:1 close:2 if:1 4.6:2 weakened:1 other:1 earnings:3 which:2 9:1 party:1 you:1 higher:2 's:9 though:1 after:1 disclosed:1 includes:1 levels:1 coming:1 included:1 stocks:5 guys:1 billion:1 lower:1 transaction:1 off:3 antitrust:1 charges:1 amid:1 approval:1 points:8 affirmed:1 basket:1 termination:1 2008:1 corporate:1 order:1 profits:1
stock_JNJ r_down	insurers:1 first-quarter:1 market:1 glimmers:1 certain:1 company:1 hope:1 doubled:1 hurt:1 access:1 while:1 earnings:1 blocking:1 's:1 spinal-device:1 procedures:1 than:1 cited:1 more:1
stock_JNJ r_down	sector:1 move:1 its:6 replacements:1 over-the-counter:1 guidance:2 analyst:1 device:2 choose:1 2012:2 hip:1 weakness:1 rise:1 they:1 fall:2 continued:1 --:2 52:2 settle:1 quarter:1 replacement:2 some:2 urgent:1 growth:3 's:2 makers:1 out:1 missed:1 profit:2 comments:1 find:1 enough:1 medicine:2 net:2 after:1 business:1 slow:1 offset:1 news:1 strong:1 care:1 kids:1 lifestyle:1 drug:2 changes:1 options:2 frequent:1 revenue:2 treatment:1 multiply:2 refined:1 throughout:1 whom:1 rivals:1 2:1 6:1 final:1 4:1 firm:1 company:1 bladder:2 but:1 reiterated:2 demand:1 prescription:1 cases:1 pain:1 than:2 posted:1 divisions:1 aren’t:1 up:1 growing:1 curb:1 more:2 remedies:1 joints:1 share:1 1.9:4 say:1 experts:1 have:1 need:1 concentration:1 their:1 relatively:1 variety:1 wound:1 detail:1 other:1 acetaminophen:1 which:2 cholera:1 used:1 first-quarter:2 may:2 price:1 reporting:2 treatments:2 forecasts:1 driven:1 4th:1 phase:1 knee:1 single:1 recent:1 fiscal:2 faster:1 medical:2 children:1 fever:1 maker:2 switch:1
stock_JNJ r_up	prevent:1 help:1 show:2 raging:1 generation:1 offerings:1 second:1 used:1 year:1 patient:1 surge:1 its:1 market:1 transplant:1 save:2 given:1 stocks:1 beginning:1 initial:2 treatment:2 next:2 cell:1 consistently:1 millionaires:1 concerns:1 details:1 fourth:1 new:1 several:1 type:1 survival:1 stock:3 extended:1 's:1 maintenance:1 may:1 price:1 after:2 includes:1 following:1 quell:1 public:1 therapy:1 updates:1 billionaires:1 news:1 stem:1 data:2 analyst:1 bulls:2 acquisitions:1 reaction:1 effectiveness:1 --:3 study:1 meaning:1 drug:3 2010:1 large:1 credit:1 good:1 growth:1 long-term:1 studies:2 side:1 mergers:1 effects:1
stock_JNJ r_up	show:1 over:2 move:1 focus:1 brain:1 including:1 its:6 cell:1 group:1 $:7 candidate:2 failed:2 under:2 has:1 executive:1 which:1 period:1 endpoint:1 therapy:1 effects:1 background:1 15:1 17th:1 --:5 did:2 side:1 deal:8 dealing:1 schizophrenia:1 7th:1 multiple:1 80:2 said:2 3rd:1 comments:1 spokesman:1 11th:1 medicine:1 new:1 25:2 reach:2 million:5 key:2 debt:4 reaction:2 pipeline:4 last:1 study:3 months:1 allows:3 drug:11 trial:1 fell:2 products:2 maker:4 late-stage:2 comment:3 revenue:1 450:1 primary:1 down:4 unit:4 pharmaceutical:2 objectives:2 initial:1 hammered:1 clinical:2 combined:2 sealed:4 expected:1 type:1 final:1 function:1 troubled:1 company:3 fund:4 hopes:1 line:1 pain:1 analyst:1 nine-year:1 main:2 960:6 n't:2 were:1 meet:1 10th:1 annual:1 share:2 high:1 have:2 seen:1 accounting:1 blockbuster:1 technology:4 any:1 around:1 sell:4 pay:4 stake:1 1:1 details:1 holding:1 development:4 draw:1 's:3 price:1 after:3 problems:1 treatments:1 beta:1 4th:1 transformational:4 allowing:1 significant:1 phase:1 diabetes:3 attempt:1 valued:3 sclerosis:1 8th:1 updates:1 latest:1
stock_JNJ r_up	advisory:1 investors:1 saying:1 plunged:1 over:1 retire:1 years:1 something:1 have:1 year:1 vote:1 return:1 plan:1 total:1 its:1 retirement:2 end:1 top:1 three:1 recommending:1 platform:1 other:1 has:1 announced:1 firm:1 's:2 may:1 company:1 shareholder:1 proxy:1 device:1 last:1 influential:1 medical:1 companies:1 against:1 large:1 compensation:1 drops:2 maker:1 launched:1 executives:1
stock_JNJ r_up	offensive:2 over:2 probe:2 allegations:2 month:1 artificial:1 settlement:2 its:3 $:9 stent:4 expectations:1 source:1 add:1 money:2 discovering:2 has:2 details:2 hip:1 modestly:1 hit:1 government:2 infringement:2 continued:1 ruled:3 unauthorized:2 countries:2 tear:1 button:1 steps:2 lapses:1 2.25:2 attorney:1 set:2 series:2 hard:1 long-running:1 elderly:1 transportation:1 11th:1 makers:1 said:7 adds:1 decision:2 since:1 legal:2 spokesman:2 investigation:1 safety:1 market:1 between:2 sliding:1 jury:3 wrangling:2 million:3 promoted:2 contamination:1 beginning:1 monitor:1 last:1 recovering:1 launch:2 latest:2 days:1 drug:2 recently:1 analysts:1 graph:1 changes:1 maker:3 heart:2 number:1 been:1 1st:1 100-plus:2 unit:3 considering:2 would:3 antipsychotic:2 long:2 next:2 few:1 statement:2 suit:3 wants:1 buy:1 company:3 recalled:1 filed:2 prices:1 technologies:2 former:1 applied:1 recall:2 following:1 toward:2 19.5:7 associated:2 something:1 owes:3 any:2 if:2 again:2 bottles:1 acquitted:1 patent:3 storage:1 aside:2 chemical:3 beat:1 potential:2 take:2 implant:1 several:2 stock:3 illegally:2 used:1 's:12 trace:2 may:2 earnings:1 price:1 after:4 uses:2 shortly:2 commodity:1 amount:2 sometimes:1 stents:2 2009:2 medical-device:3 once:1
stock_JNJ r_up	territory:1 into:1 negative:1 but:2 most:1 slide:2 drug:1 slip:1 fall:1 shines:2 stocks:3
stock_JNJ r_down	children:1 initial:2 internet:1 help:1 figure:1 up:1 cents:1 over:1 health-care:1 nutritional:2 product:2 2nd:1 '':1 10,000:4 shares:8 have:1 year:1 talks:1 headlines:1 settlement:1 its:2 panel:1 24:2 information:1 prescription-drug:1 overhaul:1 $:7 make:1 since:3 been:2 next:1 1:2 version:1 chairman:2 premarket:1 acetaminophen:1 formula:2 has:2 correct:1 earnings:1 week:3 spiked:1 ``:1 buy:2 's:5 offering:2 sixth:2 company:5 recommendations:1 watch:2 iconic:2 abuse:1 online:1 sold:2 new:1 baby:2 spree:2 prevent:1 buying:2 21:1 purchase:2 last:2 like:2 17:2 --:3 follows:1 ask:1 spent:2 public:2 dosing:1 products:2 venture:1 each:2 pharmacies:1 2009:1 traded:1 maker:2 block:2 latest:1
stock_JNJ r_down	sector:1 nursing:1 they:1 had:1 ca:1 say:1 cancel:1 moves:1 hospitals:1 market:1 plans:1 again:1 marking:1 coverage:1 $:2 million:1 decision:1 medical-devices:1 hepatitis:1 far:1 other:1 health:1 treatment:1 expected:1 sort:1 200:1 buy:1 's:4 definitive:1 opposite:1 contracts:1 dividends:1 approves:1 acquire:1 effect:1 but:1 agreement:1 groups:1 strong:1 spur:1 billion:1 homes:1 afford:1 look:1 getting:1 charges:1 cash:1 signed:1 n't:1 players:1 products:2 time:1 similar:1 maker:1 once:1
stock_JNJ r_up	emerging:1 just:1 issued:1 soon:1 industrial:1 through:1 battle:1 fifth:2 24:1 $:1 guidance:1 analyst:1 production:1 treatment:1 mail:1 weeks:1 include:2 do:1 which:1 bonds:4 big:3 rise:1 early:1 boxes:1 bookrunners:1 nearly:1 fall:3 10-year:1 ticker:1 shaping:1 30-year:2 --:2 follows:2 companies:2 borrow:1 deals:2 did:2 race:1 yields:3 diabetes:2 including:2 bond:2 parade:1 deal:1 used:1 pricing:1 further:1 11th:1 even:1 securities:1 said:3 federal:1 since:1 hepatitis:2 p.m.:1 spokesman:1 version:2 market:1 sixth:1 new:2 ever:1 correct:1 million:1 repayment:1 10-:2 marketing:1 sold:2 pushing:1 component:2 6,000:1 paper:1 recent:1 aid:1 five-:2 debt:4 come:1 declining:1 session:1 goods:2 prosecutors:1 via:1 starts:1 could:1 heating:1 reports:1 costs:1 a.m.:1 published:2 comment:2 among:1 benefited:1 into:1 coming:1 fancy:1 active:1 names:1 another:1 fake:1 unit:1 additional:1 would:4 housing:1 copies:1 least:1 much:1 rates:1 low:3 statement:1 expected:3 scheme:1 500:1 lowest:1 ``:2 selling:1 general:1 interest:1 form:1 company:1 corrected:1 big-name:1 prices:1 promote:1 than:1 case:1 fraud:1 versions:1 rival:1 up:2 n't:1 patients:1 today:1 making:1 five-month:2 issue:2 investment-grade:1 weaker:1 false:2 outstanding:1 purposes:1 days:1 '':2 say:2 drug:3 keep:1 allege:1 counterfeit:2 sell:5 maturities:1 offering:1 agency:1 issuing:1 commercial:1 split:1 fourth:2 largest:2 test:2 indictment:1 strips:2 's:12 intended:1 may:1 symbol:1 after:4 benchmark-sized:2 customs:1 running:1 but:2 preliminary:1 pair:1 data:2 man:1 lineup:1 third:1 later:1 borrowing:1 repay:1 implied:1 2006:1 entry:1 joining:1 corporate:3 charged:2
stock_JNJ r_up	just:1 among:1 being:1 money:1 paper:1 7.5:1 carefully:3 still:1 its:1 high-grade:1 announcement:1 $:4 3.75:1 weeks:1 bonds:1 largest:1 new:1 30-year:1 --:2 turns:1 companies:2 yield:1 bad:1 continue:1 activity:1 round:1 bond:2 deal:1 dividend-paying:3 relative:1 second:1 2.8:1 value:1 close:1 short-term:1 said:1 rate:1 away:1 current:1 state:1 race:1 got:1 10-:1 component:1 commercial:1 five-:1 along:1 debt:4 payout:1 healthy:1 many:1 drug:1 long-term:1 options:1 seeing:1 managers:1 insist:1 replace:1 assess:1 total:1 market:3 would:2 addition:1 there:1 least:1 much:1 rates:1 low:1 interest:1 expected:1 today:1 more:1 company’s:1 offering:1 company:1 but:2 than:1 11:1 likely:1 us:1 n't:1 record:1 loves:1 making:1 firm:1 investors:1 turned:1 investment-grade:1 sense:1 need:1 floating:1 sell:3 easing:1 things:1 make:1 six:1 split:1 buys:1 out:1 stock:1 sure:1 's:2 includes:1 maturities:1 issuance:1 coming:1 robust:1 stocks:2 extremely:1 billion:4 land:1 off:1 later:1 so:1 quantitative:1 looking:1 corporate:2
stock_JNJ r_down	advisory:1 six:1 managers:1 600:2 just:1 being:1 money:1 overheating:2 some:2 insist:1 dosing:1 because:1 looks:1 have:1 year:2 return:1 based:1 easy-money:1 its:2 market:6 if:2 proven:1 still:1 there:1 $:2 federal:1 buoyant:2 began:2 since:2 off:1 been:2 next:2 also:1 participants:2 program:2 compelling:1 child:1 which:1 acetaminophen:1 yields:1 weeks:1 has:2 might:2 's:5 unanimously:1 bonds:2 turned:1 company:1 age:1 but:1 government:1 historic:1 lows:1 recommended:1 panel:1 article:1 debt:1 than:1 recent:1 billion:2 stocks:1 volatile:1 last:2 spigot:1 --:2 weight:1 months:1 children:1 value:1 rather:1 near:1 so:2 published:1 corporate:3 away:1 bond:2
stock_JNJ r_down	thinner:1 people:1 previously:1 have:2 surgery:1 its:1 unit:1 viral:1 use:1 works:1 generic:1 been:1 class:1 also:1 other:2 health:1 which:1 new:2 hip:1 combination:1 drugs:3 clots:1 regulators:1 part:1 blood:2 known:1 knee:1 approved:3 reverse:1 treating:1 made:2 name:1 --:1 drug:2 n't:1 patients:1 prevention:1 inhibitor:1 treated:1 called:1 block:1 replacement:1
stock_JNJ r_down	marketed:2 less:2 over:1 competing:2 years:2 course:1 broader:3 signs:2 battle:1 cold:2 its:2 ground:1 24:2 renewed:1 $:7 over-the-counter:4 had:2 former:2 treatment:3 under:2 weeks:5 has:2 agreed:2 physicians:1 get:2 evaluate:1 260:4 brand:6 background:1 fall:1 awaiting:1 name:2 countries:2 --:5 follows:2 loses:1 common:1 pharmacies:2 works:1 deal:2 see:2 economic:1 trading:1 pricing:1 makers:1 viral:2 said:4 adds:2 assistance:1 since:1 hepatitis:5 royalty:2 expensive:1 medicine:2 new:6 receiving:2 boost:2 therapies:1 shows:1 million:2 seventh:1 use:2 standard:2 statistics:1 approval:3 debt:1 beginning:1 received:2 disabilities:1 drug:13 illicit:1 products:2 afternoon:1 buzz:1 south:2 major:1 presence:2 offerings:2 throughout:1 crisis:1 market:8 little:2 cough:4 would:4 leading:2 two:4 been:1 clinical:2 12-week:1 expected:1 more:3 drugs:2 company:1 acquire:2 lists:1 tapping:1 liver:2 than:4 none:1 showed:2 rights:2 programs:1 second:3 patients:3 owns:2 stopping:2 similar:1 called:1 social-media:1 medication:1 share:1 sales:2 unit:2 manner:1 have:1 partner:2 marking:2 no:2 agency:4 fears:1 also:2 other:2 details:3 which:2 online:1 types:1 charging:1 week:3 begin:1 used:1 's:17 approves:1 after:7 treatments:2 virus:2 brands:2 such:4 data:3 approved:10 79:2 older:2 disease:2 2002:1 without:2 therapy:2 overseas:2
stock_JNJ r_up	conflicting:1 requirements:1 questioning:1 tightening:1 research:1 bone:1
stock_JNJ r_up	just:1 over:1 results:1 risk:1 four:1 world:1 its:3 $:1 had:1 treatment:1 280:1 gave:1 do:1 increased:1 using:1 advanced:1 loss:1 --:8 companies:1 facing:1 small:1 rheumatoid:1 two:1 force:2 supporting:1 year:1 our:1 n't:3 said:1 hepatitis:3 increase:1 medicine:1 new:1 newly:1 boost:1 core:1 campaign:1 men:1 prescriptions:1 million:2 blockbusters:1 hours:1 focused:2 approval:1 after:1 last:1 annual:1 according:2 against:3 trial:3 products:1 published:1 arrived:1 maker:2 patents:1 first:2 cancer:2 extra:1 betting:1 one:1 13,000:1 formidable:1 says:1 unit:1 pharmaceutical:2 use:1 prostate:1 three:1 strategy:1 clinical:1 meeting:1 launching:1 screening:1 life:1 selling:1 drugs:1 company:1 hopes:1 made:1 flagship:1 patients:2 similar:1 months:1 sales:4 '':2 drug:7 around:1 also:1 which:2 largest:1 test:1 used:1 's:5 arthritis:2 reflect:1 offsetting:1 biologic:1 designed:1 data:1 approved:1 older:1 average:1 well:1 head-to-head:1
stock_JNJ r_down	session:1 build:2 disease:3 hopes:2 actively:1 trading:1 file:2 research:2 its:2 whose:1 said:2 rose:1 treatment:2 shares:1 eighth:1 vaccines:2 3:2 4:1 2015:6 details:1 500:1 higher:1 's:5 plans:2 pharmaceutical:2 drugs:2 company:2 seventh:1 new:2 regulatory:2 approval:2 stocks:1 beginning:1 analyst:1 recent:2 11:6 reaction:1 pipeline:2 17:1 --:5 climbed:1 companies:1 up:1 drug:1 points:3 momentum:2 including:2 traded:1 experimental:2
stock_JNJ r_up	pays:1 competition:1 up:1 down:1 individual:1 trading:1 8.1:1 whose:1 5.2:1 actively:1 publishing:1 22:1 rose:1 shares:1 health:1 closed:1 boost:1 public:1 hope:1 higher:1 's:1 after-hours:1 step:1 prices:2 stocks:1 session:1 climbed:1 companies:2 drive:1 points:3 500:1 time:1 first:1
stock_JNJ r_up	real:2 said:2 's:2 counterfeits:2 deal:2 --:2 strips:2 test:2 selling:2 whether:2 buying:2 they:2 distributor:2 reached:2 settlement:2 its:2 unit:2 diabetes:2
stock_JNJ r_down	seeing:1 adults:2 over-the-counter:1 targeted:1 seeking:1 acne:1 condition:1 treatment:1 say:1 products:1 numbers:1 they:1 growing:1 launching:1 more:1
stock_JNJ r_up	promoted:1 illegally:1 document:1 not:1 government:1 whether:1 company:1 probe:1 according:1 drug:1 held:1 regulators:1 settle:1 uses:1 talks:1 court:1 has:1 approved:1
stock_JNJ r_down	after:1 ordered:1 $:3 civil:1 pay:1 penalties:1 million:1 misled:1 doctors:1 state:1 safety:1 327:1 year:1 judge:1 jury:1 effectiveness:1 company:1 earlier:1 antipsychotic:1
stock_JNJ r_down	bridge:2 poor:1 help:2 boards:1 people:2 find:1 number:3 '':1 3.7:1 second:1 promised:2 have:2 cuts:2 winds:1 next:2 tomorrow:1 3.8:1 out:3 conference:2 embattled:1 cut:2 funding:3 $:2 sit:1 generic:2 poorest:2 commitments:2 been:1 makers:6 vaccines:2 outside:1 version:1 potentially:2 which:1 2015:2 international:2 you:1 has:1 correct:1 announced:2 week:2 do:1 ``:1 's:2 forced:1 far:1 problems:1 price:2 notable:1 here:2 gap:3 corporate:1 most:1 warm:1 should:2 they:1 performance:1 prices:2 world:2 legal:1 billion:2 topic:2 branded:2 surprising:1 ahead:2 countries:2 --:2 follows:1 stretching:2 up:1 drug:6 so:1 reception:1 were:2 its:4 think:1
stock_JNJ r_down	heart:2 appeals:1 metal:1 over:1 some:1 intellectual:1 four:1 patents:1 have:1 sought:1 coatings:1 along:1 scoring:1 court:2 which:1 2010:1 ruling:2 way:1 big:1 earlier:1 backed:1 frequently:1 relating:1 companies:1 stents:2 victories:1 affirmed:1 drug-coated:1 were:1 property:1 came:1
stock_JNJ r_up	comment:1 claim:1 companies:3 titan:3 patent-infringement:3 related:1 high:1 bring:3 have:2 jury:1 aged:1 technology:1 its:1 court:1 $:7 23:1 patent:4 make:3 six:1 had:2 rejecting:3 should:1 vaccines:1 their:1 program:1 upheld:3 fourth:1 parents:1 document:1 company:1 's:3 though:1 bid:3 million:3 younger:1 most:1 involving:1 editing:1 concerns:1 case:1 regarding:1 kids:2 won:1 --:2 no:1 harder:3 against:6 n't:1 verdict:4 popular:1 claims:3 290:3 software:4
stock_JNJ r_down	's:1 investors:1 increasingly:1 dividend-paying:1 worried:1 looking:1 suddenly:1 economic:1 growth:1 know:1 lot:1 need:1 you:1 stocks:1 sluggish:1
stock_JNJ r_up	slid:1 1.1:1 session:2 point:1 over:2 6.7:1 offer:1 actively:2 trading:2 rally:1 positive:1 whose:2 4.7:1 now:1 writes:1 rose:2 top:2 bonds:2 shares:3 1:1 4:1 closed:1 better:1 500:2 treatment:1 company’s:1 turmoil:1 's:2 swine-flu:1 beat:2 dividends:2 after-hours:1 but:2 news:1 stocks:6 than:1 gained:1 advance:1 lost:2 many:1 companies:2 income:1 points:4 rallies:2 mixed:2 climb:2 traded:1 blue-chip:1
stock_JNJ r_up	certain:2 into:1 labels:2 sunscreen:4 officials:1 trading:1 pass:2 before:1 announcement:1 unusual:1 consumers:2 make:2 long-awaited:2 looking:1 choose:2 requiring:2 new:2 effectiveness:2 easier:2 tests:2 's:1 medical-devices:1 regulations:2 released:2 designed:2 manufacturer:1 --:1 adopt:2 stock-exchange:1 products:2 activity:1 acquisition:1
stock_JNJ r_down	sector:1 shot:1 over:1 global:4 focus:2 years:3 drug-coated:6 session:3 comments:2 corner:1 chair:2 its:2 cardiovascular:4 move:2 whose:2 giant:1 based:2 $:14 stent:12 guidance:1 revenue:2 opportunities:2 charge:4 other:4 4:6 annual:1 total:2 8:1 has:1 chairman:2 hip:2 plants:2 good:1 around:1 anticipated:1 made:2 background:2 coating:1 areas:2 eroded:2 amid:2 lost:3 --:6 companies:3 benefit:2 after-hours:1 shed:3 significantly:2 crowd:2 some:1 we:2 competition:2 artificial:2 past:1 see:2 actively:3 trading:3 result:2 eliminating:2 jobs:2 dynamics:2 estimated:1 out:1 said:5 decision:3 shares:4 exit:12 unit:5 closed:1 evolving:2 recently:1 business:9 pharmaceutical:1 million:6 jolts:2 restructuring:2 key:1 group:2 declining:2 created:1 industry:2 months:1 greater:2 34:1 grabs:1 receives:1 makes:1 first:2 disclosure:1 major:1 heart:5 licensing:1 throughout:2 market:22 quit:1 8.5:1 puts:1 system:2 tiny:1 approved:2 78:1 500:5 gives:1 royalties:1 ``:4 slumping:1 share:5 company:8 second-quarter:2 stirs:1 customer:1 10:1 13:1 12:1 17:1 18:1 up:7 devices:3 project:2 pace:2 patients:4 were:1 following:2 next-generation:2 closing:2 called:1 1.4:1 1.5:1 1.6:1 1.7:2 sees:2 600:2 expanding:1 1.8:1 sales:5 '':4 full-year:1 dropped:1 our:2 bow:1 cardio:3 risk:1 technology:1 agency:2 tight:2 concerns:2 5:1 details:2 traded:2 stock:1 worldwide:2 's:21 plans:3 after:2 leaving:1 fell:3 device:4 stocks:3 grow:2 keep:2 billion:7 drug-eluting:4 lower:3 off:3 calls:2 fallen:1 metal:1 1,000:2 stents:6 points:3 medical-device:1 affirmed:1
stock_JNJ r_up	cancer-drug:1 help:1 over:1 global:1 drug-coated:1 speed:1 its:3 giant:1 $:4 guidance:1 4:1 8:1 has:1 around:1 anticipated:1 treating:1 exits:1 --:1 bone:1 past:1 's:7 estimated:1 said:2 shares:2 exit:1 market:1 medicine:1 body:1 recently:1 business:1 healthcare:1 jumps:1 million:2 approval:1 ahead:1 annual:1 drug:2 34:1 receives:1 makes:1 disclosure:1 major:1 cancer:1 revenue:2 licensing:1 unit:1 pharmaceutical:1 use:1 eye:2 type:1 firm:1 royalties:1 company:1 biotech:3 lift:1 customer:1 10:1 12:1 17:1 18:1 up:1 reviews:1 were:1 called:1 heart:1 unintended:1 months:1 coating:1 full-year:1 dropped:1 technology:1 risk:1 recommended:1 meeting:1 stock:1 multiple:1 plans:1 after:2 stocks:3 cost-effectiveness:1 billion:1 off:1 consequences:1 thalidomide:1 fallen:1 myeloma:1 stents:3 energizes:2 affirmed:1
stock_JNJ r_down	leaders:1 recommends:1 's:3 key:1 drugs:2 pay:1 two:1 coverage:1 opinion:1 change:1 anemia:1
stock_JNJ r_up	antibiotic:4 revenue:4 results:2 7.2:2 including:2 another:2 total:2 its:2 pharmaceutical:2 $:2 tablet:2 generic:4 forms:2 quarterly:2 product:2 's:2 million:2 most:2 approved:4 recent:2 12:2 versions:4 companies:2 accounted:2 first:2
stock_JNJ r_down	company’s:1 refuse:1 sinks:2 tumble:1 getting:1 data:1 rise:1 regulators:1 shares:1 diagnostic:1 product:1 while:3 without:1 gain:2 test:1 new:1 stocks:3 approve:1 additional:1 first:1
stock_JNJ r_down	show:2 implants:8 session:3 including:3 shares:3 whose:3 rose:2 fix:3 local:1 them:3 around:1 safe:1 breast:4 lost:1 --:5 companies:3 did:2 after-hours:1 popular:1 view:1 unexpected:2 says:1 competition:1 3.4:1 actively:3 trading:3 2.3:1 80:1 declined:1 said:5 fourth:1 comments:1 safety:3 closed:1 new:3 receiving:3 silicone:3 additional:3 gained:1 many:1 taking:1 funded:1 experience:3 stride:1 mixed:1 studies:5 frequent:3 breakeven:1 major:1 thinner:1 replace:3 market:1 8.4:1 two:2 6:1 500:3 releases:1 manufacturers:1 company:1 releasing:2 18:1 needle:1 n't:2 remain:1 complications:4 were:4 averages:1 1.4:1 slid:1 dosing:1 drug:1 surgery:3 increased:1 agency:2 4.9:1 any:2 concerns:2 which:2 implant:1 economy:1 added:1 's:4 plans:1 arthritis:1 update:1 looming:1 fell:2 preliminary:2 stocks:3 data:2 approved:2 types:2 lower:1 effective:1 largely:1 grimmer:1 points:8 2006:2 starting:1
stock_JNJ r_down	operations:1 global:2 dollar:1 outlook:3 through:1 coli:1 portfolio:1 its:5 upgrade:1 based:1 should:1 equity:1 fuel:1 has:3 risk:1 government:1 continues:1 report:1 bringing:1 hits:2 round:1 better-than-expected:1 heavy:1 prompted:1 reduce:1 growth:3 corner:1 closer:1 shares:1 medicine:1 progress:1 core:1 recently:1 sinks:2 weak:1 conglomerate:1 restructuring:1 key:1 analyzed:1 group:1 spark:1 debt:1 pipeline:1 improved:1 drug:1 maker:1 comes:1 among:1 raised:1 thinner:1 into:1 shun:1 another:1 loaded:1 reducing:1 pouring:1 shareholders:1 leverage:1 working:1 faltering:1 been:1 doubt:1 territory:1 more:1 selling:1 funds:1 company:2 slump:1 prospects:2 effort:1 than:1 rival:1 up:1 happy:1 slid:1 investors:3 health-care:1 turned:1 strain:1 caution:2 investment-grade:1 spooked:1 again:2 reshape:1 make:1 bonds:1 preventing:1 concerns:1 5:1 product:1 's:9 strokes:1 after:1 fell:1 blood:1 improving:1 such:1 stocks:4 data:2 euro:1 purchase:1 off:1 downbeat:1 disease:1 traditional:1 costs:1 2006:1 medical-device:1 once:1
stock_JNJ r_down	checkup:1 thinner:1 money:2 up:1 certain:1 midyear:1 mind:1 back:1 fared:2 dosing:1 stroke:2 glad:1 have:2 years:1 its:1 kidney:3 make:1 highlighted:1 scale:1 2011’s:2 apixaban:1 top:2 it’s:1 you’re:1 ideas:2 been:1 investment:1 increase:2 their:1 volatile:1 treatment:2 issued:2 new:3 weeks:1 2011:1 stock:1 themes:1 we:1 shakes:2 warnings:2 drugs:3 after:2 release:1 market:1 moving:1 blood:1 key:1 doctors:1 such:2 one:2 you:1 those:2 anemia:3 suggested:2 10:1 kind:2 last:1 would:1 stocks:3 wish:1 could:2 disease:2 patients:3 so:3 risks:2 time:1 far:3 study:3 studies:2 called:1
stock_JNJ r_up	lowering:1 said:1 but:1 effective:1 infections:1 developed:1 had:1 rate:1 drug:1 sugar:1 patients:1 blood:1 they:1 certain:1 new:1 higher:1 diabetes:1
stock_JNJ r_up	advent:1 presence:1 caused:1 agreed:1 partnership:1 product:1 one:1 down:1 consultants:1 surgical:1 good:1 snafus:1 handed:1 news:1 talks:1 further:1 its:2 unit:1 risk:1 batches:1 said:1 bottles:1 combat:1 over-the-counter:1 affects:1 create:1 develop:1 legislation:1 bribery:1 been:1 their:1 chemical:1 parts:1 other:1 causes:1 which:1 series:1 new:2 has:2 company:1 fines:1 more:1 breaches:1 customers:1 diversified:1 's:2 string:1 combination:2 grappling:1 drugs:2 odor:1 after:1 virus:1 lot:1 recalled:1 plan:1 active:1 span:1 manufacturing:1 expand:1 recall:2 medicines:1 companies:1 up:1 drug:3 thought:1 experimental:1 recalls:1 called:1 businesses:1 latest:2
stock_JNJ r_up	office:1 money:1 over:1 results:2 trade:2 aiding:1 surgical:1 session:2 snafus:1 shares:2 7.5:1 high-profile:1 its:3 down:1 before:1 whose:2 batches:1 group:1 $:4 over-the-counter:1 series:1 second-quarter:1 breaches:1 issued:1 has:4 agreed:1 fines:1 giants:1 customers:1 good:1 worse:1 combination:3 account:1 mortgage-backed:1 early:1 royalty:1 updates:1 provision:1 string:1 loss:1 lost:1 --:4 smell:1 medicines:1 companies:4 yield:1 dominance:1 securities:1 settle:1 after-hours:1 become:1 quarter:1 square:2 advent:1 energy:1 consultants:1 actively:2 trading:1 year:1 further:1 investment:1 said:1 trace:1 lead:1 space:2 affects:1 recorded:1 hepatitis:1 current:1 miles:1 unit:1 new:3 net:1 dating:1 announced:1 causes:1 terms:1 grappling:1 odor:1 million:2 weak:1 expansion:1 let:1 recalls:1 active:1 news:1 manufacturing:1 loans:1 recall:2 30:1 parts:1 drug:6 span:1 businesses:1 among:1 outlook:1 presence:1 one:2 feet:2 bribery:1 market:1 risk:1 8.5:1 beginning:1 housing:1 initial:1 legislation:1 third-quarter:1 been:2 next:1 their:1 government-run:1 lot:1 which:1 expected:4 more:1 billion:2 partnership:2 collapse:1 drugs:2 company:4 diversified:1 hurt:1 taken:1 chemicals:1 part:1 recalled:1 talks:2 prices:1 than:1 13:1 made:1 rival:1 up:1 project:2 while:1 were:1 property:1 called:1 acquisition:1 reviewing:1 investors:1 disclosing:1 caused:1 dropped:1 purchased:1 seen:1 swung:1 linked:1 increased:1 confirmed:1 bottles:1 5.5:1 pay:1 handed:1 chemical:2 also:2 other:2 details:1 multibillion-dollar:1 main:1 impairment:1 completed:1 stock:1 product:2 used:1 's:9 plans:1 combat:1 after:1 tied:1 extending:1 virus:1 plan:1 develop:2 expand:2 exposure:1 fiscal:1 mortgage:1 6th:1 sometimes:1 headquarters:1 thought:1 2000:1 costs:1 experimental:1 things:1 claims:1 2009:1 latest:3
stock_JNJ r_up	comment:1 limited:1 woes:1 generation:1 over:1 global:1 some:1 period:1 rival:1 past:1 second:2 economic:1 through:1 drug:5 have:2 year:2 carry:1 accounting:1 11th:1 its:1 market:2 wonder:1 drugs:1 superior:1 $:1 lead:1 start:1 ways:1 rose:1 44:1 since:1 had:1 due:1 hepatitis:2 second-quarter:1 their:1 program:1 multibillion-dollar:1 bond:1 --:3 has:2 momentum:1 expected:1 75:2 approved:1 lag:1 's:2 returned:1 prescriptions:3 though:1 may:1 share:1 company:1 earlier:1 volume:2 forward:1 announced:1 were:1 new:2 both:1 strong:1 data:1 restrained:1 structure:1 suggest:1 billion:1 early:2 regimen:1 efficacy:1 pursue:1 32:1 slowed:1 deal:1 deals:2 whether:1 growth:1 survey:1 can:1 activity:1 worries:1 become:1 quarter:2 taken:1 executives:1
stock_JNJ r_up	prevent:1 over:1 crop:3 featured:1 176:1 yanked:1 22:1 recalls:3 approved:1 concerns:1 safety:2 market:1 new:1 2011:1 more:1 product:4 clots:1 million:1 blood:1 half:3 than:1 getting:1 items:1 lines:1 according:1 drug:1 bumper:1 organization:1 consumer:1 first:3
stock_JNJ r_up	sector:1 global:1 focus:1 trade:1 session:1 artery:1 still:1 whose:1 $:2 opportunities:1 restrain:1 4:1 holiday:1 2011:1 far:1 watch:2 cheaper:1 suffering:1 orthopedic:1 during:1 like:1 suppliers:1 steeply:1 companies:2 continue:1 common:1 small:2 often:1 see:1 growth:1 margins:1 patients:1 shares:1 health:1 market:1 new:2 dominate:1 sluggish:3 jumps:2 discount:1 operating:1 boosting:1 active:1 20,000:1 pressure:1 attacks:1 study:1 37:1 drug:1 suggests:1 products:1 analysts:1 managers:1 expensive:1 use:1 been:2 orthopedics:1 treat:1 interest:1 expected:1 too:1 offer:1 funds:1 fund:1 controlling:1 doctors:1 quick:1 tactics:1 builds:1 likely:1 devices:1 while:1 growing:1 procedure:1 heart:1 sales:1 say:1 have:2 hospitals:1 mutual:1 hot:1 potentially:1 afternoon:1 stand-out:1 after:1 stocks:3 weekend:1 billion:1 discounted:1 largely:1 disease:1 costs:2 so:1 drawing:1
stock_JNJ r_up	cleared:1 has:1 's:2 said:1 proposed:1 pharmaceutical:1 ways:1 company:1 global:1 drug:3 note:1 --:1 part:1 acquisition:1 broader:1 weigh:2 decliners:1 stocks:3 market:1
stock_JNJ r_down	all:1 just:1 agreed:1 trade:1 session:1 litigation:1 whose:1 slow:1 20:1 $:3 candidate:1 penalty:1 offers:2 board:2 equity:1 employee:1 has:1 2010:1 hip:1 eventually:2 far:1 big:1 watch:2 valued:1 fall:1 shaping:1 like:1 excluding:1 --:5 companies:1 events:1 deal:2 challenges:1 see:1 growth:2 trading:2 projections:1 year:2 shares:1 market:2 new:1 led:1 regulatory:1 news:1 chapter:1 last:1 21.3:2 according:2 drug:1 long-term:1 approve:1 pays:1 private:1 one:1 active:1 total:1 unit:1 late:1 lottery:1 would:1 positive:1 top:1 next:1 their:1 expected:1 diabetes:1 more:2 suggested:1 buy:1 drugs:2 company:1 recalled:1 made:1 drug-stocks:2 official:1 up:1 future:1 acquisition:1 challenging:1 process:1 joints:1 engaged:1 sales:1 saw:2 any:1 agency:1 internal:1 earnings:1 so:1 orthopedic-device:1 's:6 track:1 prepared:1 fueled:1 levels:1 approved:1 recent:1 billion:2 short:1 snooping:1 considered:1 sale:2 filing:1 1,000:2 mass:1 weigh:1 shine:3
stock_JNJ r_down	says:2 unemployment:2 caused:2 some:2 results:2 high:2 economic:2 pricing:2 surgery:2 throughout:2 cites:2 market:4 most:2 patients:2 comments:2 than:2 delay:2 details:2 has:2 stung:2 indicating:2 turmoil:2 's:4 company:4 slump:2 sales:6 volume:2 joint:2 continued:2 analyst:2 recent:2 fiscal:4 faster:2 replacement-joint:2 pressure:4 --:6 soft:4 industry:2 n't:2 prior:2 remain:2 growing:2 quarter:4 similar:2
stock_JNJ r_up	operations:3 sector:2 all:2 help:2 summer:1 caused:2 major:2 prices:2 innovative:2 its:1 overhaul:2 21:2 similar:2 drug-company:1 unemployment:2 than:3 other:2 has:4 2010:2 indicating:2 noncore:2 big:2 stung:2 watch:1 nearly:2 cushion:2 during:2 continued:4 merchandise:1 --:6 medicines:2 companies:4 deals:2 quarter:6 soft:4 shedding:2 because:1 dean:1 significantly:2 series:1 opting:2 some:4 challenges:2 second:2 economic:2 pricing:2 year:2 surgery:2 makers:2 closer:2 represent:1 bottom:2 patients:2 comments:2 research:2 looking:2 new:3 turmoil:2 marketing:2 20:2 pressure:4 approaches:2 lucrative:1 regulatory:2 approval:2 improve:2 boy:1 kids:1 many:2 industry:2 drug:4 prior:2 products:2 faces:2 named:1 own:2 tough:2 deputy:1 licensing:2 toys:1 says:2 market:4 conference:2 little:1 girls:1 been:2 sports:1 their:10 much:1 call:2 more:1 fiscal:4 commissioner:1 pipelines:4 cope:2 company:4 slump:2 hurt:2 volume:2 boys:1 videogames:1 effort:2 former:1 replacement-joint:2 official:1 up:4 n't:2 remain:2 growing:2 animated:1 steep:2 scramble:2 crazy:1 health-care:2 share:2 sales:9 high:2 have:4 alliances:2 cites:2 patent:2 threatens:2 granted:2 agency:1 savings:2 delay:2 also:4 internal:2 units:2 instead:2 development:2 hurdles:2 's:8 programmers:1 such:2 opportunity:1 approved:2 cliff:2 acquisitions:2 faster:2 lines:2 shore:4 costs:4 keeps:2 senior:1 drawing:2
stock_JNJ r_up	major:2 sales:2 domestic:2 results:4 product:2 strain:2 economic:2 privately:2 tenuous:2 year:2 unfavorable:2 market:2 out:2 shown:2 pressured:2 since:2 question:2 next:2 orthopedics:2 health:2 defibrillators:2 has:2 conditions:2 week:2 turmoil:2 begin:2 cardiology:2 big:2 implantable:2 reporting:2 focus:2 early:2 orthopedic:2 key:2 front:2 suggested:2 replacement-joint:2 held:2 --:4 markets:2 medical:2 companies:2 remain:4 came:2 study:2 medical-device:2
stock_JNJ r_down	operations:2 rating:1 presence:2 able:2 agreed:2 ``:2 four:1 downgrade:1 itself:2 looks:2 another:2 our:2 dermatology:4 portfolio:2 its:2 ratings:1 150:2 said:3 $:8 would:1 area:2 remains:2 revenue:2 recorded:2 pleased:2 345:4 add:2 attractive:2 strong:2 believe:2 has:2 remaining:1 product:2 million:4 's:6 prescriptions:2 government:1 company:2 acquire:2 includes:2 '':2 part:2 brands:2 not:1 affect:1 debt:1 expand:2 arena:2 divisions:2 non-financial:1 we:2 companies:1 2010:2 ortho:2 growing:2 franchise:2
stock_JNJ r_down	agreed:2 four:1 against:4 committee:2 hell:1 its:1 litigation:2 giant:1 stent:1 opportunities:1 investigational:1 board:3 pursuing:2 quarterly:1 has:1 his:1 burden:1 report:2 developments:1 companies:1 some:1 challenges:2 decided:2 makers:1 stats:1 driving:1 showcase:1 legal:2 forecast:2 nominees:1 new:1 approach:1 scientific:1 grandparents:1 diagnostic:1 imaging:1 regulatory:2 post:1 manufacturing:2 director:1 compliance:2 galore:1 connection:2 plus:1 drug-coated:1 slightly:3 housing:1 block:1 tools:1 tomorrow:1 create:2 catalysts:1 their:1 taken:1 ``:1 drugs:1 company:3 rejected:1 expected:1 worked:1 effort:1 past:1 car:1 officials:2 heart:1 certain:1 health-care:1 '':1 drug:1 have:1 no:1 also:1 earnings:3 which:1 products:1 higher:3 week:1 's:11 crashes:1 may:1 reflect:1 but:2 data:1 recent:1 land:1 charges:1 disease:1 directors:1 latest:1
stock_JNJ r_down	rating:1 help:3 pointing:2 less:2 over:2 despite:5 concern:1 focus:1 trade:1 manager:1 session:1 including:1 higher:3 signs:1 debt-ceiling:2 headlines:1 its:9 issues:4 consider:1 whose:1 giant:5 20:13 over-the-counter:2 rose:5 debts:1 state:2 than:2 program:1 device:2 colitis:2 exit:4 has:5 drug:2 recasts:1 details:2 do:1 good:1 advisory:1 risk:1 bonds:2 beat:2 bid:1 continues:2 watch:3 top-quality:2 results:4 early:1 worst:1 updates:2 background:1 fall:2 not:1 difference:2 expectations:2 --:16 conditions:1 medicines:2 companies:1 yield:1 morning:1 continue:1 yields:2 lose:1 worries:2 recalls:8 stock:4 rheumatoid:1 8:1 respond:1 ethical:1 because:2 people:1 series:2 some:2 hurdles:1 related:1 group:1 challenges:1 second:1 growth:7 result:1 stronger-than-expected:1 financials:2 out:1 index:4 said:1 consumers:1 ways:1 affects:1 since:3 patients:1 comments:2 pressures:2 participants:2 health:2 unit:6 between:2 affecting:1 expresses:2 sluggish:1 heart-device:4 comparable:2 after:1 led:2 stalemate:2 business:6 pharmaceutical:2 ulcerative:2 possibility:1 reported:5 restructuring:3 necessarily:1 others:2 approval:1 100:2 debt:3 beginning:2 panel:1 76:1 shaking:2 could:3 losses:2 membership:1 reports:2 keep:1 prior:2 products:2 pediatric:2 5th:1 72:1 raised:1 revenue:1 year:1 revamp:2 disease:2 chronic:1 market-beating:1 sees:1 narrowed:2 federal:1 market:8 decline:4 use:3 stocks:2 figure:1 would:1 major:1 top:2 two:1 been:3 while:3 start:2 returns:3 much:2 rates:3 lifting:2 which:2 show:1 stage:1 markets:1 500:3 selling:1 seeking:1 company:1 stress:1 new:1 expected:1 insurer:1 adult:1 doctors:1 focusing:2 trying:2 second-quarter:6 those:4 he:1 13:3 default:2 1998:1 points:6 offices:1 n't:1 below:2 actively:1 9th:1 were:2 taking:1 performer:1 associated:3 investors:2 health-care:4 sales:8 500,000:1 persistent:1 full-year:1 caution:2 unlikely:1 have:4 hit:1 recover:2 hospitals:1 if:3 sell:1 thing:1 government:2 shares:1 also:1 other:4 earnings:5 fourth:1 commentary:1 outlook:1 wonder:3 day:2 economy:4 product:8 added:2 's:13 fiesta:1 price:2 arthritis:1 treatments:1 analyst:1 fueled:1 drag:3 fell:4 but:1 throughout:2 such:4 coveted:1 approved:1 expand:1 lower:1 off:2 especially:2 charges:2 medical:2 futures:3 stronger:2 yielding:1 profit:4 costs:4 so:2 center:1 banks:1 2009:2 corporate:5 standoff:2
stock_JNJ r_down	advisory:1 help:1 saying:1 being:1 developed:1 compound:1 dollar:2 outlook:1 rest:1 quarters:1 questions:1 forecast:1 its:3 before:1 impact:1 investor:1 had:1 should:1 failed:1 citing:1 concerns:1 voted:1 2011:1 pill:1 eventually:1 updated:1 big:1 competitive:1 performance:1 continued:2 cognitive:1 --:4 companies:1 50:4 thinners:1 stock:1 see:1 growth:2 year:1 thinks:1 said:1 profit:2 marketed:1 patients:1 research:1 does:1 safety:1 new:2 falling:1 sluggish:1 told:1 prescriptions:1 reported:2 lucrative:1 address:1 beginning:1 panel:1 roundup:1 study:1 30:3 drug:5 suggests:1 negative:1 rose:2 long-term:1 slightly:1 experimental:1 raised:1 revenue:2 highly:1 restrict:1 market:1 pharmaceutical:1 5th:1 add:1 needed:1 advisories:2 spike:2 diabetes:1 type:1 more:1 drugs:1 share:1 company:2 gain:3 second-quarter:2 raising:1 stroke:1 n't:1 while:2 future:1 can:1 biotech:1 weaker:2 surprises:2 certain:1 health-care:1 tax:2 sales:3 helped:2 full-year:1 against:1 reports:1 seen:1 blockbuster:1 capture:1 same:1 also:1 other:1 earnings:4 9:2 commentary:1 economy:1 used:1 's:4 information:1 price:1 football:1 effect:1 blood:1 date:1 class:1 recent:1 federal:1 chief:1 practices:1 corporate:1 investments:1 prevention:1 latest:1
stock_JNJ r_up	advisory:2 shot:1 being:1 competitive:1 drug-price:1 focusing:1 manager:1 including:1 its:5 $:1 merger:1 young:1 increasingly:1 charge:1 various:1 pill:1 eventually:1 expirations:1 seeking:1 not:2 bigger:1 --:8 companies:1 facing:1 shortage:2 through:1 development:1 because:1 deal:1 people:1 series:1 some:1 pricing:2 slew:1 said:1 federal:2 while:1 increase:1 discounts:1 safety:1 goes:1 new:4 across:1 told:1 thinners:1 rebates:1 pressure:2 lucrative:1 backed:2 panel:2 thinks:1 rare:1 treated:1 could:1 firing:1 drug:6 bow:1 planned:1 pediatric:2 blood:1 already:1 cancer:3 supply:2 feel:1 clout:2 highly:1 market:1 pharmaceutical:2 use:2 additional:2 would:1 needed:1 data:2 top:1 due:2 been:1 their:1 pharmacy-benefits:1 type:1 start:2 more:2 shortages:1 drugs:5 company:1 but:1 doctors:2 prices:1 prescription:1 behalf:1 rival:1 clients:1 patients:4 can:1 similar:1 greater:1 30:3 providers:1 health-care:1 share:1 high:1 stroke:1 warning:2 have:3 seen:1 negotiations:1 increased:1 capture:1 patent:1 makers:4 also:2 if:1 gaining:1 used:1 's:5 may:1 hamstrung:1 negotiating:1 29.1:1 billion:1 purchase:1 chief:1 prevention:1 latest:1
stock_JNJ r_up	among:1 via:1 says:1 played:1 reductions:1 series:2 over:2 years:2 past:2 hiring:1 paper:1 have:2 hires:2 cites:2 unit:1 staff:1 cut:2 factors:1 contributed:2 two:2 virtual:1 freezes:2 preventing:1 also:1 behind:3 difficulties:1 role:1 medicine:3 new:2 cited:1 damaging:2 independent:1 ``:2 's:8 longevity:1 may:2 company:2 problems:2 infection:1 said:2 investigation:1 internal:1 report:4 freeze:1 headcount:1 recent:2 '':2 off:2 integrating:1 --:3 avoiding:2 employees:2 laying:2 together:1 directors:2 costs:2 came:1 recalls:4 efforts:2 led:1 consumer:1 acquisition:1
stock_JNJ r_down	developing:1 cancer:1 less:1 into:1 health-care:1 surprisingly:1 disease:1 full:1 mostly:1 drug:1 7.4:1 multiple:1 treatments:1 data:1 event:2 market:1 blue:1 use:1 dominates:1 but:1 gold:1 would:1 provide:1 advisers:1 contains:1 recommending:1 chips:1 their:1 only:1 potential:1 role:1 treatment:4 which:1 2010:1 new:1 type:1 pill:1 body:1 billion:1 product:1 attention:1 's:4 option:1 maker:1 safe:2 combination:1 possible:1 possibility:1 sales:1 working:1 effects:1 coming:1 backed:1 hedge:1 little:1 cost-effectiveness:1 haven:2 $:1 treating:1 regimen:2 third:2 publicly:1 thalidomide:1 --:5 clients:1 funded:1 myeloma:1 against:1 side:1 default:3 continue:1 came:1 including:1 diversify:1 quarter:1 called:1 bone:1
stock_JNJ r_down	less:1 results:1 ninth:1 4.8:3 including:1 7.4:1 its:8 fifth:1 $:2 rose:1 guidance:2 worth:1 fund:1 analyst:1 only:1 treatment:4 has:2 2011:2 pill:1 casting:1 around:1 combination:1 loss:3 continues:1 boost:1 effects:1 despite:1 aggressively:1 --:13 follows:1 companies:1 item:1 benefit:1 continue:1 stopped:1 quarter:5 side:1 shunned:1 deal:3 second:3 growth:1 projections:2 second-quarter:1 year:1 close:1 11th:1 recording:1 dominates:1 profit:1 saw:1 exchange:2 current:1 version:1 safety:1 unit:2 innovation:1 medicine:1 new:2 net:2 approach:1 correct:1 full:1 business:1 months:1 seventh:1 reported:1 approaches:1 takeover:1 backed:1 article:1 debt:1 beginning:1 remaining:1 earlier:1 reaction:1 10th:1 working:1 could:1 larger:1 drug:7 foreign:2 published:1 narrow:1 changes:1 maker:6 first:1 appeared:1 expectations:1 down:1 market:2 strong:1 would:1 remains:2 contains:1 three:1 slowly:1 4:1 acquisitions:2 ``:1 option:1 mostly:1 drugs:2 company:1 specialty:1 but:1 failure:1 reel:1 than:1 regimen:2 made:1 developing:1 up:1 value:1 2010:1 n't:1 while:1 more:2 31:1 mistake:1 listings:1 sees:1 circus:1 exceeded:1 sales:5 sale:2 '':1 full-year:2 moves:1 technology:1 if:1 sell:2 confirms:1 provide:1 pay:1 detail:1 same:1 potential:1 role:1 details:1 which:1 gets:1 stock:2 product:2 's:7 reportedly:1 track:2 price:1 after:1 treatments:1 said:2 transformational:2 coming:1 data:1 billion:2 third:1 older:1 6th:1 disease:1 allow:1 reaffirmed:1 came:1 latest:1
stock_JNJ r_down	advisory:1 just:1 rating:1 executive:1 results:2 years:2 shares:2 its:1 votes:1 candidate:1 expectations:1 analyst:1 1,400:1 4:1 earnings:2 get:1 continues:1 gridlock:1 despite:3 affect:1 defibrillator:3 continued:2 level:1 --:3 shy:1 reduces:1 companies:1 loses:1 better-than-expected:2 requirement:1 back:2 pills:1 out:1 throughout:1 compensation:1 comments:1 market:3 new:2 conditions:2 jobs:1 weak:1 reported:2 restructuring:3 buyback:1 debt:2 downgraded:1 1,200:1 many:1 amount:1 climb:2 comes:1 first:1 tough:2 danger:1 reducing:1 unit:1 investors:1 would:1 top:3 two:1 reduction:1 too:1 more:1 lowering:1 buy:2 company:1 second-quarter:2 announcing:2 bill:1 maximum:1 cast:1 while:2 figure:1 sales:3 recommends:1 experts:1 sought:1 moves:2 if:2 49:6 targets:1 also:2 details:1 which:1 plans:2 paid:1 most:1 plan:1 brass:1 ago:1 scrambling:1 amid:2 medical:1 daily:1 automatically:1 starting:1
stock_JNJ r_down	lowers:1 3,000:2 tough:1 just:2 pills:6 sales:1 dose:1 continued:1 unit:4 experts:2 investment-grade:1 second-quarter:1 year:3 sought:2 next:2 debate:1 declined:1 sell:1 packages:2 appear:2 49:3 mounting:1 six:2 recommendation:2 reduction:2 its:1 also:2 recommended:3 other:2 earnings:2 slowest:1 defibrillator:1 2011:2 intends:2 week:1 lowering:2 product:2 recommends:2 's:2 4,000:2 business:1 company:1 conditions:1 reported:1 market:2 said:2 eight:2 two:2 fall:2 prepares:1 despite:1 years:2 beginning:2 day:2 ago:2 lower:2 level:2 --:1 shy:2 medical:2 uncertainty:1 borrowing:1 maximum:5 daily:2 dosage:2 pace:1 amount:2 regular:2 products:2 baby-formula:1 evaluating:1 amid:1 release:1 climb:1 better-than-expected:1 starting:2 reduced:2 comes:2 bond:1
stock_JNJ r_down	spicy:2 high-quality:1 form:1 being:1 cheap:1 dividend-paying:1 steady:2 but:1 1:2 mauled:1 3:2 bear:1 sexy:1 not:1 dividend:2 neither:1 stocks:3 comes:1 relatively:1
stock_JNJ r_down	key:1 rating:1 reversing:1 already:1 force:1 significantly:1 investors:1 asset-backed:1 trend:1 consistent:1 year:1 some:1 spectrum:1 one:1 down:1 medical:1 cellphones:1 have:2 measure:1 portfolio:1 rewarded:1 quality:1 its:1 market:2 out:2 sell:2 again:1 anticipation:1 5.5:2 would:1 their:1 holdings:1 managers:1 people:1 premiums:1 been:1 sugar:1 may:2 clinical:1 which:1 portfolios:1 technology:1 app:1 even:1 prized:1 added:1 risk:1 mobile-phone:1 started:1 funds:1 basic:1 studies:1 nursing-home:1 reduce:1 largest:1 moving:2 blood:1 they:1 losing:1 debt:4 diabetes:1 fatter:1 helped:1 search:1 over:1 reverse:1 stocks:1 --:4 shift:1 could:1 drop:1 according:1 yield:1 keep:1 securities:1 credit:2 benefit:1 products:1 uses:1 corporate:2 average:1 bond:1
stock_JNJ r_down	raised:1 deal:1 dollar:3 growth:1 cut:1 seems:1 been:1 returns:1 does:1 way:1 falling:2 has:1 ceiling:1 opposite:1 stop:1 fall:1 debt:1 inevitable:1 none:1 invest:1 clear:1 n't:1 continue:1 investments:2
stock_JNJ r_down	emerging:1 help:1 over:1 bull:3 find:1 expects:1 years:2 brain:1 through:1 questions:2 appetite:2 its:4 issues:1 before:1 slow:1 personal:1 nervous:1 woo:2 symptoms:1 has:1 decades:1 pill:2 ...:2 them:1 his:1 rejected:1 familiar:1 rebound:1 introduce:2 report:1 world:1 level:1 --:8 seek:1 versions:1 companies:1 loses:1 large:1 cholesterol:3 small:1 view:1 because:1 slower:2 methods:1 people:2 scared:1 competition:2 growth:1 out:2 even:4 consumers:3 investing:3 research:1 current:2 enough:1 version:3 market:4 new:2 ground:1 blames:1 explosion:1 popular:2 protection:1 lucrative:1 others:2 news:1 stresses:1 patent:1 prescription:2 limits:1 getting:1 starts:1 could:3 according:1 drug:4 prior:1 expire:1 diagnosed:1 disclosure:2 raised:1 dilemma:1 cancer:1 appropriate:1 right:3 raises:1 expensive:2 standing:1 silent:1 would:1 best-selling:1 initial:2 question:1 strategy:3 too:1 expected:2 finances:1 wants:2 ``:1 buy:2 drugs:1 bolsters:1 pricey:1 properly:1 demand:1 squeeze:1 effort:1 than:2 begins:1 developing:1 bids:1 matter:1 patients:2 convince:1 can:1 strategies:1 distribution:1 have:1 physicians:1 sales:3 '':1 battered:1 prostate-cancer:1 need:1 attract:1 if:1 sell:1 generic:1 doctor:2 not:1 pay:1 progressing:2 successful:1 twitching:2 other:1 take:1 which:1 you:1 stock:1 polar:1 used:1 's:11 may:2 price:2 after:1 treatments:2 most:1 fast-growing:3 but:2 phase:1 accepting:1 prostate:1 reimbursement:1 short:1 surprising:2 maybe:1 life:1 disease:1 without:2 reports:1 practices:1 sources:1 time:1 triggering:1
stock_JNJ r_up	agreed:1 some:1 against:1 thanks:1 court:1 provide:1 fight:1 potential:1 ammunition:1 2012:1 cost-cutting:1 his:1 's:2 beat:1 lab:1 stem:1 fall:1 acquisitions:1 effective:1 created:1 medical:1 devices:1 maker:1 premiums:1 can:1 cells:1 medical-device:1
stock_JNJ r_down	gold:2 freefall:1 scared:1 deep:1 buy:2 have:1 sense:1 its:2 sell:2 faithful:1 bonds:2 chaos:1 few:1 3:2 investors:1 markets:1 blue:2 used:1 do:1 government:1 contracts:1 chips:2 guest:1 customer:1 trades:2 holes:1 columnist:1 ultimate:1 pockets:1
stock_JNJ r_down	mandatory:1 process:1 flow:1 opting:1 cheap:1 medical-technology:1 up:1 economic:1 plead:2 reached:2 education:1 its:2 uncertainties:1 law:2 guilty:2 antipsychotic:2 federal:2 away:1 tries:1 violation:2 stockpile:2 outbreak:1 teens:1 has:2 more:2 firm:1 sex:1 settle:1 huge:1 marketing:2 agreement:2 host:1 salmonella:1 strong:1 probes:1 building:1 30:1 companies:3 cash:4 connection:2 reserves:1 principle:2 profits:1
stock_JNJ r_up	operations:1 just:1 less:1 over:1 global:2 trade:1 four:1 manager:1 still:3 opportunities:2 source:1 buying:1 equity:1 violations:1 has:2 trimming:1 activities:1 his:1 government:1 familiar:1 possible:1 five:1 they:1 despite:1 improper:1 resolve:1 staples:1 --:4 convictions:1 companies:3 payments:3 voluntarily:1 people:1 acquired:1 energy:1 some:2 growth:1 discussions:1 even:2 provided:2 said:3 looking:1 outside:2 investigation:1 firms:1 law:1 members:1 strong:1 last:1 according:1 against:1 foreign:1 connection:1 maker:1 own:1 campaign:1 revenue:1 down:1 bribery:1 industrials:1 question:1 two:1 unseat:1 board:1 ``:2 sessions:1 company:1 diversified:1 fund:1 than:1 present:2 he:2 10:1 made:3 matter:2 those:1 were:1 under:1 pessimistic:1 crazy:1 adviser:1 certain:1 diversification:1 sales:1 '':2 drug:1 if:1 information:2 regions:1 concerns:1 potentially:1 which:1 you:1 explains:1 staying:1 's:4 robots:1 important:1 shareholder:1 debt:1 authorities:1 'm:2 stocks:1 why:1 filing:1 portion:1 2009:1 consumer:1 having:1
stock_JNJ r_down	operations:1 global:2 month:1 manager:1 session:1 still:2 opportunities:2 should:1 source:1 those:1 equity:1 has:1 smart:1 trimming:1 advantage:1 they:1 despite:1 staples:1 --:4 hunt:1 companies:3 've:1 payments:1 voluntarily:1 leaders:1 energy:1 some:2 growth:1 investment:1 declined:1 even:2 provided:1 said:1 away:1 outside:1 firms:1 we:1 business:1 met:1 industrials:1 article:1 strong:1 published:1 long-term:1 maker:1 own:1 revenue:1 improper:1 market:1 swings:1 revive:1 strategy:1 ``:1 enable:1 diversified:1 took:1 but:1 fund:1 present:2 he:1 kind:1 made:1 us:1 wild:1 diversification:1 '':1 say:1 seen:1 if:1 information:1 ideas:1 regions:1 concerns:1 potentially:1 take:1 you:1 convictions:1 economy:1 staying:1 's:2 eight:1 debt:1 authorities:1 portion:1 consumer:1 having:1
stock_JNJ r_up	keeping:1 's:1 string:1 last:1 tabs:1 million:1 900:1 been:1 've:1 cost:1 sales:1 which:1 year:1 recalls:1 $:1
stock_JNJ r_down	series:1 health-care:1 certain:1 another:1 unit:1 giant:1 said:2 ingredients:1 recalling:1 distributed:1 two:1 helps:2 which:3 issued:1 medicine:1 formed:1 has:1 nose:1 product:3 after:1 's:1 combination:1 million:1 levels:1 compound:2 known:1 packages:1 recall:1 medicines:1 sodium:1 spokeswoman:1 provide:1 products:1 relief:1 release:1 recalls:1 slightly:1 latest:1
stock_JNJ r_down	happy:1 tears:1 end:3 crusade:2 s:1 latest:1 come:1 he:1
stock_JNJ r_down	n't:3 done:1 yet:1
stock_JNJ r_down	pharmaceutical:1 plant:1 business:1 shortages:1 drugs:1 caused:1 some:1 drug:1 exit:1 faces:1 ban:1 supplies:1 has:1 its:1
stock_JNJ r_up	current:1 buy:1 uncertain:1 high:1 high-yielding:1 stocks:1 options:1 market:1 volatility:1
stock_JNJ r_up	says:1 investors:1 pro:1 some:1 results:1 looks:1 broader:1 market:1 long:1 should:1 which:1 largest:1 mend:1 has:1 into:1 his:1 's:1 weakness:1 quarterly:1 favorites:1 device:1 world:1 buying:1 like:1 announcing:1 solid:1 long-term:1 maker:1
stock_JNJ r_up	than:2
stock_JNJ r_up	adults:1 chronic:1 pain:1 unit:1 had:1 day:1 version:1 taken:1 strengths:2 headache:1 available:1 's:1 most:1 effects:1 approval:1 approved:1 moderate:1 drug:2 twice:1 severe:1 common:1 2008:1 side:1
stock_JNJ r_up	``:1 sentence:1 follows:1 itself:1 26:1 '':1 version:2 a.m.:1 published:1 approval:1 correct:1 first:1
stock_JNJ r_down	shop:1 less:2 money:1 month:1 report:1 purchasing:1 using:1 22:2 had:3 shortcut:1 actually:1 0.5:1 has:1 them:1 bonds:1 safe:1 break:1 they:1 not:1 during:1 argues:2 investor:1 lost:1 countries:1 identifying:2 companies:2 set:1 list:1 some:2 back:1 past:2 cost:1 home:1 insurance:1 even:1 provided:1 appear:1 research:1 print:1 ability:1 were:1 story:1 credits:3 protection:1 put:1 dividend:1 safer:1 protect:2 her:1 country:1 larger:1 discussed:1 against:2 times:1 credit:1 s:3 point:1 previously:1 betting:1 sovereign:1 corporations:2 use:1 would:1 two:1 been:1 their:1 way:1 survive:1 today:1 ``:1 funds:1 stress:1 gain:1 than:4 he:1 wherewithal:1 kind:1 made:2 default:2 while:1 can:1 many:1 property:1 risky:1 1.7:1 investors:1 almost:1 tax:1 argument:1 0.6:1 periods:1 have:3 seen:1 payers:1 information:1 compared:1 spreads:1 same:1 instance:1 recommended:1 arguments:1 which:1 subsidiaries:1 bets:2 multiple:1 may:1 yesterday:1 tied:1 most:1 courtesy:1 70:4 multinationals:1 proxies:1 weekend:1 recent:1 lower:2 seize:1 3-7:1 starting:1 costs:1 corporate:1
stock_JNJ r_up	required:1 says:2 tougher:1 official:1 implants:4 tracking:1 '':1 surgical:1 through:1 have:1 market:2 information:1 said:1 additional:1 while:1 better:1 does:1 safety:1 treat:1 rates:2 women:1 boost:1 participation:1 firm:1 ``:1 used:1 's:1 complete:1 manufacturers:1 silicone:2 share:1 price:1 safe:1 seventh:1 but:1 stay:1 regulations:1 mesh:1 breast:2 significant:1 child:1 potential:1 condition:1 like:1 building:1 reflect:1 made:1 products:1 effective:1 --:5 work:2 companies:1 drug:1 n't:1 remain:2 complications:1 long-term:2 studies:2 called:1
stock_JNJ r_down	required:1 official:1 implants:1 accused:1 market:1 said:1 eye:1 remain:1 rates:1 boost:1 manufacturers:1 delivery:1 breast:1 potato:1 --:1 enrollment:1 work:1 infections:1 while:1 evaluating:1 long-term:1 studies:1
stock_JNJ r_down	says:1 best:2 money:2 some:1 proven:1 one:2 manager:1 seem:1 moves:2 its:1 market:1 out:1 even:1 given:1 newsletter:1 equities:1 blue-chip:1 long:1 lately:1 5:2 editor:1 strong:1 income:1 yields:1 has:1 misguided:1 higher:2 run:1 risk:2 exchange:1 may:1 little:1 low:1 permabull:2 dividend:1 now:2 than:1 case:1 stocks:3 investment:1 so:1 making:2 reward:1
stock_JNJ r_up	undervalued:2 setback:1 session:2 staff:1 whose:2 atrial:1 writes:2 storms:2 environment:1 treatment:1 hit:1 halt:1 batten:1 rise:1 putting:1 valuable:1 uncertain:1 chips:2 bank:1 term:2 lost:2 level:1 drop:2 companies:2 steps:1 common:1 worries:1 choppy:1 prevent:1 idea:1 actively:2 trading:2 further:2 2.7:1 2.5:1 2.4:1 blue:2 anticlotting:1 while:1 shares:2 current:1 3:2 capital:1 boost:1 franc:1 completely:1 approval:1 debt:1 extreme:1 prospects:1 central:1 many:1 could:1 hatches:3 against:1 keep:1 traded:2 down:3 weather:1 market:2 sovereign:1 long:2 fibrillation:1 markets:3 500:2 head:1 today’s:1 immediate:1 true:1 weathering:1 tactics:1 rival:1 work:1 patients:1 1.7:1 investors:1 1.8:1 1.9:1 drug:2 rally:2 end:1 nuts:1 same:1 recommended:1 potential:1 declined:2 soar:1 's:3 strokes:1 fell:2 stocks:7 lower:3 assets:1 banks:1
stock_JNJ r_up	have:1 declined:1 6.5:1 actively:1 trading:1 drug:1 prostate-cancer:1 moves:1 market:1 rundown:1 whose:2 101:1 8.7:1 shares:2 treatment:1 closed:1 biggest:2 chemotherapy:1 has:1 500:1 gaining:2 men:1 's:2 after:1 regulators:1 fell:1 new:1 stocks:3 approved:1 declining:2 session:1 lower:1 lost:1 companies:1 disease:1 daily:1 points:3 after-hours:1 making:1
stock_JNJ r_down	all:1 appeals:1 says:2 less:1 reasons:1 warns:1 reports:1 approval:1 go:1 doesn’t:1 market:5 25:2 shareholders:1 veteran:1 may:1 volatile:1 treatment:1 lot:1 markets:1 buy:2 which:1 climbs:1 dividends:1 company:1 operating:1 letter:1 timing:2 dividend:2 lower:1 vaudeville:2 solution:1 yield:2 leaving:1 officer:1 writes:1 something:1
stock_JNJ r_down	advisory:3 impedes:1 unexpected:1 often:2 give:1 certain:2 some:1 sales:1 fellow:1 surgical:2 abstention:1 drug:2 committee:1 voted:1 resignation:1 tougher:2 its:2 issues:1 seemed:1 one:2 adding:1 lead:2 merger:1 affects:2 top:1 heavily:1 arm:1 delay:1 regulation:2 clinical:2 approve:1 treat:2 forces:1 breach:1 ammunition:1 markets:1 across:1 painful:2 more:2 week:1 turmoil:1 used:2 's:1 broadly:2 dim:1 drugs:1 relaxed:1 after:1 tumble:1 prospects:1 mesh:2 fall:1 approval:1 stocks:1 approved:1 bank:1 panel:2 restrictions:1 lower:2 federal:1 --:1 rival:1 could:1 official:1 slumps:1 thousands:2 trial:1 women:2 condition:2 products:2 car:1 rivaroxaban:1 drops:1 studies:2 called:2
stock_JNJ r_down	enforcement:1 laws:1 food:1 responsible:2 up:1 drug:1 officer:1 stepping:1 authorities:1 violations:1 hold:1 corporate:2 executives:1
stock_JNJ r_up	own:1 sees:1 just:1 low-priced:1 reduce:1 '':1 beneficiaries:1 newsletter:1 hospitals:1 makers:1 pharmaceutical:1 $:2 hospital:1 opportunities:1 insurance:1 their:1 deficit:1 which:1 angels:1 editor:1 ``:1 big:1 plan:1 not:1 10:2 calls:1 companies:1 drug:1 savings:1 wringing:1 fallen:1
stock_JNJ r_up	increasingly:2 money:1 executive:4 trade:3 session:4 deadline:2 comments:1 battle:1 headlines:1 its:6 whose:4 group:1 $:6 seems:1 than:1 late:1 raising:1 premarket:1 equity:1 details:2 has:4 might:1 pending:1 gave:2 then:1 his:3 food:2 bid:1 watch:2 early:1 additional:2 one:2 successor:1 skeptical:2 like:1 lost:1 --:7 companies:4 become:2 speculation:1 shed:1 says:1 long-running:1 up:1 actively:4 trading:3 year:2 edged:1 3.8:1 3.9:1 said:3 mortgage:2 away:2 shares:6 new:1 announced:1 outgoing:2 recently:2 business:2 handful:1 free:1 takeover:1 chairman:1 come:2 private-label:2 transition:3 hired:4 stand:1 mixed:1 traded:1 maker:1 succeeds:1 previously:2 walk:2 likes:1 table:2 throughout:1 your:3 shareholders:2 8.4:1 would:1 top:1 rivals:2 expected:6 succeed:3 500:1 more:1 head:2 offer:4 company:3 negotiating:2 else:2 part:2 analyst:1 buying:1 10:1 grew:2 join:1 14:2 17:2 cash:1 devices:2 retire:2 while:1 nine:1 2012:1 months:2 process:2 catheters:1 world-wide:1 home:1 negotiations:2 5.2:2 end:1 acrimony:1 47:1 role:1 take:4 announcements:1 you:1 out:2 begin:2 's:10 intended:1 replacing:1 diagnostics:1 disclosed:2 buyback:1 most:1 fell:2 eight:1 plan:2 device:2 president:2 stocks:4 billion:2 off:1 effective:1 medical:3 later:1 well:1 departure:1 stents:1 chief:2 points:3 pay:3 senior:1 corporate:1 spend:1 medical-device:1 latest:1
stock_JNJ r_up	marketed:1 follows:1 agreed:1 allegations:1 according:1 '':1 p.m:1 plead:1 diversity:1 fine:1 its:1 unit:1 85:1 scale:1 court:1 $:3 title:1 pay:1 managed-care:1 charge:1 version:1 fourth:1 largest:1 has:1 boost:1 correct:1 stock:1 criminal:1 ``:1 his:1 's:3 big:1 company:1 million:1 nation:1 retirement:1 uses:1 document:1 13:1 gets:1 unauthorized:1 heart-failure:1 guilty:1 economies:1 drug:1 settle:1 planned:1 time:1
stock_JNJ r_up	pact:1 unusual:1 's:3 would:1 executive:1 agreement:1 noncompete:1 keep:1 led:1 senior:1 employment:1 enforce:1 terms:1 joining:1
stock_JNJ r_down	all:1 over:1 trade:1 portfolio:2 cold:1 its:3 buyers:1 group:1 $:5 over-the-counter:2 has:2 chairman:1 get:1 familiar:1 bid:1 fall:1 buyout:1 target:1 --:2 recalls:1 week:1 900,000:3 because:1 hard:1 year:1 home:1 bidders:1 slew:1 closer:1 said:1 medicine:2 new:2 told:1 recently:1 reason:1 takeover:1 complicated:1 come:1 prospects:1 last:3 annual:1 according:1 drug:2 couple:1 maker:1 named:1 supply:2 staple:1 unit:2 5th:1 been:1 more:1 firm:1 salary:2 season:2 brand:1 but:1 cabinet:1 include:1 join:1 look:1 rival:1 flu:3 up:2 devices:1 situation:1 looms:2 fellow:1 arrangement:2 take:1 you:1 company:2 stock:1 worldwide:1 product:1 's:4 that’s:1 may:1 most:1 medications:1 device:1 president:1 building:1 short:2 medical:2 snapping:1 person:1 diagnostics:1 consumer:1
stock_JNJ r_up	worldwide:1 900,000:3 named:1 president:1 's:1 its:2 said:1 group:1 $:5 arrangement:2 1:1 chairman:1 expected:1 new:2 2012:1 week:1 then:1 recently:1 get:1 most:1 complicated:1 device:1 join:1 salary:1 last:1 17:1 --:1 rival:1 medical:2 annual:1 devices:1 diagnostics:1 become:1 maker:1
stock_JNJ r_down	heart-rhythm:1 tougher:1 sales:1 cost:1 drug:1 have:1 recovery:1 mounting:1 began:1 take:1 more:1 week:1 caplets:1 company:1 step:1 than:1 billion:1 lost:1 medicines:1 regulators:1 shipping:1 steps:1 recalls:1 toward:1 dollars:1
stock_JNJ r_down	methods:1 people:1 national:1 testing:1 longevity:1 proposes:1 kidney:1 subject:1 dialysis:1 research:1 only:1 donor:1 fatal:1 smoke-free:1 dispute:1 's:2 may:1 break:1 new:1 11:1 protected:1 laws:1
stock_JNJ r_down	respond:1 advisory:1 says:1 produces:1 supported:1 some:2 potent:2 stroke:1 including:2 have:2 children:1 unit:1 use:2 said:1 additional:1 application:1 anemia:2 less:2 had:1 been:1 its:3 symptoms:1 adverse:1 other:1 which:1 under:1 150,000:1 include:1 type:1 events:1 do:1 testing:2 's:6 risk:1 extend:1 than:2 after:2 ulcerative:1 treatments:1 tied:1 release:1 batches:2 recalled:2 blood:1 internal:2 authorities:1 revealed:2 approved:1 colitis:2 panel:1 received:1 has:2 necessary:2 syringes:2 17:3 countries:2 --:2 issue:1 age:1 disease:2 drug:6 n't:1 patients:3 pediatric:2 were:2 popular:1 200,000:4 appraisal:1 favorable:1
stock_JNJ r_up	limited:2 all:3 expects:2 trade:2 against:1 session:2 thumbs:2 its:1 whose:2 giant:2 $:3 enough:2 late:1 disclosed:1 premarket:1 weeks:3 has:2 borrowed:1 his:5 slate:2 medicine:1 closely:1 investor:2 --:3 companies:3 after-hours:1 become:3 nominees:2 constraints:1 deal:1 list:3 likely:2 actively:2 trading:2 said:1 capacity:1 decision:1 shares:3 current:2 waiting:3 smallest:1 supplier:1 new:2 told:2 available:3 wo:2 million:1 drug:2 appears:1 manufacturer:1 determining:2 transition:1 contract:1 credit:1 cancer:2 supply:6 within:3 down:2 reached:1 market:2 shareholders:3 additional:3 would:2 due:1 next:2 treat:2 expected:2 board:2 ``:1 sufficient:1 but:3 doctors:2 line:1 160:1 16:1 cash:1 n't:2 patients:3 spooking:1 unlikely:1 have:2 give:2 household:2 purposes:1 general:1 '':1 something:1 want:1 watched:1 sell:2 5.5:1 six:3 detail:1 potential:1 company:1 economy:1 's:10 plans:2 may:1 after:3 fell:2 eighth:1 short:1 corporate:1 position:1 pulled:2 filing:1
stock_JNJ r_up	limited:1 all:1 cancer:1 supply:1 within:1 expects:1 likely:1 additional:1 six:1 waiting:1 next:1 enough:1 treat:1 weeks:1 has:1 told:1 available:1 wo:1 but:1 doctors:1 list:1 drug:1 n't:1 patients:1 become:1
stock_JNJ r_down	heart:3 appeals:2 help:1 point:2 global:1 50/50:1 held:2 opportunities:3 consumer-products:1 175:1 technology:1 its:1 unit:1 after:1 n't:2 said:1 court:3 $:1 district:1 stents:3 federal:1 literally:1 concerned:1 one-time:1 investment:1 affirmed:1 stock-market:1 potentially:1 treat:1 which:1 wasteland:1 bought:1 full:1 's:1 separate:1 share:1 million:1 joint:1 were:1 provide:1 ownership:1 doctors:1 backed:1 decision:1 relating:1 payment:1 earlier:1 coatings:1 buybacks:3 patents:1 did:2 metal:1 disease:1 infringe:2 patent:2 ruling:2 venture:1 defeat:1 dispute:1 original:1 comes:1
stock_JNJ r_up	limited:1 infant:1 over:1 relieve:1 50/50:1 trade:2 session:5 through:1 headlines:1 its:3 issues:1 whose:5 $:4 over-the-counter:1 rose:1 supply:1 had:1 failed:1 citing:1 under:1 2011:1 watch:2 primary:1 early:1 joint:3 --:3 medicines:1 companies:5 50:1 trimmed:1 continue:1 after-hours:1 recalls:1 quarter:1 reduced:1 financial:1 acquired:1 heartburn:1 estimates:1 related:1 growth:1 trading:4 pain:1 declined:1 gross:1 said:1 factory:1 shares:5 forecast:1 exit:1 closed:1 medicine:1 bought:1 full:2 recently:3 million:3 affiliates:1 explore:1 manufacturing:1 gained:3 both:1 prescription:1 receive:1 study:1 according:1 drug:1 products:1 mixed:2 traded:2 maker:1 late-stage:1 among:1 outlook:1 revenue:1 1.6:1 consumer-products:1 175:3 market:1 one-time:2 1989:1 expected:2 500:3 9.3:1 drugs:1 share:1 brand:1 formed:1 but:2 part:1 subsidiary:1 pre-market:1 11:2 endpoint:1 14:1 versions:1 optimism:1 actively:5 venture:3 growing:1 meet:1 margin:1 1.4:1 slid:3 1.3:2 chip:2 1.8:1 sales:2 1:1 which:3 switching:1 higher:1 gaining:1 added:3 's:8 may:1 problems:1 ownership:2 brands:1 stocks:3 payment:3 fiscal:1 third:1 amid:1 well:2 points:4 corporate:1
stock_JNJ r_down	developed:1 results:2 trade:1 known:1 session:2 its:1 cardiovascular:1 whose:2 death:1 $:1 include:1 hit:1 weakness:1 watch:1 12:1 therapy:1 continued:2 condition:1 loss:1 term:1 like:1 lost:1 companies:2 morning:1 after-hours:1 reduced:1 blood-thinning:1 3.4:1 actively:2 trading:2 declined:1 said:2 profit:1 projected:1 shares:2 surprise:1 infrastructure:1 recently:1 standard:1 met:1 estimate:1 study:1 drug:2 74:1 plus:1 placebo:1 traded:1 maker:1 late-stage:1 fourth-quarter:1 primary:1 brought:1 reducing:1 top:1 third-quarter:1 attack:2 memory:1 expected:1 500:1 more:1 efficacy:1 company:1 prices:1 line:1 below:1 endpoint:1 showed:1 rate:1 patients:1 heart:3 1.1:1 chip:1 reduction:1 stroke:2 sudden:1 have:1 swung:1 any:1 compared:1 syndrome:2 storage:1 also:2 which:1 events:1 used:1 's:5 fell:3 blood:1 significant:1 70:1 stocks:1 segment:1 fiscal:2 lower:2 flow:1 points:2 weigh:1
stock_JNJ r_down	right:1 financial:1 consider:2 deal:1 simple:1 into:1 back:1 month:1 one:1 year:1 soon:1 species:1 market:3 3.9:1 $:1 lo:1 since:1 crisis:1 endangered:1 finally:1 combined:1 which:1 biggest:1 8:2 has:1 2011:2 announced:1 too:1 billion:1 safe:1 's:1 get:1 far:1 felt:1 falls:2 takeover:1 they:1 timing:1 buyout:1 stocks:2 than:1 bigger:1 volatility:2 buyouts:1 10:3 like:1 value:2 suggests:1 2007:1 act:1 model:1
stock_JNJ r_up	set:1 bad:2 exists:1 29:1 high:1 talking:1 experts:1 investors:1 reached:1 range:1 market:1 afraid:2 20:1 just:1 media:1 below:1 long:1 enough:1 500:1 big:2 didn’t:1 stay:1 touching:1 bear:2 land:1 calling:1 while:1 analysts:1
stock_JNJ r_up	chain:2 show:1 violation:1 agreed:1 dollar:1 results:1 trade:2 four:1 quotes:1 session:2 through:1 battle:1 its:4 whose:2 indicator:1 cut:2 $:4 had:1 improvement:2 economy:1 concerns:1 premarket:1 suffered:1 has:1 heart-failure:1 indicating:1 government:1 joint:1 orthopedic:1 closely:1 not:2 continued:3 loss:1 replacement-joint:1 --:4 sluggish:1 companies:2 fewer:1 slide:2 including:1 quarter:1 surgeries:1 replacement:2 smaller:1 often:1 ten:1 tepid:1 violated:1 widened:1 growth:1 result:1 year:2 's:12 surgery:1 85:3 said:3 consumers:1 profit:2 benefit:1 shares:2 enough:1 unit:1 7:1 denied:1 got:1 boost:1 jobs:1 slight:2 million:1 weak:3 pressure:1 weaker-than-expected:1 offset:1 directions:1 news:1 pancreatic:1 last:2 ahead:1 soft:2 industry:2 guilty:1 drug:2 fell:1 products:2 context:1 maker:1 first:1 outlook:2 cancer:1 robust:2 market:3 use:1 hospital:1 two:1 long:1 way:1 expected:2 tax:1 company:4 delayed:1 but:2 hurt:1 failure:1 demand:2 prices:1 prescription:1 pain:1 former:2 showed:1 devices:1 matter:1 patients:2 actively:2 can:1 were:1 heart:1 medication:1 joints:2 share:1 sales:6 full-year:2 dropped:2 seen:1 watched:1 health-related:1 pay:1 delay:1 also:2 ortho:1 earnings:2 performance:1 higher:1 such:1 used:1 first-quarter:3 though:1 halted:1 75:2 levels:2 intent:1 services:1 knee:1 approved:1 died:2 fiscal:4 amid:1 mislabeling:1 costs:1 original:1 medical-device:1
stock_JNJ r_up	deck:1 money:3 unlikely:1 need:1 moves:2 yet:1 market:1 out:1 little:1 top:1 5:2 storm:1 instead:1 has:1 tolerance:1 yield-hunting:2 risk:1 get:1 most:2 now:2 borrowers:1 trader:3 points:1 making:2 corporate:1 bond:1
stock_JNJ r_up	heart:2 heart-rhythm:1 share:1 rate:2 questions:1 seen:1 throughout:1 its:1 market:1 said:1 additional:1 get:1 had:1 system:3 analyst:1 whether:1 clinical:1 details:1 new:1 poised:1 faulty:1 therapies:1 higher:1 product:1 's:1 separate:1 beat:1 benchmark:1 but:1 effects:2 regulatory:1 approval:1 than:2 raising:1 recent:1 reaction:1 treats:1 effective:2 --:4 traditional:1 trial:2 common:1 found:1 more:1 side:2 gain:1
stock_JNJ r_down	major:2 benefited:1 woes:1 plethora:1 health-care:1 tax:1 month:2 challenges:1 spending:1 pricing:1 research:1 cuts:1 15:1 exclusivity:1 blockbuster:1 jobs:1 makers:1 landscape:1 closer:1 hold:1 end:1 antipsychotic:1 their:2 patent:3 its:2 late:1 pressures:1 behind:1 other:1 goes:1 net:1 sluggish:1 economy:1 expiring:1 draw:1 's:1 expirations:1 than:1 government:1 cholesterol:1 return:1 break:1 next:1 cut:1 key:1 put:1 changing:1 line:1 trying:2 20,000:1 potential:1 recall:1 off:1 third:1 most:1 ever:1 industry:1 companies:1 according:1 drug:2 pace:1 more:1 while:1 profits:1 2004:1 faces:2 report:1 overseas:1 quarter:1 patents:1
stock_JNJ r_up	sell:1 cash-strapped:1 fashion:1 namesake:1 move:1 agreed:1 million:1 reduce:1 maker:1 apparel:1 looks:1 brands:1 debt:1 its:2 comes:1 $:1
stock_JNJ r_down	could:1 revenue:1 certain:1 into:1 number:1 month:1 '':1 timing:1 likely:1 growth:1 cuts:1 further:1 centers:1 customers:1 squeeze:1 heads:1 crisis:1 version:1 earnings:1 products:1 correct:1 more:1 lowering:1 ``:1 plans:1 season:1 faces:1 problems:1 looming:1 hurt:1 its:1 train:1 putting:1 prices:1 debt:1 concerns:1 declining:1 off:1 third:1 --:2 follows:1 medical:1 devices:1 item:1 patients:1 escalating:1 a.m.:1 published:1 beleaguered:1 surgeries:1 industry:1
stock_JNJ r_down	2,300:1 restore:1 help:1 cancer:2 supply:3 companies:1 cited:1 setback:1 disease:1 hair:1 brain:1 say:1 scientist:1 summer:1 battle:2 facing:1 research:1 two-year:1 seemed:1 illnesses:1 forced:1 cut:1 working:1 top:1 there:1 factory:1 contractor:1 better:1 switch:1 waiting:1 academia:1 combine:1 has:1 numerous:1 week:1 urge:1 's:3 worse:1 effects:1 join:1 problems:1 but:1 prepared:1 most:1 understand:1 breast:1 they:1 during:1 one:1 pharmaceutical:1 advanced:1 governments:1 loss:1 short:1 off:1 her:2 older:1 --:4 list:1 persistent:1 drug:3 n't:1 patients:1 're:1 she:2 shortage:1 initiative:1 efforts:1 side:1 latest:1
stock_JNJ r_up	help:3 dollar:1 results:3 brain:1 session:1 6.3:6 battle:1 research:1 its:4 previous:1 4.95:1 giant:1 one:1 $:2 22:1 graph:1 fix:1 better:1 economy:2 combine:1 equity:1 quarterly:1 2011:2 pending:2 2012:2 around:1 watch:2 expects:1 boost:1 makes:1 background:1 during:1 now:1 major:1 governments:1 summit:1 showed:1 success:1 --:7 conditions:1 companies:1 academia:1 morning:1 facing:1 continue:2 announced:1 raised:1 stock:3 mergers:1 view:1 set:1 urge:1 trend:1 scientist:1 related:4 euro-zone:1 challenges:2 slowed:1 growth:2 trading:1 year:1 our:1 damped:1 revisions:1 index:2 said:1 bottom:1 profit:2 blue-chip:1 bearish:1 forecast:1 crisis:2 sluggish:2 whipped:1 recently:1 pharmaceutical:1 weak:1 handful:1 seventh:1 reported:2 news:1 estimate:1 manufacturing:2 downward:1 gained:1 reaction:1 quarter:2 ahead:1 many:1 could:1 losses:1 drug:1 range:1 products:5 planned:2 rose:1 action:1 efforts:1 slightly:1 first:1 comment:1 among:1 adjusted:1 tone:1 slipped:1 private:1 negative:1 initiative:1 corporations:1 250:1 throughout:1 earning:1 market:2 decline:2 debt:2 failed:1 top:1 there:1 third-quarter:3 per-share:1 doomsday:1 rates:4 recapture:1 6:6 biggest:1 markets:1 final:1 500:1 more:1 ``:1 nickel:1 mostly:1 season:1 company:3 but:2 lift:4 understand:1 favorable:4 sharply:1 hopes:1 analyst:1 those:1 posted:2 '':1 join:1 hour:1 solid:1 batch:1 while:2 economic:1 were:1 closing:2 steep:1 acquisition:6 dropped:1 illnesses:1 sees:2 health-care:2 sales:6 expenses:1 helped:2 currency:2 full-year:1 reports:2 write-downs:2 100:1 end:2 also:1 points:4 5:1 details:1 which:1 higher:1 week:1 conflicting:1 's:6 see:1 earnings:5 price:1 after:2 reflect:1 most:1 fell:3 stocks:1 data:1 eighth:1 lifting:1 recent:1 acquisitions:1 lower:2 third:1 amid:3 futures:2 disease:1 costs:2 launched:1 weigh:2 medical-device:2 nearly:1
stock_JNJ r_down	1.5:3 investors:1 move:1 allegations:1 command:1 baby:1 settlement:1 check:1 unit:1 out:1 sell:1 pharmaceutical:1 shareholders:1 said:1 $:3 breakup:1 recorded:1 its:3 charge:1 potential:1 stemming:1 formula:1 remaining:1 higher:1 plans:1 government:1 valuation:1 company:1 possible:1 uses:1 investigation:1 hopes:1 spin:1 billion:1 off:1 unauthorized:1 medical:1 cover:1 drug:1 products:1 planned:1 allow:1 promoted:1 history:1
stock_JNJ r_down	heart:1 weaker:1 tough:2 heart-rhythm:1 examining:1 headwinds:1 sales:1 '':1 quotes:1 because:1 sees:1 throughout:1 market:3 improperly:1 25:4 takes:1 5.7:1 third-quarter:1 52-week:1 much:1 earnings:2 new:1 before:1 over:1 announced:1 low:1 ``:1 's:2 company:1 setting:1 weak:1 fell:2 fall:1 defibrillator:1 posted:1 made:1 --:4 amid:1 industry:1 trades:1 $:1 whether:1 takeover:1 context:1 time:1 2009:1 maker:1 medical-device:1
stock_JNJ r_up	comment:1 painkiller:1 being:2 into:2 probe:2 long-running:1 confirm:1 assess:1 not:1 arrangements:1 have:5 further:2 pain:3 any:1 market:5 pharmaceutical:3 confirmed:2 said:7 opened:5 pharmaceuticals:1 generic:6 restricted:3 spokesman:1 had:1 declined:1 access:3 commission:1 investigation:4 suspicion:1 unit:1 which:1 between:3 policy:1 agreements:2 has:6 cooperating:1 corporate:1 details:1 giant:1 ``:3 object:1 's:1 generic-drug:1 may:4 company:3 killer:3 effect:1 investigated:1 possibly:1 we:2 probed:1 but:1 they:3 entry:1 authorities:1 branches:1 he:1 peer:2 matter:1 received:1 off:1 provide:2 antitrust:5 whether:1 fully:1 versions:1 '':2 against:1 keep:1 --:3 competitors:3 hindering:1 can:2 notification:1 investigating:1 powers:1 added:1
stock_JNJ r_up	's:2 hearing:1 investigates:1 gain:1 behavior:1 ground:1
stock_JNJ r_down	emerging:1 dollar:1 results:1 soften:1 cuts:2 7.9:1 year-earlier:1 its:2 impact:2 giant:2 cut:1 pharma:1 rose:1 better:1 only:1 program:1 under:1 main:1 rise:1 expects:1 cutting:1 continued:1 --:7 $:3 force:1 due:1 cost:1 third-quarter:2 year:1 close:2 said:2 profit:2 decision:1 pressures:1 new:1 net:2 franc:4 missing:1 pressure:1 reason:1 weaker-than-expected:1 offset:1 major:1 strong:2 care:1 last:1 reported:1 months:1 job:1 drug:3 launched:1 efforts:1 discusses:1 outlook:1 into:1 revamp:2 transform:1 throughout:1 market:1 eye:1 three:2 pharmaceuticals:1 themselves:1 markets:1 cited:1 minor:1 firm:1 partly:1 drugs:1 company:1 hurt:1 prices:1 factories:2 save:2 work:1 remain:1 can:1 acquisition:1 played:1 pro:1 something:1 strength:1 end:1 1:1 role:1 's:2 price:3 keeps:1 workforce:1 forecasts:1 stocks:1 grow:1 overlooked:1 billion:3 amid:1 costs:2 axe:1
stock_JNJ r_up	show:2 detailing:2 implants:2 notice:2 third-quarter:2 '':4 quotes:1 throughout:1 its:6 market:4 discloses:2 said:4 profit:4 notification:2 facility:4 had:2 three:1 also:2 which:2 hip:4 flat:4 ``:4 's:2 business:2 weakness:2 houses:2 orthopedic:2 knee:4 continued:4 received:2 like:2 joint:2 --:8 region:1 devices:4 context:1 following:2 softness:2 inspection:2 maker:2
stock_JNJ r_up	comment:1 revenue:3 sales:3 trails:2 results:1 13th:1 lies:1 through:1 legal:2 year:2 throughout:1 year-earlier:2 its:4 fifth:1 21st:1 said:2 expiration:2 patent:2 rose:3 top:2 third-quarter:2 comments:1 next:2 charge:2 earnings:2 details:2 hepatitis:1 stock:2 modestly:1 updated:1 good:1 gains:2 reaction:1 drugs:5 sixth:1 price:1 but:2 period:2 reported:1 weighed:2 4th:1 background:1 8:3 news:1 post:2 strong:3 analyst:1 vaccine:5 diabetes:5 loss:2 17th:1 soared:2 ahead:1 --:6 rival:2 up:1 drug:5 profit:2 while:2 high-yielding:1 faces:2 down:2 higher:3 5th:1 executives:1
stock_JNJ r_down	golden:1 30:1 says:1 have:1 cancer:4 among:1 testing:1 according:1 '':1 against:1 been:1 summer:1 drug:1 2,500:1 affected:1 result:1 cut:1 potential:1 $:1 trials:1 delays:1 problems:1 parachutes:1 least:1 research:1 also:1 waiting:1 clinical:2 treatment:1 which:1 supplier:1 has:1 patients:2 pending:1 more:2 ``:1 only:1 's:3 filings:1 payouts:1 drugs:2 put:1 million:1 due:1 but:1 not:1 line:1 hold:2 than:2 those:1 opened:1 acquisitions:1 four:1 off:1 manufacturing:1 --:3 amid:1 many:1 list:1 50:1 analysis:1 face:1 chief:1 ongoing:1 either:1 shortage:3 requests:1 studies:1 other:1 executives:1
stock_JNJ r_down	heart:2 associated:1 adults:2 1.2:2 two:1 children:2 cardiovascular:1 n't:6 young:2 research:1 increase:2 potential:1 deficit:1 online:1 medicine:1 treat:2 used:2 led:1 risk:2 drugs:3 million:2 problems:2 agencies:1 involving:2 date:1 largest:1 showed:2 --:1 study:4 funded:1 large:2 did:2 risks:1 attention:1 published:1 serious:2 looking:1 disorder:1 professor:1
stock_JNJ r_up	heart:1 adults:1 campaign:1 ``:1 boycott:1 '':1 rate:1 makers:1 appear:1 longstanding:1 mounting:1 young:1 legal:1 call:1 listed:1 pitching:1 gives:1 do:1 them:1 risk:1 drugs:1 problems:1 regulations:1 uses:1 birth:1 not:1 overturn:1 raise:1 groups:1 kids:1 medicines:1 n't:1 bottle:1 serious:1
stock_JNJ r_up	stock:1 cancer:4 companies:2 sales:1 growth:1 drug:3 determine:1 its:2 market:1 comments:1 compared:3 adds:1 details:1 doctor:1 beginning:1 5th:1 shares:1 concerns:1 extends:1 treatment:1 5:1 price:1 more:2 extended:3 plans:1 survival:4 men:3 overall:4 early:1 said:2 five:3 nearly:4 background:1 news:1 prostate:4 than:2 advanced:3 2012:1 third:1 lost:1 --:4 double:1 study:1 months:4 median:1 value:1 involved:1 growing:1 meet:1 placebo:3 filing:1 experimental:3 updates:1
stock_JNJ r_down	decide:3 proposed:2 show:1 increasingly:1 issued:1 probe:4 competitive:1 its:3 fifth:1 25:1 $:5 should:1 citing:1 investigation:2 treatment:2 has:4 move:1 bid:3 early:1 possibly:1 background:1 fall:1 lost:1 --:11 small:1 quarter:1 says:1 deal:1 competition:2 growth:2 said:3 adds:1 lead:1 giving:3 decision:2 shares:1 increase:1 difficulties:1 market:2 opening:1 sixth:2 million:2 seventh:2 weaker-than-expected:1 concentrated:2 improved:1 would:1 could:1 current:1 in-depth:4 drug:1 comment:3 already:2 cancer:1 into:1 unit:4 pharmaceutical:2 21.3:3 due:2 been:3 statement:1 markets:2 final:2 more:1 ``:3 company:5 despite:1 than:1 case:3 launches:2 value:1 until:3 limit:2 were:1 growing:1 10th:1 acquisition:3 weaker:1 share:2 sales:3 '':3 have:1 make:2 concerns:5 fourth:1 's:12 price:2 modest:1 anti-trust:1 authorities:3 prostate:1 billion:3 reimbursement:1 third:1 antitrust:5 medical:1
stock_JNJ r_down	pharmaceutical:1 kids:1 's:2 combination:1 prevent:1 investing:1 rose:1 health-care:1 flu:1 its:1 conglomerate:1 strokes:1 bad:1 thinner:1 blood:1 sharply:1 authorities:1 approved:2 after:1 treatment:1
stock_JNJ r_up	outpaces:1 limited:1 cancer:1 summer:1 caused:1 growth:1 have:1 its:2 said:1 pay:1 since:1 much:1 earnings:1 supplier:1 has:1 division:1 head:1 company:1 problems:1 sharply:1 dividend:1 manufacturing:1 resolve:1 industry:1 drug:1 spend:1 n't:1 does:1 shortage:1 options:1
stock_JNJ r_down	benefit:1 heart:4 anticlotting:1 says:1 have:1 prevent:1 certain:1 blood-thinning:1 brain:1 preventing:1 another:1 close:1 surgery:1 short-term:1 hospitalized:2 index:1 assessing:1 goal:1 people:1 brand:1 young:1 been:2 research:1 passive:1 failed:1 attack:1 strange:1 treatment:1 way:1 better:1 new:1 has:2 clots:2 stock:2 function:1 's:3 undergoing:1 apixaban:1 showing:1 under:1 screenings:1 failure:2 involving:1 blood:2 significant:1 contractors:1 sold:1 article:1 pain:1 than:1 he:1 known:1 fraud:1 name:1 showed:1 --:2 study:2 chest:1 drug:3 patients:2 'd:1 unstable:1 published:1 become:1 looking:1 athletes:1 think:1 incomplete:1 meet:1
stock_JNJ r_down	rating:1 says:1 own:2 above-average:1 risk:1 earned:1 very:1 delivered:1 companies:1 returns:1 eight:2 low:1 have:2 portfolio:2 those:1
stock_JNJ r_down	sentenced:1 statements:1 issued:1 over:1 health-care:1 product:1 years:1 four:1 hopes:1 accused:1 retired:1 message:1 well:2 large:1 use:1 court:1 federal:1 footnotes:1 top:1 six:1 had:1 officers:1 send:1 their:2 complex:1 promoting:1 details:1 prison:1 increasing:1 might:1 more:1 violating:1 's:1 government:1 becoming:1 cement:1 uses:1 sharply:1 judge:1 he:1 strong:1 former:2 longer:1 past:1 sentencing:1 roles:1 unauthorized:2 involved:1 medical:1 annual:1 companies:2 reports:1 other:1 length:1 games:1 medical-device:1 wish:1 promotion:1 laws:1 maker:1 bone:1 executives:2
stock_JNJ r_down	saying:1 just:1 caused:1 agreed:2 executive:1 mainly:1 actions:1 known:1 per:2 battle:1 its:2 developer:1 whose:1 bribes:1 $:12 highlights:1 than:1 better:1 contract:1 foster:1 treatment:2 prison:2 troubled:1 over:1 sinking:1 his:1 premium:1 halt:1 government:1 big:1 'not:1 early:1 updates:1 background:1 resolve:1 unauthorized:2 --:10 companies:1 race:1 shortage:1 bone:2 weighs:1 says:2 deal:3 list:1 challenges:1 likely:1 cost:1 trading:1 our:1 80:1 manufacturer:1 said:2 rep:1 hepatitis:6 yet:1 waiting:1 does:1 health:1 unit:1 routine:1 new:2 announced:1 business:2 million:1 strained:1 agreement:1 control:1 paid:1 article:1 manufacturing:2 supplying:1 10.4:3 settling:1 reaction:1 kids:1 involved:1 employees:1 months:2 running:1 drug:6 products:2 analysts:1 published:1 promotion:2 maker:3 executives:1 among:1 cancer:2 revenue:1 win:1 into:2 60:1 suspended:1 market:3 has:1 additional:1 placing:1 tiny:2 their:1 maintenance:2 expected:1 care:1 more:2 probe:1 buy:1 continue:1 drugs:4 company:4 acquire:1 debate:1 but:1 dealings:1 pricey:2 prices:1 former:2 11:4 12:1 developing:2 whether:1 n't:1 89:1 nine:2 critical:1 were:2 growing:1 distribution:1 balance:1 2,700:1 bet:1 sentenced:2 have:1 cover:1 share:2 site:1 fixes:1 against:2 prostate-cancer:1 need:1 blockbuster:1 no:1 pay:4 agency:1 shares:1 other:1 potential:2 role:2 which:1 9:2 stock:1 profile:1 plant:3 's:9 after:1 problems:1 treatments:4 cement:2 virus:2 uses:2 improving:1 foothold:1 preventive:1 probes:1 billion:3 reimbursement:1 required:1 infections:1 roughly:1 costs:1 overseas:2 overdue:2 medical-device:2 nearly:2
stock_JNJ r_down	responsible:2 sell-off:1 agreed:1 executive:3 underlying:2 looks:1 skin:1 its:1 giant:1 death:1 knowledge:2 analyst:1 better:1 treatment:1 under:2 violations:2 has:1 achieve:1 updated:1 which:1 food:2 they:2 despite:1 judge:1 now:2 continued:1 unauthorized:1 --:11 did:2 officer:2 liable:2 quick:1 bone:1 attorney:2 says:1 some:1 direct:2 challenges:2 likely:1 cost:2 happen:1 even:2 said:1 prison:1 comments:2 3:2 health:1 conduct:2 boost:1 victory:2 focuses:1 turning:1 white-collar:1 faced:1 buck:1 pipeline:1 months:1 drug:3 climb:1 maker:1 executives:4 owned:1 brought:2 improving:1 privately:1 throughout:1 risk:1 pharmaceutical:1 second:1 positive:1 alleged:2 mark:2 their:1 growth:2 treat:1 prosecutor:1 reaction:1 drugs:1 funds:1 company:2 acquire:1 pricey:1 known:1 former:6 criminal:1 roles:1 developing:1 see:1 n't:3 defense:2 nine:1 were:1 sentenced:2 prostate-cancer:1 certain:2 share:1 incremental:1 have:2 if:2 drivers:1 holds:2 details:3 fourth:1 9:2 profile:1 product:1 exactly:1 's:5 price:1 cement:1 helping:1 running:2 uses:1 sentencing:3 promotion:1 reimbursement:2 third:1 amid:1 cover:2 agency:2 truck:1 corporate:2 medical-device:1 laws:2
stock_JNJ r_down	inspectors:1 raised:1 says:1 they:1 cancer:1 certain:1 into:1 contamination:1 technicians:1 three:1 say:1 promise:1 65:1 sees:1 made:1 open:1 special:1 whose:1 use:1 batches:1 potential:1 pharma:1 restricted:1 question:1 recommended:1 shares:1 seller:1 forestry:1 drugs:1 3:2 investigation:1 health:1 fourth:1 include:1 sent:1 independent:1 plant:1 's:1 revisit:1 wo:1 company:2 after:1 trees:1 long-term:1 regulators:1 short:1 lows:1 key:1 found:1 report:1 one:1 valuation:1 plunging:1 fraud:1 were:1 recall:1 could:1 but:1 leaving:1 n't:1 risks:1 owns:1 indices:1 claims:1
stock_JNJ r_up	30:1 agreed:1 indicating:1 sales:1 ended:1 another:1 173:1 its:2 market:1 adding:1 said:1 $:1 generic:3 review:1 anticlotting:1 application:1 version:3 health:1 stable:1 products:1 posted:1 pill:2 cited:1 dispute:1 product:1 's:4 million:1 regulators:1 approval:2 data:1 women:1 regarding:1 12:1 months:1 companies:1 drug:2 called:2 patent:1 speedy:1 victory:1 birth-control:2 granted:2
stock_JNJ r_up	comment:1 summer:2 all:1 says:1 shutdown:1 cancer:1 ``:1 back:1 '':1 bring:1 have:1 7th:1 spokeswoman:1 said:1 make:1 since:1 does:1 weeks:1 has:2 available:1 exploring:2 plant:1 's:4 resume:1 estimate:1 production:1 recent:2 again:1 --:3 drug:1 n't:1 shortage:2 options:2
stock_JNJ r_down	available:1 exploring:1 ``:1 said:1 's:3 cancer:1 again:1 make:1 all:1 drug:1 '':1 summer:1 shortage:1 weeks:1 has:1 options:1 recent:1
stock_JNJ r_up	restriction:1 contraceptive:1 buy:1 end:1 emergency:1 whether:1 could:1 pill:1 without:1 can:1 decide:1 prescription:1 age:1
stock_JNJ r_up	right:1 's:4 just:1 doing:1 waiting:1 next:1 headline:1 while:1 much:1 nothing:1 along:1 now:1 market:1 out:1
stock_JNJ r_down	150:1 1.6:1 hold:1 among:1 into:1 milestone:1 shed:1 myeloma:1 chronic:1 actively:1 trading:1 drug:1 suspected:1 's:2 2.1:1 quality:1 declined:1 container:1 index:1 stocks:1 develop:1 $:2 basis:1 two:1 shares:1 2:1 treatment:1 closed:1 between:1 new:1 entered:1 recent:1 company:1 cited:1 split:1 development:1 manufacturer:1 after:1 multiple:1 whose:1 collaboration:1 million:2 leukemia:1 plant:1 lapses:1 regulators:1 fell:1 upfront:1 regulatory:1 subsidiary:1 lymphoma:1 payment:1 additional:1 lower:1 troubled:1 worldwide:1 receive:1 inspection:1 companies:2 up:1 contract:1 session:1 payments:1 after-hours:1 825:1 discovery:1 oral:1
stock_JNJ r_up	all:2 among:1 caused:1 agreed:1 doctors:1 trade:1 session:3 rejecting:1 talks:1 its:3 whose:3 batches:1 $:3 23:2 rose:3 guidance:2 except:1 citing:1 unable:1 premarket:1 include:1 advises:1 broadly:1 watch:1 background:1 treating:1 countries:1 --:3 drop:1 companies:3 morning:1 shortage:1 stock:1 view:2 leaders:1 woes:1 guidelines:1 slashed:1 actively:3 trading:2 calling:1 closer:1 index:3 projected:1 shares:3 sequential:1 health:1 7:1 between:1 medicine:1 new:1 million:2 recently:2 business:1 inspect:1 diagnostic:2 108:1 27:1 members:1 contamination:2 news:1 100:1 manufacturer:2 gained:3 climbed:3 contract:1 traded:2 processor:1 fourth-quarter:1 secure:1 cancer:2 revenue:1 awaited:1 two:1 throughout:1 decline:1 deal:1 would:1 due:1 least:1 expected:1 markets:1 500:1 more:1 drugs:1 company:1 wireless:1 lowered:1 recalled:1 demand:1 those:1 11:2 13:1 made:2 16:1 pursue:1 recall:1 up:1 nations:1 economic:1 risks:1 were:1 dropped:1 1.5:1 1.6:1 1.1:1 investors:1 1.3:1 backing:1 certain:1 agent:2 drug:1 have:3 treaty:1 4.7:1 1:1 recommended:1 potential:1 details:1 which:1 higher:2 's:6 delivered:1 problems:1 applications:1 ties:1 stocks:2 data:1 fiscal:1 lower:1 downbeat:1 changes:1 futures:2 overnight:1 maker:1 reports:1 points:4
stock_JNJ r_down	sector:2 agreed:2 implants:2 surgical:4 businesses:2 skin:2 its:4 batches:2 based:1 $:8 disorders:2 had:1 enough:1 including:2 contractor:1 better:1 production:1 combine:2 treatment:2 has:2 count:1 3:4 orthopedic:2 awaiting:1 list:1 release:2 divest:2 ailments:2 prevent:2 testing:1 direct:4 competition:2 likely:2 year:2 dermatology:2 close:2 estimated:1 said:10 combined:2 tools:2 ovarian:1 current:2 waiting:1 provides:2 new:4 preserve:2 business:6 million:4 address:1 100:2 manufacturing:1 manufacturer:2 receive:1 annual:2 contract:2 maker:2 cancer:2 supply:4 instruments:4 2,000:1 three:2 offerings:2 suspended:1 quality:1 would:2 hospital:4 due:2 been:4 treat:3 final:1 more:2 drugs:2 company:5 line:2 prices:2 165:4 cases:2 than:3 must:2 begins:1 cash:2 spokeswoman:1 patients:2 cancers:1 process:1 expanding:2 health-care:2 sales:2 drug:3 have:4 other:1 which:3 higher:2 plant:1 used:2 's:10 though:1 may:1 problems:2 allocation:1 device:2 segment:2 acquisitions:4 purchase:2 short:2 treats:1 medical:2 1,000:1 diagnosis:2 order:2 once:1
stock_JNJ r_down	sector:1 summer:1 help:1 demand:2 executive:2 domestic:2 cautions:1 trade:4 report:2 session:6 still:1 its:3 whose:6 batches:2 $:2 disorders:1 rose:3 ease:1 supply:2 same-store:2 except:2 only:2 production:1 prison:2 single-digit:2 8:2 has:2 2012:2 do:2 his:2 affected:1 increased:2 supplier:1 judge:2 provided:2 above:2 --:7 medicines:1 companies:7 did:1 after-hours:3 release:2 quarter:2 bone:2 shed:1 says:1 66:1 woes:1 doing:2 list:1 testing:2 product:5 used:1 up:2 3.4:1 actively:6 trading:4 year:1 estimated:1 declined:1 category:2 index:2 said:3 adds:1 bullish:1 entertainment:2 federal:2 since:1 shares:6 increase:1 waiting:1 safety:1 various:1 closed:1 medicine:1 new:1 electronics:2 comparable:2 recently:1 attention:1 contamination:1 regulatory:2 manufacturing:2 beginning:1 declining:2 manufacturer:3 gained:1 reaction:1 cautious:1 concerns:1 study:1 months:2 drug:3 analysts:2 8.8:2 promotion:2 retail:2 traded:1 other:4 shortage:2 comment:1 fourth-quarter:4 major:1 slipped:1 presence:1 address:1 retailer:2 number:1 one:3 suspended:1 cancer:2 second:1 basis:2 illegal:2 computing:2 question:1 due:3 been:1 too:1 6:1 expected:4 9.6:2 type:2 treat:2 drugs:1 company:2 but:2 short:1 stems:1 former:2 he:1 11:1 made:1 uncertain:1 12100:1 recall:2 appliance:2 batch:2 n't:2 patients:2 growth:4 risks:1 were:4 10th:1 could:1 sentenced:2 heart:1 1.3:1 sales:6 nascent:2 gadgets:2 good:3 contract:3 cites:1 risk:1 again:2 doctor:1 percent:4 mid:2 antiviral:1 recommended:1 potential:2 role:2 widely:1 several:1 higher:1 plant:1 added:1 's:14 information:1 may:1 problems:2 update:2 cement:2 eight:2 such:2 stocks:3 segment:2 29:2 79:1 recent:2 fiscal:2 lower:1 tracking:2 third:2 mobile:2 resolution:1 well:3 overshadowed:2 1,000:1 which:1 points:5 serious:1 consumer:2 filing:2 medical-device:2
stock_JNJ r_up	outlook:1 managers:1 doing:1 money:1 some:1 bearish:2 surgical:1 least:1 market:1 if:1 these:1 giant:1 $:1 21.3:1 merger:1 make:1 it’s:1 expectations:1 shares:1 their:1 live:1 new:1 implant:1 that’s:1 offer:1 drugs:1 funds:3 company:1 exactly:1 despite:1 device:1 one:1 opportunity:1 approved:1 buying:1 billion:1 days:1 bullish:2 --:1 medical:1 up:1 times:2 thing:2 three:1 healthcare:1 whole:1
stock_JNJ r_up	set:1 tone:1 investors:1 can:2 sights:1 focus:1 been:1 including:1 higher:1 have:1 year:1 portfolio:2 saw:1 your:2 acquisitive:1 out:1 resisting:1 just:1 top:1 burst:1 stocks:1 next:1 everything:1 which:1 recommend:1 show:1 new:1 has:2 stock:1 gains:1 beat:2 continues:1 utilities:1 but:1 2012’s:1 overture:1 its:1 takeover:1 gridlock:3 defensive:1 gate:1 stay:1 target:1 cautious:1 staples:1 sectors:1 always:1 morning:1 trimmed:1 else:1 analysts:1 action:1 nice:1 consumer:1
stock_JNJ r_down	often:1 stodgy:1 pay:1 high:1 their:1 cousins:1 dividends:1 derided:1 stocks:1
stock_JNJ r_up	saying:1 would:1 they:1 people:1 being:1 certain:1 rid:1 nearing:1 related:2 affected:1 date:1 identify:2 have:1 return:2 protein:2 quickly:1 targets:2 users:1 said:2 bottles:1 lead:2 no:1 there:1 dispose:1 research:2 delay:1 their:1 safety:1 potentially:2 coated:3 caplets:3 medicine:1 new:2 if:1 therapies:2 expiration:1 pills:1 do:1 product:1 used:1 's:7 intended:1 get:1 may:1 some:1 company:1 million:1 possible:1 unused:1 fund:2 recalled:1 key:2 not:3 affect:2 pain:1 concerns:1 count:1 12:3 products:2 getting:1 recall:3 could:2 level:1 disease:2 experience:1 dissolve:1 n't:2 so:2 relief:2 tablets:2 efforts:2 consumer:1 asked:1 consumers:1
stock_JNJ r_up	since:1 managed:1 have:1 cancer:1 caused:1 back:1 ovarian:1 bring:1 including:1 contract:1 another:1 1,000:1 its:1 out:1 spokeswoman:1 said:1 squeeze:1 six:1 remain:1 late:1 waiting:1 does:1 which:1 supplier:2 supplies:1 troubled:1 until:1 2012:3 then:1 plant:1 's:2 sole:1 but:1 batches:1 shifting:1 new:1 earliest:1 beginning:1 production:1 manufacturer:1 ago:1 treats:1 receive:2 months:1 list:1 drug:2 options:1 n't:1 pursue:1 patients:2 cancers:1 shortage:1 other:2 expect:1
stock_JNJ r_up	walking:1 trade:2 its:4 weekly:1 litigation:1 $:1 residential:1 had:1 former:3 lender:1 woes:1 details:1 has:2 pending:1 2012:2 hip:1 do:1 his:1 publicity:1 risk:1 bonds:1 far:2 minimal:1 early:1 fall:3 years:1 day:1 bank:2 like:1 level:1 --:4 high-yield:1 list:2 facing:1 skills:1 bad:1 officer:1 make-or-break:1 bond:2 smaller:1 accuses:1 deal:1 declines:1 some:1 year:3 our:1 out:1 competitor:2 mortgage:1 bottom:1 worsen:1 since:1 capital:2 four-week:1 get:1 seeks:1 impact:1 turning:1 business:1 ratios:1 beginning:1 raiding:3 both:1 last:1 ahead:1 secrets:2 employees:2 21:1 against:4 products:2 positive:1 climb:1 replacement:1 slightly:1 think:1 executives:1 economists:1 liabilities:1 two:1 spinal:2 1st:1 force:3 reducing:1 market:1 rely:1 jobless:1 lawsuit:3 top:1 three:2 long:1 next:1 their:2 returns:3 expected:2 today:1 more:1 lowest:1 generating:1 company:3 filed:2 acquiring:1 line:1 than:1 buying:1 he:3 join:1 recall:2 could:2 detailed:1 troublesome:1 associated:1 stealing:2 sales:5 financial:1 investment-grade:1 have:2 home:1 close:2 if:1 'll:2 guru:1 veteran:1 seeking:1 chief:1 also:3 parts:2 damages:2 which:2 papers:1 figures:1 spinal-device:1 to-do:1 's:9 may:1 cement:1 involving:2 improving:1 billion:1 short:2 assets:1 fallen:1 average:1 metal:1 maker:2 competitors:1 reputation:1 so:1 claims:1 2008:1 latest:1
stock_JNJ r_up	manufacturing:1 's:1 look:1 revival:1 fundamentals:1 potentially:1 rebound:1 30:1 dollar:1 reports:1 investment:1 yields:1 market:1 promising:1 improving:1 dividend:1 technicals:1 stocks:1 make:1 best:1 attractive:1
stock_JNJ r_down	after:1 's:3 success:1 classic:1 underperforming:1 year:1 reports:1 second:1 consecutive:1 known:1 strategies:1 2011:2 over:1 decade:1 previous:1
stock_JNJ r_down	fourth-quarter:1 revenue:1 sales:1 surgical:1 prostate-cancer:1 recently:1 its:2 steeper:1 decline:2 20:3 antipsychotic:1 patent:1 rose:1 makers:1 much:1 treat:1 which:1 conduct:1 new:1 2012:3 used:1 's:1 incontinence:1 mesh:1 expects:1 reported:1 fell:1 women:1 stress:1 urinary:1 lost:1 drug:1 ordering:1 protection:1 products:1 studies:1 profits:1
stock_JNJ r_down	consider:1 bring:1 year:1 portfolio:1 your:2 out:1 different:1 ways:2 review:1 ideas:2 same:1 investment:2 you:1 2011:1 more:1 head:1 noise:1 lamps:1 10:3 money-making:2 these:1 might:1 could:1 investments:1 turn:1 position:1 2012:3 think:1
stock_JNJ r_up	plant:1 made:1 prescription:1 over-the-counter:1 warned:1 medicines:1 were:1 potential:1 certain:1 pain:1 manufacturing:1 pills:1 involving:1
stock_JNJ r_up	heart:1 lower:1 associated:1 risk:2 generation:1 blood:1 thinners:1 attack:1 drug:1 stroke:1 part:1 gain:1 new:2 increased:1 approval:1 study:1 first:1
stock_JNJ r_down	managers:1 flawed:1 orange-juice:1 evidence:1 news:1 existence:1 growers:1 use:1 said:1 their:1 seriously:1 roiled:1 orange:1 markets:1 cite:1 week:1 inefficient:1 company:1 were:1 fund:1 regulators:1 not:1 using:1 approved:1 like:1 futures:1 analysis:1 fungicide:1 justify:1
stock_JNJ r_up	anyway:1 year:1 doesn’t:1 worry:1 gains:1 writes:1 fickle:2 market:2 goes:1 capital:1 new:1 gets:1 defy:2 them:1 plans:1 gym:1 but:1 reported:1 letter:1 case:1 benefits:1 warned:1 without:1
stock_JNJ r_up	taste:1 branding:1 executive:1 some:1 chef:1 experts:1 gearing:1 union:1 decision:1 chief:1 split:1 largest:1 biggest:1 several:1 chairman:1 's:3 nation:2 banks:1 become:1 diabetes:1 organizations:1 roles:1 companies:1 up:1 drug:1 leaving:1 bad:1 push:1 including:1
stock_JNJ r_down	resolve:1 declined:1 $:3 clinical:1 158:3 marketing:1 million:1 sales:1 related:1 data:1 experimental:1 asking:1 drug:2 pay:1 claims:1 more:1 diabetes:1 approve:1 its:1 unit:1 antipsychotic:1
stock_JNJ r_up	definition:1 illness:1 's:1 $:2 158:2 some:1 analyzing:1 sprouts:1 worries:1 pulls:1 salmonella:1 autism:1 mental:1
stock_JNJ r_down	's:3 includes:1 tape:1 earnings:1 including:1 more:1 bunch:1
stock_JNJ r_up	just:1 among:1 settlements:1 results:5 through:1 broader:1 headlines:1 its:2 giant:1 busy:1 four-day:1 economy:1 quarterly:1 main:1 2011:2 virtually:1 generics:1 watching:1 far:1 watch:3 early:2 fall:3 day:3 standstill:1 like:1 drop:1 've:1 higher:1 declines:1 up:2 see:1 89:1 trading:2 year:1 avoided:1 slew:1 said:1 profit:1 legal:1 yet:1 dominates:1 closed:2 between:1 consecutive:1 technology:1 we:1 business:1 opening:1 wrangling:1 mulled:1 bulls:1 reported:2 active:1 strong:1 dry:1 ahead:1 could:1 losses:2 quiet:1 mixed:1 product-liability:1 fourth-quarter:1 major:1 point:1 due:1 another:1 message:1 winning:1 market:1 exciting:1 few:1 bears:1 two:1 paint:1 fought:1 way:1 expected:1 more:1 flat:1 season:1 fireworks:1 but:1 finished:1 part:1 than:1 include:1 morning:2 batch:1 while:1 growth:1 three:1 were:2 streak:1 investors:1 0.1:1 snapping:1 health-care:1 sales:2 weighed:1 dropped:1 seen:1 saw:1 recovery:1 generic:1 suggest:1 11.7:1 indexes:2 points:1 earnings:2 which:1 new:1 stock:2 's:2 though:1 action:1 involving:1 stocks:5 lower:1 off:2 especially:1 third:1 amid:1 futures:3 stronger:1 costs:1 tech:1 components:1 deflated:2 corporate:2 latest:1
stock_JNJ r_up	declines:1 sales:2 fortunes:1 65:1 year:1 substantially:1 avoided:1 said:1 $:1 5.6:1 rose:1 research:1 5:2 consecutive:1 boost:1 2012:2 bid:3 medications:1 they:1 billion:1 like:1 third:1 --:1 2011:1 could:1 companies:1 see:3 takeout:1 analysts:3 horizon:1 higher:3
stock_JNJ r_up	firm:1 royalties:1 benefit:1 higher:1
stock_JNJ r_down	among:1 already:1 slip:1 crowd:2 proposals:1 some:1 discovered:1 radar:1 have:3 year:1 disclosures:1 investors:1 no:1 political:1 been:1 their:1 doubt:1 under:1 stepped:1 more:1 activities:1 that’s:1 beat:2 dividends:2 reason:1 proxy:1 doubts:1 100:1 stocks:3 longer:1 10:2 look:1 these:1 income-paying:2 companies:1 up:1 submitted:1 matter:1 many:1 push:1 cash-rich:1 efforts:1 corporate:1 having:1
stock_JNJ r_up	less:1 revamp:1 year:1 naming:1 unit:1 out:1 again:1 $:1 million:1 over-the-counter:1 supply:1 diseases:1 wipe:1 tropical:1 other:1 new:2 troubled:1 oversight:1 after:1 increased:1 government:1 sparked:1 problems:1 agencies:1 leadership:1 nearly:1 manufacturing:1 than:1 10:3 toward:1 makes:1 medicines:1 companies:1 up:1 drug:2 2020:1 clutch:1 push:1 aid:1 800:1 shaking:1 once:1
stock_JNJ r_up	fourth-quarter:1 high-risk:1 cancer:1 declines:1 them:1 competition:1 ending:1 '':1 defense:1 drug:1 have:1 plan:1 win:1 insurance:1 seemed:1 envy:1 generic:1 charges:1 cliff:1 acquitted:1 patent:1 there:1 due:1 long:1 research:1 weapons:1 few:1 pool:1 which:1 bribe:1 new:1 skin-cancer:1 told:1 scored:1 ``:1 reporting:1 jury:1 string:1 combat:1 drugs:1 each:1 hurt:1 contract:1 two:1 they:1 device:1 during:1 drought:1 prostate:1 approved:1 advanced:1 recent:1 criminal:1 minister:1 successes:1 companies:1 disease:1 against:1 profit:1 were:1 military:1 investigators:1
stock_JNJ r_down	billion:2 named:1 's:1 $:2 end:1 surge:1 1:1 succeed:1 decade:1 8:1 president:1 market:1
stock_JNJ r_down	increase:1 also:1 profit:1 amid:1 reported:1 revenue:1 modest:1 fewer:1 acquisition-related:1 charges:1 restructuring:1 swung:1 maker:1
stock_JNJ r_up	peers:1 premium:1 investors:1 price:1 lower:1 should:1 n't:2 trading:1 before:1 its:1 buying:1 wait:1
stock_JNJ r_down	said:1 $:1 22:1 charges:1 pay:1 company:1 million:1 its:1 public:1 settle:1 decade:1 former:1 doctors:1 distributor:1 than:2 unit:1 more:2
stock_JNJ r_up	revenue:1 rose:1 there:1 companies:1 but:1 face:1 more:1 fourth:1 expected:1 firms:1 quarter:1 trouble:1 shows:1
stock_JNJ r_down	money:1 over:1 manage:1 back:1 '':1 expensive:1 short-term:1 needs:1 their:1 treasurers:1 shortcut:1 companies:1 complex:1 market:2 threaten:1 biosimilar:1 ``:1 regulations:1 fund:1 regulators:1 preparing:1 change:1 made:1 created:1 medicines:1 versions:1 proposals:1 cash:1 against:1 securities:1 matter:1 push:1 could:2 first:1
stock_JNJ r_down	share-price:1 estimates:1 returns:1 drug:1 delivering:1 while:1 continue:1 earnings:1 potent:1 beating:1 maker:1 can:1
stock_JNJ r_up	harm:1 has:1 cancer:1 any:1 warned:1 clear:1 distributed:1 drug:1 much:1 n't:1 version:1 done:1 but:1 found:1 if:1 its:1 counterfeit:1
stock_JNJ r_up	's:1 leukemia:1 drug:1 batch:1 concerns:1 recalled:1 due:1 one:1 its:1 unit:1
stock_JNJ r_up	heart:1 raised:1 valve:1 associated:1 help:1 weight:1 people:1 sales:1 caused:1 harm:1 good:1 design:1 have:1 heels:1 says:1 its:3 n't:1 giant:1 said:1 rivals:1 supply:1 due:1 been:1 strategy:1 adverse:1 concerns:1 pains:1 new:1 has:1 events:1 regain:1 introducing:1 flaw:1 earlier:1 's:4 string:1 company:1 sets:1 results:1 possible:1 but:3 back:1 helping:1 following:1 recalled:1 effects:1 nip:1 efforts:1 problem:1 entire:1 great:1 effective:1 reported:1 taking:1 drug:1 regulator:1 ensure:1 lose:1 long-term:1 recalls:1 obesity:1 side:1 risky:1
stock_JNJ r_up	consider:1 office:1 people:1 sting:1 '':1 bribery:1 contract:1 patent:1 its:1 setbacks:1 quit:1 given:1 targeting:1 cancer:1 federal:1 supply:1 two:3 dismissed:1 approved:1 late:1 chairman:1 new:2 save:1 2010:1 duties:1 treatment:1 ``:1 after:1 's:1 business:1 drugs:1 bid:1 succession:1 phony:1 arthritis:1 part:1 judge:1 subsidiary:1 lawsuit:1 appointed:1 involving:1 case:2 short:1 16:1 suppliers:1 expanded:1 arrested:1 against:1 foreign:1 trial:1 race:1 were:1 military:1 rheumatoid:1
stock_JNJ r_down	stance:1 picked:1 deal:1 can:1 over:1 executive:1 back:1 private:1 involve:1 caution:1 another:1 take:1 its:2 takes:1 implementation:1 next:1 drugs:1 economy:1 equity:1 biggest:2 new:1 proposal:1 leader:1 more:1 acquisitions:1 plant:1 's:3 business:2 both:1 may:1 dividends:1 watch:2 longtime:1 supplies:1 front:1 news:1 buyout:1 debt:1 day:1 developments:1 repairing:1 skeptical:1 target:1 four:1 amid:1 uncertainty:1 morning:1 chief:1 products:1 acquisition:1 closing:1 toward:1 consumer:1 order:1 mergers:1 first:1
stock_JNJ r_up	advisory:1 incoming:1 consumer-product:1 challenges:1 individual:1 drug:3 approval:2 insurance:1 decade:2 lead:1 federal:1 clearing:1 shares:1 rates:1 way:1 new:1 more:2 's:1 which:1 after:1 overwhelmingly:1 diet:1 weight-loss:2 fending:1 backed:2 off:1 cough:1 than:2 panel:2 prescription:2 could:1 doubled:1 first:2
stock_JNJ r_down	because:1 executive:1 product:1 cut:1 increase:1 performance:1 partially:1 2011:1 2010:1 restoring:1 outgoing:1 his:1 's:2 bonus:1 company:1 he:1 received:1 55:3 annual:1 chief:1 dealt:1 recalls:1
stock_JNJ r_down	successor:1 her:1 old-school:1 over:1 executive:3 agent:1 replace:1 single:1 added:1 questions:1 yet:1 departed:1 shareholders:1 renewed:1 destiny:1 candidate:1 person:1 discussion:1 selected:1 had:1 been:1 name:1 another:1 board:1 has:2 resignation:1 told:1 his:3 's:6 relationship:1 company:1 but:1 ex-employee:1 drew:1 unnamed:1 revealed:1 him:1 he:2 mystery:1 romantic:1 level:1 did:1 official:1 morning:1 n't:2 communications:1 chief:2 future:1 abrupt:1 analysts:1 speculation:1
stock_JNJ r_up	``:2 good:1 solid:1 earnings:1 deliver:1 bad:1 times:1 '':2 manager:1 growth:1 can:1 picks:1 some:1 stocks:1 his:1 looks:1
stock_JNJ r_down	proposed:1 being:1 developed:1 guided:1 executive:1 results:1 bapineuzumab:2 helm:1 its:1 25:2 $:1 28:1 should:1 platform:1 treatment:1 has:3 agreed:1 get:1 very:2 maritime:1 therapy:1 not:3 success:2 harbor:1 companies:1 financially:1 either:1 become:1 approaching:1 best:3 provided:1 said:1 bullish:3 decision:1 since:1 anticlotting:1 profitability:1 research:1 3:1 asking:1 new:2 regulators:1 key:1 balance:1 could:1 months:1 drug:2 long-term:1 experimental:1 powerful:1 three:1 down:1 market:1 publication:1 would:1 transform:1 least:1 expected:1 until:2 ``:1 delayed:1 but:1 hopes:1 pilot:1 '':1 record:1 while:1 revenues:1 biotech:1 share:1 dash:1 fortunes:1 have:1 blockbuster:1 occur:1 information:1 trials:1 agency:1 any:1 1:1 which:1 stepped:1 stock:1 arrives:1 's:2 huge:1 after:1 stay:2 changing:1 data:2 billion:1 2003:1 chief:1 timers:1 worst:2
stock_JNJ r_up	says:1 help:1 cancer:1 some:1 purposes:1 '':2 drug:3 prostate-cancer:1 remove:1 objections:1 use:1 rather:1 had:1 long-acting:1 clinical:1 treatment:1 new:1 pill:1 supporting:1 ``:2 earlier:1 's:2 drugs:1 survival:1 men:1 tested:1 properly:1 using:1 injection:1 prostate:1 than:1 cycle:1 improved:1 could:1 daily:1 n't:2 trial:1 preventive:1
stock_JNJ r_down	150:1 right:1 help:1 deal:1 1.3:1 move:1 reduce:1 stroke:1 alternative:1 total:1 drinking:1 $:2 rejects:1 generic:1 rose:1 its:1 potential:1 treat:1 moderate:1 million:1 's:3 risk:1 advantage:1 may:2 acquire:2 took:1 fell:1 upfront:1 defibrillator:1 grow:1 women:1 billion:1 payments:1 maker:1
stock_JNJ r_up	says:1 cancer:1 testing:1 sex:1 high:1 have:2 before:1 25:1 $:1 spending:1 been:1 genetic:1 's:1 risk:1 insurer:1 may:2 rise:1 prostate:1 billion:1 developing:1 study:1 having:1 time:1 reduced:1 first:1
stock_JNJ r_up	advisory:1 unanimously:1 continue:1 federal:1 developed:1 companies:1 should:1 drugs:1 said:1 other:1 class:1 experimental:1 panel:1
stock_JNJ r_down	billion:1 resolve:1 prosecutors:1 $:1 proposed:1 allegations:1 roughly:1 rejected:1 1:1 uses:1 drug:1 unapproved:1 promoted:1 settlement:1 antipsychotic:1
stock_JNJ r_down	financial:1 questions:1 campaign:1 small-cap:1 some:1 ``:1 years:1 '':1 culture:1 likely:1 raises:1 prostate-cancer:1 hit:1 morning:1 bank:1 tells:1 bankruptcy:1 retirement:1 $:4 working:1 collect:1 merger:2 your:1 pressures:1 attack:1 concerns:1 device:3 screening:1 biggest:1 boom:2 twice:1 more:2 gives:1 outgoing:1 his:1 's:5 says:1 get:2 credence:1 company:1 million:2 here:2 analyst:3 letter:1 coming:1 services:1 news:1 medical:1 deepest:1 after:1 stands:1 acquisitions:1 valued:1 benefits:2 antismoking:1 scathing:1 banking:1 margin:1 study:1 industry:1 companies:1 up:1 value:1 unveils:1 deferred:2 compensation:2 pension:1 firestorm:1 making:1 view:1 corporate:1 think:1 mergers:1 us:1
stock_JNJ r_down	suggested:1 do:1 prove:1 industry:1 companies:1 two:1 discoveries:1 need:1 ruling:1 new:1 jolted:1 biotechnology:1 more:1 really:1 their:1 patents:1 out:1
stock_JNJ r_up	30:1 over:1 allegations:1 period:1 years:1 see:1 names:1 dozen:1 industries:1 $:1 22:1 pay:1 top:1 penalties:1 listing:1 new:1 has:1 agreed:1 more:1 's:2 million:1 includes:1 job:1 orthopedic:1 they:1 doctors:1 one:1 than:1 wide:1 like:1 countries:1 --:1 annual:1 range:1 settle:1 products:1 each:1 corporate:1 maker:1
stock_JNJ r_up	saying:1 retired:1 down:1 3.3:1 stepping:1 technology:1 its:1 ribbon:1 cut:1 $:1 two:1 few:1 other:1 board:2 long-time:1 announced:1 chairman:1 supercomputer:1 million:1 houses:1 join:1 center:1 directors:2 changes:1
stock_JNJ r_up	all:1 work:1 handle:1 forming:1 brand:1 global:1 joint:1 advertising:1 venture:1 consolidating:1
stock_JNJ r_down	million:1 acquire:1 's:1 $:1 business:1 offer:1 global:1 binding:1 cash:1 made:1 trauma:1 280:1
stock_JNJ r_down	drugs:1 patients:1 hepatitis:1 two:1 most:1 virus:1 small:1 studies:1
stock_JNJ r_down	month:3 report:1 businesses:1 helm:1 suffer:1 find:1 adding:1 pause:1 should:1 platform:2 stock-market:1 has:1 fines:1 ...:1 hit:1 risk:1 get:1 revelations:1 worst:3 accumulate:1 world:1 trade:1 day:2 --:1 drop:1 companies:1 fewer:1 morning:1 did:1 she:1 deal:1 doing:1 see:2 bare:1 calling:1 arm:1 its:1 new:4 jobs:3 business:1 wo:1 reported:1 protection:1 weaker-than-expected:1 search:1 last:1 taking:1 reports:1 social:2 first:2 question:1 private:2 networking:1 leverage:1 give:1 apps:2 long:1 their:4 much:1 way:1 expected:1 outweighs:1 door:1 company:1 landing:1 sharply:3 benefits:1 than:1 showed:1 n't:2 hoping:1 investors:2 soars:3 say:1 something:2 have:1 information:1 patent:1 media:1 government:1 indexes:1 role:1 take:1 which:1 largest:1 answer:1 gets:1 stock:2 week:1 's:8 users:2 track:1 spot:1 react:2 chance:2 lay:1 stocks:2 data:4 resell:1 lower:3 futures:3 reputation:1 consumer:1
stock_JNJ r_down	named:1 move:1 turned:1 down:1 disappointing:1 woman:1 close:1 run:1 its:1 succeeding:1 pharmaceutical:1 $:1 had:1 been:1 event:1 new:2 gets:1 sold:1 week:1 ranking:1 executive:2 's:5 some:1 company:2 after:1 highest:1 women:1 billion:1 10:1 bid:1 publicly:1 industry:1 well:1 pharma:1 leaving:1 chief:1 protected:1 she:1 comes:1
stock_JNJ r_down	own:1 investors:1 sales:1 controversial:1 close:1 naming:1 your:1 market:1 replacements:1 tomorrow:1 system:1 its:1 under:1 new:1 hope:1 higher:1 hip:1 modestly:1 run:1 may:1 most:1 orthopedic:1 improving:1 knee:1 bit:1 recent:1 quarter:1 reported:1 providing:1
stock_JNJ r_up	billion:1 ordered:1 $:3 1.2:3 pay:1 company:1 after:1 marketing:1 past:1 state:1 found:1 judge:1 jury:1 laws:1 's:2 violated:1 antipsychotic:1
stock_JNJ r_down	heavy:1 industrial:1 features:1 win:2 dose:1 reports:1 investor’s:1 recently:1 calendar:1 manufacturing:1 drivers:1 other:1 earnings:1 income:1 has:1 week:1 's:3 stocks’:1 persist:1 but:1 quest:2 stocks:3 data:1 desire:1 appeal:1 these:1 notes:1 well:1 yield:2 construction:1 activity:1 cooled:1
stock_JNJ r_up	over:1 global:1 ending:1 own:2 deadline:1 $:5 writes:1 production:2 treatment:1 2015:1 edging:1 agreed:1 dispute:1 real:2 good:1 rise:1 120:1 nearly:1 world:1 now:1 gloom:2 domain:1 says:1 economic:1 makers:1 capacity:2 decision:1 research:1 market:1 million:3 news:1 along:1 improve:1 cautious:2 last:1 starts:2 21:1 drug:1 products:1 experimental:1 outlook:1 industrial:1 cancer:1 one:1 rising:2 total:1 your:2 unit:1 passes:1 fee:1 additional:1 utilization:2 submit:1 until:1 more:1 firm:1 wounds:1 milestones:1 than:1 must:1 rights:1 up:1 future:1 called:1 have:1 estate:2 certain:1 0.2:1 0.7:1 want:1 rally:1 seen:3 if:1 court:1 patent:1 pay:2 40:1 application:1 9:1 a.m.:2 you:2 week:1 's:4 may:1 earlier:1 involving:1 letter:1 develop:1 stocks:2 billion:1 stents:1 prevention:1
stock_JNJ r_up	among:1 industrial:1 session:1 diminished:1 health-care:1 domestic:1 sales:1 trade:1 four:1 active:1 see:1 because:1 trading:1 beckons:1 signs:1 first-quarter:1 market:2 ground:1 blue:1 decline:1 stocks:1 actively:1 patent:1 housing:1 schedule:1 shares:1 improvement:1 companies:1 concerns:1 earnings:1 expected:1 flat:1 's:2 expirations:1 slight:1 big:1 company:1 watch:4 but:1 early:1 reported:1 offset:1 report:1 manufacturing:1 chips:1 day:1 gained:1 could:1 borrowing:1 drug:1 costs:1 mixed:1 output:1 corporate:1 constraints:1
stock_JNJ r_down	week:1 average:1 says:2 woes:2 people:1 feel:1 global:3 some:1 sales:1 community:1 evidence:1 jump:2 brands:1 13,000:1 finish:1 year:1 's:3 cold:1 research:1 quality:1 makers:1 market:1 relationships:1 replacements:1 ebb:2 no:1 generic:1 rose:1 make:1 rebounded:1 centers:1 young:1 next:1 increase:1 food:1 leap:1 concerns:1 health:1 earnings:1 above:1 between:1 new:1 you:1 local:1 until:1 more:1 hip:1 pushing:1 return:1 increased:1 may:3 under:1 further:1 pressure:1 orthopedic:1 link:1 debt:1 not:1 knee:1 picking:1 stocks:4 than:1 improve:1 14:1 challenge:1 device:1 companies:1 up:1 drug:1 maker:1 their:1 suggests:1 bad:1 appetite:1 tech:1 can:1 saw:1 popular:1 obesity:1 providing:1 its:2 options:1 first:1
stock_JNJ r_down	acquisitions:1 both:1 prospects:1 's:4 like:2 earners:1 questionable:1 us:1 morning:1 banking:1 merit:1 stable:1 biggest:1 news:1 sees:1 more:2 mergers:1 bankruptcy:1
stock_JNJ r_up	all:1 just:1 executive:1 resorts:1 go:1 hate:1 networks:1 had:2 only:3 planted:1 those:2 has:1 do:2 someone:1 doors:1 introduce:1 know:2 they:1 hands:1 not:1 --:1 companies:1 morning:1 bad:1 she:3 recommendations:1 security:1 some:1 back:2 've:4 even:1 regulator:1 away:1 critical:1 messenger:1 hacked:2 offline:2 told:1 shut:1 regulators:1 approval:1 panel:1 joke:1 drug:3 keep:1 ensure:1 experimental:1 software:1 secure:1 into:2 number:1 system:1 down:1 news:1 your:3 conference:1 networking:1 there:2 two:1 been:3 vendors:1 way:1 authorization:1 systems:2 ``:2 door:1 maintenance:1 company:1 rejected:1 compromised:1 present:1 whether:1 us:1 n't:2 sometimes:1 ...:1 eyes:1 '':2 good:1 experts:1 have:1 if:1 information:2 also:1 recommended:1 tactic:1 you:2 developers:1 worldwide:1 's:3 welcome:1 yesterday:1 chance:1 important:1 but:1 data:1 types:1 diabetes:1 building:1 realized:1 kept:1 later:1 chief:1 without:1 components:1 prying:1 corporate:1
stock_JNJ r_up	help:1 doing:1 win:1 sales:1 say:1 harness:1 through:1 tools:1 slow:1 media:1 been:1 seller:1 enough:1 build:1 new:1 has:1 cosmetics:1 them:1 smartphones:1 like:1 n't:1 customers:1 social:1 tablets:1
stock_JNJ r_up	being:1 executive:1 's:2 market:1 eye-health:1 said:1 over-the-counter:1 fixing:1 1:1 medicine:1 new:1 company:2 damaging:1 his:1 turning:1 business:1 drugs:1 stung:1 problems:1 recent:1 incoming:1 recall:1 devices:1 chief:1 following:1 recalls:1 toward:1 priority:1
stock_JNJ r_up	examining:1 previously:1 month:1 bribery:1 have:1 resigned:1 miss:1 no-hitter:1 group:1 had:1 expectations:1 been:1 earnings:1 department:1 analysts:1 's:4 becoming:1 earlier:1 component:1 possible:1 scrutiny:1 broke:1 president:1 worked:1 audit:1 prosecutors:1 vice:1 amid:1 up:1 morning:1 she:1 overseas:1 first:1
stock_JNJ r_up	dysfunction:1 first-quarter:1 would:1 against:1 rose:1 controls:1 sales:1 drug:2 approved:1 helped:1 erectile:1 cost:1 growth:1 earnings:1 offset:1 67:3 's:4 slower-than-expected:1 compete:1 maker:1 treat:1
stock_JNJ r_up	revenue:1 into:1 brought:1 its:1 if:1 said:1 22:3 generic:1 rose:1 boot:1 find:1 does:1 earnings:1 way:1 new:1 boost:1 higher:1 's:2 risk:1 get:1 drugs:1 becoming:1 reported:1 sharply:1 could:1 companies:1 drug:1 n't:1 admit:1 maker:1
stock_JNJ r_up	things:1 major:1 have:1 people:1 into:1 fall:1 influence:1 sales:1 competition:1 years:1 player:1 female:1 mile:1 election:1 picked:2 politics:1 's:2 they:1 grow:1 its:2 declined:1 feared:1 tumbled:1 turn:1 now:1 eye:1 missed:1 no:1 generic:1 much:1 top:1 revenue:1 generally:1 copies:1 rival:1 their:1 secret:1 interested:1 5:2 too:1 which:1 billionaires:2 stepped:1 stock:1 interests:1 product:1 executive:1 first-quarter:2 business:1 10:1 company:1 stature:1 keeping:1 recruiters:1 should:1 71:1 coming:2 stocks:3 ranks:1 senior:1 women:2 purchase:1 pipeline:1 worldwide:1 highlights:1 stabilize:1 indicates:1 19:1 amid:2 wealthiest:1 industry:1 up:2 drug:1 n't:1 profit:1 analysts:1 country:1 did:1 efforts:1 positions:1 investments:1 gain:1
stock_JNJ r_up	biotech:1 old:1 can:1 simple:1 some:1 results:1 '':1 manager:1 names:1 another:1 year:1 smart:1 80:1 moves:1 technology:1 delivered:1 investing:1 writes:1 since:1 almost:1 other:1 quarterly:1 has:1 announced:1 stock:3 ``:1 rise:1 's:3 high-dividend:1 loss:1 after:1 fund:1 not:3 stocks:1 appears:1 down:1 great:1 last:1 plunged:1 value:1 continue:1 high-yielding:2 pick:2 following:1 corporate:1 maker:2 medical-device:1
stock_JNJ r_down	acquisitions:1 's:1 morning:1 banking:1 biggest:1 news:1 more:1 mergers:1 bankruptcy:1
stock_JNJ r_up	all:1 one:1 showing:1 allies:1 its:1 adding:1 irony:1 it’s:1 late:1 too:1 interest:1 has:1 until:1 shows:1 independent:3 's:1 may:2 weakness:1 brand:1 but:1 stay:1 such:1 trying:1 capitalize:1 bid:1 companies:1 value:1 keep:2 realizes:1 time:1 usually:1 away:1 latest:1
stock_JNJ r_down	1.5:1 development:1 3.0:1 summer:3 companies:1 agreed:1 estimates:1 sales:1 quarters:1 included:1 drug:1 have:1 2.0:1 2.5:1 developer:1 said:1 20:1 $:3 share:1 eligible:1 bears:2 transfer:1 bearish:1 40:1 should:1 current:1 favor:1 treatment:1 income:1 units:1 survey:1 percentage:1 mid-teens:1 =:5 nice:2 worldwide:1 royalties:1 product:1 full:1 's:1 around:1 season:1 milder:1 million:3 upon:1 agreement:1 but:1 most:2 operating:1 basis:1 regulatory:1 based:1 payment:1 play:2 milestones:2 15:1 sectors:1 license:1 rights:3 receive:1 launch:1 list:1 up:2 premature:1 plus:1 analysts:2 time:1 mixed:1 retain:1 closing:1 per:1 agree:1
stock_JNJ r_down	restore:2 less:2 agreed:1 trade:3 session:6 slimmer:2 its:1 developer:1 whose:1 26:1 20:1 $:5 eligible:1 rose:4 treatment:1 premarket:1 worst-performing:2 wave:2 during:2 unique:1 loss:2 companies:4 worldwide:1 says:1 society:1 actively:4 trading:1 premature:1 first-quarter:2 index:1 said:1 jumped:2 away:1 shares:5 falling:1 full:1 recently:1 marketing:2 million:3 continuing:1 agreement:1 hours:1 regulatory:1 gained:1 milestones:2 service:2 license:1 launch:1 receive:1 shift:1 drug:1 amount:2 plus:1 retain:1 slightly:1 among:2 features:1 cancer:2 coupon:2 one:2 8.7:1 basis:1 transfer:1 quickly:2 clinical:1 development:1 expected:5 percentage:1 molecular:1 more:2 royalties:1 releases:1 offer:1 drugs:1 company:1 wake:1 runup:2 than:2 posted:2 11:1 15:1 target:1 rights:3 19:2 18:1 cells:1 up:2 value:2 closing:1 display:1 1.4:1 sales:3 have:1 40:1 which:1 online:2 units:1 mid-teens:1 week:1 product:1 added:1 's:5 after:2 upon:1 treatments:1 helping:2 most:1 significant:2 stocks:3 data:1 payment:1 recent:2 building:2 medical:1 spent:2 points:3 came:1 talk:1
stock_JNJ r_up	cancer:1 people:1 health-care:1 one-third:1 price:1 prostate-cancer:1 signs:1 further:1 surgery:1 its:1 before:1 n't:1 use:2 cut:1 group:1 cost-effectiveness:1 decision:1 six:1 yet:1 looking:1 memory:1 show:1 size:1 company:1 pill:1 do:1 earlier:1 's:8 reversed:1 men:1 tested:1 eliminated:1 prostate:2 approved:1 after:1 loss:1 publicly:1 showed:1 --:2 study:1 months:1 funded:1 drug:1 reduced:1 regulator:1 trial:1 patients:1 greatly:1 time:1 small:1 treated:1 tumors:1 first:1
stock_JNJ r_down	size:1 limited:1 before:1 six:1 associated:1 distributors:1 being:1 some:1 defect:1 one:1 packaging:1 tumors:1 have:2 surgery:1 pills:2 unit:1 dents:1 cancer:1 said:3 group:1 voluntary:1 consumers:1 wholesale:1 recalling:1 prostate:2 review:1 there:1 due:1 looking:1 adverse:1 only:1 potential:2 safety:1 treatment:1 lot:1 months:1 discovering:1 has:1 events:1 store:1 division:1 men:1 's:3 which:1 slight:1 one-third:1 54,000:3 after:1 use:1 number:1 units:1 were:1 recalled:1 nearly:1 internal:1 not:1 hole:1 packages:3 revealed:1 concerns:1 no:1 showed:1 level:1 tear:2 recall:2 could:1 shelves:1 eliminated:1 reduced:1 --:2 patients:1 greatly:1 contain:1 small:2 treated:1 study:1
stock_JNJ r_down	keeping:1 all:1 some:1 study:1 companies:1 cash:2 least:1 balances:1 60:3 their:2 according:1 nearly:1 holding:1 published:1 accounting:1 overseas:1 offshore:1 analysts:1
stock_JNJ r_up	1.5:1 companies:1 estimates:1 quarters:1 3.0:1 2.0:1 2.5:1 based:1 agency:1 anticlotting:1 per:1 current:1 recommended:1 income:1 =:5 's:2 share:1 operating:1 included:1 approval:1 expand:1 medical:1 list:1 drug:1 survey:1 analysts:2
stock_JNJ r_up	people:1 estimates:1 results:1 middle:1 signs:1 riskiest:1 its:1 best:1 psoriatic:1 conference:1 said:1 treat:1 affects:1 support:1 moderate:1 severe:1 symptoms:2 majority:1 clinical:1 colitis:1 which:2 new:1 include:1 stock:2 's:2 bargains:2 700,000:1 arthritis:2 ulcerative:1 expansion:1 released:1 uses:1 overbought:1 known:1 active:2 approved:2 condition:1 hiding:2 treating:1 2009:1 improved:1 assets:1 safest:1 medical:1 disease:1 drug:1 deals:1 trial:1 patients:1 hunts:1 rheumatoid:1 could:1 bond:2
stock_JNJ r_down	biotech:2 raised:1 via:1 useful:1 pledge:1 initiative:1 increasingly:1 over:1 out:1 share:1 anyway:1 crop:1 drive:1 capital:1 sought:1 see:1 rising:1 have:1 year:2 wider:1 research:1 find:1 help:1 adding:1 ultimately:1 develop:1 $:1 fight:1 generation:1 program:1 health:1 board:1 scientists:1 employee:1 new:5 has:1 issue:1 across:1 hope:1 more:1 development:1 million:1 's:3 pharmaceutical:1 drugs:1 funds:1 handful:1 bankers:1 but:1 soon:1 step:1 every:1 members:1 date:1 authorities:1 region:1 approval:1 clients:1 former:1 staring:1 balance:1 attempt:1 launch:1 --:1 markets:1 medicines:2 developing:1 companies:2 up:1 forced:1 so:1 information:1 costs:1 could:2 far:1 lives:1 drugmakers:2 its:1 taking:1 first:2
stock_JNJ r_up	heart:1 help:1 advisory:1 increasingly:1 blood-thinning:1 makers:1 drug:3 year:1 fight:1 find:1 narrowly:1 votes:1 group:1 federal:1 anticlotting:1 its:1 increase:1 attack:1 voted:1 international:1 more:1 's:2 risk:1 emergency:1 medicines:1 funds:1 use:2 lives:1 plan:1 new:1 develop:1 panel:2 attempt:1 launches:1 study:1 expanded:2 against:2 taking:1 every:1 finds:1 first:1
stock_JNJ r_up	soon:2 quarters:1 disabled:1 facilities:1 through:1 alternative:2 its:4 issues:1 25:1 based:1 22:1 also:1 explain:1 should:1 treatment:2 has:1 2010:1 take:1 division:2 means:1 online:1 possible:2 governance:1 vacuum:1 strategic:1 did:3 companies:2 morning:1 --:5 investigate:4 starting:1 security:1 respond:2 says:1 list:1 warns:1 some:1 back:1 related:5 likely:1 3.0:1 2.0:1 adequately:1 2.5:1 said:8 expert:1 nuclear:1 per:1 current:3 new:3 discovery:1 reporting:1 upon:1 operating:1 received:3 boards:1 larger:1 drug:2 sensitive:1 survey:1 analysts:2 vaginal:5 industrial:1 cleaner:1 one:1 complaints:5 addressed:1 long:1 unit:6 raise:1 opportunity:1 two:2 been:1 their:4 treat:4 statement:1 more:2 ``:1 complete:2 estimates:1 company:3 sophisticated:1 failure:1 properly:4 hopes:1 highest:1 than:2 supplemental:2 regimen:2 made:1 rejection:2 developing:2 submitted:2 pill:4 n't:3 evaluating:2 light:1 strategies:1 problem:1 piece:1 called:1 1.5:1 share:1 '':1 warning:1 forced:1 malware:1 agency:1 officers:1 pills:2 application:4 details:1 which:1 income:1 =:5 200:1 information:1 welcome:1 problems:1 virus:2 levels:1 reassess:1 letter:4 preliminary:2 included:1 weekend:1 response:2 refreshing:1 third:1 consumer:4 chief:1 part:2 organization:1 oral:2
stock_JNJ r_down	even:1 ``:2 record-low:1 could:1 fall:1 send:1 '':2 prices:1 yields:1 bull:1 further:1 says:1 higher:1 bond:1
stock_JNJ r_up	sector:1 summer:1 over:2 global:1 focus:1 trade:1 session:3 per:1 headlines:1 adding:1 20:1 $:2 lackluster:2 2.5:2 should:1 potential:1 split:1 game:2 quarters:1 continued:1 lost:1 --:1 companies:5 50:1 morning:1 separately:1 activity:1 worries:2 round:1 shed:1 says:1 list:1 some:1 funds:2 euro-zone:1 likely:1 actively:3 trading:2 3.0:1 2.2:1 2.0:1 declined:1 out:1 index:3 scale:1 remain:1 shares:3 current:2 3:1 volatile:1 numerous:1 recently:3 whose:2 conglomerate:1 operating:1 defensive:1 based:1 100:1 debt:1 nonfarm:1 last:1 76:1 31:1 losses:1 according:1 sank:1 survey:3 analysts:2 mixed:1 traded:2 slipped:1 into:1 number:1 one:2 down:2 62:1 downside:1 another:1 crisis:1 manufacturing:1 service:1 prove:1 three:1 their:1 expected:1 500:1 more:2 estimates:1 prospects:1 but:1 released:1 hopes:1 payrolls:1 than:3 11:1 wins:2 slack:1 official:1 up:2 value:1 while:1 growth:1 invest:1 could:2 risky:1 1.5:1 seven:1 catalysts:1 investors:1 best:1 health-care:1 share:2 slowing:1 have:1 take:1 any:1 48:1 rather:1 make:1 other:1 3.8:1 which:1 income:1 =:5 stock:1 week:1 conflicting:1 play:1 added:1 's:7 price:1 most:1 fell:3 included:1 stocks:2 data:2 amid:1 futures:3 perhaps:1 points:9 so:1 time:1 easing:1 overseas:1
stock_JNJ r_down	gained:1 index:1 13:1 's:1 lost:1 17:1 jumped:1 after:1 companies:1 shares:1 hours:1 points:2 trading:1 actively:1 closed:1 mixed:1 stocks:1
stock_JNJ r_up	among:1 deaths:1 being:1 within:1 them:1 years:1 surgical:2 including:1 aimed:1 reports:1 their:1 out:1 fire:1 use:1 wire:1 mud:1 electricity:1 trials:1 intense:1 few:1 participants:1 clinical:1 which:1 test:2 new:1 injury:1 thousands:1 more:1 200:1 product:1 relieve:1 interest:1 may:1 genes:1 but:1 analyzes:1 break:1 mesh:2 sales:1 than:1 women:1 several:1 products:1 resistant:1 numerous:1 tumors:1 early-stage:1 companies:1 disease:1 drug:2 courses:1 stopped:1 eager:1 stopping:1 simply:1 bond:1 challenge:1 attracting:1
stock_JNJ r_up	says:1 founder:1 house:1 global:2 ``:1 we:1 years:2 '':1 second:1 seats:1 sees:1 crisis:2 best:2 even:1 said:2 just:1 next:1 going:1 might:1 final:1 play:1 bonds:1 fund:1 complicated:1 not:1 president:1 hedge:1 10:2 --:1 high-yield:2 according:1 're:1 act:2 first:2
stock_JNJ r_up	health-care:1 dayside:1 slip:2 plans:1 giant:1 ads:1 ease:1 shares:4 charge:1 take:1 quarterly:1 effectiveness:1 build:1 company’s:1 evening:1 gains:3 after:3 hours:2 data:1 outlines:1 ahead:1 products:1
stock_JNJ r_down	trade:5 session:5 shares:5 headlines:1 its:10 based:1 $:5 only:1 board:2 401:3 has:2 his:2 bid:1 online:2 watch:2 employers:1 early:1 quarters:1 investor:2 condition:1 treating:1 list:1 yield:1 officer:4 companies:6 estimates:1 direct:1 seat:2 growth:2 3.0:1 2.0:1 investment:2 2.5:1 said:7 per:1 current:1 activist:2 international:2 newly:2 fractures:1 hours:4 operating:3 created:2 industry:2 experience:2 survey:1 analysts:2 shareholder:2 efforts:2 maker:5 lenses:2 control:3 named:2 family:2 instruments:2 one:2 down:1 device:2 your:4 size:2 management:2 nominee:2 21.3:1 area:2 support:2 system:1 their:1 2:1 interest:1 expected:5 appoint:2 offer:1 funds:2 company:4 he:2 largest:2 rival:1 require:1 work:1 up:2 devices:2 actively:5 can:1 were:4 k:3 region:2 1.4:2 1.5:1 choosing:1 investors:1 1.3:2 expanding:2 share:1 general:2 good:1 technology:2 dozen:1 sell:1 mutual:1 beyond:1 savings:1 take:3 income:1 you:1 =:5 's:9 plans:1 nest:1 after:4 resign:2 most:1 wrist:1 two:1 serious:1 included:1 president:4 billion:1 off:2 vice:2 egg:1 medical:4 investments:1 chief:4 contact:2 so:1 time:2 position:2 senior:2 corporate:1 spend:2 medical-device:1 joining:2
stock_JNJ r_up	all:3 19.7:5 deal:3 reduce:1 expects:3 competition:1 product:1 known:1 close:3 its:10 sell:4 said:4 $:7 21.3:2 proposed:1 system:4 injuries:1 intends:1 systems:1 fractures:3 treating:4 illegally:1 's:4 bid:5 after:3 line:1 wrist:3 rest:1 regulatory:3 along:1 condition:2 billion:5 received:3 would:1 charges:1 rival:2 require:3 resolving:1 these:1 acquisition:1 serious:3 clearance:3 maker:4 medical-device:4
stock_JNJ r_up	mandate:2 expects:4 trade:7 session:5 6.2:2 headlines:1 p.m.:1 its:12 partners:2 giant:1 cut:2 group:2 $:4 guidance:6 recommending:1 offers:2 premarket:2 enthusiasm:1 has:2 momentum:4 watch:2 early:1 boost:2 fallout:1 fall:4 buyout:1 years:1 name:1 follows:1 companies:5 banking:1 quarter:2 quicker:1 individual:1 trading:2 said:2 potential:1 decision:1 shares:7 research:2 looking:2 version:1 provider:2 new:2 firms:2 conditions:2 hours:2 operating:2 dividend:2 beginning:2 half:1 last:2 column:1 prior:4 a.m.:1 analysts:1 published:2 retail:2 changes:2 maker:1 first:1 upgraded:1 outlook:2 revenue:2 down:3 upgrades:2 market:2 her:1 top:2 three:1 growth:2 interest:1 time:1 expected:6 today:1 ``:2 company:4 corrected:1 corporate:1 biggest:4 focusing:1 attract:2 than:1 15:2 hike:1 value:2 actively:5 were:4 trio:1 investors:3 cited:1 sales:2 '':2 full-year:2 writes:1 fiscal-year:4 technology:2 end:2 pay:2 sales-growth:2 which:2 becoming:2 's:19 plans:2 may:1 firm’s:1 after:2 reflect:2 shareholder:2 device:1 law:1 segment:2 fiscal:2 lower:2 short:4 off:2 third:2 fallen:2 without:1 costs:1 healthcare:1 overseas:2 reward:2 consumer:2 profits:1 latest:2
stock_JNJ r_up	outlook:2 financial:1 revised:2 emerging:2 growth:2 optimism:1 year:1 return:2 its:4 market:2 steered:2 ratings:2 stocks:1 investing:2 make:1 negative:2 citing:2 outlooks:1 decade:1 stable:2 expected:2 new:2 markets:2 's:6 pharmaceutical:2 earlier:1 weak:1 77:2 performance:2 roller-coaster:1 strong:2 data:1 high-yield:3 work:1 eclipsed:1 reports:1 continue:1 products:4 strategies:1
stock_JNJ r_up	actively:1 index:1 's:1 increased:1 whose:1 rose:1 companies:1 up:1 shares:1 75:1 points:3 trading:1 21:1 were:1 recently:1 8:1 orthopedics:1 stocks:2 higher:1
stock_JNJ r_up	1.5:1 companies:1 estimates:1 quarters:1 3.0:1 2.0:1 investment:1 2.5:1 based:1 per:1 its:1 current:1 income:1 new:1 type:1 's:4 drugs:1 boosted:1 operating:1 included:1 buying:1 rights:1 =:5 list:1 disease:1 drug:1 survey:1 analysts:2 share:1 experimental:1
stock_JNJ r_up	health-care:1 find:2 out:1 court:1 defend:1 able:1 competitors:1 their:1 worth:1 movement:1 's:3 advantage:1 seeking:1 priced:1 popular:1 stocks:2 moat’:2 ‘wide:2 options:1 benefit:1 verdict:1 following:1 writes:1 profits:1
stock_JNJ r_down	1.5:2 billion:2 people:2 into:2 some:1 $:2 one:1 wrap:1 close:2 its:2 highest:1 antipsychotic:1 would:1 lawsuits:1 least:2 payment:2 state:1 investigation:1 largest:1 ever:1 capital:1 off-label:1 case:1 investigations:1 drugs:1 familiar:1 marketing:1 income:1 sums:1 appreciation:1 said:1 deliver:1 date:1 trying:1 sides:1 probes:2 settling:2 both:1 completing:1 according:1 together:1 matter:1 can:1 promotion:1 discussing:2 other:1 acquisition:1
stock_JNJ r_up	operations:2 rating:2 all:1 just:2 global:2 trade:3 session:3 find:1 cut:2 $:2 expectations:1 late:1 treatment:2 worth:2 broadly:1 possible:2 das:1 not:1 bis:1 did:2 die:1 companies:4 morning:1 securities:1 yields:1 tougher:2 actively:3 trading:1 best:1 said:2 broad:1 review:2 anticlotting:2 shares:4 its:3 looking:1 conditions:2 downgrades:1 handful:2 hours:1 downgrade:2 dividend:1 downgraded:2 search:1 created:1 drug:2 credit:2 pick:1 approve:2 three:1 für:1 use:2 leading:1 breed:1 two:2 expected:3 firm:2 but:1 part:2 known:2 line:1 than:2 paying:2 account:2 slack:1 notches:2 der:1 expanded:2 up:2 n't:2 patients:2 economic:2 were:2 3.2:2 problem:2 pack:1 heart:2 investors:1 payers:1 syndrome:2 sluggish:2 rather:2 equities:1 mit:1 higher:3 's:9 after:2 regulations:2 stocks:3 largely:1 traded:1 350:1 banks:2 notch:1 came:1
stock_JNJ r_down	few:2 1.5:1 2.5:1 thinner:2 heart-rhythm:2 quarters:1 being:2 developed:3 estimates:1 back:2 reviewed:2 stroke:2 set:2 per:1 3.0:1 seen:2 blocks:2 throughout:2 seek:2 market:3 blocked:3 information:5 2.0:1 based:1 atrial:2 rejects:1 support:2 anticlotting:1 months:2 least:3 current:1 application:3 clinical:3 treatment:2 multibillion-dollar:2 income:1 new:5 =:5 more:5 used:2 's:4 which:2 anti-clotting:3 share:1 but:2 regulators:2 operating:1 blood:2 included:1 approval:4 decision:2 now:1 data:3 potential:2 reaction:2 --:6 disorder:2 fibrillation:2 no:2 companies:3 list:1 drug:4 called:2 trial:2 patients:2 survey:1 analysts:2 further:2 stock:2 studies:2 having:2 prevention:2
stock_JNJ r_up	advisory:1 two-day:1 ceramic:1 implants:2 during:1 plastic:1 out:1 rose:1 there:1 discuss:1 concerns:1 safety:1 meeting:1 more:1 hip:1 selling:1 effects:1 half:1 such:1 than:1 panel:1 made:1 --:1 amid:1 metal:1 materials:1 side:1 first:1
stock_JNJ r_up	advisory:2 two-day:1 well:1 ceramic:1 implants:3 article:1 plastic:1 out:1 information:1 additional:1 would:1 needed:1 make:2 there:1 should:1 benefit:1 discuss:1 being:1 concerns:1 safety:1 systems:1 which:1 get:1 meeting:1 more:1 hip:2 them:1 warnings:1 recommendations:2 most:1 effects:1 such:1 than:1 types:1 panel:2 made:1 --:1 amid:1 metal:3 asked:1 n't:1 whether:1 patients:1 materials:1 those:1 published:1 other:1 side:1
stock_JNJ r_up	hit:1 ranking:1 right:1 's:5 takes:1 billing:1 give:1 top:1 annual:1 behind:1 reputation:1 survey:1 our:1 once:1 more:1
stock_JNJ r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_JNJ r_up	all:1 because:1 tablets:1 pills:1 unit:3 sell:1 needs:1 said:2 generic:2 submit:1 its:2 application:1 version:1 various:1 market:1 statement:1 new:1 strengths:1 product:1 's:1 regulatory:1 approval:2 copy:1 received:2 contraceptive:1 has:2 --:2 drug:1 recalling:1 vaginal:1 maker:1
stock_JNJ r_down	billion:1 said:1 end:1 $:1 people:1 thinking:1 familiar:1 could:1 private:1 early:1 go:1 2007:1 3.7:1 year:1 ready:1 's:1 eye-care:1 company:2 public:1 taken:1
stock_JNJ r_down	blue:1 least:1 boast:1 all-time:1 highs:1 number:1 shares:1 hitting:1 their:1 records:1 surpass:1 year:1 chips:1 decade:1 2012:1
stock_JNJ r_up	survey:1 1.5:1 named:3 futures:2 force:3 3.0:1 investors:2 per:1 list:1 executive:3 reduce:6 trade:1 edition:1 unit:2 actively:1 35:4 unveiled:3 filed:2 2.0:1 its:16 stock-index:2 size:3 current:1 said:2 based:1 lead:2 start:2 review:2 estimates:1 ministers:2 shares:1 priority:2 also:3 earnings:2 income:1 expected:1 new:5 has:2 markets:2 more:3 head:3 's:5 plans:3 business:3 season:2 company:3 await:2 commercial:3 specialty:3 drug:2 applications:2 operating:4 =:5 finance:2 included:1 president:3 euro-zone:2 than:3 supplemental:2 session:1 10:1 lower:2 designation:2 third:3 launch:2 meeting:2 work:3 companies:2 aims:3 chief:3 costs:3 quarters:1 analysts:2 following:2 2.5:1 share:1 2012:1
stock_JNJ r_up	control:1 sector:1 review:1 broader:1 anticlotting:1 into:1 number:1 competition:1 years:1 past:1 have:1 year:1 's:3 exclusivity:1 blockbuster:1 lower-priced:1 market:1 bolster:1 generic:1 granted:1 visit:1 struggles:1 been:1 makers:1 forms:1 their:1 state:1 raft:1 firms:1 clots:1 pipelines:1 deeper:1 cope:1 drugs:1 fast-track:1 nation:1 growing:1 deep:1 industrywide:1 regulatory:1 during:1 importance:1 vein:1 cliff:1 treating:1 loss:1 blood:1 coping:1 57:1 orbit:1 drug:3 deals:1 patent:1 patients:1 costs:1 small:1 entry:1 secretary:1 pulled:1 taking:1 comes:1 first:1
stock_JNJ r_up	control:1 sector:1 broader:1 number:1 competition:1 past:1 have:1 year:1 exclusivity:1 blockbuster:1 lower-priced:1 market:1 bolster:1 generic:1 struggles:1 been:1 makers:1 their:1 raft:1 firms:1 pipelines:1 cope:1 drugs:1 industrywide:1 during:1 cliff:1 loss:1 coping:1 drug:2 deals:1 patent:1 costs:1 entry:1
stock_JNJ r_down	conference:1 week:1 old:1 center:1 both:1 media:2 annual:1 challenges:1 likely:1 new:1 technology:1 lingering:1
stock_JNJ r_up	sector:1 major:1 financial:1 plethora:1 economic:1 signs:1 go:1 improvement:1 technology:1 housing:1 show:1 due:1 next:2 expected:3 public:1 week:2 season:1 handful:1 demand:1 strong:1 investor:1 especially:1 sectors:1 companies:1 up:1 reports:2 picks:1 players:1
stock_JNJ r_down	heavy:1 1.5:1 named:1 industrial:1 3.0:1 just:1 bell:1 list:1 estimates:1 soon:1 matter:1 quarters:1 report:1 accused:1 drug:1 have:1 fake:1 largest:1 2.0:1 2.5:1 before:1 planning:1 current:1 given:1 said:1 based:1 companies:1 their:1 initial:1 two:1 per:1 underlying:1 also:1 production:1 potentially:1 earnings:1 pursuing:1 new:1 firms:1 criminal:1 =:5 company:1 2012:3 selling:1 's:8 offering:1 get:1 may:1 share:1 slate:1 attention:1 treatments:1 paid:1 most:1 whether:1 know:1 address:1 prices:1 people:1 man:1 included:1 off:1 survey:1 versions:1 --:1 dangerous:1 could:1 device:1 guilty:1 income:1 reports:1 public:1 charges:1 're:2 products:1 analysts:2 familiar:1 operating:1 efforts:1 maker:1
stock_JNJ r_up	saying:1 they:1 seeing:2 adjusted:1 quarters:1 prices:2 including:2 legal:5 unfavorable:1 settlement:1 speed:1 its:3 anticipation:1 antipsychotic:1 surprises:2 segments:2 bell:1 expectations:4 than:1 orthopedic:2 advisories:2 quarterly:1 lawmakers:1 fatal:1 might:1 earnings:12 hit:1 risk:1 big:1 trading:1 watch:2 focus:2 early:1 inflation:1 background:2 report:1 bank:1 semiannual:1 loss:2 --:6 reduces:2 companies:1 leading:1 morning:2 settle:1 yields:1 recalls:1 economy:2 steam:1 view:1 dour:1 because:1 weight:1 higher:2 trend:1 medical-device:2 some:1 back:1 related:1 up:1 trends:5 growth:3 merits:1 exceeded:1 among:1 out:3 waiting:1 profit:4 disruptions:2 blue-chip:1 disease:1 contributed:2 comments:1 forecast:3 increase:1 state:1 investigation:1 health:1 new:3 conditions:1 sliding:1 shows:1 body:1 slight:2 marketing:1 conglomerate:5 reported:2 making:1 losing:1 news:2 questioning:1 beginning:2 declining:1 roundup:1 acquisition-related:4 toward:1 central:2 items:3 could:2 losses:1 days:1 reports:2 4th:5 products:1 testimony:1 discusses:1 maker:2 first:1 fourth-quarter:2 reversing:1 cancer:1 revenue:10 into:1 excess:1 2nd:2 down:2 chronic:1 decrease:1 names:1 narrowed:2 throughout:1 considering:1 decline:3 investors:1 analyst:1 come:1 negative:5 been:1 bump:1 reduction:1 address:1 assessment:1 fiscal:2 mired:1 stockpicker:1 season:1 offered:1 hurt:5 lowered:2 lows:1 year-over-year:2 hopes:1 improved:2 trying:1 active:1 second-quarter:4 has:1 all-time:1 foods:1 while:3 future:1 three:2 aid:1 2012:3 acquisition:1 shook:1 streak:1 heart:1 trio:1 impacts:3 ran:1 health-care:3 sales:1 expenses:4 weighed:3 currency:7 full-year:3 against:1 have:1 rally:1 recover:1 linked:1 string:1 forced:1 49:14 studying:1 consumer:3 other:5 speech:1 details:2 fourth:1 largest:2 company:2 stock:2 's:24 see:1 may:1 digesting:1 after:1 falls:2 fell:4 two:1 stocks:2 data:1 bleak:1 diabetes:1 acquisitions:3 lower:1 short:2 off:1 calls:1 charges:2 amid:4 bankers:1 chief:2 costs:6 came:1 corporate:2 profits:1 latest:3
stock_JNJ r_up	less:2 domestic:1 results:1 month:2 unfavorable:1 still:1 its:1 issues:1 rose:1 expectations:1 than:2 details:2 2012:2 rise:1 orthopedic:1 background:1 international:2 execution:1 pharmaceutical:1 loss:1 excluding:1 --:7 softness:2 replacement:1 says:2 weight:1 dealing:1 some:3 second:2 growth:1 year:2 knees:1 profit:2 comments:1 forecast:1 outside:1 new:3 exchange:1 reported:1 restructuring:1 weight-loss:3 offset:1 approval:2 drug:4 foreign:1 planned:2 pick:1 maker:1 comment:1 outlook:1 down:1 throughout:2 unit:1 decline:2 adjusted:1 2:3 rates:1 markets:2 health-care:1 company:6 but:3 reiterated:1 gain:1 second-quarter:2 posted:1 11:3 split:3 up:2 aims:1 while:1 weaker:1 certain:1 contribute:1 exceeded:1 sales:4 weighed:1 full-year:1 confirms:1 saw:1 cites:1 marking:2 end:1 4.8:1 hampered:1 other:1 earnings:5 higher:1 's:7 track:1 modest:1 4th:1 approved:2 off:1 charges:2 costs:2 medical-device:1 hips:1
stock_JNJ r_up	operations:1 saying:1 because:1 people:2 being:1 developed:1 hurts:1 ``:2 expects:1 reaches:1 years:1 '':2 held:1 growth:1 have:1 skin:1 terms:1 yet:1 unit:1 developer:1 one:1 said:2 patches:1 found:1 convenient:1 revenue:1 integration:1 least:1 wearable:1 spokesman:1 acquired:2 must:1 disclosed:1 lot:1 continued:1 before:1 has:3 active:1 take:1 available:2 11:1 product:1 health-care:1 's:4 option:1 than:1 offer:1 earnings:1 company:1 injections:1 potent:1 number:1 several:1 market:1 fell:1 recalled:1 designed:1 closely:1 meet:1 restructuring:1 now:1 multiple:1 second-quarter:1 diabetes:1 three-day:1 dosing:1 13:1 milestones:1 ingredient:1 charges:1 up:1 past:1 mask:1 spent:1 daily:1 patch:4 n't:3 insulin:5 beefing:1 small:1 become:1 overseas:1 more:1 its:1
stock_JNJ r_down	comment:1 week:1 raised:2 note:1 have:3 deal:1 saying:2 into:1 executive:1 some:2 covers:2 '':1 zero:1 through:1 raises:1 questions:3 year:1 2.2:3 federal:1 now:1 conference:1 n't:1 said:1 $:3 would:1 patent:3 much:1 respond:1 holds:2 bearish:1 practices:1 website:2 very:1 revenue:1 settle:1 call:1 which:2 newly:2 has:2 company:2 told:1 firm:1 billion:1 ``:1 analysts:1 's:7 investigations:1 may:2 marketing:1 sufficient:2 after:2 reached:1 fell:2 strong:1 not:2 article:2 stocks:2 approved:2 11:2 prospects:2 short:2 prosecutors:1 immediately:1 --:2 positions:4 drug:6 spokeswoman:1 did:1 protection:3 2020:1 predicted:1 weight-loss:2 published:2 including:2 maker:2 patents:2 8th:1
stock_JNJ r_down	all:2 money:1 years:2 four:2 bapineuzumab:4 including:2 still:2 find:2 impact:1 based:1 thinking:2 had:1 3:2 failed:2 potential:2 treatment:6 factor:1 has:3 local:1 anticipated:2 they:1 one:1 countries:1 --:3 list:1 underlying:2 promise:1 because:2 companies:1 testing:1 estimates:1 see:1 3.0:1 2.0:1 makers:2 2.5:1 shown:1 said:4 affects:2 since:2 per:1 its:6 current:3 state:1 international:1 continuing:2 operating:1 address:2 industry:1 drug:3 times:2 remains:1 survey:1 analysts:2 changes:2 options:2 first:4 major:1 highly:2 set:2 hurdle:1 market:2 millions:2 service:1 spending:2 three:4 least:4 their:4 vendors:1 much:1 complete:1 form:2 company:2 but:1 goals:2 n't:1 patients:2 ongoing:2 behavior:2 quarters:1 1.5:1 navigate:1 share:1 sales:1 proven:1 needs:1 unlikely:1 have:1 surge:1 any:1 huge:1 different:1 develop:2 other:3 complex:1 which:2 income:1 =:5 stock:1 's:14 reach:2 leukemia:2 regulations:2 significant:1 included:1 transfers:1 meaningful:1 effective:2 studies:4 disease:2 without:2 memories:2 late-stage:1
stock_JNJ r_down	all:1 high-risk:1 find:1 results:2 trade:2 four:1 session:2 including:1 its:6 whose:2 cut:1 $:1 22:1 thinking:1 guidance:1 28:1 29:1 failed:1 only:1 potential:1 somewhat:1 treatment:2 fourth:1 weakness:1 anticipated:1 gloomy:1 continued:3 loss:1 runs:1 lost:3 companies:5 large:1 bapineuzumab:3 activity:1 worries:1 quarter:1 heavy:1 shed:3 set:1 actively:5 trading:5 slumped:1 makers:1 index:3 said:5 pressured:1 memories:1 shares:5 forecast:1 3:1 closed:1 reading:1 recently:2 continuing:1 weak:1 hours:2 operating:1 address:1 manufacturing:1 104:1 losses:1 drug:2 trial:1 studies:2 other:1 experimental:1 late-stage:1 highly:1 millions:1 spending:1 underlying:1 their:3 genetic:1 clinical:1 memory:1 expected:2 upbeat:1 markets:1 form:1 lower:4 goals:1 sharply:2 7.1:1 12:1 17:1 enrollment:1 for-profit:1 n't:1 patients:2 ongoing:1 behavior:1 were:2 called:1 slowing:1 tide:1 pushed:1 partner:1 weaken:1 develop:1 also:1 points:9 stemming:1 which:2 stock:1 's:13 plans:1 after:2 reach:1 workforce:1 76:1 fell:3 eight:1 student:1 stocks:3 fiscal:1 peers:1 tracking:1 effective:1 downbeat:1 changes:1 futures:1 disease:1 without:1 costs:1 affects:1 weigh:1 first:2
stock_JNJ r_up	major:1 because:2 cost:1 investors:3 cuts:1 profit:1 sales:2 competition:1 years:1 past:1 via:1 optimism:1 further:1 return:1 margins:1 reprieve:1 enticing:1 both:1 stormy:1 few:1 patent:2 rose:1 top:1 breed:1 shares:1 looking:1 their:1 much:1 way:1 big:1 quarterly:1 new:1 has:1 markets:1 stock:1 ``:1 's:1 expirations:1 seeking:1 funds:1 company:1 took:1 expects:1 part:1 known:1 cleared:1 pharmaceutical:1 cliff:1 case:1 '':1 hits:1 cautious:1 off:1 industry:1 expanded:1 companies:1 drug:1 generic:1 growth:1 products:1 exchange-traded:1 were:1 fallen:1 profits:1
stock_JNJ r_up	comment:2 appeals:1 background:1 declines:4 tax:4 period:2 backs:2 helped:4 full-year:2 growth:1 handed:1 second-quarter:3 exceeded:2 throughout:1 year-earlier:4 its:2 declined:2 improperly:1 1:2 while:2 adds:1 antipsychotic:1 analyst:1 profit:4 lawsuit:1 5th:1 solid:1 had:1 exceeding:2 been:1 forecast:2 2nd-quarter:1 multi-year:1 state:1 earnings:5 fourth:1 details:1 stock:1 's:7 gains:2 dismissal:1 drugs:4 marketing:1 price:1 results:2 sales:3 acquisition-related:2 restructuring:1 fell:1 newer:2 offset:3 court:1 reiterated:2 beginning:1 expectations:4 legal:1 11:7 high:1 target:2 third:1 older:2 --:6 amid:2 notes:1 up:2 drug:5 charges:1 benefit:4 costs:2 analysts:2 2012:4 maker:4 victory:1
stock_JNJ r_down	1.5:1 based:1 adviser:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1 informed:1
stock_JNJ r_up	help:1 over:1 '':2 slots:1 fill:1 content:1 acting:1 experiment:1 health:1 out:1 website:1 ``:2 business:1 rolled:1 men:1 qualified:1 schools:1 picking:1 women:1 branded:1 lifestyle:1 recipes:1 well:1 products:1
stock_JNJ r_down	begun:1 cancer:2 supply:1 testing:1 one:1 talks:1 bribery:1 including:1 have:1 overhauling:1 wrap:1 its:1 expensive:1 use:1 additional:1 her:1 provide:1 trials:1 ovarian:1 clinical:1 turnaround:1 treatment:1 expected:1 new:1 take:1 probe:1 combination:1 pushing:1 job:1 years:1 whether:1 up:1 drug:2 improves:1 steps:1 team:1 first:1 experimental:1 executives:1
stock_JNJ r_up	into:1 some:1 states:1 say:1 including:1 reached:1 run-up:1 pause:1 antipsychotic:1 illegal:1 dud:1 hepatitis:1 rivals:2 boon:1 developers:1 might:1 principle:1 firm:1 good:2 investigations:1 may:2 marketing:1 after:1 agreement:1 but:1 380:1 said:1 news:2 settling:1 rival:1 drug:2 bad:2 practices:1 analysts:3 promotion:1
stock_JNJ r_down	1.5:1 list:1 estimates:1 primary:3 related:3 quarters:1 four:3 included:1 actively:1 3.2:1 per:1 3.0:1 2.0:1 its:3 2.5:1 index:1 said:3 based:1 21:1 22:1 generic:1 rose:2 shares:1 current:1 failed:3 clinical:3 treatment:3 closed:1 income:1 violations:1 =:5 law:1 higher:1 's:11 increased:1 drugs:1 share:1 after:4 possible:1 hours:1 operating:1 goals:3 they:3 investigating:1 improving:3 world:1 stocks:1 potential:3 advanced:3 manufacturer:1 off:3 largest:1 companies:2 trading:1 points:3 survey:1 analysts:2 meet:3 studies:3
stock_JNJ r_down	uneventful:1 pointing:1 global:1 allegations:1 trade:1 7.1:1 shocked:1 headlines:1 settlement:1 its:2 digest:1 faces:1 rundown:1 25:1 26:1 27:1 $:1 thinking:1 rose:5 had:1 failed:1 other:1 1,400:3 under:2 quarterly:1 potentially:1 has:1 gave:1 then:1 move:1 gains:3 prepaid:1 loss:1 dollar:1 watch:2 early:1 closely:1 therapy:1 tanks:2 not:1 during:1 he:1 aiming:1 continued:2 day:1 advanced:1 14.5:1 equities:1 wider-than-expected:1 antipsychotic:1 called:1 stimulus:1 drop:2 companies:4 --:1 slide:1 settle:1 works:1 towards:1 pressure:1 set:1 financial:1 people:1 51:1 testing:1 long-running:1 back:1 refusing:1 jump:1 3.7:1 second:1 actively:4 trading:7 out:1 even:1 index:5 said:2 sentiment:1 federal:1 jumped:3 while:1 shares:8 outside:1 investigation:1 stock-index:1 closed:1 1400:3 strategist:1 regain:1 we:1 recently:3 sinks:1 marketing:1 million:1 giant:1 update:1 hours:4 abandon:1 active:1 picking:1 strong:1 come:1 reports:1 hiding:1 session:1 reaction:1 prospects:1 subdued:1 last:1 76:1 could:1 months:2 against:1 34:1 trial:1 carrier:1 economic:1 act:1 climb:2 first:2 into:1 awaited:1 bribery:1 rising:1 likes:1 another:1 inquiries:1 open:1 100:1 market:2 bolster:1 derivatives:1 most:1 additional:1 prompting:2 three:2 been:1 their:1 clinical:1 treat:1 statement:1 cycle:1 markets:2 final:1 500:4 gained:1 ``:2 interest:1 drugs:1 took:1 immediate:1 wireless:1 prices:1 central:1 96:1 12:1 official:1 up:4 pace:1 calamity:1 growth:1 9.2:1 were:3 wild:1 probes:1 closing:1 minutes:1 central-bank:1 costly:1 investors:2 give:1 health-care:1 surpassing:1 dearth:1 '':2 way:1 drug:1 have:1 ready:1 watched:1 seem:1 relatively:1 huge:1 finalize:1 pay:1 government:1 topped:1 traders:1 practices:1 pivotal:1 earnings:1 gets:1 higher:3 week:1 added:3 's:9 transactions:1 may:1 after:5 utilities:1 director:1 banks:2 but:2 coming:1 'm:1 stocks:9 data:2 promotion:1 repeat:1 euro:1 rallied:1 takes:1 sectors:1 following:1 amid:1 futures:4 managing:1 points:12 shade:1 time:3 push:1 fresh:2 overseas:1 late-stage:1 corporate:1
stock_JNJ r_up	credible:1 3,000:1 '':1 likely:1 optimism:1 index:1 recovery:1 would:1 thinking:1 three:1 lifts:2 1,400:3 above:4 500:3 stock:2 ``:1 's:1 rise:3 stocks:1 closing:1 study:1 months:1 drug:1 continue:1 time:1 lacked:1 first:1
stock_JNJ r_down	because:1 financial:1 deal:1 underscores:1 high:1 brain:1 see:1 need:1 payoff:1 partners:1 does:1 between:1 new:1 week:1 's:4 scientific:1 treatments:1 but:1 understanding:1 failure:1 potential:1 search:1 ahead:1 medical:1 companies:1 disease:1 drug:2 n't:3 disorder:1 experimental:1
stock_JNJ r_down	1.5:1 investors:1 companies:1 estimates:1 quarters:1 3.0:1 headlines:1 2.0:1 2.5:1 rundown:1 based:1 per:1 current:1 interest:1 income:1 =:5 share:1 watch:2 early:1 operating:1 included:1 list:1 survey:1 analysts:2 corporate:1
stock_JNJ r_up	reveals:1 own:1 generation:1 investment:1 market:1 their:1 holdings:1 transfer:1 next:1 indicate:1 potential:1 write-offs:1 duties:1 stock:1 giants:1 's:1 may:1 clue:1 carrying:1 sheets:1 than:1 pickers:1 goodwill:1 companies:2 analysis:1 more:2 future:1 balance:1 consumer:1 reduced:1
stock_JNJ r_down	named:1 show:1 executive:1 begin:1 trade:1 '':1 active:1 see:1 session:1 legal:1 year:1 need:1 its:1 huge:1 stocks:1 eye:2 no:1 stayed:1 traders:2 new:1 has:1 leader:1 2013:1 stock:1 division:1 ``:1 selling:1 's:4 business:1 government:1 company:1 after:1 watch:2 diet:1 early:1 said:1 plan:1 prices:1 manufacturing:2 data:3 change:1 contraction:1 lower:3 last:1 target:1 could:1 futures:3 unmet:1 drug:1 edge:2 activity:1 action:1 consumer:1 medical:1 left:1
stock_JNJ r_down	treating:1 drinking:1 federal:1 warned:1 had:1 diet:1 've:1 drinks:1 their:1 survey:1 doctors:1 more:1 removed:1 children:2 shows:1
stock_JNJ r_down	1.5:1 another:2 list:1 probe:2 estimates:1 ``:1 trade:1 '':1 unit:2 session:1 trading:2 per:1 3.0:1 patient:2 2.0:1 2.5:1 synthetic:1 derivatives:1 said:2 based:1 triggered:2 trial:2 exec:2 treatment:2 shares:1 former:1 current:1 only:1 clinical:2 role:1 fifth:2 income:1 expected:1 survey:1 you:1 has:2 =:5 analysts:2 head:1 oil:2 's:4 business:1 get:1 far:1 share:1 million:2 operating:1 investigation:1 milestone:2 included:1 quarters:1 payment:2 $:2 lymphoma:2 especially:1 tapped:1 enrollment:2 board:1 companies:2 50:2 blunder:1 credit:1 actively:1 so:1 can:1 fiasco:1 comes:1
stock_JNJ r_up	saying:1 product:1 said:1 last:1 initiated:1 lots:1 recall:1 medical:1 month:1 fire:1 putty:1 bone:1 certain:1 catch:1 during:1 surgery:1 could:1 unit:1
stock_JNJ r_down	saying:1 over:1 trade:3 session:3 6.2:1 its:5 giant:2 $:2 guidance:4 expectations:2 premarket:1 get:1 during:1 month:1 furniture:2 companies:3 recall:1 become:1 quarter:4 bone:1 lifted:2 declines:2 second:2 cost:1 surgery:1 gross:2 said:1 actively:3 missed:2 profit:2 recorded:2 shares:3 current:2 led:2 revived:2 hours:1 putty:1 strong:2 last:1 could:1 drug:1 controversy:1 faces:1 already:1 revenue:6 retailer:2 housewares:2 unit:1 next:1 much:1 growth:2 expected:4 initiated:1 fire:1 offered:2 but:1 lowered:2 catch:1 second-quarter:2 10:2 18:2 computer:2 margin:2 slid:2 weaker:2 certain:1 sales:2 full-year:2 blockbuster:1 sell:1 also:2 earnings:2 company:3 week:1 4.5:1 product:1 's:11 may:1 after:1 fell:2 segment:2 fiscal:4 downbeat:2 medical:1 lots:1 clearance:1 consumer:2
stock_JNJ r_up	closely:1 setback:2 mild:3 signs:4 battle:2 its:3 slow:2 misses:2 failed:6 concerns:1 questioned:1 custom:1 rules:1 overall:3 anticipated:3 updates:1 background:1 discuss:2 condition:2 pooled:5 cognitive:6 --:7 benefit:3 steps:2 either:3 each:4 set:3 says:2 significantly:2 some:1 said:4 missed:1 expert:1 comments:1 3:3 moderate:1 business:1 regulators:2 although:3 beginning:2 both:3 industry:2 against:2 suggests:2 products:1 analysts:1 positive:1 studies:9 experimental:2 executives:1 raised:1 key:1 primary:2 highly:3 throughout:1 decline:4 additional:1 would:1 recalling:1 meaningful:1 5th:1 two:9 next:2 clinical:3 treatment:4 ``:1 efficacy:2 reaction:1 company:2 but:3 goals:6 cases:3 than:1 showed:4 whether:1 work:1 patients:6 more:1 slowing:4 '':1 drug:8 watched:1 saw:1 marking:2 provide:1 trials:3 agency:1 field:1 potential:3 details:1 fourth:1 units:1 orthopedic-device:1 stock:1 's:25 though:1 price:1 after:1 reach:3 running:1 levels:1 significant:1 such:1 data:5 disease:9 late-stage:2 latest:2
stock_JNJ r_down	1.5:1 companies:1 estimates:1 quarters:1 '':1 3.0:1 2.0:1 2.5:1 story:2 based:1 $:1 per:1 current:1 income:1 =:5 ``:1 's:1 share:1 operating:1 included:1 10:1 name:1 list:1 survey:1 analysts:2 published:1 first:1
stock_JNJ r_up	dour:1 1.1:1 slipped:2 unchanged:1 four:1 ended:1 3.4:1 actively:2 trading:2 growing:1 stream:1 headlines:1 technology:1 its:1 unit:1 relatively:1 rundown:1 index:2 confidence:1 said:1 investors:1 22:1 rose:1 housing:1 shares:2 royalty:1 closed:2 upbeat:1 reading:1 's:2 interest:1 mostly:1 10:2 company:1 after:2 watch:2 specialty:1 new:1 hours:2 mixed:1 fell:1 offset:1 prices:1 stocks:2 pharmaceutical:1 advanced:1 $:2 delivery:1 early:1 lower:1 has:1 lost:1 rights:1 33:1 corporate:1 companies:2 drug:1 points:5 report:1 providing:1 consumer:1
stock_JNJ r_down	1.4:1 advisory:2 shed:1 have:2 slipped:1 saying:1 1.8:1 actively:1 trading:2 another:2 's:7 its:2 unit:2 index:1 cancer:2 said:2 21:1 would:1 federal:2 granted:2 benefit:1 shares:1 priority:2 application:2 treatment:3 chemotherapy:2 status:2 product:1 recently:1 combination:2 men:2 use:2 backed:2 stocks:1 prostate:2 panel:2 lower:1 lost:1 --:1 many:1 companies:1 disease:2 drug:4 n't:2 patients:3 points:3 were:1 slightly:1 review:2
stock_JNJ r_down	exclusive:1 medication:2 1.1:1 cancer:1 global:1 allegations:2 related:2 up:3 states:2 multiple:1 its:3 unit:2 bankruptcy:1 said:1 develop:1 $:9 pay:2 granted:1 treatment:1 biggest:1 has:1 worth:1 more:1 billion:1 's:3 form:1 marketing:2 company:1 million:2 news:1 antipsychotic:2 acquisitions:1 prescription:2 license:1 could:1 36:6 deal:1 morning:1 banking:1 settle:2 bone:1 found:1 myeloma:1 mergers:1
stock_JNJ r_up	lessons:2 but:1 pharma:1 investors:1 may:1 study:1 some:1 diet:1 offers:1 fizzled:1 have:1 new:1 skinny:2 stocks:1 monkeys:2 insights:1
stock_JNJ r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_JNJ r_up	status:2 some:1 sign:1 planning:1 its:2 unit:2 before:1 combination:2 review:2 recruiting:1 priority:2 their:1 outside:1 other:2 treatment:2 has:1 ever:1 therapies:2 firm:1 used:2 's:4 degree:1 tuberculosis:2 than:1 received:2 companies:1 succession:1 fallen:1
stock_JNJ r_up	1.5:1 caused:2 agreed:2 estimates:1 quarters:1 growth:2 3.0:1 settlement:2 its:2 2.5:1 use:2 2.0:1 based:1 antipsychotic:2 claiming:2 per:1 current:1 list:1 income:1 =:5 's:2 share:1 operating:1 breast:2 included:1 lawsuit:2 boy:2 --:1 companies:1 drug:2 survey:1 analysts:2 last-minute:2
stock_JNJ r_up	shed:1 help:1 appeared:2 testing:2 some:3 have:2 further:1 11th:1 still:1 debate:1 subject:1 provide:2 beginning:1 had:1 benefit:2 research:2 targets:2 clinical:2 meaningful:2 's:9 any:2 effect:3 but:3 its:2 data:1 reaction:1 --:3 light:1 could:1 disease:2 drug:3 n't:3 did:3 patients:3 officer:1 release:1 similar:1 experimental:2
stock_JNJ r_down	people:1 moved:1 life-sciences:1 its:2 health:1 stable:1 brand:1 2012:1 firm:1 shopping:1 valuations:1 familiar:1 dental:1 part:1 half:1 brands:1 law:1 effort:1 according:2 matter:1 survey:1 upward:1 consumer:1 first:1
stock_JNJ r_up	named:2 division:2 executive:4 years:2 held:2 committee:2 skin:1 's:2 its:4 terminated:1 group:2 since:2 two:1 member:2 chief:2 clinical:1 role:2 chairman:2 white:1 has:4 2010:2 worldwide:2 care:2 experienced:1 appointment:2 after:3 five:2 blood:1 based:2 president:4 diabetes:2 effective:2 cells:1 spent:2 drug:1 trial:1 patients:1 1:2 she:4 2005:2 serious:1 drops:1 disorder:1 experimental:1 joining:2
stock_JNJ r_down	all:1 unemployment:1 over:1 ninth:2 years:1 bring:1 through:1 doesn’t:1 its:3 24:2 now:1 $:1 it’s:1 going:1 policy:1 has:1 unveiling:1 mortgage-backed:1 background:2 month:1 like:1 name:2 --:8 '':1 doubled:1 securities:1 addicted:2 become:2 went:1 round:1 spins:2 bond:1 partying:1 see:1 said:1 health:2 resilient:1 new:1 conference:1 jobs:2 business:2 monetary:1 news:1 strong:1 sending:1 central:1 comes:2 first:2 comment:2 commitment:1 replace:2 down:2 long:1 throughout:2 market:1 bolster:1 little:2 takes:1 least:2 euphoria:1 trigger:1 rates:1 low:1 more:3 ``:1 buy:1 asset:1 insurer:2 but:3 effort:1 buying:1 fades:1 10:3 grocery:2 these:1 work:1 likely:1 remain:1 wild:1 unusually:1 health-care:2 high:1 want:1 if:1 fixing:1 40:1 fourth:2 economy:1 may:1 after:1 most:1 plan:1 stocks:4 eighth:2 billion:1 off:2 assets:1 2007:1 once:1 pulled:1 latest:1
stock_JNJ r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_JNJ r_up	among:1 round-up:1 prevent:1 over:1 stroke:1 analysis:1 have:1 news:1 surgery:1 debate:1 best:1 $:2 treatment:1 therapies:1 physicians:1 around:1 artery:2 venture-capital:1 neck:1 whether:1 many:1 taking:1 drug:1 stents:1 patients:1 place:1
stock_JNJ r_up	caused:1 share:2 2nd:4 second:2 year:2 led:2 estimated:2 giant:2 compared:2 jumped:2 since:1 1:1 reduction:1 500:1 stock:3 count:2 's:2 nearly:2 fall:1 second-quarter:1 buybacks:3 third:2 companies:2 according:1 surge:1 2007:1 quarter:5 first:4
stock_JNJ r_up	sees:1 cited:1 setback:1 month:1 unlikely:1 approval:1 tough:2 throughout:1 continent:1 cites:1 declined:1 sell:1 delay:1 said:1 would:1 decision:1 there:1 comments:1 next:1 environment:2 details:1 recommend:1 treatment:1 's:1 marketing:1 company:1 long:1 diet:2 delayed:1 races:1 regulatory:2 president:2 approved:1 10:1 getting:1 --:3 drug:3 regulator:1 slide:1 obesity:1 its:1
stock_JNJ r_down	1.5:1 ad:1 list:1 estimates:1 quarters:1 course:1 3.0:1 home:1 2.0:1 2.5:1 city:1 based:1 per:1 current:1 location:1 income:1 firms:1 =:5 advertising:1 's:1 share:1 preferred:1 high-tech:1 operating:1 included:1 many:1 industry:1 companies:1 survey:1 analysts:2 growing:1
stock_JNJ r_up	likes:1
stock_JNJ r_up	all:1 executive:1 years:2 front:1 fear:2 suffer:1 its:2 based:1 it’s:1 credited:1 late:2 only:2 potentially:1 save:1 then:4 his:3 boon:1 very:2 not:3 quarters:1 presidential:1 lost:1 list:1 served:2 quarter:1 because:1 pledge:1 companies:1 long-running:1 election:1 3.0:1 year:1 our:2 2.0:1 87:6 2.5:1 out:2 said:2 while:1 per:1 children:2 current:1 passion:2 market:1 international:2 leader:2 operating:1 others:1 perilous:1 search:1 country:2 37:2 survey:1 analysts:2 comes:2 first:2 named:1 benefited:2 saving:1 civic:2 commitment:2 whatever:1 unit:1 takes:1 working:2 1989:2 anyone:1 orthopedics:1 don’t:2 statement:2 until:2 ``:4 families:2 way:2 funds:2 but:2 fund:1 lift:2 he:2 sectors:1 up:2 estimates:1 can:3 1.5:1 investors:2 give:2 defined:2 certain:1 share:1 head:1 '':4 mutual:1 role:2 chairman:2 which:2 income:1 =:5 corporate:2 stock:2 product:2 after:1 director:2 included:1 president:3 died:2 third:1 maybe:1 age:2 well:2 spent:2 chief:1 responsibility:2 time:1 starting:2
stock_JNJ r_down	do:3 little:2 giant:1 led:1 study:1 results:3 drug:4 1980s:1 chief:1 fortunes:1 much:1 lift:1 shares:2 during:1 age:1 company:1 87:3 died:1 don’t:1
stock_JNJ r_up	breakthrough:1 's:2 writes:1 innovative:1 but:1 its:1 n't:2 sleep:1 aid:1 new:1 has:1 hardly:1 touted:1
stock_JNJ r_up	non-executive:1 ambassador:1 's:2 willingness:1 notable:1 father:1 there:1 companies:1 one:1 leads:1 thing:1 other:1 chairman:1 big:1 new:1 bet:1 he:1
stock_JNJ r_down	1.5:1 3.0:1 cancer:2 supply:2 process:2 companies:1 estimates:1 one:1 included:1 slowed:1 another:1 signs:1 2.0:1 2.5:1 short-term:2 based:1 would:2 provide:2 positive:1 fix:2 per:1 current:1 treatment:1 memory:1 new:3 has:1 =:5 's:3 share:1 income:1 operating:1 regulatory:2 approval:2 manufacturing:2 data:1 applied:2 loss:1 showed:2 study:1 list:1 drug:3 trial:1 patients:1 survey:1 analysts:2 shortage:2 quarters:1 experimental:1
stock_JNJ r_down	control:2 major:2 telecoms:1 investors:1 over:1 sales:2 years:1 high:1 likely:2 diverse:1 including:2 shares:1 swinging:1 dividend:1 15:1 exclusivity:2 blockbuster:2 makers:2 market:4 3rd:4 watching:2 anniversary:1 been:1 downgraded:1 signals:2 favor:1 attractive:1 has:1 shows:1 stock:1 3.6:1 's:2 cope:2 drugs:4 yield:1 utilities:1 newer:2 longer-term:1 continued:2 former:2 recent:2 wide:1 pipeline:1 last:1 third:2 --:2 should:1 losses:2 companies:3 remain:1 drug:3 record:1 range:1 costs:2 strategies:2 efforts:4 quarter:2 view:1
stock_JNJ r_down	complaint:1 has:1 group:1 investors:1 rights:1 institutional:1 voting:1 address:1 had:1 calling:1 tech:1 likes:1 exchanges:1 bumpy:1 stock:1 recent:1
stock_JNJ r_up	financial:2 one:2 offerings:2 trading:2 year:2 should:2 technology:2 its:2 market:2 no:2 initial:2 had:2 next:4 start:2 which:2 big:2 expected:2 weeks:2 public:2 week:6 season:2 showing:2 completely:2 off:2 busiest:2 drop:2 companies:2 up:2 heats:2
stock_JNJ r_up	restore:1 help:1 developed:3 milestone:2 expects:1 hopes:1 hepatitis:5 fifth:2 based:2 $:7 late:2 production:1 choose:1 2015:1 has:3 remaining:1 earnings:1 eventually:1 results:3 therapy:1 updates:1 decide:2 new:4 report:2 2:1 --:3 50:6 20th:1 exceed:1 product:1 said:3 near:1 comments:1 access:1 assuming:1 supplies:1 newly:1 patient:2 million:2 reported:1 regulators:1 stage:2 suggested:1 transition:1 influential:1 could:1 larger:2 drug:4 guide:2 trial:7 survey:1 studies:1 experimental:5 late-stage:3 industrial:1 cancer:1 into:2 another:2 unit:2 positive:2 three:3 clinical:8 selling:1 releases:1 drugs:5 brings:1 company:4 prices:1 analyst:1 regimen:6 enrollment:2 patients:3 future:1 taking:2 annual:1 give:1 sales:1 helped:2 reports:2 triggered:2 trials:2 also:2 details:1 fourth:1 stock:1 begin:1 's:1 most:3 virus:3 data:2 payment:2 billion:1 light:1 green:1 components:1
stock_JNJ r_up	all:1 global:1 results:9 month:2 four:2 research:4 quarterly:2 worth:1 worse:2 far:1 rise:7 gloomy:1 worst:1 updates:1 continued:1 --:8 sluggish:1 notes:1 companies:7 speculation:1 says:1 estimates:1 past:1 second:1 investment:1 blue:1 index:5 adds:1 ever:2 full:3 conglomerate:3 reported:4 others:2 100:1 strong:2 37:1 reports:6 credit:2 analysts:2 pick:1 action:1 maker:4 private:1 market:2 prove:1 remains:2 positive:1 one-day:1 third-quarter:10 next:2 few:1 noting:1 markets:1 today:1 more:3 ``:4 formally:1 hurt:2 sharply:1 95:1 rebounding:1 history:1 isn’t:1 wane:1 0.1:3 0.3:2 0.2:1 0.5:2 0.4:1 0.7:1 0.6:2 bolstered:1 end:1 sit:1 provide:1 feature:1 1:1 earnings:23 stock:5 may:4 overall:1 await:1 spot:1 fueled:4 coming:1 such:1 data:3 grow:1 purchase:4 sectors:1 amid:4 futures:4 chief:2 so:1 over:2 6.5:2 including:2 cuts:1 still:1 its:5 scoring:1 expectations:2 better:2 production:1 fade:1 weeks:1 main:1 edging:1 2012:2 modestly:1 combination:1 views:1 not:1 now:1 day:2 bank:1 drop:1 each:1 quarter:3 lofty:1 stalling:1 financial:3 trading:1 expect:2 year:3 substantially:1 event:1 out:1 bullish:1 profit:8 blue-chip:5 since:7 projected:1 mere:1 bailout:1 health:1 navigating:1 strategist:1 after:3 acquisition-related:3 beginning:1 care:1 advance:1 could:1 7:1 thing:1 first:5 major:1 industrial:2 revenue:1 number:1 impossible:1 utilization:1 5th:1 their:3 percentage:1 garner:1 season:1 completed:3 today’s:1 sentiment:1 released:1 than:1 13:2 deluge:1 17:1 19:1 likely:2 stall:1 were:1 acquisition:4 browser:1 1.4:1 sees:2 investors:3 pessimism:1 unlikely:2 have:2 seen:4 able:1 retail-sales:1 also:1 take:1 though:1 price:3 especially:1 mobile:1 corporate:1 later:1 request:1 points:1 consumer:2 gold:1 one-off:1 7.3:13 bright:1 businesses:2 feat:1 line:2 giant:1 writes:1 only:1 crimp:1 posted:1 giants:1 get:3 watch:2 nearly:1 reversal:1 report:2 during:1 chips:1 taxes:1 release:1 through:1 thanks:1 housing-market:1 relative:1 financials:1 closer:1 capacity:1 forecast:1 behind:1 closed:1 wo:2 a.m:1 attention:1 weak:1 clues:1 franchise:1 news:1 last:1 according:1 a.m.:1 among:1 point:1 appeared:1 period:1 throughout:2 considers:1 decline:2 industrials:1 decent:1 selloff:1 three:1 been:4 quickly:1 much:2 expected:1 upbeat:1 500:3 offered:2 lift:3 these:1 cash:1 n't:3 while:2 aid:1 19.7:3 health-care:5 dubious:1 parse:1 tenor:1 technology:1 pruning:1 if:1 one-quarter:1 potentially:1 units:1 higher:5 week:3 independent:1 chain-store:1 boosted:1 reporting:2 yesterday:2 forecasts:1 viewing:1 recent:5 lower:1 off:1 charges:3 well:2 costs:4 components:2 bounced:1 docket:1 just:2 being:1 quarters:2 topped:1 seats:1 41:1 weekly:1 $:5 rose:1 seems:1 board:1 has:3 momentum:1 rebound:1 suffering:1 five:2 background:1 consensus:1 yields:1 officer:1 output:1 parade:1 deal:3 some:2 back:1 eyeing:1 hair:1 streaming:1 economic:1 ignore:1 exceeding:1 comments:1 exit:2 bellwethers:1 core:1 earlier:1 roundup:1 rallying:1 boards:1 surge:2 mixed:1 slightly:1 outlook:1 own:1 due:1 down:2 rising:2 raises:1 your:1 leaks:1 spending:1 housing:1 long:1 start:1 9.9:1 biggest:3 billion:3 becoming:1 but:2 gain:3 225:1 analyst:1 he:1 up:13 growth:6 cautiously:1 certain:1 sales:5 slowing:1 '':4 full-year:1 rally:1 no:1 40:2 slew:1 other:1 details:1 's:14 mulling:1 fell:5 coverage:1 stocks:1 ago:2 lukewarm:1 directors:1 medical-device:4 2005:1 push:1 lineup:1 starting:1 profits:1
stock_JNJ r_up	limited:2 rating:1 offensive:1 over:2 expects:1 quarters:1 including:1 saying:1 its:4 seemed:1 style:1 surprises:2 fix:1 had:1 add:1 production:1 candidates:1 policy:1 troubled:1 2011:1 gave:1 them:1 his:1 hit:1 get:1 auto:1 continues:1 words:1 hands:1 hall:1 --:1 notes:1 generally:1 companies:2 identified:1 taxes:1 consensus:1 progress:1 night:1 went:1 stock:1 says:2 suspended:1 energy:1 creation:1 some:1 economic:1 trading:1 reaffirmed:1 close:2 closer:1 said:1 literally:1 shares:1 debate:1 bailout:1 health:1 closed:1 got:1 bellwethers:1 job:1 opposition:1 contamination:1 put:1 manufacturing:4 manufacturer:1 resumed:2 last:1 could:1 contract:1 times:1 makes:1 facility:1 appeared:1 number:1 one:1 another:1 financial:1 unit:1 debt:1 positive:1 top:1 two:1 start:1 advisories:2 statement:1 markets:1 roundup:1 formally:1 company:1 released:1 multi-month:1 trying:1 raising:1 he:1 town:1 has:1 future:1 were:1 aid:1 site:1 good:1 drug:1 views:1 upgrading:1 1:1 earnings:2 strong:1 higher:2 plant:3 added:1 's:5 highs:1 after:2 problems:1 helping:1 allowing:1 authorities:1 data:1 posted:1 lines:2 face:2 reports:1 corporate:1 attacking:1 latest:1
stock_JNJ r_up	sector:1 over:1 according:1 past:1 lung:1 buoyed:1 index:1 housing:1 threatening:1 shares:1 going:1 decade:1 new:1 earnings:1 though:1 released:1 weighed:1 tuberculosis:1 progress:1 report:2 data:1 disappointing:1 made:1 countries:1 many:1 largely:1 disease:1 against:1 blue-chip:1
stock_JNJ r_down	managers:1 challenging:1 sales:1 another:1 summary:1 its:1 heart-rhythm:1 wealth:1 stent:1 conditions:1 core:1 's:2 company:1 continues:1 reported:1 coverage:1 declining:1 loss:1 markets:1 daily:1 face:1 quarter:1 medical-device:1 latest:1
stock_JNJ r_down	low-priced:1 deal:3 increasingly:1 over:1 700:3 competition:1 2nd:1 buy:1 have:1 fees:1 seen:1 market:1 developer:2 generous:1 said:1 $:3 million:1 ingredient:1 had:1 legal:1 also:1 other:1 potentially:1 treatment:2 fourth:1 which:1 details:1 widespread:1 branded:1 agreed:1 deficit:1 gives:1 acquire:2 recently:1 plans:1 drugs:2 big:1 sparked:1 but:1 includes:1 valued:1 entry:1 active:1 objections:1 beginning:1 approved:1 raising:1 generics:1 quarter:1 success:1 liquid:3 --:3 into:1 clients:1 revolt:1 up:1 drug:2 face:1 recession:1 attention:1 found:1 closing:1 bills:1 disorder:2 first:1
stock_JNJ r_up	times:1 contaminated:1 batches:1 flying:1 stops:1 vaccines:1 flights:1 connecting:1 health:1 's:1 after:1 immediate:1 possibly:1 they:1 both:1 longer:1 ahead:1 flu:2 face:1 regulator:1 shots:1 were:1 ban:1 found:1
stock_JNJ r_down	shed:2 pose:2 point:1 1.8:1 all:1 one:1 surgical:2 session:1 trading:2 's:3 risk:2 index:2 potential:2 due:2 shares:2 accessories:2 points:5 safety:2 treatment:2 closed:1 expected:1 has:2 more:2 flat:2 used:2 edged:2 which:1 3:1 reporting:1 results:1 quarterly:1 recalled:2 nearly:1 trade:1 2:1 stocks:2 procedures:2 than:2 gained:1 malfunctions:2 lower:1 lost:1 companies:2 up:2 devices:2 7:1 recently:1 actively:2 3.5:1 were:1 serious:2 slightly:1
stock_JNJ r_up	weaker:1 says:1 just:1 revenue:1 doing:1 alongside:1 into:1 executive:1 sales:1 high:1 tier:1 growth:1 vendor:1 81:1 its:3 cut:2 productivity:1 profit:1 top:1 third-quarter:1 also:1 cosmetics:1 new:1 suffered:1 boost:1 across:1 move:1 's:3 business:2 stanch:1 tries:1 fell:1 ambition:1 known:1 dividend:1 you:1 he:2 globally:1 school:2 made:1 anything:1 schools:1 reignite:1 clear:1 flow:1 aim:1 recently:1 costs:1 learn:1 vault:1 turnover:1
stock_JNJ r_down	raised:1 sales:1 catalysts:1 disappointing:1 growth:1 hepatitis:1 price:1 its:2 long:1 start:1 much:1 third-quarter:1 shares:1 few:1 concerns:1 falling:1 markets:1 fibrosis:1 stock:1 's:2 roster:1 drugs:1 company:1 after:1 treatments:1 offers:1 fell:1 key:1 those:1 jump:1 prospects:1 17:1 cystic:1
stock_JNJ r_down	trade:2 session:2 shares:2 portfolio:1 24:1 based:1 $:3 rose:3 improvement:1 gains:1 far:1 quarters:1 presidential:2 real-estate:1 list:1 race:1 after-hours:1 2.25:1 declared:1 companies:3 estimates:1 challenger:1 actively:2 3.2:1 election:2 3.0:1 2.0:1 investment:2 special:1 index:2 said:1 profit:1 jumped:1 while:1 per:1 current:1 between:1 weighing:1 ranges:1 step:1 operating:1 dividend:1 hours:1 survey:1 analysts:2 traded:1 point:1 into:1 another:1 trust:1 market:1 derivatives:1 third-quarter:1 6:1 expected:2 markets:1 500:1 company:2 than:1 those:1 keeping:1 remain:1 trading:1 toward:1 1.5:1 investors:1 0.2:1 share:2 marking:1 tight:2 2.5:1 income:1 sidelines:1 =:5 stock:1 's:7 conversion:1 looming:1 fell:1 72:1 included:1 billion:1 light:1 futures:1 well:1 points:2 so:1 overseas:1
stock_JNJ r_up	heart:1 investors:1 small-cap:1 some:1 them:1 sign:1 trading:1 home:1 ultimately:1 no:1 other:1 rates:1 treatment:1 which:1 provider:1 widespread:1 available:1 comparable:1 health-care:1 's:1 government:1 treatments:1 results:1 failure:1 safer:1 stocks:1 than:1 those:1 condition:1 lower:1 showed:1 could:1 companies:1 borrow:1 picks:1 specific:1 below:1 yields:1 experimental:1 mixed:1 invests:1 late-stage:1 study:1 bet:1 mean:1
stock_JNJ r_down	results:1 billions:1 election:1 campaigning:1 bankruptcy:1 $:2 22:2 charge:1 much:1 pretty:1 biggest:1 more:1 we:1 holding:1 news:1 acquisitions:1 --:1 dollars:1 months:1 spent:1 us:1 leave:1 banking:1 were:1 mergers:1
stock_JNJ r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_JNJ r_down	among:1 financial:2 investors:1 proven:1 not:1 say:1 statements:1 effort:1 their:1 has:1 frustrated:1 more:1 them:1 finance:1 useful:1 tags:1 rules:1 they:1 supposed:1 put:1 data:1 internally:1 require:1 departments:1 item:1 benefit:1 analysts:1 each:1 growing:1
stock_JNJ r_down	losses:1 absorb:1 set:1 generation:1 money:1 some:1 site:1 cash:1 departments:2 say:1 reports:1 financier:2 year:1 run:2 floating:1 32:2 establish:1 investment:1 2.4:4 use:1 networking:1 $:5 procurement:1 holdings:4 transfer:1 had:1 aside:1 shares:1 next:1 rules:1 charge:1 stock:1 responsibility:1 requiring:1 new:3 net:1 he:1 corporate:1 duties:1 more:4 finance:1 's:1 asset:1 offering:1 insurer:1 replacing:1 funds:4 price:1 earlier:1 possible:1 legal:1 reported:5 regulators:1 putting:1 recommendations:1 money-market:1 regulatory:2 overhaul:1 eliminated:1 now:1 than:2 buying:1 partially:1 billion:2 valued:2 pickers:1 third:1 fund:2 --:1 positions:3 board:1 steady:1 leading:1 value:4 having:1 prior:2 while:1 hedge:2 massive:1 social:1 professional:1 quarter:3 its:1 filing:2 stakes:1
stock_JNJ r_down	raised:1 alliance:1 210:3 major:1 year:1 said:1 networking:1 $:3 trials:1 had:1 shares:1 clinical:1 treatment:1 new:2 he:1 earlier:1 insurer:1 forming:1 company:1 million:1 site:1 reported:1 professional:1 eliminated:1 buying:1 diabetes:1 fund:1 --:1 positions:1 drug:1 while:1 without:1 social:1 biotechnology:1 late-stage:1 maker:1 stakes:1
stock_JNJ r_up	highs:1 1.4:3 bid:1 billion:1 just:1 being:1 over:1 shareholders:1 $:3 high:1 bringing:1 agreed:1 buy:1 heated:1 's:1 cold:1 offered:1 find:1 market:1 even:1 cancer:2 errors:1 retracts:1 trials:1 closer:1 had:1 contractor:1 delay:1 clinical:1 rates:1 lifting:1 mid-stage:1 finding:1 riding:1 weeks:1 main:1 oversight:1 war:1 more:1 development:1 nutrition:1 kicked:1 raising:1 get:1 season:1 company:2 third-party:1 vitamin:1 but:2 early:1 remedy:1 bidding:1 contractors:2 hopes:1 creeps:1 buyout:1 data:1 multiyear:1 after:2 derail:1 tricky:1 made:1 off:1 improved:1 lower-priced:1 --:3 might:1 could:1 flu:1 drug:4 dramatically:1 trial:1 can:1 survival:1 popular:1 stock:1 its:1 maker:1 experimental:1 first:1
stock_JNJ r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_JNJ r_down	bump:1 tax:1 rate:1 nears:2 expect:1 go:1 seen:2 special:1 their:1 issue:1 more:1 payout:1 repeat:1 dividends:2 but:1 didn’t:1 dividend:3 cliff:2 fiscal:2 dates:1 companies:1 up:2 games:2 supposed:1
stock_JNJ r_up	reduce:1 investors:1 some:1 high:2 have:1 cuts:1 spending:1 ease:2 returns:1 funds:1 threaten:1 economy:1 expiring:1 staying:1 risk:1 one-two:1 may:1 tax:1 breaks:1 punch:1 invested:1 designed:1 derail:1 anxiety:2 above-average:1 low-volatility:2 solution:1 provide:1 exchange-traded:1 time:1 long-term:1 found:1 stock:2 automatic:1
stock_JNJ r_down	1.5:1 2.5:1 proposed:2 being:2 developed:2 estimates:1 quarters:1 '':2 3.0:1 2.0:1 unit:2 said:3 based:1 companies:1 per:1 current:1 appeared:2 treat:2 income:1 =:5 ``:2 form:2 share:1 safe:2 operating:1 tuberculosis:2 included:1 --:1 list:1 drug:2 survey:1 analysts:2 experimental:2
stock_JNJ r_up	comment:1 requiring:1 some:2 device:1 say:1 rule:7 have:1 fear:2 makers:3 relationships:1 information:2 bracing:2 broad:2 overly:2 spokesman:1 potential:1 new:4 issue:1 public:2 them:2 around:1 government:3 could:2 doctors:3 report:3 concerns:1 improve:1 --:5 require:2 companies:3 drug:1 mislead:2 payments:1 transparency:1 10th:1 scope:1 medical-device:2
stock_JNJ r_down	advisory:1 treat:1 deaths:1 --:1 amid:1 supported:1 studies:1 drug:1 early:1 federal:1 clinical:1 concerns:1 unit:1 tuberculosis:1 seen:1 approval:1 imbalance:1 type:1 experimental:1 panel:1
stock_JNJ r_up	named:3 investors:1 executive:3 alternatives:1 year:3 its:9 next:3 better:1 rates:1 chairman:3 interest:1 new:6 forcing:1 leader:3 2013:4 take:1 health-care:3 plans:3 some:1 company:1 conglomerate:2 leadership:3 former:3 completing:3 transition:3 retire:3 chief:3 risks:1
stock_JNJ r_down	1.5:1 companies:1 estimates:1 quarters:1 3.0:1 2.0:1 owning:1 conference:1 based:1 per:1 current:1 2.5:1 income:1 =:5 share:1 operating:1 included:1 ahead:1 list:1 suggests:1 survey:1 analysts:2
stock_JNJ r_up	saying:1 they:2 just:1 money:1 starting:1 bright:1 its:1 writes:2 treatment:1 has:2 might:1 them:1 around:1 get:2 beat:2 results:1 caps:3 unseen:1 did:1 companies:2 worries:1 cash-rich:1 bills:1 mean:2 poor:1 testing:1 back:1 lion:1 home:2 out:2 must-read:1 away:1 shares:1 outside:1 does:2 firms:1 run:1 ability:1 dividends:1 small:3 abroad:1 limits:1 could:2 leaving:1 massive:1 efforts:1 experimental:1 year-end:2 suddenly:1 terminated:1 riskier:1 there:1 been:1 their:4 much:2 clinical:1 until:3 ``:1 buy:1 efficacy:1 tax:1 but:2 trying:1 piles:1 cash:3 n't:3 policies:1 balance:1 appraisal:1 have:2 investors:1 share:1 '':1 want:1 further:1 disclosures:1 honest:1 end:1 pay:2 sitting:1 far:1 shining:1 roll:1 development:2 's:5 may:1 stay:1 lay:1 sheets:1 light:1 disease:1 so:1 cash-poor:1 overseas:1 corporate:1 liquidity:1 justify:1
stock_JNJ r_up	fourth-quarter:1 revenue:1 expects:1 one:1 reluctant:1 together:1 world:1 organizational:1 's:1 create:1 its:2 braces:1 previous:1 universities:1 management:1 end:1 shuffling:1 profit:1 guidance:1 been:1 their:1 does:1 make:1 way:1 largest:1 has:1 public:1 disclose:1 such:1 jobs:1 diseases:1 get:1 pushing:1 corporations:1 stem:1 said:1 adult:1 tackle:1 banding:1 part:1 change:1 lower:1 piles:1 downbeat:1 always:1 cells:1 23:1 companies:2 cash:1 drug:1 order:1 n't:3 cutting:1 overseas:1 maker:1 numbers:1
stock_JNJ r_up	fourth-quarter:1 lower:1 management:1 jobs:1 said:1 shuffling:1 profit:1 guidance:1 revenue:1 expects:1 its:1 downbeat:1 cutting:1 braces:1 organizational:1 end:1 part:1 maker:1 change:1 previous:1
stock_JNJ r_up	around:1 1.5:1 valued:1 's:1 deal:1 business:1 could:1 company:1 health-care:1 $:1 meter:1 billion:1 blood:1 suitor:1 last:1 more:1 remaining:1 glucose:1
stock_JNJ r_up	1.5:1 cancer:4 companies:1 estimates:1 quarters:1 course:1 3.0:1 2.0:1 2.5:1 whose:1 use:3 based:1 positive:1 review:1 had:1 per:1 priority:1 program:1 treatment:1 provides:1 under:1 chemotherapy:4 current:1 has:1 2011:1 pill:3 after:1 's:10 option:2 income:1 share:1 earlier:2 operating:1 new:1 included:1 approval:1 cases:3 prostate:4 approved:4 received:1 receiving:3 survey:1 --:3 =:5 expanded:3 list:1 disease:2 prior:3 patients:1 indication:1 analysts:2 opinion:1 providing:1 comes:1 late-stage:3
stock_JNJ r_up	cancer:2 course:1 whose:1 use:1 positive:1 review:1 had:1 priority:1 program:1 treatment:1 provides:1 under:1 chemotherapy:2 has:1 2011:1 pill:1 after:1 's:4 option:2 earlier:2 new:1 approval:1 cases:1 prostate:2 approved:2 received:1 receiving:1 --:3 expanded:1 disease:2 prior:1 patients:1 indication:1 opinion:1 providing:1 comes:1 late-stage:1
stock_JNJ r_down	health-care:1 sale:1 seek:1 large:1 additional:1 informal:1 treatment:1 interest:1 conduct:1 instead:1 receiving:1 's:3 wo:1 after:1 but:1 explore:1 hired:1 regulatory:1 approval:1 several:1 study:1 companies:1 disease:1 n't:1 time:1 experimental:1
stock_JNJ r_down	considering:1 most:1 year-end:1 around:1 just:1 also:1 did:2 jumped:1 away:1 annual:1 up:1 n't:2 few:1 ones:1 worst:1 which:3 weeks:1 stocks:1 might:1 worth:1 best:1
stock_JNJ r_up	1.5:1 says:1 quarters:1 revenue:1 list:1 over:1 global:1 estimates:1 income:1 related:1 trade:1 chronic:1 2.9:1 actively:1 experts:1 per:1 3.0:1 years:1 's:1 coatings:1 2.0:1 underappreciated:1 its:2 2.5:1 whose:1 use:1 medications:1 based:1 $:1 profit:1 white:1 factory:1 artificial:1 current:1 economy:1 charge:1 treat:1 dioxide:1 expected:1 poised:1 has:1 =:5 today:1 longtime:1 division:2 used:1 pain:1 champion:1 pharmaceutical:1 may:1 problems:1 forgettable:1 after:1 deliver:1 operating:1 coming:1 included:1 stocks:1 multiyear:1 billion:1 analysts:2 demand:1 benefits:1 titanium:1 recall:1 companies:2 persistent:1 stretch:1 growth:2 survey:1 risks:1 quashed:1 paints:1 following:1 weak:1 share:1 marred:1 consumer:1 hips:1
stock_JNJ r_up	sentenced:1 ago:1 selling:1 products:1 versions:1 --:1 dangerous:1 potentially:1 years:2 five:1 medical-products:1 fake:1 distributor:1 probation:1 several:1
stock_JNJ r_down	surprisingly:1 fatal:1 's:5 caused:1 unprepared:1 some:2 parts:1 drug:2 label:1 placed:1 patients:2 warning:1 hepatitis:1 tuberculosis:1 skin:1 growing:1 new:1 problem:1 has:1
stock_JNJ r_up	distributors:1 parties:2 allegations:1 ``:1 one:1 '':1 nothing:1 investors:1 29.4:2 2.3:1 its:1 millions:1 pharmaceutical:1 little:1 $:5 million:2 chosen:1 pay:1 near:1 field:1 behind:1 agreements:1 accusations:1 founder:1 2.4:3 offshore:1 knowing:1 specialist:1 complaint:1 used:1 's:3 which:1 government:1 marketing:1 company:1 handful:1 raising:1 despite:1 included:1 subsidiary:1 those:1 deny:1 third:2 did:1 capitalist:1 dollar:1 n't:1 communications:1 admit:1 customers:1 venture:1
stock_JNJ r_down	investors:1 agreed:1 allegations:1 number:1 four:1 bribery:1 year:1 investment:2 market:1 $:3 pay:1 ideas:2 their:1 2013:3 stock:1 million:1 lucky:1 affiliates:1 bull:2 29.4:3 believe:1 10:2 money-making:2 turns:1 average:1 settle:1 historical:1 overseas:1
stock_JNJ r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_JNJ r_up	raised:1 's:2 estimates:1 lower:1 rate:1 royalty:1 news:1
stock_JNJ r_down	period:4 repurchases:2 '':4 second:2 through:2 dropped:2 have:2 year-earlier:2 declined:2 impact:2 said:2 $:4 3rd:4 down:2 potential:2 17.7:2 fourth:2 taken:2 approach:2 500:2 stock:4 billion:4 ``:4 's:2 fiscal:2 may:2 4th:4 continued:2 analyst:2 cliff:2 buybacks:6 7.2:2 cautious:2 third:4 uncertainty:2 companies:4 according:2 value:2 spending:2 were:4 senior:2 quarter:8 erratic:2
stock_JNJ r_up	less:2 existing:1 suffer:3 24:2 death:2 based:4 had:2 treatment:6 weeks:2 include:2 boxed:2 big:3 possibly:1 tuberculosis:6 2:2 prominent:3 regarding:2 success:2 --:13 prescribing:2 people:1 's:20 affects:1 comments:2 label:3 safety:2 therapies:1 imbalance:2 reaching:2 approvals:2 alone:1 group:6 100:3 faced:2 resistant:7 many:1 drug:10 placebo:2 studies:4 asked:2 ca:1 one:2 approval:8 risk:2 has:4 clinical:4 treat:6 type:2 form:5 but:11 than:5 those:2 fatal:1 showed:2 official:2 n't:1 patients:3 risks:2 growing:3 deaths:2 globally:3 warning:3 unlikely:3 world-wide:1 seen:2 increased:2 information:2 compared:2 granted:2 concerns:2 details:2 which:4 temporary:2 warnings:2 may:3 approves:3 after:2 eight:2 uncommon:3 pair:2 data:4 approved:3 goodwill:3 requires:3 required:2 disease:4 traditional:2 accelerated:6 consumer:2
stock_JNJ r_up	up:1 secure:1 apartments:1 allegations:1 sales:1 evidence:1 officials:1 have:2 year:1 pipelines:1 makers:1 bribes:1 $:1 hospital:1 been:1 1:1 potential:1 5:2 treatment:1 branch:1 across:1 2013:2 's:4 form:1 our:1 offered:1 promising:1 treatments:1 here:1 most:1 tuberculosis:1 report:1 approval:1 relating:1 recent:1 billion:1 country:1 employees:1 months:1 list:1 according:1 drug:1 deals:1 accelerated:1 offices:1 granted:1 order:1
stock_JNJ r_up	annual:1 's:3 wish:1 clients:1 list:1 their:1 potential:1 2013:2 year:1 has:1 come:1 sent:1
stock_JNJ r_down	adds:1 four:1 broader:1 year:1 throughout:1 market:1 compared:1 end:1 trials:1 submit:1 clinical:2 details:1 said:1 efficacy:1 collaboration:1 levels:1 goals:1 background:1 regulatory:1 approval:1 beginning:1 diabetes:2 hits:1 third:1 --:3 companies:1 drug:5 insulin:1 placebo:1 studies:1 reduced:1 experimental:1 plan:1
stock_JNJ r_up	comment:1 advisory:1 raised:3 proposed:3 process:1 approved:1 cash:1 reviewed:1 stroke:3 experts:1 committee:1 measure:3 go:1 find:1 metric:1 cardiovascular:1 sell:1 information:1 he:2 said:3 adds:1 gold:1 would:1 free:1 review:1 agency:4 sugar:3 tech:1 concerns:4 safety:3 treat:1 which:1 under:1 new:1 panel:1 type:2 brand:1 seeks:1 can:1 fractures:1 lowering:3 's:2 risk:1 name:1 seeking:1 drugs:1 big:1 company:1 but:4 analyst:1 willing:1 pharma:1 part:2 if:1 blood:3 key:4 approval:3 potential:3 diabetes:5 manager:1 made:1 calls:1 effective:4 --:5 medical:1 miners:1 flow:1 up:1 drug:8 flags:1 risks:3 called:1 8th:1
stock_JNJ r_up	heart:1 trying:1 advantage:1 --:1 keep:1 up:1 competition:1 replacement:1 edge:1 focused:1 ramps:1 has:1 valves:1
stock_JNJ r_up	advisory:1 cardiovascular:1 proposed:1 less:1 patients:1 drug:1 benefit:1 concerns:1 risks:1 despite:1 backed:1 panel:1 potential:1 diabetes:1
stock_JNJ r_up	limited:1 background:1 cancer:3 advisory:2 process:3 some:2 its:3 panel:5 cardiovascular:2 use:1 said:3 end:1 proposed:2 federal:2 less:2 backs:1 adopted:3 members:2 potential:3 treatment:6 has:3 impairment:1 recommends:1 's:5 kidney:1 seeking:1 earlier:3 part:1 benefit:2 decide:1 backed:2 approval:4 concerns:2 diabetes:3 received:3 --:5 amid:2 could:1 allows:3 drug:5 patients:3 risks:2 starting:1 8th:1
stock_JNJ r_down	lackluster:1 up:1 drug:1 their:1 leadership:1 output:1 improve:1 effort:1 makers:1 shook:1
stock_JNJ r_up	$:1 spine-products:1 pay:1 offered:1 million:1 cash:1 fast-growing:1 orthopedics:1 foothold:1 maker:1 market:1
stock_JNJ r_up	biotech:1 unsolicited:1 agency:1 proposed:1 clinical:1 joints:1 evidence:2 human:1 's:1 investment:1 market:1 said:1 cancer:1 initial:1 metal-on-metal:2 artificial:1 any:1 their:1 asking:1 inquiry:1 between:1 test:1 safety:1 has:1 meeting:1 email:1 hip:2 led:1 marketing:1 company:2 require:1 diagnostic:1 produce:1 gain:1 new:1 approval:1 stay:1 received:1 made:1 medical:1 companies:1 order:1 products:1 making:1 maker:1
stock_JNJ r_down	stock:3 emerging:1 fourth-quarter:4 increasingly:1 weekend:4 concern:1 results:8 reduce:2 existing:3 prices:3 session:2 including:3 higher:3 its:4 stock-index:1 lessons:1 whose:1 now:1 group:1 $:2 also:2 rose:4 guidance:6 send:3 had:3 expectations:6 opportunities:1 actually:3 going:3 choose:1 gay:1 items:1 quarterly:3 pay:1 weeks:1 must:3 over:2 2013:5 trimming:1 do:5 his:1 hit:1 gains:3 sitting:1 beat:4 big:3 rise:3 overall:2 1,500:4 homes:2 early:1 mention:1 longest:1 they:1 new:2 not:5 world:1 month:2 investor:4 advanced:2 term:2 places:2 always:1 notes:2 companies:8 delivered:2 estimates:1 indication:1 clearing:1 sustainable:1 through:2 five-year:5 sees:1 vision:1 mean:2 manages:1 right:3 says:2 significantly:3 generation:2 energy:1 hard:2 some:1 10:1 unexpectedly:4 likely:1 been:1 trading:3 expect:3 69:2 close:1 estimated:1 targets:2 declined:2 out:3 index:11 said:12 potential:1 opened:1 lead:1 space:1 managing:2 open:4 since:1 future:1 near:2 best:1 find:1 4:1 laid:1 does:1 health:1 deficit:2 closed:3 between:1 surprise:2 lowered:2 size:1 strategist:5 reporting:1 we:3 quarter:3 bold:1 business:1 existing-home:1 continuing:1 were:5 component:5 here:1 reported:2 regional:4 invest:1 ambitious:1 address:1 active:3 major:1 exciting:3 care:1 gained:1 goods:1 last:2 ahead:5 country:1 could:2 changed:1 equal:1 exiting:1 investment:5 thing:1 women:1 choices:1 economic:1 positive:2 2.25:1 traded:3 think:2 first:1 among:1 embraces:1 brief:1 noting:2 into:1 others:3 awaited:2 down:3 clear:1 62:2 done:1 embraced:2 corporations:3 thick:2 winning:1 miss:1 100:3 market:3 cost:1 caring:1 derivatives:2 little:1 long:4 second:1 decent:2 trillion:1 political:1 least:1 point:2 anyone:1 start:3 much:4 low:2 lot:1 which:3 expected:1 trend:1 investing:1 markets:1 capital:1 500:11 more:3 lowering:1 ``:13 faring:1 posting:1 mostly:2 insurer:3 season:5 6:2 but:3 hurt:2 short:1 crop:1 focusing:1 than:5 those:1 he:2 11:1 '':13 include:1 showed:2 rights:2 indefinitely:1 expanded:1 edged:3 up:5 believes:2 n't:4 hardest:1 're:2 cautiously:4 shares:1 amid:1 growing:2 problem:1 providing:3 17:1 industry:1 streak:1 biotech:1 1.7:1 tap:3 1.1:1 investors:4 0.1:1 lines:1 0.3:2 0.2:1 turned:1 sales:8 high:1 middle:2 say:1 buy:1 have:3 home:4 need:1 1:1 surge:3 technology:1 trade:2 relatively:1 sell:1 funny:1 upcoming:3 rather:1 way:1 make:1 six:1 inaugural:1 billion:1 indexes:1 note:3 very:2 belief:1 materials:3 speech:1 earnings:18 fourth:1 reject:1 insurers:1 economy:2 all:2 extended:1 's:10 agenda:1 see:1 again:1 our:1 highs:4 after:2 problems:1 director:2 most:1 fell:6 invested:1 build:1 stocks:11 data:6 stock-market:3 built:1 manufacturing:4 break:4 realized:2 cause:1 off:2 sentiment:4 sectors:1 considered:2 corporate:3 lift:3 futures:6 stronger:2 profit:1 chief:5 points:10 so:2 components:1 healthcare:1 2.5:1 overseas:1 voting:1 consumer:1 dragged:2 came:2 nearly:1
stock_JNJ r_up	help:1 money:1 years:1 held:1 its:2 before:2 scoring:1 giant:1 $:3 writes:1 outside:1 actually:1 permanently:1 2013:1 them:1 sitting:1 increases:1 net:1 did:1 companies:1 securities:1 stopped:1 back:1 officials:1 projections:1 year:2 home:1 shining:1 must-read:1 said:2 missed:1 investing:1 reinvest:1 enough:1 learned:2 boost:1 we:1 earlier:1 state:1 improve:1 career:1 country:1 employees:1 according:1 against:1 thing:2 workers:1 first:1 fourth-quarter:1 win:1 number:1 accounts:1 her:2 recalling:1 there:1 two:1 their:1 much:1 lot:1 biggest:1 function:1 ``:1 company:2 but:1 phone:1 analyst:1 slumber:1 cash:2 n't:1 growing:1 making:1 spotlight:1 acquisition:1 joints:1 health-care:1 sales:1 sleeping:1 '':1 have:1 saw:1 check:1 funny:1 documents:1 court:1 get:1 concerns:1 earnings:2 implant:1 's:6 plans:1 after:1 problems:1 yesterday:1 forecasts:1 most:1 levels:1 peak:1 29.1:1 2008:1 soared:1 billion:3 programs:1 metal:1 investments:1 profit:1 stockpile:1 overseas:1 filing:1
stock_JNJ r_down	buyers:1 $:1 least:1 eye-health:1 asking:1 price:1 launching:1 roundup:1 's:3 around:1 business:1 venture-capital:1 company:1 after:1 possible:1 news:1 billion:1 10:1 owners:1 analysis:1 leaning:1 toward:1
stock_JNJ r_up	decline:1 plans:1 revenue:1 slowed:1 its:1 job:1 fourth:1 cuts:1 quarter:1 maker:1 medical-device:1 more:1
stock_JNJ r_down	complaint:1 antitrust:1 agreed:1 alleging:1 companies:1 two:1 each:1 other:1 competing:1 authorities:1 avoid:1 sent:1 formal:1
stock_JNJ r_up	investors:1 money:1 into:1 style:1 have:1 out:1 profitable:1 mutual:3 jour:1 next:2 7:2 correction:2 more:1 buy:2 funds:3 after:2 ultimately:1 herd:1 most:1 du:1 than:1 categories:1 following:1 stock:1 pulled:1
stock_JNJ r_down	crowd:2 money:1 into:1 testing:1 years:1 style:1 have:1 profitable:1 stumbled:1 wallflowers:1 develop:1 investors:1 should:2 failed:1 clinical:1 jour:1 vaccine:2 7:2 new:1 stock:1 funds:3 categories:1 mutual:3 herd:1 most:2 tuberculosis:1 ultimately:1 90:1 du:1 than:1 advanced:1 protect:1 study:1 ignore:1 following:1 more:1 pulled:1 first:1
stock_JNJ r_up	still:1 among:1 now:1 you’ve:1 have:1 invest:1 advice:1 dividend-paying:3 overwhelmingly:1 number:1 reports:1 large:1 finally:1 decided:1 choose:1 heed:1 pick:2 you:1 stocks:4 turns:1 out:1
stock_JNJ r_down	investors:1 against:1 earnings:1 reports:1 round:1 weighed:1 small:1 gain:1 weakness:1 squeezed:1 latest:1 markets:1 day:1 out:1
stock_JNJ r_up	outlook:1 six:1 investors:1 revenue:1 over:1 hallmark:1 ninth:1 years:1 13th:1 phase:1 comments:1 our:1 next:1 seek:1 its:2 copycat:1 said:2 'll:1 patent:3 review:1 biosimilars:1 able:1 per-share:1 fight:1 few:1 details:1 meeting:1 international:2 2017:1 biosimilar:1 markets:1 launching:2 earnings:2 ``:1 '':1 expirations:1 business:1 drugs:2 company:1 expansion:1 period:1 we:1 protection:1 grow:1 new:1 prepares:1 beginning:1 analyst:1 cliff:1 aggressively:1 --:3 many:1 flow:1 cash:1 2013:3 lose:1 history:1
stock_JNJ r_up	exclusive:1 deal:1 certain:1 overlooked:2 years:1 market:1 sell:1 bear-market:2 $:1 over-the-counter:1 bears:1 pay:1 three:1 strategy:2 which:1 under:1 struck:1 has:1 across:1 profitable:1 very:1 million:1 rights:1 medicines:1 438:1
stock_JNJ r_down	prosecutors:1 laundering:1 money:1 over:1 between:1 deals:1 bribery:1 1998:1 2006:1 were:1 subsidiary:1 charged:1
stock_JNJ r_up	's:3 pickers:1 generation:1 selected:1 companies:1 likely:1 new:2 stock:1 revealed:1 stakes:1
stock_JNJ r_up	conference:1 week:1 his:1 's:1 views:1 vaccines:1 future:1 shared:1
stock_JNJ r_up	core:1 results:1 reverse:1 beauty:1 may:1 markets:1 company:1 global:1 weak:1 effort:1 years:1 said:1 footprint:1 further:1 narrow:1 refocuses:1 its:1
stock_JNJ r_down	deaths:1 over:1 product:2 '':1 not:1 tissue:1 cease:1 subsidiary:1 further:1 hospitals:1 any:1 death:1 lead:1 placing:1 surgeons:1 should:1 orthopedics:1 safety:1 products:1 has:1 issue:1 2010:1 stock:1 function:1 ``:1 's:2 business:1 though:1 marketing:1 company:3 component:1 them:1 infection:1 unused:1 pressure:1 said:2 recalled:2 compromised:1 they:1 device:1 knee:1 concerns:1 loss:2 immediately:1 did:1 warned:1 return:1 practices:1 affiliate:1 can:1 report:1 investigating:1 soft:1 replacement:1
stock_JNJ r_down	major:1 move:1 expects:1 related:1 currency:1 anticipating:1 100:1 's:1 its:1 impact:1 said:1 $:1 devaluation:1 charge:1 first-quarter:1 million:1 post:1 recent:1 companies:1 roughly:1 range:1 broad:1 latest:1
stock_JNJ r_up	liabilities:1 skilled:1 say:1 businesses:1 have:1 close:1 attract:1 insurance:1 staffers:1 their:1 workers:1 necessary:1 unions:1 other:1 new:1 more:1 satisfy:1 them:2 led:1 plans:2 hires:1 most:1 such:1 line:1 tracking:1 off:1 taking:1 companies:2 keep:1 traditional:1 costs:1 pension:1 action:1
stock_JNJ r_down	appeal:1 screen:1 30:1 unearths:1 nearly:1 favorites:1 our:1 stocks:1 could:1
stock_JNJ r_up	moves:1 financial:1 blue-chip:1 since:1 one-third:1 accounted:1 have:1 rally:1 stocks:1 's:2 crisis:1 market:1
stock_JNJ r_down	stock:1 pointing:1 including:1 its:2 previous:1 impact:1 surged:1 writes:1 include:1 momentum:1 tenacious:1 hit:1 gains:1 big:2 reputations:1 world:1 multiyear:1 like:1 companies:5 large:1 retailers:1 higher:2 financial:2 back:2 jump:1 exceeded:1 further:1 event:1 best:3 out:1 quality:1 shares:1 got:1 shocks:1 were:1 advance:1 search:1 employees:1 annual:1 so:1 survey:1 social:1 efforts:1 into:1 60:1 trust:1 open:1 crisis:1 market:1 rated:1 start:1 system:1 their:1 returns:1 rates:1 low:1 interest:1 markets:1 today:1 essentially:1 part:1 convinced:1 10:2 keeping:1 has:2 up:1 record:1 pumped:1 making:1 treated:1 dollars:1 0.9:1 losses:1 investors:2 high:2 rally:1 seek:1 any:1 around:1 began:1 overcoming:1 tech:1 forcing:1 economy:1 product:1 's:5 highs:1 yesterday:1 tied:1 fueled:1 stocks:1 futures:1 reputation:2 responsibility:1 2009:1 investments:1
stock_JNJ r_up	impressive:1 assets:1 their:1 funds:1 results:1 record:1 only:1 have:1 were:1 size:1
stock_JNJ r_up	do:1 boomers:1 wealth:1 third:1 generation:1 lose:1 percent:1 better:1 inherited:1 baby:1 90:1
stock_JNJ r_up	his:1 plans:1 make:1 spinoff:1 medical-supplies:1 focused:1 talks:1 company:1 more:1
stock_JNJ r_down	10:1 ``:1 planned:1 's:1 prompted:1 bonus:1 company:1 health-care:1 reduce:1 officers:1 '':1 other:1 board:1 said:1 mixed:1 performance:1 senior:1 its:1 2012:1
stock_JNJ r_up	fewer:1 major:1 says:1 we:1 show:1 process:1 companies:1 into:2 dollar:2 ``:2 '':2 sure:1 trading:1 us:1 file:1 year:1 hit:1 its:2 buoyed:1 definitely:1 impact:1 partners:1 said:1 stronger:1 beefing:1 make:2 since:1 outside:1 been:1 lately:1 flounder:1 find:1 corporate:1 5:1 earnings:1 upbeat:1 has:1 2010:1 hurt:1 life:1 costlier:1 's:2 less:1 football:1 gas:1 masks:1 prepared:1 job:1 got:1 highest:1 data:1 after:1 manufacturer:1 training:1 made:1 safety:1 ahead:1 programs:1 tear:1 starting:1 dollars:1 level:1 harder:1 up:3 rule:1 worth:1 like:1 players:1 economic:1 products:1 profits:1 overseas:1 changes:1 almost:1 patents:1
stock_JNJ r_up	acquisitions:1 said:1 door:1 like:1 pursue:1 markets:1 fast-growing:1 open:1 maker:1 more:1
stock_JNJ r_up	less:1 legal:1 year:1 still:1 7.9:1 $:1 top:1 40:3 total:1 new:1 more:1 earlier:1 's:3 though:1 company:1 million:1 than:2 received:1 valued:1 up:1 compensation:1 officer:1 2012:1
stock_JNJ r_down	investors:1 shift:1 'pay:1 compensation:1 role:1 highlights:1 growing:1 performance:1 toward:1 shaping:1
stock_JNJ r_up	among:1 reducing:1 investors:1 junk:2 biggest:1 '':1 want:1 easy-money:1 technology:1 its:1 out:2 begin:1 stocks:4 holdings:1 won’t:1 their:1 going:1 which:1 policy:1 if:1 might:1 critical:1 ``:1 's:2 said:1 business:1 most:1 ones:1 gain:1 now:2 casualties:1 reverses:1 low-quality:1 off:1 spigot:1 indefinitely:1 turns:1 future:1 continue:1 2006:1 stand:2 policies:1 lose:1 writes:1
stock_JNJ r_up	limited:1 poaching:1 talent:2 supply:1 workers:1 support:1 harder:1 compensation:1 find:1 challenges:1 their:1 say:1 qualified:1 right:1 businesses:1 make:1
stock_JNJ r_up	weaker:1 investors:1 show:1 trade:2 session:2 long:1 further:1 market:1 spending:1 due:1 shares:2 improvement:1 expected:3 holiday:1 markets:1 stock:1 rise:1 's:2 returned:1 after:1 construction:1 manufacturing:1 weekend:1 lower:1 futures:1 companies:2 against:1 later:1 actively:2 backdrop:1
stock_JNJ r_up	second:1 have:1 led:1 market:1 shares:1 traders:1 going:1 way:1 under:1 gets:1 2013:1 more:1 's:1 gains:1 slight:1 but:1 early:1 stocks:1 positioning:1 pullback:1 popular:1 quarter:1 options:1
stock_JNJ r_up	appeals:1 executive:1 patent-infringement:1 because:1 drug:1 subsidiary:1 recover:1 technology:1 makers:1 n't:1 court:1 $:1 doctor:1 federal:1 make:1 violates:1 their:1 treatment:1 biggest:1 has:1 easier:1 's:2 payouts:1 rules:1 some:1 company:1 million:1 award:1 recalled:1 complaints:1 bottles:2 ethics:1 did:1 against:1 infringe:1 patent:1 compensation:1 ruling:1 policies:1 revising:1 overturned:1 otherwise:1
stock_JNJ r_down	operations:1 cons:1 being:1 agreed:1 global:1 allegations:1 bribery:1 's:1 its:1 market:1 4.5:3 better:1 giant:1 cut:2 $:3 pay:1 pros:1 incentive:1 1:1 needed:1 encourage:1 exit:1 400:1 electronics:1 diabetes:1 company:1 common:1 closer:1 used:1 kinds:1 get:1 some:1 implantable:1 million:1 continuing:1 most:1 regulators:1 levels:1 moving:1 push:1 than:1 monitor:1 resolve:1 look:1 programs:1 goal:1 employees:1 shape:1 devices:1 foreign:1 costs:1 insulin:1 wellness:1 small:1 streamline:1 headcount:1 more:1
stock_JNJ r_up	shed:1 drop:1 investors:1 win:1 into:1 tax:1 college:1 broader:1 close:1 recovers:3 its:1 market:2 again:1 $:4 hunting:1 turn:1 equities:1 reboot:1 honors:1 above:3 expected:1 new:1 proposal:1 main:1 425:3 higher:1 modestly:1 life:1 rise:2 million:1 mentality:2 ‘buy-the-dip’:2 plan:1 student:1 stocks:3 rebounds:1 movers:2 buying:1 campus:1 33:1 losses:1 bargain:1 breathes:1 1,000:1 credit:1 opportunity:1 view:1
stock_JNJ r_up	lifted:1 give:1 money:1 within:1 moved:1 63:1 experts:1 year:1 industrials:1 spending:1 less:1 labor:1 striking:1 other:1 upbeat:1 events:1 500:1 added:1 paid:1 doctors:1 report:1 distance:1 last:1 1600:1 double-digit:1 presentations:1 dinners:1 while:1 points:1 payments:1 benchmarks:1 reduced:1
stock_JNJ r_down	ratings:1 's:1 have:1 they:1 may:1 country:1 based:1 companies:1 than:1 rates:1 way:1 financial:1 debt:1 institutions:1 change:1 higher:1
stock_JNJ r_up	gold:3 golden:1 move:1 years:3 session:1 economy:1 broader:1 its:3 before:1 busy:1 over-the-counter:1 writes:1 point:1 expectations:1 suffered:1 decades:1 2013:2 good:1 hit:2 finance:1 big:1 rebound:4 rise:2 watch:2 wave:1 among:1 worst:1 they:1 trade:1 rebounds:1 day:3 level:1 3-day:2 companies:2 facing:1 release:1 stock:3 tumble:2 some:1 back:1 bounce:1 past:1 actively:1 trading:1 expect:1 's:4 closes:1 both:1 sentiment:1 jumped:1 section:1 while:1 shares:1 increase:1 health:1 opening:1 reported:1 departures:1 losing:2 strong:1 driven:1 quarter:1 movers:2 involved:1 losses:1 drug:1 keep:1 prior:1 products:1 analysts:1 top:1 strongly:1 revenue:1 question:1 one:1 market:2 decline:1 confidence:1 8.5:1 investors:1 housing:1 selloff:1 three:1 their:1 biggest:1 upbeat:1 today:1 buy:1 sessions:1 reiterated:1 expected:1 recalled:1 signaling:1 sharply:1 prices:2 highest:1 surged:1 15:1 up:2 hardest:2 're:1 following:1 acquisition:1 streak:2 bell:1 almost:1 sales:1 helped:1 beats:2 reports:1 sharp:1 ready:1 return:1 bolstered:1 greater:1 ratings:1 also:1 earnings:4 higher:1 snaps:2 first-quarter:2 may:1 after:5 yesterday:1 forecasts:2 chiefs:1 coming:1 stocks:2 data:2 recruiters:1 omen:1 futures:3 bounces:1 points:1 medical-device:1
stock_JNJ r_up	roundup:1 saying:1 surprises:2 companies:1 reports:1 quarters:1 advisories:2 earnings:1 future:1 corporate:1 latest:1
stock_JNJ r_down	sticking:1 higher:1 bump:1 one:1 thanks:1 have:1 signs:1 years:1 its:1 out:1 shareholders:1 potential:1 sluggish:1 economy:1 life:1 's:2 sectors:1 price:1 part:1 not:1 sustained:1 manufacturing:1 faith:1 showed:1 surprising:1 whether:1 clear:1 more:1 time:1 first:1 weakest:1
stock_JNJ r_up	deal:1 over:1 some:1 years:1 states:1 have:1 partner:1 aggressive:1 makers:1 unusual:1 deceptive:1 $:1 three:1 next:1 start:1 marketing:1 firms:1 several:1 worth:1 more:1 capitalists:1 million:1 up:1 drug:1 drug-discovery:1 venture:1 become:1
stock_JNJ r_down	lightly:1 trend:1 some:1 helped:1 first-quarter:1 their:2 health:2 earnings:1 tell:1 do:1 them:1 's:2 insurer:1 hazardous:1 reported:1 doctors:1 services:1 using:1 continued:1 could:1 stronger:1 n't:1 patients:1
stock_JNJ r_down	has:1 said:1 's:1 just:1 anymore:1 beauty:1 upon:1 taking:1 months:1 dynamic:1 resigned:1 chairman:1 time:1 post:1 exciting:1 company:1 after:1 stock:1
stock_JNJ r_up	both:1 own:1 look:1 reportedly:1 merger:1 cheap:1 their:1 stopped:1 have:1 between:1 talks:1 merits:1 stocks:1
stock_JNJ r_down	's:2 offering:1 win:1 could:1 its:1 score:1 mammoth:1 over:1 today:1 bond:1
stock_JNJ r_down	conscience:1 investing:1 saints:2 responsible:1 socially:1 than:1 better:1 wallet:1 white:1 hat:1 your:2 sinners:2
stock_JNJ r_down	biotech:1 data:1 drug:1 interim:1 2:1 strong:1 saw:1
stock_JNJ r_up	said:1 's:3 treat:1 disorders:1 immune:1 failed:1 help:1 disease:1 research:1 trial:1 patients:1 clinical:1 brain:1 disappointment:1 already:1 medicine:1 latest:1 antibody:1 its:1 market:1 late-stage:1
stock_JNJ r_down	contributors:1 point:1 over:1 some:1 high:1 15000:3 run:1 your:1 even:1 little:1 blue-chip:1 since:1 two:1 setting:1 5:1 above:1 biggest:1 music:1 has:1 ever:1 more:1 we:1 's:1 risen:1 yesterday:1 manic:1 news:1 than:1 past:1 average:1 months:1 analysis:1 looked:1 record:1 points:1 time:1 fresh:1 closing:1 800:1 ease:1 first:1
stock_JNJ r_down	agreement:1 hold:1 's:1 federal:1 could:1 into:1 lawsuits:1 sales:1 private:1 practices:1 leave:1 investigation:1 vulnerable:1 multibillion-dollar:1 settlement:1 avoid:1 seeks:1 wording:1
stock_JNJ r_up	raised:1 thwart:1 significantly:1 deal:1 painkiller:1 ago:1 powerful:1 seven:1 up:1 pushed:1 through:1 reports:1 broader:1 year:2 shrinking:1 short-term:1 slow:1 recovery:1 federal:1 revenue:1 improvement:1 better:1 also:1 version:1 rates:1 deficit:3 expected:1 new:1 out:1 finances:1 combined:1 billion:1 's:1 government:1 less:1 tax:1 earlier:1 but:1 pressure:1 abuse:1 now:1 than:3 ruled:1 fiscal:1 faster:1 versions:1 months:1 steady:1 budget:1 drug:1 $:1 n't:2 does:1 have:1 time:1 easing:1 first:1 changes:1 other:1 laws:1
stock_JNJ r_down	no-interest:1 tax:1 back:1 trade:1 held:1 session:1 heated:1 battle:1 considering:1 few:1 make:1 shares:1 their:1 expected:1 has:1 we:1 's:4 around:1 generic-drug:1 company:1 after:1 free:1 early:1 approaches:1 takeover:1 feds:1 reading:1 they:1 loans:1 abroad:1 fray:1 made:1 were:1 bring:1 whether:1 could:1 rebuffed:1 companies:1 cash:1 while:1 actively:1 stories:1 evaluating:1 enter:1 options:1
stock_JNJ r_up	stocks:4 have:1 zig:1 these:1 writes:1 steady:1 due:2 shares:1 tend:1 pullback:2 performance:1 stunning:1 reached:1 defensive:1 year:1 seen:1 has:1 top:1 those:1 economy:1
stock_JNJ r_up	all:1 says:1 need:1 risk:1 equities:1 presents:1 income:1 you:1 bubble:1 them:1 buy:1 's:2 greater:1 possibly:1 know:1 bull:1 not:1 inflate:1 central:1 ahead:1 meeting:1 50:2 policies:1 nervous:1 banks:1
stock_JNJ r_down	blind:1 senators:1 they:1 less:1 money:1 four-year:1 number:2 trade:1 surgical:1 session:1 trading:1 submit:1 have:1 pain:1 seek:1 its:1 unit:1 filings:2 25:1 mutual:1 said:1 would:1 creating:1 way:1 shares:1 trusts:1 their:4 which:1 expected:1 new:3 2017:3 previous:1 boost:1 finances:1 more:2 back:1 product:2 poised:1 's:1 plans:1 aging:1 funds:1 brand:1 sales:1 putting:1 significant:1 same:1 device:1 frequently:1 line:1 scrutiny:1 than:2 cycle:1 handle:1 10:3 stocks:1 made:1 submission:1 changed:1 companies:1 roughly:1 investments:1 amount:1 actively:1 extensions:1 maker:1 solutions:1
stock_JNJ r_up	we:1 some:1 early:1 're:1 stories:1 reading:1
stock_JNJ r_down	deal:1 move:1 1.8:1 four:1 planning:1 identify:1 considering:1 $:1 would:1 top:1 their:1 candidates:1 holding:1 new:1 newly:1 selling:1 's:3 returned:1 billionaire:1 company:1 joint:1 succeed:1 manufacturing:1 billion:1 publicly:1 roles:1 could:1 up:1 contract:1 venture:1 senior:1 fetch:1 executives:1
stock_JNJ r_up	key:1 oncology:1 because:2 they:1 office:1 certain:1 preliminary:1 tax:1 ``:2 evidence:1 '':2 say:1 substantial:1 year:1 go:1 improvement:1 market:1 decline:1 surveys:1 based:1 cancer:3 suggests:1 breakthroughs:1 agency:1 been:1 should:1 may:1 clinical:1 helps:1 which:1 transformative:1 sale:1 has:1 therapies:1 difficult:1 development:1 eyes:1 's:1 diseases:1 mull:1 shortages:2 drugs:2 billionaire:1 safe:1 took:1 but:1 effect:1 volume:1 doctors:1 important:1 decide:1 new:2 choices:1 law:1 treating:1 breakthrough:1 appeal:1 last:1 effective:1 --:2 could:1 according:1 drug:3 face:1 whether:1 continue:1 products:1 serious:1 loses:1 head:1 experimental:1 view:1
stock_JNJ r_down	certain:1 others:1 some:1 evidence:1 '':1 substantial:1 have:1 based:1 breakthroughs:1 improvement:1 clinical:1 ``:1 diseases:1 drugs:2 designated:1 preliminary:1 designates:1 why:1 treating:1 could:1 uncertainty:1 companies:1 drug:1 n't:1 suggests:1 while:1 so:1 serious:1
stock_JNJ r_down	body:1 money:1 into:1 health-care:1 including:1 any:1 said:1 group:1 promote:1 packs:1 three:1 its:1 asking:1 health:1 denied:1 discovering:1 new:1 releasing:1 law:2 ingredient:1 pills:1 them:1 contribute:1 around:1 organizations:1 million:1 but:1 key:1 news:1 strong:1 after:1 roundup:1 venture-capital:1 recall:1 according:1 analysis:1 n't:1 she:1 birth-control:1 pulling:1 efforts:1 latest:1
stock_JNJ r_up	supply-chain:1 consider:1 prefer:1 you’re:1 expertise:1 want:1 churn:1 market:1 short-term:1 universities:1 management:1 three:1 3:4 inventory:1 holding:1 capital:1 you:1 more:1 majors:1 recently:1 gains:1 may:1 here:1 long-term:3 demand:1 timing:1 than:1 buying:1 unconcerned:1 yielding:2 picks:3 procurement:1 have:1 growing:1
stock_JNJ r_up	such:1 his:1 office:1 than:1 sights:1 next:1 involve:1 player:1 much:1 corner:1 new:1 buyer:1 found:1 maker:1 has:2 might:1 stint:1 bigger:1 he:1
stock_JNJ r_down	1.3:1 according:1 estimated:1 blockbuster:1 no:1 generic:1 affecting:1 new:1 therapies:1 more:1 's:2 cocktail:1 million:1 cheaper:1 joint:1 than:1 treating:1 made:1 effective:1 study:1 funded:1 disease:1 drug:1 severe:1
stock_JNJ r_down	1.3:1 according:1 estimated:1 blockbuster:1 no:1 generic:1 affecting:1 new:1 therapies:1 more:1 cocktail:1 million:1 cheaper:1 joint:1 than:1 treating:1 made:1 effective:1 study:1 funded:1 disease:1 drug:1 severe:1
stock_JNJ r_up	vs.:1 investors:1 do:1 feel:1 allegations:1 back:1 bribery:1 dividend:3 tipster:1 news:1 debate:1 staff:1 even:1 hunters:2 shares:1 should:1 buying:1 widespread:1 stock:2 sound:1 play:2 around:1 both:1 drugs:1 some:1 prescribe:1 choice:1 sales:1 anonymous:1 doctors:1 such:1 cases:1 those:1 roundup:1 venture-capital:1 unauthorized:1 involved:1 uses:1 stronger:1 analysis:1 can:1 investigating:1 its:1 writes:1
stock_JNJ r_up	contains:1 basic:1 chain:1 can:1 series:1 some:1 related:1 years:1 four:2 drug:6 another:1 throughout:1 cites:1 unit:1 setbacks:1 terminated:2 functions:1 compared:1 based:1 details:1 six:1 had:2 patients:3 stops:1 research:1 better:1 other:1 clinical:2 safety:1 treatment:1 mid-stage:1 which:1 new:2 implant:3 effectiveness:1 assurance:1 more:1 memory:1 tests:4 used:2 's:15 halt:1 bonds:1 silicone:4 believe:1 after:2 said:1 link:1 breast:1 background:1 setback:1 approval:1 one:1 data:1 approved:1 elderly:1 gel:2 has:1 reverse:1 --:3 study:1 hunt:2 companies:1 agency:1 disease:3 maker:1 n't:1 trial:2 women:1 does:1 reasonable:1 action:1 therapy:1 latest:1 industry:1 experimental:2 liver:4
stock_JNJ r_up	billion:2 investors:1 cents:2 producer:1 dumped:1 some:1 expects:1 screens:1 n't:1 agreed:1 through:1 dropped:1 technology:1 its:4 developer:1 move:2 25:2 cancer:2 $:8 would:1 much:1 +:2 privately:2 two:1 per:1 1:4 held:2 drug:1 potentially:2 weeks:1 2011:1 semiconductors:1 painful:1 stock:1 flat:1 used:1 's:3 offering:1 business:2 after:1 giant:1 reported:1 shareholder:1 enhance:1 dividend:1 prostate:2 those:1 secondary:1 payout:1 acquire:1 valued:2 acquiring:1 14:1 announcing:1 glass:1 hike:1 31:1 losses:1 up:1 deal:2 bolster:1 large:1 were:1 6.3:1 speculation:1 2012:1 first:1
stock_JNJ r_up	summer:3 official:1 managers:1 claim:1 money:3 image:1 half:1 proven:1 arms:1 weather:1 recommending:1 home:1 your:2 market:1 ground:1 tussle:1 their:1 tarnish:1 business-friendly:1 state:2 long:2 mix:1 hot:2 other:1 between:2 yields:1 struggling:1 relations:1 's:2 government:1 governors:1 rise:1 break:1 because:1 new:1 put:2 competing:1 stocks:1 than:1 dicey:1 blue-chips:1 publicly:1 largely:1 could:1 months:1 companies:2 officials:1 products:1 exchange-traded:1 courting:1 traded:1 generations:1 bond:1
stock_JNJ r_down	hurt:1 business-friendly:1 tussle:1 government:1 could:1 over:1 half:1 companies:2 arms:1 relations:1 two:1 state:1 image:1 between:2 's:3 nation:1 its:1 public:1
